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Autologous cell transplantation is a promising approach to enhance burn wound re-
epithelialisation. It was introduced to clinical practice decades ago with current delivery
techniques involving spraying autologous cultured or uncultured cells in low-viscosity sus-
pensions. This delivery method is limited since it results in an uneven distribution on the
wound bed and cell loss as the liquid is not retained on the skin surface.
In this thesis, a sprayable gel that solidifies on the surface of the skin has been developed
to circumvent this problem. A gellan-based fluid gel system was developed with flexible
viscoelastic properties that can be tuned by a biocompatible polymer concentration and
ionic strength to facilitate spray delivery. The material liquefies at high shear during
spraying with self-healing properties of the gel causing it to solidify on the receiving sur-
face. Results present the development and characterisation of a gellan fluid gel for the
encapsulation and spray-delivery of cells onto surfaces, aiming for reduced cell spillage,
improved spray uniformity and maintenance of cell viability and function.
Additionally, the same polymer was used to formulate a gellan film that can be rehy-
drated in acetic acid for the treatment of wound infections. Gellan is a versatile polymer
as shown by the formulations explored in this study and a promising candidate for cell
and drug delivery applications.
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• A pilot randomised controlled trial to examine the e cacy and optimal dose of Acetic
Acid to treat colonised burns wounds (AceticA):protocol development, data analysis
• A RandomizEd Trial of ENtERal Glutamine to MinimIZE Thermal Injury (Re-Energize):
patient recruitment, study drug prescription
• Burns Objective Scar Scale (BOSS): clinical study procedures
• Gellan Contact Study (GCS): clinical assessor
All studies are/were carried out at University Hospitals Birmingham.
CHAPTER 1
INTRODUCTION
The original autologous keratinocyte culture and transplantation technique was intro-
duced over 3 decades ago in burn patients to achieve faster re-epithelialisation. Various
keratinocyte application methods have improved from cell sheets to single-cell solutions
delivered with a spray system. However, further enhancement of cell culture, cell viability
and function in vivo, cell carrier and cell delivery systems remain themes of interest. Hy-
drogels such as chitosan, alginate, fibrin and collagen are frequently used in burn wound
care and have advantageous characteristics as cell carriers. It is likely that keratinocyte
transplantation will in future be mediated by spray devices, but optimisation of applica-
tion technique and carrier type is necessary. An overview of keratinocyte transplantation
in burn wounds concentrating on application methods and future therapeutic cell delivery
options with a special interest in hydrogels and spray devices for cell delivery is given.
The aim of this thesis is to determine what properties of the hydrogel are important
to enable delivery of drugs or cells to promote wound healing, this is reflected by the
following objectives:
• Design a hydrogel with optimal features for spray delivery
• The rheological properties of the hydrogel in comparison to current standards
• Investigate viability and function of encapsulated cells in the hydrogel environment
and following spray delivery
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• Explore other delivery techniques
The following chapter includes work that is published in the review paper Advances
in keratinocyte delivery in burn wound care1 and as a bookchapter entitled: Natural
polymers: biomaterials for skin sca↵olds2
1.1 Burn injury
Burn injuries are complicated wounds to manage with a relative high mortality rate in
especially large area burns and elderly patients [1]. Substantial tissue damage and ex-
tensive fluid loss can cause impaired vital functions of the skin. Rapid epithelialisation
is mandatory to restore the barrier function of the skin and enhance healing. Patholog-
ical scar formation (hypertrophic scarring) can occur as a long term sequelae of delayed
wound healing. When healing is delayed, the potential short term common complica-
tions include wound infection a↵ecting the local healing process or systemic inflammatory
and immunological responses which subsequently can cause life threatening sepsis and
multi-organ failure. In the United States, approximately 400,000 fire/burn injuries were
recorded in 2017 in a population of about 326 million, including a total of 3398 (0.85
%) reported fatal injuries [2]. Fortunately, survival rates have improved drastically over
the last century due to advancements in burn care such as early surgical intervention,
critical care support and wound care [3, 4]. However, despite further technological ad-
vancements in the last 30 years, survival rates have not improved significantly over the
last three decades and now seem to be plateauing in countries with high-standard burn
care [5–7]. Furthermore, since modern standard burn care allows the majority of patients
to survive thermal injury, other outcome measurements aiming to improve quality of life
become more relevant. For example, shortening length of hospital stay, decreasing the
number of trips to the operating theatre and optimizing the quality of restored tissue.
Functional and aesthetic outcome of the restored tissue are reflected by scar quality in
1DOI: 10.1016/j.addr.2017.06.012
2Paperback ISBN: 9780081025468, expectated publication date: 1st of July 2019.
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terms of pigmentation, pliability, sensation, hair growth and function (prevention of scar
contraction). All of these factors require a specialized approach aiming on regeneration of
tissue instead of tissue repair. Progress in short term results (life saving wound coverage)
remains essential. Subsequently, advances of long term results are desired to facilitate the
need for quality of life improvement of the increasing population of burn survivors. An-
swers to these challenges are sought in the field of tissue engineering. Although, advances
in engineered skin equivalents and cell-delivery to the wound bed are emerging in burn
care, they currently do not meet the expected results and translation to clinical practice
is challenging. Keratinocyte delivery was the first skin cell transplantation successfully
translated to clinical burn care. In the last four decades this method has been investigated
widely and numerous researchers have contributed to a variety of improvements.
1.2 Skin
1.2.1 Epidermis
The skin is the largest organ of the body and has a barrier function, preventing the pas-
sage of water, electrolytes and pathogens (Figure 1.1). The epidermis is predominantly
formed from highly specialized epithelial cells called keratinocytes. Other cells which can
be found in the epidermis include Langerhans’ cells, melanocytes and Merkel cells, which
are responsible for immune regulation, pigmentation and sensory function. Keratinocytes
play a key role in epidermal restoration following injury through proliferation and re-
epithelialisation (Figure 1.2). Solely epidermal injuries will achieve re-epithelialisation
from proliferated keratinocytes and heal by regeneration without scarring [8, 9]. Di↵eren-
tiated keratinocytes perform their barrier function through the provision of a mechanical
barrier in the formation of a keratinised layer and by reacting to invasion of pathogens
via release of pro-inflammatory mediators which subsequently attract leukocytes to the
site of invasion.
3
Figure 1.1: Layers and function of the skin. The uppermost layer of the skin is the epider-
mis. The epidermis consists of 5 main layers described from deep to superficial: stratum
basale, stratum spinosum, stratum granulosum, stratum lucidum and stratum corneum.
The epidermis has two distinct functions: a protective barrier function against trauma and
fighting o↵ pathogens as well as a controlling function regulating body temperature, fluid
and electrolyte balance. Other functions of the epidermis include production of vitamin
D, pigmentation, providing mechanical strength and it has a role in cutaneous immune
function. [Source: histology image provided by Dr. GM Reynolds PhD CSci FIBMS,
Liver Unit of Queen Elizabeth Hospital Birmingham, UK. Image adapted by Britt ter
Horst, with permission from G M Reynolds.]
Keratinocyte di↵erentiation and proliferation markers
Keratinocytes proliferate from the basal cells of the innermost layer of the skin (stra-
tum basale). The epidermal stem cells are attached by hemi-desmosomes to the stratum
basale and can divide into either more stem cells, which persist indefinitely and to main-
tain the layer’s regenerative capacity, or into transit amplifying cells which have limited
division potential. As the transit amplifying cells continue to divide and proliferate, dif-
ferentiation occurs. Throughout this di↵erentiation process, the keratinocytes migrate
upwards towards the stratum spinosum and stratum granulosum to eventually become
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corneocytes which form a relatively impermeable outer layer, the stratum corneum. Once
fully di↵erentiated, these corneocytes lose their nucleus and cytoplasmic organelles and
will eventually be shed o↵ via desquamation. The estimated time for turnover from epi-
dermal stem cell to desquamation in healthy human skin is around 39 days [10]. During
this process, keratinocytes express several di↵erentiation proteins including keratins which
are intermediate filament proteins in epithelial cells. Keratins play a host of important
function including the provision of structural support, protection of epithelial cells from
mechanical and non-mechanical stress and the regulation of apoptosis and protein syn-
thesis [11]. There are 37 known functional human epithelial keratin genes, divided in
type 1 and 2 genes. Mutations in these genes are associated with skin diseases such as
epidermolysis bullosa simplex (keratin 5, 14) with structural weak epidermal basal cells or
epidermolytic hyperkeratosis (keratin 1 and 10) [12]. Keratin expression is frequently used
as a marker for epidermal proliferation and di↵erentiation in cell culture, with keratin 14
(K14) being used for the basal layer and keratin 10 for the spinous layer. Other di↵eren-
tiation markers starting at the basal layer are K5, and K15, spinous layers K1 and K10,
transglutaminase and involucrin, at the granular layer. Filagrine, loricrin and caspase-14
activation are hypothesised to play a role in terminal keratinocyte di↵erentiation [13–15]
(Figure 1.2).
Factors promoting keratinocyte di↵erentiation
A major regulator of keratinocyte di↵erentiation is the calcium gradient. Extracellular
calcium concentration is lowest in the stratum basale and gradually increases until the
stratum granulosum. Elevated levels of extracellular calcium concentrations stimulate for-
mation of intercellular contacts and the increase ofintracellular free calcium concentrations
via transmembrane calcium influx, which subsequently initiates di↵erentiation via stimu-
lation of the calcium receptor (CaR) [14]. This has consequences for the culture technique
of keratinocytes in vivo, high calcium concentration induces di↵erentiation, whereas in low
calcium concentration keratinocytes remain proliferative [14–16]. E-cadherin provides ad-
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Figure 1.2: Keratinocyte di↵erentiation and markers. Diagram is showing di↵erentiation
of keratinocytes in the epidermis with expression of stratification markers. Basal ker-
atinocytes express Keratin 5, keratin 14 and keratin 15. When keratinocytes di↵erentiate
they move upwards into the suprabasal layers: stratum spinosum, stratum granulosum
and finally stratum corneum. Di↵erentiating keratinocytes express specific markers in
each epidermal layer. [Source: Britt ter Horst]
herens junctions for adhesion between cells which is crucial for keratinocyte di↵erentiation.
In addition, following a signalling pathway e-cadherin can increase the intracellular cal-
cium concentration [14, 17]. Furthermore, 1,25-Dihydroxyvitamin D3 (Vitamin D3) is
known to influence keratinocyte di↵erentiation by regulating gene expression and modu-
lating calcium concentrations [18, 19]. Logically, factors that promote proliferation will
inhibit di↵erentiation of keratinocytes. Factors known to promote proliferation are TGF-
↵, vitamin A, transcription factor p63 and epidermal growth factor (EGF).
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Keratinocyte interaction with other epidermal cells
Within the epidermis, keratinocytes interact with other surrounding cell types for exam-
ple, melanocytes. Melanin production (melanogenesis), occurs in the melanocytes and
protects the DNA of melanocytes and keratinocytes from ultraviolet radiation and con-
tributes to the colouration of the skin. Keratinocytes take up melanin via the melanin
containing melanosomes produced by melanocytes [20]. The interactions between ker-
atinocytes and fibroblasts in wound healing have been well described in literature, where
a double paracrine signalling concept is proposed. Keratinocytes instruct fibroblasts to
produce growth factors and cytokines such as keratinocyte growth factor, fibroblast growth
factor-7, GM-CSF and IL-6 [21]. Consequently, expression of these growth factors initi-
ates keratinocyte proliferation. The transcription factor activator protein-1 seems to play
an important role in this process [22]. Furthermore,under the control of keratinocytes, fi-
broblasts can obtain a myofibroblast phenotype, which is important for wound contraction
[21].
1.2.2 Dermis and basement membrane
Underneath the epidermis, the dermal layer acts as a support network, providing strength
and elasticity to the skin. Fibroblasts are the key cells of the dermis. Fibroblasts are re-
sponsible for the production and maintenance of the extracellular matrix which is formed
by fibrous components (collagen and elastin) embedded in non-fibrous elements such as
proteoglycans and glycosaminoglycans (GAGs). Collagens are the main structural element
of the extracellular matrix (ECM) and provide tensile strength, regulate cell adhesion and
support migration. Other cellular components include endothelial cells, smooth muscle
cells and mast cells [23]. The vascular deep and superficial plexus lie within the upper
and lower part of the reticular dermis respectively and supply the dermis and epider-
mis. The epidermis and dermis are firmly connected by the basement membrane, and the
epidermal-dermal junction is bordered and stabilized by the anchoring of keratinocyte-
derived collagen (type VII) fibrils into the dermis. Additionally, collagen XVII, a struc-
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tural component of hemidesmosomes, mediates the anchoring of basal epithelial cells to
the basement membrane [24]. If this junction is disrupted, serious morbidity such as seen
in epidermolysis bullosa can occur [12]. Several structures originate in the dermis and
extend into the epidermis such as sensory nerves, sweat glands and hair follicles. Hair
follicles are lined with epidermal keratinocytes and contain multipotent stem cells [25].
Therefore, if the dermis is only partially injured these adnexal structures can deliver cells
that can proliferate, migrate and regenerate the epidermis. However, the dermis lacks
the intrinsic capability of regeneration and heals by fibrosis and scar formation. Sensory
nerves are responsible for mediating pain and itch, control inflammation and there is
evidence that shows that they may also influence the remodeling phase [9].
1.3 Wound healing and keratinocytes
1.3.1 The role of keratinocytes in wound healing
The skin barrier function can be disrupted by trauma such as a thermal injury. Wound
healing usually occurs via four overlapping phases; haemostasis, inflammation, prolifera-
tion and remodeling. Normally this process is su cient to allow the skin to repair itself
after injury. However, extensive skin loss, as seen in burn victims, requires intervention to
allow for tissue restoration. Burn injuries are often caused by heat, however, electricity,
radiation, chemicals or friction can also result in similar injuries clinically [26]. Following
thermal injury, a complex healing process will start with the involvement of numerous
specialised and interacting cells, molecules and pathways. The cellular response involves
macrophages, platelets, fibroblasts, epithelial and endothelial cells. In addition to the
various cellular interactions, proteins and glycoproteins such as growth factors, cytokines,
chemokines, inhibitors and their receptors can also influence healing. Although, burns
heal di↵erently from normal wound healing, the phases of healing remain the same [27].
Keratinocytes and fibroblasts play an important role in the proliferative phase which
is focused on the replacement of the damaged ECM and restoration of tissue structure
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and function. Activation of keratinocytes and fibroblasts by macrophages via cytokine
and growth factor release causes angiogenesis, collagen production, ECM production and
epithelialisation [28].
Angiogenesis
The restoration of the vascular network is essential as angiogenesis supports cell activity
by providing oxygen and nutrients to the wound bed. Once endothelial cells are activated
by macrophages, they loosen their cell to cell junctions in order to migrate. This process
as well as endothelial proliferation is encouraged by a hypoxic and acidotic environment
which is typically found in wounds. Finally, revascularisation occurs when sprouted vessels
organise into capillary networks. Vascularisation consequently neutralizes the hypoxic and
acidotic wound environment and leads to decreased production of angiogenic factors. This
eventually results in reduction of endothelial cell migration and proliferation [8, 29].
Epithelialisation
Within hours of injury re-epithelialisation starts with a vital role being played by ker-
atinocytes. The quantity of epidermal stem cells residing in stem cell niches such as in the
hair follicles, sebaceous glands and basal layers of the interfollicular epidermis determines
the regenerative capability of the skin [8, 25]. Activated by growth factors released by
macrophages, keratinocytes migrate to the wound bed and fill the defect (Figure 1.3). In
order for keratinocytes to start their migration they undergo phenotypical alterations by
loosening of intercellular adhesions, although some desmosome contacts are sustained [8].
Furthermore, cells can separate from the basal layer once hemidesmosomes are disrupted
which allows them to migrate laterally [8, 30]. When integrin receptors are expressed,
the keratinocytes flatten and the altered basal keratinocytes migrate over the granulation
tissue to form a monolayer of epithelial cells, but remain under the non-viable eschar of
the burn wound. While moving they secrete proteolytic enzymes that enable the degra-
dation of provisional matrix and promotes further cell migration [31]. After aconfluent
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sheet of cells covers the wound bed, the cells then divide to form a multi-layered stratified
epithelium and mature under the influence of TGF- 1 and TGF- 2 [32]. Keratinocytes
play a vital role in especially the proliferative phase of burn wound healing leading to ep-
ithelialisation and restoration of the vascular network. For this reason and the possibility
of in vitro keratinocyte culture, keratinocytes are considered an excellent candidate for
cell transplantation.
Figure 1.3: Role of keratinocytes in re-epithelialisation. Schematic illustration of a skin
injury with keratinocytes as key cells. Keratinocytes are activated via pro-inflammatory
cytokines and growth factors released in the wound bed. Once activated, keratinocytes
from the wound edges and dermal appendages migrate over the provisional matrix and
finally close the defect in a process called epithelization. When the basal layer is spared
from injury, basal keratinocytes can support this process by upward migration as occurs
in non-injured skin. Activated keratinocytes communicate with other cell types present
in the epidermis. Epithelial cells proliferate and di↵erentiate to achieve a stratified ep-
ithelium with restoration of the barrier function of the skin. Maturation of the wound
continues over a period of several months with fibroblasts remodeling the underlying der-
mis.
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1.3.2 Pathophysiology of burn injury
Major burn injury, defined as approximately 20% of the total body surface area (TBSA)
burned, causes burn shock due to severe haemodynamic and haematopoietic dysfunc-
tion [27] secondary to immediate evaporative and direct fluid losses [33], extensive loss
of proteins, reduced colloid oncotic pressure and wound oedema development. With-
out intervention the fluid loss will result in desiccation of deeper tissues and further cell
death leading to an increase in wound depth. A moist wound bed is necessary for ep-
ithelial cell movement and therefore for successful re-epithelialisation [9]. Furthermore,
with disruption of the barrier function of the skin, microorganisms have easy access and
when entering the microcirculation can cause systemic infection. Presence of these acute
systemic responses are related with increased morbidity and mortality numbers [34, 35],
especially in the elderly [1].
1.3.3 Rationale for keratinocyte transplantation
Traditional therapy for severe burns is surgical debridement and autologous skin graft.
However, with extensive burn injury healthy donor site is scarce and alternatives to restore
skin function are necessary. When rapid epithelialisation can be achieved the skin barrier
function is restored and this can determine a patient’s likelihood of survival. Clearly, it is
important in the treatment of a burn injury to focus on quick re-epithelialisation. There-
fore, development of successful and e cient autologous skin replacement techniques is
highly desirable. Wound closure will not occur without epithelialisation and epithelialisa-
tion will not occur without the presence of keratinocytes in the wound bed [8]. Therefore,
keratinocyte transplantation was introduced as part of the burn wound care arsenal over
30 years ago. However, the original autologous keratinocyte transplantation technique
has several disadvantages which has spurred researchers to seek for improvements in cell
culture technique, delivery systems and also the optimisation of the timing of keratinocyte
transplantation [36].
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1.4 Cell transplantation technology
1.4.1 Cell source
Keratinocytes and their progenitor cells can be sourced locally from stem cell niches in
hair follicles. Several stem cell niches are known: mesenchymal stem cells (MSC) resident
in the dermal papilla and multipotent hair follicle stem cells (HFSC) and melanocyte
stem cells in the superior bulge [37]. HFSCs are essential for normal morphogenesis of
hair follicles, sebaceous glands and contribute to formation of the three epithelial cell lines
[38]. Progenitor cells also reside in the bone marrow and could arise from embryonic cell
lines [39].
1.4.2 Historical development of keratinocyte culture
The first successful in vitro human keratinocyte expansion, achieved by Rheinwald and
Green in 1975, paved the way towards autologous cell transplantation in burn care [40].
Keratinocytes were successfully cultured in the presence of fibroblast feeder cells. How-
ever, to prevent these fibroblasts from outgrowing the keratinocyte population, irradi-
ated murine 3T3 fibroblast feeder cells, which have lost their mitotic ability but remain
metabolically active, were used [40]. Besides the use of feeder cells, culture media of-
ten contains fetal bovine serum with growth factors, hormones and antibiotics [40–42].
Keratinocytes are able to be grown into colonies and subsequently form a stratified ep-
ithelium and human keratinocyte stem cells were proven to have an enormous prolifer-
ation potential. Subsequently, small cell sheets of two or three layers of confluent ker-
atinocytes were produced and not long after, the first human transplantation became a
reality [43, 44]. Keratinocytes cultured for clinical use must have the regenerative ca-
pablity to form an e↵ective epidermis after transplantation. It is thought that in vitro
di↵erentiating keratinocytes do not contribute significantly to regeneration in vivo [45].
Instead, keratinocyte stem cells and their transient amplifying cells seem to have excellent
regenerative capacities [46]. Thus, culturing keratinocytes that keep the ability to pro-
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duce progeny once transplanted, seems key for successful epidermis formation following
transplantation. The degree of di↵erentiation in vitro can be controlled by the method of
culture. Fully di↵erentiated keratinocytes (confluent) multilayers as well as pre-confluent
single cells can be produced and delivered to the wound bed [16, 47]. In a histological com-
parison of cultured pre-confluent and uncultured keratinocytes seeded on a collagen-GAG
matrix in a pig model, both provided a fully di↵erentiated epidermis in 14 days. A thicker
and confluent cell layer, however, was obtained more rapidly with the cultured cells [48].
The original culture method has been the subject of much debate, because the murine fi-
broblast feeder layers can potentially result in transplantation of animal components with
the keratinocyte product. Due to the serious risk of animal-derived disease transmission
to human epithelium in the transplantation process, it is not advised to use undefined
xenogeneic materials in the treatment of patients. Additionally, radioactive irradiation
of murine fibroblasts in this technique is accompanied with higher costs and potential
uptake of irradiated DNA via the murine fibroblasts into the transplanted keratinocytes
might cause cell destruction [49].
1.4.3 Progress towards xenobiotic free culture techniques
To limit or exclude the transmission risk, other keratinocyte culture protocols without
feeder cells and limited or no use of xenogeneic media products have been developed
[16, 47]. Jubin et al. showed that human keratinocytes can be successfully expanded
in co-culture with non-irradiated autologous human fibroblasts in Rheinwald and Green
medium, but still supplemented with fetal bovine serum (FBS) to maintain their prolif-
erative phenotype in vitro [50]. A further approach to minimise xenogeneic products in
culture media was introduced when serum free medium was used for the expansion of
keratinocytes with non-irradiated human fibroblasts on several substrates [51]. However,
FBS still had to be used to expand the human fibroblasts initially. Although the cul-
ture media are free of serum, often other products used in the culture media still contain
animal-derived proteins. This could be solved by the use of only human material, how-
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ever the risk of infection remains and high costs in an already expensive process makes
this option less favourable. Successful culture of human keratinocytes in a serum-free
and feeder-free culture was demonstrated in vitro in a skin equivalent model by Coolen
et al. With the addition of collagen type IV, serum substitute and keratinocyte growth
factor (KGF) a di↵erentiated epidermis could be formed [52]. Lamb et al. demonstrated
that although keratinocytes grown in serum-free and feeder-free conditions did show suf-
ficient propagation, these cells were not able to support mature epidermis formation in
an in vitro skin model. However, when re-introduced to serum-containing media they
then did form a stratified epidermis. Moreover, when heat-inactivated serum was used an
improved stratified epidermis was formed, indicating that serum products also contains
(heat-sensitive) factors that can inhibit in vitro epidermis formation [53]. Lenihan et al.
compared three commercially available feeder-free media systems; CnT-07 medium (Cell-
nTech, Bern, Switzerland), EDGS (Gibco), S7 (Gibco) with the original Rheinwald and
Green method [40] for expansion of human keratinocytes for clinical usage. A maximum
of 3 weeks culture time (passaged twice) was allowed, as the ideal transplantation window
was considered between 4 and 20 days. They found that all three feeder free culture
media supported keratinocyte growth. However, the only fully xenobiotic free media (S7)
had a low cumulative population doubling time and therefore did not reach su cient cell
numbers to be considered for clinical usage at day 21 and was therefore excluded from
further analyses [54]. Using feeder-free and serum-free media is less labour intensive and
beneficial for use in the clinical setting, further research will have to show whether ker-
atinocytes maintain their proliferative potential in vivo. Besides elimination of xenobiotic
materials from culture media, the elimination of antibiotics is a further goal to improve
keratinocyte cell expansion for usage in the clinical setting [55].
1.4.4 Additions to keratinocyte culture
To further encourage and optimise skin regeneration following burn injury, improvements
have been made to the keratinocyte transplantation process. These have included the
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addition of multiple other cell types and growth factors during keratinocyte culture or
transplantation. The addition of melanocytes in the keratinocyte culturing process has
been proposed to solve the problem of potential irregular pigmentation of the post burn
scar. Co-culturing of keratinocytes with melanocytes has been investigated in patients
with vitiligo and in full thickness wound healing in animal models [56–59]. In humans,
more evidence is available for uncultured cell suspensions containing keratinocytes and
melanocytes for the treatment of hypopigmented lesions [60–63]. However, these pilot
studies are limited by small sample sizes and lack of controls. Controlled clinical studies
are needed to support the findings before this technique can be accepted as standard clin-
ical practice. Cultured epithelial autografts lack a vascular plexus and burn wounds often
have insu cient vascularisation due to the disruption of the dermal layer. Therefore, ap-
proaches to promote angiogenesis via the addition of autologous or allogenic endothelial
cells into skin grafts have been proposed [64–66]. Also, adipose derived stem cells (ASCs)
have received attention with respect to their potential to enhance wound healing. Huang
et al. seeded human ASCs onto a dermal acellular skin substitute in vitro to enhance
vascularisation. When transplanted to full thickness wounds in nude mice, an increase in
blood vessel density was found two weeks post transplantation compared to controls [67].
Another approach is to add growth factors like epidermal growth factor (EGF) [68]. Ad-
ditionally, co-delivery of cultured keratinocytes with EGF in a fibrin matrix demonstrated
improvement of epidermal regeneration in full thickness wounds in a murine model [69].
Furthermore, Supp et al. genetically modified keratinocytes with an overexpression of
vascular endothelial growth factor (VEGF) to stimulate angiogenesis in skin substitutes
in animal studies [70–72]. Besides adding factors, modifications of the 3D structure of
skin substitutes to stimulate faster ingrowth of vascular structures have also been pro-
posed [73]. Of interest from a tissue engineering perspective, is whether transplanted cells
actually survive and function in vivo.
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1.5 Keratinocyte viability after transplantation
Cell survival of transplanted keratinocytes in vivo is of great interest for tissue engineering
purposes. Vernez et al. evaluated the cell viability and apoptosis balance in clinical sam-
ples taken from cultured epidermal autografts prior to transplantation [74]. Although, all
samples showed high levels of cell viability and low levels of apoptosis, variable biological
activity of certain parameters between samples of di↵erent patients was observed. It was
suggested that this could impact on therapeutic e cacy [74]. In a pig model Navarro
et al. found no altered cell viability before and after spraying a suspension of cultured
keratinocytes to full thickness wounds [75]. Duncan et al. examined cultured human
keratinocyte proliferation measured with the MTT assay after spray delivery to a de-
epidermalised dermis (DED) in vitro and found no significant cell death or reduced cell
proliferation [41]. These studies seem to support that cells remain viable and maintain
proliferative capability after spray cell delivery to a wound bed.
1.6 Methods of keratinocytes transplantation
1.6.1 Introduction: grafting of burn wounds
Ambroise Paré (1510–1590 CE) was probably the first to describe the surgical intervention
for early excision of burn wounds [76]. Surgical burn care has progressed tremendously
since then and methods which have now become well established in burn care include
early excision of burn wounds, the development of autologous and allogenic skin grafts
and the use of skin substitutes [77, 78]. Techniques involving transplantation of healthy
human skin to damaged areas are still the gold standard in deep or full thickness burn
wounds. However, challenges arise when large areas are a↵ected and donor sites are scarce.
Subsequently, many skin graft expansion techniques have been developed to reduce donor
site size, these techniques include meshing of the graft (maximum expansion ratio of 1:9),
modified meek technique (expansion ratio of 1:9), epidermal blister grafting (expansion
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ratio of 1:1) and several techniques of micro grafting such as epidermal CelluTome™ micro-
grafting (expansion ratio of 1:6), or XpansionKitr micro-grafting (maximum expansion
ratio: 1:100). Developers of cellular based techniques claim to deliver even higher expan-
sion rates, such as cultured epithelial sheets (expansion rate 1:1000) and uncultured cell
suspensions (maximum expansion rate 1:100) [79–81]. However, to the knowledge of the
authors no other studies have been able to support these findings. Furthermore, proce-
dures to harvest skin are time consuming, can lead to longer healing times with prolonged
hospital stay and can be accompanied by donor site complications. Additionally, skin
grafts do not always meet the desired cosmetic outcomes. Therefore, methods to enhance
the results of skin grafting and alternatives to it have been subject of much research in the
last few decades. Specifically, progress towards a permanent epidermal replacement or its
improved regeneration is the main goal of cellular based therapy. In Figure 1.4 di↵erent
methods of autologous keratinocyte transplantation are schematically summarized.
1.6.2 Cultured keratinocyte sheets
Cultured autologous keratinocyte sheets
In 1981, O’Connor et al. reported the first transplant of cultured autologous keratinocytes
to treat a burn injury [44]. Cultured epithelial autografts (CEA) were developed to re-
place the epidermis and restore the barrier function of the skin [82–84]. In the last
three decades CEAs have been adapted and introduced to the clinical setting (Figure
1.5). Nowadays, several commercialised bioengineered skin products derived from autol-
ogous cells are available. In general, clinicians harvest autologous skin and the company
produces a graftable substrate seeded with the autologous cells for clinical use in approx-
imately 2 weeks (Epicel, Genzyme, Cambridge, MA and Laserskin, Fidia, Italy). The
timeframe wherein viability of the grafts can be ascertained (shelf-life) is 24–48 hours.
These services will often involve high costs and a certain waiting time and narrow ap-
plication timeframe. In 2007, the FDA approved the use of CEAs for use in patients
with deep dermal or full thickness burns greater than, or equal to 30% TBSA (Epicel,
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Figure 1.4: Methods of autologous keratinocyte transplantation to burn wounds. In pa-
tients with burn injury keratinocytes can be isolated from a small skin biopsy as illustrated
above. The autologous keratinocytes can be cultured and delivered to the wound bed of
the patient by several methods. First to be developed was a sheet of cultured epithelial
cells, thereafter a single cell suspension applied to the wound by dripping from a syringe
and latest development is application of cultured or uncultured cells in single-suspension
with a spray device.
Genzyme, Cambridge, MA) [44, 82]. The main advantage of cultured epithelial auto-
grafts is that large areas of the body can be covered with autologous cells derived from
a small biopsy and improvement in the speed of re-epithelialisation has been reported.
In terms of cosmetic results, CEA seems to have better results when compared to wide
mesh autograft in extensive burns [85]. However, several authors who have reviewed the
use of cultured epithelial autografts in burn care have found variability in terms of graft
take and cosmetic outcomes [47, 86, 87]. A major disadvantage of this technique is the
long time interval between biopsy and grafting. Although the average culture time has
improved from 5 weeks [44] to about 3 weeks [88, 89], variability among patients has
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been described, especially among di↵erent age groups [90]. Following burn excision, the
wound can be temporary covered with allograft and/or xenograft dressings for several
weeks until CEA is ready. However, this is related to a higher risk of wound coloniza-
tion and infection [47]. The ideal timing for keratinocyte transplantation is di cult to
determine as it is dependent on several factors including hospital facilities and patient
conditions [89, 91]. Furthermore, both short and long term clinical limitations such as
the formation of bullae, poor take rates, fragility of the sheets and wound contractures
have been reported [91–93]. These may be due to the lack of a dermal component that is
necessary to support the new epidermal layer. The restoration of the dermis is important
for the skin to regain mechanical strength and to facilitate adherence of the new or trans-
planted epidermis [37]. Although in one study, an advanced application technique with
allograft wound bed preparation and combination of CEA with wide meshed autograft
seems to improve take rates up to 84% [94]. Cell culture is an expensive process and the
cost/benefit relationship of this method is heavily debated [95]. Finally, the potential
of graft site malignancy after keratinocyte transplantation has been highlighted [96, 97].
However, the type of malignancy reported, squamous cell carcinoma, is also known to
occur in burn wounds and scars in the absence of keratinocyte transplantation [98].
Dermal substitutes including cultured keratinocytes
With a complete absence of a dermal component, the cultured keratinocytes are thought
to be of limited value in treating full-thickness burns due to the poor quality of the
resulting epidermis. Consequently, this has led researchers to optimise the wound bed
via the use of allogenic or artificial substitutes prior to keratinocyte transplantation. A
further approach is to grow or seed the cultured keratinocytes on a (dermal) substitute
to facilitate secure transplantation and improve healing potential [83]. This concept was
introduced by Hansbrough and Boyce in 1989 [99]. Many types of delivery systems have
since followed, and have been extensively discussed in the literature throughout the years
[84, 100, 101]. Limitations in keratinocyte cell culture methods and transplantation have
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Figure 1.5: Burn wound coverage with cultured epithelial autografts applied in sheets.
In this example, successful burn wound healing in about 2 weeks was achieved when
the sheets were removed a week after application. a) Deep second degree burn in the
back of a 29-year old patient after excision of the burn b) application of cultured ker-
atinocyte sheets c) removal of sheets 8 days after surgery and d) complete healing 16
days after surgery. [Reprinted from Burns Volume 41, Issue 1, Pages 71–79, Cultured
autologous keratinocytes in the treatment of large and deep burns: A retrospective study
over 15 years, Celine Auxenfans, Veronique Menet, Zulma Catherine, Hristo Shipkov,
Pierre Lacroix, Marc Bertin-Maghit, Odile Damour, Fabienne Braye, Copyright (2017),
with permission from Elsevier.]
impeded the widespread use of this technique in the clinical setting. The use of single-cell
suspension was introduced predominantly to shorten the culture time.
1.6.3 Autologous keratinocyte transplantation in suspension
To overcome the main negative features of epidermal sheets which are the long culture
times and poor cell adhesion to the wound bed, delivery of cells in suspension has been
investigated. While epidermal sheets contain cultured confluent cells that passed the
phase of exponential growth, cell suspension delivery systems can be designed to contain
pre-confluent cells. Ideally, these cells are harvested or passaged when reaching a 70–80%
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coverage of culture dishes to ensure their proliferative capability and avoid confluence,
hence the term pre- or sub confluent cells. When a su cient cell number is reached (after
approximately 2 weeks of culture), the cells are detached and suspended in a saline solution
for clinical use. As di↵erentiation in vitro is not desirable, keratinocytes in a pre-confluent
suspension form are often preferred for transplantation (Figure 1.6). Nowadays, several
commercially available spray cell delivery products are used clinically to enhance burn
wound healing. These techniques can be categorised by the type and level of confluence
of the transplanted cells.
Pre-confluent keratinocytes suspension
The use of pre-confluent cells can shorten culturing time and facilitate more rapidly
available cellular grafts, which in theory is likely to reduce the risk of wound infections and
consequently the length of hospital stay [102, 103]. A commercial suspension consisting of
autologous pre-confluent keratinocytes has been available since 2007 for aerosol delivery.
Hartman et al. treated 19 patients with deep dermal face and neck burns with a spray
apparatus with an estimated spray pressure of 8.2 mmHg, which seems to be a surprisingly
low delivery pressure using autologous cultured epithelial cells of 80–90% confluence at
the end of passage 0 [104]. An alternative commercially available cell spray system is
KerahealTM , which was developed by MCTT, Korea. This system utilises an autologous
non-di↵erentiated pre-confluent keratinocyte suspension, which is sprayed to the burn
wound followed by fibrin spray application. The KerahealTM methodology is similar to
conventional CEA and requires 2–3 weeks of culture time, but the cells are provided
in a suspension instead of sheet. To date, two single centre retrospective studies have
evaluated the clinical outcomes of the sprayed cell suspension in combination with wide
meshed skin grafts in a total of 39 (6 patients who died or were lost to follow up were
excluded from follow up analyses) patients with severe burns. Graft take rate two weeks
after application is surprisingly di↵erent between the studies, but after 8 weeks the take
rates are both above 90%. A follow up of 1–2 years was achieved in both studies with
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Figure 1.6: Spray delivery of cultured keratinocytes to enhance burn wound healing.
In this example, a mixed depth burn to the abdomen was treated with solely sprayed
cultured keratinocytes (no additional mesh grafting) 27 days after injury. The wound
was considered to have healed completely 10 days after treatment. Unfortunately, long
term outcomes in terms of scar quality were not available for this patient. [Reprinted from
Burns Volume 36, Issue 3, Pages e10–e20, Sprayed cultured autologous keratinocytes used
alone or in combination with meshed autografts to accelerate wound closure in di cult-to-
heal burns patients, S. Elizabeth James, Simon Booth, Baljit Dheansa, Dawn J. Mann,
Michael J. Reid, Rostislav V. Shevchenko, Philip M. Gilbert, Copyright (2017), with
permission from Elsevier.
a Vancouver scar scale (VSS) assessment. Scar evaluation 12 months after surgery was
lower in Lee et al. [103] with an average VSS of 3 compared to an average VSS of 5 in
Yim et al. [102]. Various developers have introduced adjustments to the technique in
terms of the application device, cell detachment process, confluency of transplanted cell
and application setting in order to meet clinical needs.
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Uncultured keratinocytes suspension
A further approach is the use of uncultured autologous cells for direct application onto
burn wounds without pre-processing in a tissue culture lab. In a single procedure, a small
piece (2 × 2 cm) of skin is harvested by the surgeon and then placed in an enzymatic
solution followed by manual scraping of the epidermal layer, the skin specimen is placed
in a bu↵er solution and subsequently filtered before use. The company provides a kit
which allows the clinical team to process the cells in a single treatment session without
the need for a lab technician or transport of the cells elsewhere [86, 105]. The use of
an uncultured mixture of autologous epidermal cells (keratinocytes, melanocytes, dermal
fibroblasts) was introduced to clinical practice in 2005 as a standardized spray device
under the name ReCellr (Avita Medical Europe Ltd., Melbourne, UK). The purported
benefits of this system are the elimination of lengthy culture times and the delivery of
a mixture of autologous epidermal cells [106]. Since its introduction, several studies
have demonstrated promising outcomes with the use of ReCellr for acute burn wounds
or in the treatment of hypopigmentation. These studies ranged from case reports to
larger comparative studies [61, 107–111]. Although most papers have shown promising
results, the potential value of spray cell transplantation in burns is di cult to evaluate
due to the heterogeneity of the studies in terms of clinical outcomes explored, patient
population, wound characteristics, type of treatment and study design [101]. Gerlach et
al. used a similar approach with direct application of an uncultured autologous epidermal
suspension on the wound bed using a fine needle spray in a single treatment session.
Although, a small number of patients was treated and results were not compared to
controls [105, 112]. The question arises whether a large wound area can be covered by the
harvest of cells without expansion from a small skin specimen. In an in vitro study an
expansion ratio of over 1:100 was calculated for uncultured cells sprayed with a density of
104 cells/cm2 for an estimated surface coverage [81]. However, there is no other literature
to support the claimed expansion rate. To allow the comparison of clinical data, it has
been recommended by the National Institute for Health and Clinical Excellence (NICE)
23
that studies evaluating spray delivery of uncultured cells need to include at least: the
time to 95% healing of the burn wound, length of hospital stay, scar assessment, physical
function and cosmetic appearance of the burned area and compare these results with the
current standard of care [113]. To date, randomized controlled clinical trials and non-
commercial studies investigating e↵ectiveness compared to conventional treatment are
lacking. Challenges arise in consistent assessment for burn wound healing as objective
non-invasive assessment tools have not yet been incorporated widely in routine burn care
and might not be superior to visual expert assessment [27]. Therefore, researchers rely on
subjective clinical assessments for acute burn wound healing and late outcomes in terms
of scarring [114].
Allogeneic neonatal keratinocytes suspension
Several research groups have explored the possibility of the transplantation of fetal allo-
genic cells with the purpose of stimulating regeneration of residual cells in the wound.
Neonatal foreskin derived allogenic cells have low immunogenic properties which is pre-
ferred in tissue transplantation. This work has resulted in the creation of skin substitutes
that have been seeded with allogenic cells such as Apligraf (Organogenesis, Canton, MA)
and Orcel (Ortec International, Inc., New York, New York). Similar to the developments
in autologous cell delivery, allogenic cell suspensions have also been investigated as an
alternative method of cell delivery. A cell suspension, code named HP802–47, which con-
tains allogenic neonatal non-proliferating human keratinocytes and fibroblasts in thrombin
was developed for the use in chronic wounds. Multi-centre randomized controlled phase
IIa and IIb studies were conducted and have demonstrated promising outcomes in wound
closure of venous leg ulcers [115–119]. Subsequently, a double blinded Phase III study
followed in North America and Europe comparing wound closure after HP802-247 treat-
ment or placebo in venous leg ulcers. However, the study was unexpectedly halted in
the preliminary stages due to disappointing results [120]. No clinical studies have been
conducted for the treatment of burn wounds with HP802-247.
24
Other clinical studies using cell sprays
Delivery of mesenchymal stem cell (MSC) to (burn) wounds is considered very promising
due their capacity to di↵erentiate into multiple lineages and potential beneficial e↵ects
on the immune response [55, 66, 121]. However, only few clinical studies investigated the
use of mesenchymal stem cells to treat burn wounds have been performed so far [122–
124]. Ueda conducted a pilot study of 10 patients treated with cultured mucosal epithelial
autograft (CMEA) delivered to deep dermal burn wounds without adverse events and a
healing time of approximately 12 days (range 7–14 days) [125]. Iman et al. compared spray
delivery versus intradermal injection of autologous cultured keratinocyte-melanocyte sus-
pension to treat hypopigmented burn scars in a total of 28 patients. Although patients
might show a beneficial result with pigmentation, no statistical di↵erence in type of appli-
cation was found [60]. Cell transplantation techniques have changed significantly after the
introduction of di↵erent cell-carriers and various forms of cell spray techniques. Neverthe-
less, some shortcomings of the suspension application technique have yet to be addressed.
For example, spraying on an uneven wound bed that often also occurs on a curved body
contour, can result in uneven spreading of the cell suspension or dripping o↵ the wound
bed [47, 126]. A potentially useful development of keratinocyte transplantation is to im-
prove the method of delivery in order to optimise cell delivery to the designated area and
stimulate cell adherence to the wound bed. More recently, cell transplantation exploiting
hydrogel carriers have gained interest among researchers. In the past decade biomateri-
als to mediate cell delivery and accommodate cells in a 3D microenvironment have been
investigated. A plethora of synthetic and natural polymers which may form hydrogels




Hydrogels are defined as polymer networks with the ability to swell and absorb water
within their structure. Due to their hydrophilic nature and flexibility they are very
similar mechanically to human soft-tissue. Both natural and synthetic hydrogels could be
considered for tissue engineering. Natural hydrogels benefit from high biological a nity
and are often easily degradable, but the risk of infection transmission and di culties with
purification has increased the popularity of synthetic hydrogels [127, 128]. Biopolymer gels
can be formed out of polysaccharides or proteins. For example, polysaccharides obtained
from plants (gum acacia, guar gum, starch, psyllium [129]), seaweeds (alginate, agarose,
carrageenans), micro-organisms (dextran, gellan gum) or animal derived (chitosan, chitin,
hyaluronic acid) and proteins gained from animal or human tissue (collagen, fibrin, gelatin,
elastin) or animal products (silk sericin, silk fibroin) [130].
Polysaccharides
Polysaccharides are often used in wound dressings as shown in Table 1.1, examples are
calcium alginate, cellulose and chitosan-based dressings. The use of polysaccharides has
also found its way in tissue engineering for wound healing. Polysaccharides consist of
linked monosaccharides and are sourced from renewable resources such as plants and ani-
mals. As these resources are widely available in nature, polysaccharides are an attractive
candidate for researchers. The most commonly used polysaccharides and proteins for skin
repair applications are listed in Table 1.1.
Alginate
Alginate is a linear anionic polymer that consists of mannuronic acid referred to as M
blocks and guluronic acid (G block) units. Alginates with a high proportion of G blocks
are easier to process and seem to have lower immunogenicity and therefore, are more
suitable for biomaterials [131]. Alginate is usually sourced from the cell wall of brown
algae but can also be synthesized by certain bacteria. Its widespread use in biomedical
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Table 1.1: Natural polymers and their properties commonly used for skin repair and re-
generation. ECM = extracellular matrix. a polymer can be modified to be biodegradable,
b starch derivates have cell binding capacities, c derivates are biodegradable.
Type Polymer Source Degradation Biodegradable Cell binding
Polysaccharides
Agarose Red algae Non-degradable No Low





Starch Plants Enzymatic cleavage Yes Highb

















Dextran Bacteria Phagocytosis Yesc Low
Bacterial
cellulose














Enzymatic cleavage Yes High
Elastin ECM Enzymatic cleavage Yes High




Silk fibroin Bombyx mori Proteolytic Yes High
applications is due to beneficial properties like biocompatibility, non-immunogenity, sim-
ple gelation process, ability to control its degradation and relatively low cost. Alginate is
a versatile polymer, its mechanical properties can be tuned by the type and concentration
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of crosslinker [132]. Alginate can form hydrogels by ionic crosslinking with cations such as
Ca2+. The divalent cations will bind exclusively to the G blocks. Covalent cross-linking is
another approach, but as the reagent can be cytotoxic a secondary cleaning step is often
required. While covalent crosslinking is permanent, ionic crosslinking can be reversed.
Also, photo-crosslinking under mild conditions has been introduced for in vivo gelation of
alginate onto the eye [133]. Lack of cell adhesion ligands and its poorly controlled natural
degradation have limited its suitability for some applications. However, alginate can be
modified to gain higher cell adhesivity by peptide coupling such as arginyl-glycyl-aspartic
acid (RGD) to the polymer [134, 135]. Degradation can be influenced by the amount
of G blocks present, with higher content resulting in slower degradation. Oxidation of
photo-crosslinked alginate prior to methacrylation has shown to speed up biodegradation
due to a higher susceptibility to hydrolysis [136]. Commercially available alginate based
wound dressings such as Kaltostatr and AlgiSiter are widely used in acute burn care,
donor wound site coverage [137, 138], venous leg ulcers [139] and pressure ulcers [140].
Although (calcium) alginate dressings have been used for many years in wound care, clin-
ical data is still poor as not many well-designed clinical trials have been conducted [141].
Numerous researchers have demonstrated that cells can be successfully encapsulated in
alginate hydrogels [142, 143]. Alginate as a culture matrix can improve proliferation of
microencapsulated human pluripotent stem cells [144] and supports viability and function
of other cell types [132, 135, 145]. Alginate based macroporous systems for cell culture are
now commercially available with di↵erent pore sizes to suit specific cell types. These ster-
ile sca↵olds are ionically gelated and then dried. After rehydration and cell seeding they
turn into hydrogels [135]. The first transplantation of alginate beads with encapsulated
pancreatic cells into the human body happened in the 1980’s [146]. Despite attempts
to encapsulate skin cells into alginate sca↵olds [145], a similar development for alginate
based cellular regenerative sca↵olds to treat wounds has not been established.
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Cellulose
Cellulose is the most abundant biopolymer in nature and can be derived from a variety of
organisms such as plants (vascular plants or algae) and bacteria (Acetobacter Xylinum).
Biosynthesis of bacterial cellulose fibrils eventually results in the development of a large
nanofibrous-network on the outer side of the bacterium with a macroscopically gelati-
nous appearance [147]. These fibers are around 20–100 nm thick and oriented in an
uni-directional fashion [148]. Cellulose derived from plants or specifically wood generally
have a smaller diameter (3–5 nm) forming bundles of 20–50 nm thick [149, 150]. Other dif-
ferences are the higher water holding capacity and lower crystallinity of bacterial cellulose
[147]. Cellulose hydrogels can be formed by crosslinking solutions of cellulose derivates
such as methylcellulose and sodium carboxymethyl cellulose [151].
Hydrogels can also be formed by ion-crosslinking of negatively charged nanofibrillated
cellulose (wood-derived) with divalent or trivalent cations [149, 152]. Bacterial cellulose
has gained interest for the development of skin replacement therapy because of its 3D
architecture with high mechanical strength, high water holding capacity and biocompati-
bility. Interestingly, its natural negatively charged surface can be altered with or without
[153] the use of matrix ligands to improve cell attachment.
Clinically available acellular products such as Biofillr (Fibrocel) or Nanocellr (Thai
Nano Cellulose Co Ltd), are available for the treatment of a variety of wounds (burns,
chronic ulcers, following excision of skin cancers and as donor site dressing) [154, 155].
Recently, a bacterial cellulose hydrogel was proposed as cell carrier and wound dressing
to stimulate wound healing in a full thickness mice model. Bacterial cellulose hydrogel
was mixed with an acrylic acid solution and cells (human keratinocytes and dermal fi-
broblasts) were seeded into the hydrogel. The results, as shown in Figure 1.7, indicate
that this sca↵old seems to be suitable as cell carrier and full thickness wound healing in a
mice model was achieved, however the sca↵old was not compared to a control treatment
[156].
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Figure 1.7: Bacterial cellulose cellular sca↵old. Live and dead stain of dermal fibrob-
lasts (DF) and epidermal keratinocytes (EK) on the bacterial cellulose hydrogel and
on culture plastic at day 1 and day 3 (a). MTT assay results for proliferation of cells
on the hydrogel at day 1 and day 7 showed no significant di↵erences between any of
the groups (b). Percentage of wound healing of full thickness punch biopsy wounds
in rats treated with bacterial cellulose hydrogel with and without cells and no treat-
ment control. Significant di↵erences with the no treatment group are marked with (*),
(**), (***) for (p<0.05), (p<0.01) and (p<0.001) respectively (c). Clinical photos taken
at day 0, 7, 9, 11, 13 (d). Figures were adapted from Yun et al. [156], open ac-
cess article, published under Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/).
Chitosan
Chitosan is a polysaccharide obtained from de-acetylated chitin which is the structural
component in the exoskeleton of crustaceans or fungi [157]. The polymer is named chitosan
when over 50% of chitin is de-acetylated. It is a weak base that can be dissolved in acidic
solutions, this could be a limitation for applications where solubility in a pH neutral
environment is desired. Chitosan has unique characteristics as it is one of few cationic
natural polymers and can form polyelectrolyte complexes with polymers of the opposite
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charge [158]. Chitosan has gained interest for tissue engineering purposes due to its many
advantageous properties: it is non-toxic, promotes haemostasis, high cell adhesivity and
is biodegradable [131, 159]. A relatively rapid biodegradation in vitro has been described
with the use of lysozyme [160]. Degradability of chitosan can be influenced by a higher
degree of deacetylation [160] and molecular weight [161], resulting in slower degradation
in the body. However, its degradation in the body is not yet fully understood [162].
Crosslinking techniques that successfully formed hydrogels include ionic [163], chemical
[164], physical crosslinker [165] and photo-polymerization [166]. But chitosan on its own
has weak mechanical properties and modifications or blending with other polymers is
often required.
The positive charge of chitosan is of particular interest for researchers as adherence
to negatively charged surfaces or cells is increased [167]. As a wound dressing chitosan
has shown to be haemostatic, anti-microbial and improve wound healing [168], especially
in burn wounds [169]. Its antimicrobial properties are thought to be caused by the ionic
bonding of chitosan onto negatively charged bacteria surfaces leading to altered perme-
ability with intracellular content being released and ultimately cell death [170]. The
influence of chitosan on platelets is not well understood, but platelets seem to adhere to
chitosan derivates and aggregate causing a thrombogenic e↵ect [171]. The haemostatic
e↵ect of chitosan has led to commercially available dressings such as HemConr bandage
(HemConMedical Technologies, Inc.) and Celoxr gauze (MedTrade) marketed for the
local treatment of bleeding wounds [172]. Chitosan is a bioactive polymer that has a
promise as sca↵old for tissue regeneration as it is cytocompatible towards many cell types
[173]. Hilmi et al described the use of a chitosan 3D culture sca↵old with incorporation
of human dermal fibroblasts and reported cell survival up to 14 days. The interconnected
pores that were formed were considered to support fibroblast attachment to the sca↵old
(Figure 1.8b-d) [174]. Keratinocytes and especially fibroblasts seem to adhere better onto
chitosan with a lower degree of deacetylation as shown in Figure 1.8a [175].
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Figure 1.8: Cell compatibility of chitosan sca↵olds. Cell adhesion of keratinocytes and
fibroblasts to chitosan decreases when degree of acetylation (DA%) increases (a). Scanning
electron microscope of a porous chitosan sca↵old with interconnected pores, scale bars
140 µm (b). Confocal microscopy images of the sca↵old used as 3D templates for human
dermal fibroblasts culture showed homogenously spread and viable cells, scale bars 100
µm (c, d). Permission to publish figure (a) was obtained from Elsevier [175]. Figures (b,
c, d). were adapted from Hilmi et al [174], open access article published under Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0 ).
Gellan
Gellan gum is a FDA approved product that is regularly used in the food industry as a
thickener. It is a hydrophilic anionic polysaccharide produced by the bacterium Pseu-
domonas elodea that consists of D-glucuronic acid, L-rhamnose and D-glucose subunits
[176]. The favourable physicochemical features of gellan has generated much interest for
its use in pharmaceutical and biomedical applications [130]. The enzyme galactoman-
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nanase can degrade gellan [177], but also common human enzymes such as lysozyme or
trypsin [178]. Native gellan gum is acylated and is often referred to as high-acyl group,
the deacylated form (or low-acyl gellan) is more commonly used in tissue engineering
(chemical structure illustrated in Figure 1.9), the rate of degradation is slower in low acyl
group gellan as shown by Lee et al [179]. However, it remains unclear whether gellan
completely degrades in the body as Ferris at al noted degradation in terms of mass loss
up to 28 days, but no further degradation in the following 140 days [180].
Figure 1.9: The chemical structure of low-acyl gellan gum.
In terms of tissue engineering, gellan-based injectable materials have previously been
used for cartilage reconstruction [181]. Various autologous cell types such as preosteoblasts,
fibroblasts and chondrocytes were successfully encapsulated within a hydrogel [181, 182].
Furthermore, a topical application of gellan in the form of an anti-adhesive and non-toxic
dressing was found to stimulate healing and improved the scarring outcome in a rodent
study [183]. However, no gellan based skin sca↵olds are available for clinical use at the
moment.
Dextran
Dextran is a hydrophilic natural polysaccharide produced by bacteria and its degradation
occurs via phagocytosis [184]. Dextran derived hydrogels can be formed by chemical or
physical cross-linking or via radical polymerisation. Since dextran based hydrogels have a
limited cell adherence and do not seem to a↵ect cell viability, they have been used in drug
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delivery. These features in combination with slow degradation have limited its use for
tissue engineering in wound healing. Therefore, research groups have attempted to tailor
the properties of dextran hydrogels to improve its cell adhesion [185], biocompatibility
[186] and have modified its degradation profile [187] to ultimately enhance functional-
ity in tissue engineered sca↵olds for burn wound healing [188]. The application of an
acellular dextran hydrogel has been investigated in full thickness burns in mice and was
found to stimulate angiogenesis and skin regeneration [188]. Similar results were seen in
a full thickness porcine model, and additionally an improved dermal reconstruction and
re-innervation was observed [189]. More recently, a hypoxia–inducible dextran hydrogel
promoting neovascularization has been proposed by the same research group [190]. In
terms of cell delivery to wounds, keratinocytes have been seeded into collagen-coated dex-
tran microspheres transplanted as micrografts to full thickness wounds in athymic nude
mouse model, but intradermal epithelial cysts were formed possibly due to high carrier
adherence and slow degradation of the microspheres [191].
Hyaluronic acid
Hyaluronic acid (HA) is an anionic, linear polymer that is present in all living organisms
and can be found in connective tissue especially in the dermis of the skin, but it is also
abundant in vitreous humor of the eye and synovial fluid. It can be derived from many
tissues via extraction and enzyme digestion methods or by bacterial synthesis. HA is an
important glycosaminoglycan consisting of d-glucuronic acid and N-acetyl-d-glucosamine.
Degradation in natural tissue occurs by enzymatic cleavage with di↵erent types of en-
zymes among tissues [192]. Rapid biodegradation is found to be problematic in certain
biomedical applications, for example, in a rodent study a half-life of only 24 hours fol-
lowing joint and skin injection was found [193]. Hence, for biomedical applications HA
requires modification to be able to form a hydrogel and also to reduce biodegradation
in vivo [194] which then can be administered by injection or incorporated in dressings
[195]. Examples of HA hydrogels formed by chemical crosslinking are dermal fillers with
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prolonged durability, histological studies have reported HA presence in the skin for up
to 9-23 months [196]. As a highly hydrophilic polymer its use as lubricant and biolog-
ical absorber injected to deteriorating joints has been widely explored [197]. A variety
biological functions of HA have been recognized such as its role in cell motility, adhesion
and regulation [198]. The chain length and molecular weight of hyaluronic acid plays an
important role in its biological function. In an in vitro cell study, rat cardiomyocytes
underwent ischemic-reperfusion injury and were incubated with low molecular weight HA
(LMW-HA, 100 kDa) or high molecular weight HA (HMW-HA 1000kDa) and it was found
that cell viability and wound healing (scratch wound assay) of HMW-HA pre-treated cells
were significantly improved. Proteomic expression assays demonstrated a significant re-
covery of cytoskeleton regulation proteins in samples following injury when pre-treated
with HMW-HA and not with LMW-HA, suggesting cytoskeletal rearrangement by HMW-
HA [199]. Likewise, Wu et al investigated the e↵ect of HA in chemically burned (alkali)
human corneal cells and suggested superior cell viability and more rapid wound healing
in cells treated with HMW-HA (1525 kDa) when compared to LMW-HA (127kDa) [200].
However, in other studies focussing on wound healing, small HA fragments seem to have
a beneficial e↵ect on wound healing [201], potentially due to its role in stimulating pro-
inflammatory mediators [202]. Advantages of LMW-HA is its solubility in serum making
it suitable for systemic distribution. Furthermore, HA can bind to CD44 and receptor
for HA-mediated motility (RHAMM) cell surface receptors. Binding of HA to CD44
triggers internalization, because CD44 is overexpressed in cancer cells it can be used in
anticancer drug delivery [202]. HA interaction with RHAMM is linked to cell motility
and cell focal adhesion and interplays with CD44. HA can be functionalized with cell
adhesion peptides to enhance cell attachment to other cell types [195]. The diversity in
chemical modification techniques o↵ers opportunities for copolymeric biomaterials and
makes HA a versatile polymer for the use in tissue engineering. Cells that are naturally
surrounded by HA rich connective tissue in the body have commonly been encapsulated
into HA sca↵olds such as chondrocytes and dermal fibroblasts. A plethora of biomedical
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materials based on hyaluronic acid derivates have been commercialised for deteriorating
joints, (commercial) skincare and wound healing purposes. For wound healing specifically,
rodent full thickness skin wound models have suggested a beneficial e↵ect of HA to wound
healing [203] using sca↵olds containing HA [204–208]. A sca↵old available for human use
is hyalomatrixr (Anika therapeutics, former Fidia Advanced Biopolymers, Padua, Italy),
a sterilized matrix based on hyaluronic acid derivate (benzyl ester of hyaluronic acid)
with an outerlayer of semi-permeable silicone. The sca↵old can be directly delivered to
the wound bed and aims to attract cellular ingrowth of fibroblasts and ECM components
and promote vascular ingrowth. It has been used as dermal replacement in serious sur-
gical wounds [209] and following scar release in adult patients with final autologous skin
graft applied to most patients in 2-4 weeks after sca↵old placement [210]. Gravante et al
used Hyalomatrixr in paediatric burn patients as dermal replacement therapy following
dermabrasion debridement and considered it safe to use and reported no adverse events
[211]. However, no large good quality control studies in humans are available that focus
on wound healing. Hyalograftr is a HA sca↵old seeded with autologous human dermal
fibroblasts. Han et al compared the use of an acellular HA sca↵old (Hyalomatrix) to
the same sca↵old seeded with human dermal fibroblasts (Hyalograft) in terms of wound
healing in 35 patients with a soft tissue defect to the face following basal cell carcinoma
removal. Although the study lacks statistical power, the outcomes were in favour of the
cellular sca↵old with less scar contracture and a flatter scar compared to the acellular
sca↵old [212].
Starch
Starches can be derived from widespread available plant sources such as potato, corn, rice,
oat [213], or wheat [214]. Thermosensitive starch hydrogels can be formed by  -glycerol
phosphate cross-linking [215]. Chemically modified starches have been used for drug
delivery and tissue engineering. For example, an injectable starch-chitosan hydrogel was
developed for the delivery of chondrocytes by Viyoch et al. Due to the non-ionic nature
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of starch it can easily blend with other polymers and in this study, starch was found
to increase the pore size and water absorption ability of the resulting polymer blend
[215]. Although, starch-based hydrogels are easily available and degraded by enzymatic
degradation it has not been widely explored for wound healing purposes [214].
Proteins
A protein is a linear polymer made up from amino acids. The DNA code in cells is con-
verted to synthesize proteins, a process undertaken by a range of other cellular compo-
nents, the type and composition of the amino acids determines the proteins’ final structure
and function [216]. Proteins can be derived from blood products (fibrin), mammalian tis-
sue (collagen, gelatin and elastin) or other animal products (silk fibroin and silk sericin).
Advantages in using proteins are that they are biodegradable and usually enhance cell
adhesion to the sca↵old. Some disadvantages are a low mechanical strength of protein
skin sca↵olds and the availability and costs of human/animal products. The properties of
proteins for the use in skin sca↵olds are listed in Table 1.1. The most abundant protein
in the human body and the main structural component of the dermal layer of the skin, is
collagen. Therefore, many bio-engineered skin sca↵olds consist out of collagen. However,
researchers have been exploring other proteins for the development of skin sca↵olds. Here,
we describe those proteins that have most commonly been incorporated in cellular and
acellular skin sca↵olds.
Silk proteins
Silk produced by the silk worm Bombyx mori contains two major proteins named silk
sericin and silk fibroin. Due to its mechanical strength and biocompatibility, fibroin has
been widely used in textiles, drug delivery and as a biomaterial [217]. For example, a
fibroin/hyaluron sca↵old supporting mesenchymal stem cell adhesion has been developed
[218]. Alterations to fibroin degradability and surface modification have been successfully
performed to meet biomedical needs [219]. Fibroin fiber ropes have been used as suture
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material for closure of surgical wounds for many years, and this clinical success has paved
the way for its use in other di↵erent biomedical applications such as solubilized fibers
to produce sponges, films and hydrogels used in wound healing and tissue engineering
[220]. For example, in the development of a tympanic membrane replacement, a fibroin
substrate that stimulates human keratinocyte growth was engineered [221].
In contrast, silk sericin has not yet been explored that extensively, and for many years silk
sericin was discarded as a waste product in the derivation of fibroin. Sericin is the glue that
is found between the fibroin fibers. Its positive features such as non-immunogenity, serum-
dependent cell-adherence and its specific anti-oxidant, anti-bacterial and anti-coagulative
features make sericin a promising candidate for biomedical applications such as in skin
regeneration [222–224]. Teramoto et al described a low cell-adherence where other stud-
ies have shown a high cell adherence in di↵erent cell types [223–225]. These contrasting
results might be explained by a serum-dependent cell adherence of sericin.
Fibrin
Fibrin is an insoluble protein, a product from fibrinogen found in blood plasma. Upon
tissue injury the proteolytic thrombin is activated which cleaves the soluble fibrinogen into
the insoluble protein fibrin. Because it naturally forms a fibrous mesh that acts as blood
clotting agent, it has been widely investigated for wound healing applications. Especially,
as a haemostatic tissue sealant [226] in surgical wound closure where a hydrogel can be
dripped or sprayed onto a wound surface to enhance healing or as glue when subsequently
a skin graft is applied on top. Fibrin has been translated to clinical practice success-
fully in the form of a spray, powder or sheet consisting of fibrin, thrombin, calcium ions,
factor VIII and a protease [227]. This tissue sealant has shown to enforce engraftment
of autologous skin grafts in burn wound care [228] and skin substitutes [229]. Because
activation by thrombin is required these products are usually provided in a dual syringe
system that can mix upon application to the body. Some products such as Cryosealr
(Thermogenesis, US) [230] and Vivostatr (Vivolution A/S, Denmark) utilize autologous
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blood plasma for on-site preparation of the sealant, however, this can be a disadvantage
in patients that are potentially haemodynamic unstable. An alternative is the use of FDA
approved human pooled plasma (Artiss). However, the high costs of the system limits its
widespread use globally [228, 231]. Other proteins that have been used as tissue sealants
are gelatin and albumin, however gelatin has not been used for skin wounds. Although
albumin based tissue adhesives are FDA approved for cardiac and vascular surgery [232],
no reports in skin wounds have been found. Also polysaccharides like chitosan, chitin,
dextran, chondroitin sulfate, hyaluronic acid can be used to form tissue adhesives [227].
Chitosan as a positively charged polymer is thought to attract red blood cells which ac-
celerates the blood clotting. A sponge form of chitosan is on the market as haemostatic,
adhesive material in acute wound care [172]. Although dextran, chondroitin sulfate and
hyaluronic acid show promise as tissue adhesive in corneal defects [233–235], their use in
skin wounds has not been explored yet. Fibrin is easily degraded by proteolytic enzymes
in the body and therefore fibrin-hydrogels or sca↵olds usually have weak mechanical prop-
erties. Improving these mechanical properties can be achieved by optimizing crosslinker
concentration, pH [236], or utilizing degradation regulators and fibrin stabilisers such as
aprotinin and tranexamic acid [237]. Additionally, to reinforce fibrin sca↵olds they can
be combined with other polymers to form interpenetrating polymer networks (IPN) [238].
Encouraging results have been established by a fibrin-hyaluronic network with increasing
structural stability of the gel, but decreased proliferation of encapsulated fibroblasts oc-
curred in sti↵er materials [239]. Besides its role in blood clotting, the fibrin network is
also a nest for cells to attach, proliferate and migrate through. Fibrin as a sealant has also
been used to coat sca↵olds for improved cell adhesion [240] and in bilayered substitutes
as a natural barrier to separate the epidermal and dermal layer. Due to its high bio-
compatibility and high a nity to cells, a variety of cell types have been encapsulated in
fibrin carriers such as fibroblasts [241], keratinocytes [242, 243], mesenchymal stem cells
[123] and combinations of cells seeded into or onto fibrin sca↵old [244] or gels [195, 245].
Although, degradation of autologous fibrin is rapid, no toxic by-products are released in
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the natural degradation process and no rejection occurs upon transplantation. Fibrin
gel in its natural form seems most suitable for applications that do not require a high
mechanical strength or long duration in situ. Recently, the addition of angiogenesis stim-
ulating factors to fibrin sca↵olds has been shown to improve the regeneration of ischemic
tissue [246]. Interestingly, higher thrombin concentration in fibrin matrices appears to
diminish neovascularisation and epithelisation time [247]. This is potentially due to slow
sca↵old degradation as thrombin activates factor XIII which induces the cross-linking of
fibrin monomers and consequently reduces the natural degradation process.
Collagen
Collagen is the most abundant protein in the human body and the main component of
the extracellular matrix [248]. It is the main structural protein in the dermal layer of
the skin with an essential role in wound healing. Therefore, many skin sca↵olds have
been developed based on collagen as primary component [249]. A total of 29 collagen
types have been described. Collagen type 1 is most frequently used in skin sca↵olds as
it is the abundant protein in native dermal tissue. In the early 80’s Burke and Yannas
published their first clinical study of a permanent artificial dermal template based on
bovine collagen and shark chondroitin 6-sulfate which led to the development of the
commercialised dermal substitute Integra [250, 251]. At the same time, the first burn
patient was treated by grafting of their wounds with cultured autologous keratinocytes
[44] following the method that Rheinwald and Green had developed just a few years
before [40, 43]. Based on the recent developments in that decade Hansbrough and Boyce
were able to develop a collagen-glycosaminoglycan sca↵old seeded with viable cultured
autologous keratinocytes and fibroblasts and published successful engraftment into burns
patient [99].
Ever since, collagen-based materials in di↵erent forms have been developed for wound
healing and translated to clinical practice. Such as hydrogels for hydration of dry wounds
(Woun’Dresr Collagen Hydrogel), as injectable sca↵old [65], collagen sponges [143] (Skin-
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Temp™II Dressings for superficial wound and blisters), powder [252] and an extensive list
of collagen films/dressings [253]. The natural mechanical strength of collagen is weakened
by its extraction process. To reinforce the collagen and control its in vivo degradation,
new bonds can be formed by in vitro crosslinking. Collagen hydrogels are typically formed
by chemical, physical or enzymatic crosslinking [249]. Such as in Pelnacr, a lyophilized
porcine atelocollagen porous sponge that is crosslinked by 0.05 M acetic acid contain-
ing 0.2 wt% glutaraldehyde [254]. For biomaterials, chemical crosslinking is usually less
suitable as cytotoxicity can occur upon degradation in vivo [255]. Other forms include
composite acellular skin substitutes such as Biobrane, Integra [256] and Matridermr [64].
In Matridermr collagen type III and V is incorporated in combination with type 1 collagen
and coated with elastin hydroxylate [257].
The majority of cellular skin sca↵olds available on the market are based on animal
derived collagen. Collagen based cellular skin substitutes include Orcelr, StrataGraftr,
Apligraftr [84, 258], DenovoSkinr, Transcyter [259] and Engineered Skin Substitute
(ESS) [260]. These substitutes are incorporated with autologous cells from a healthy part
of the patient’s skin or allogenic cells. More recently, the incorporation of adipose derived
stem cells in a collagen hydrogel was investigated and seem to improve wound healing in
a rodent burn model [261].
Collagen gels as bio-ink [262] and in cell-laden bioprinted sca↵olds have also been
studied. For example, in an attempt to stimulate vascularisation in neural tissue, Lee et
al conducted an experimental study where cells, collagen and VEGF-releasing fibrin gel
were bioprinted to form a sca↵old [263].
Hydrogels in burn care
Hydrogels currently available for patient care have been reviewed by many researchers,
but a skin substitute that is able to achieve complete skin regeneration has not yet been
reported [84, 264–267]. However, hydrogels play a promising role in the development
of next generation skin substitutes in burn care and are often used as wound dressings
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[141, 268], regenerative sca↵olds or delivery devices for cells and therapeutic e.g. drugs,
growth factors etc. Hydrogels have several characteristics to promote skin healing such
as the ability to absorb and release water, which is useful in regulating burn wound
exudate. Furthermore, the architecture of hydrogels can be modified to mimic the body’s
own extracellular matrix and their tunable mechanical properties can provide customised
elasticity and flexibility [127, 269] and make them suitable candidates for skin regeneration
[68, 261, 270–274].
1.8 Methods of spray deposition
1.8.1 Spray parameters and cell viability
Cell transplantation can be achieved by several techniques. In this section the focus lies on
cell transplantation to the tissue via aerosol or spray delivery. Sprayed cells are expected
to be damaged at time of impact to the receiving surface. Following impact, the cell
membrane can elongate and deform. Cell rupture and subsequently cell death can occur
in largely overstretched cell membranes [275]. More precisely, cells can tolerate a cell
membrane area stretch of up to 5% before it becomes detrimental to cell survival. Cell
elongation, deformation and subsequent cell survival depends on many variables such
as target surface characteristics, viscosity of the transporting fluid/media and velocity
of the delivered cell containing droplet, nozzle distance and diameter. Veazey et al.
investigated the cell viability of xenogeneic 70% confluence fibroblasts immediately after
aerosol delivery with an airbrush system and their growth behaviour in a culture model
[276]. The airbrush system used could be adjusted for di↵erent nozzle diameters (312, 494,
746 µm) and air pressure at delivery (ranging from 41 kPa to 124 kPa). It was found that
cell viability directly measured post aerosol delivery significantly decreased with higher
pressure and smaller nozzle diameter. For cell proliferation studies, only the highest
pressure with smallest nozzle diameter combination showed a delayed population doubling
time and the time to reach confluence was doubled [276]. In another in vitro study
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with 80% confluence neonatal dermal rat fibroblasts an analytical model was proposed to
describe the impact of several spray parameters in a droplet-based spray application to
the cell viability. Sti↵ness of the tissue surface, high cell-viscosity and cell velocity had
a negative influence on cell viability post spray impact, whereas a larger cell-containing
droplet diameter had a positive e↵ect on cell viability. The latter was explained as a
cushioning e↵ect of the droplet to the surface protecting the cell within the droplet [277].
In other words, cell viability is expected to be highest in large and low-viscosity single cell-
containing droplets sprayed with low-velocity onto a soft tissue surface. Wounds would
serve as a soft receiving surface for cell transplantation and can be expected to be highly
viscous when hydrogels are used. Hence, tailored spray devices, with pressures and nozzle
diameters optimized for cell survival can play an important role in improving cell delivery.
1.8.2 Spray systems
Spray systems are being widely used in many industries. Surprisingly little research has
focused on the influence of the type of aerosol device on mammalian cell survival after
transplantation.
Low and high pressure spray nozzle
Fredriksson et al. evaluated 7 di↵erent application techniques for cell transplantation on
cell viability and proliferation in an in vitro study. Based on current clinical practice they
included commercially available spray systems: spray nozzle systems such as the Harvest
SK/S Spray Applicator Kitr, high and low pressure Tissomat applicator in combination
with a Duploject™ spray nozzle, a Duploject™ spray nozzle without additional pressure
control and two non-spray systems: pipetting and paintbrushing. This study showed an
approximate 50% drop in viable cell count immediately after transplantation when using
a high pressure device (200 kPa) and a further decline to nearly 40% viable cell count after
2 weeks of culturing, which was comparable to the paintbrush [278]. In contrast, Harkin
et al. measured a 20% higher post aerosol delivery cell survival with similar pressures
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[279]. The immediate cell survival is comparable with other studies utilising low pressure
delivery methods/systems [276]. Although no statistically significant di↵erences were
displayed, the poorest cell viability after 2 weeks was seen in the high pressure device and
paintbrush [278]. Fredriksson et al. hypothesised that an additional application of fibrin
sealant might improve cell survival. Furthermore, the authors emphasized the importance
of measuring the proliferation capacity of cells post aerosolisation, since a large di↵erence
was seen in their data among the di↵erent devices. Interestingly, the delivery pressure and
nozzle diameter of clinically used manual cell spray devices is unclear and might impact on
cell viability and proliferation capacity. Aerosol delivery with handheld airbrush systems
with adjustable airpressure supply have also been previously investigated and studies
have demonstrated consistent acceptable cell viability of above 80% with low delivery
pressure (below 69 kPa) [276]. According to Veazey et al, this system should also be
compatible with alginate, gellan, hyaluronic and hyaluronate-based hydrogel cell carriers
[280]. However, to date, there is no published data to support this statement.
Liquid atomizer
Liquid atomizers or nebulizers originally designed for aerosol drug delivery to the trachea
have also been explored for cell delivery. In burns, inhalation injury can occur with
damage to the trachea and drug- or cell delivery could be used to improve the healing of
these injured areas. Sosnowski et al. investigated the use of 5 di↵erent atomizers for cell
delivery to the trachea in terms of cell viability. However, a droplet size below 20 µm was
found to be incompatible for fibroblast encapsulation and 3 nebulizer devices had to be
excluded. The nasal atomizer (NA) and Microsprayer Aerosolizer (MSA) had above 90%
viable cells post spraying, but the viable cell count in the NA group declined to 65% 48h
after spraying, indicating that it was a more destructive aerosol technique [281].
All spray cell delivery techniques have been investigated in vitro or rodent studies, which
has led to the development of commercial spray devices that are now available in clinical
practice for burn wound treatment.
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1.9 Potential therapeutic applications
1.9.1 Future approaches keratinocyte transplantation
Several reviews in the last decade have discussed the future implications of skin tissue
engineering and/or specifically keratinocyte cell transplantation in the treatment of burns
[36, 37, 55, 266, 267, 282]. Larger burn wounds often require mesh grafting. Autologous
epidermal cell transplantation can complement mesh grafting by stimulating rapid epithe-
lialization, which is highly desirable to improve patient’s chance of survival and eventually
improve scarring. Burns specific clinical studies investigating keratinocyte transplantation
are available, but due to heterogeneity of the studies and di↵erent outcome parameters
the evidence remains low. Comparative trials with standardized outcomes and ideally
randomized treatment for available cell transplantation techniques are required. Due to
the disadvantages of CEA sheets, future research is focused on optimizing keratinocyte
proliferation by transplantation of pre- or sub confluence cells. Further improvement of
keratinocyte culture method in terms of culture time, reducing infection risk and elimina-
tion of xenobiotic products and also antibiotics needs to be further investigated. Graft at-
tachment in keratinocyte transplantation remains an important focus for research. Boyce
and Supp developed a cultured skin substitute containing cultured human keratinocytes
and fibroblasts attached to a collagen-glycosaminoglycan matrix which seems to form a
basement membrane at the dermal-epidermal junction in vitro [283]. Importance of base-
ment membrane formation and rapid epithelialisation has to be taken into account in next
generation cell spray or carrier delivery methods [283, 284].
1.9.2 Future spray cell delivery systems for burns wound care
Spray cell delivery to burn wounds can overcome the major issues of conventional grafting
techniques by reducing donor site and enhance fast re-epithelialisation. The available
delivery systems can be improved by optimizing spray features to aim for high cell viability
and proliferation. This should be tailored according to cell type and receiver surface.
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Spray features to optimise might be: air delivery pressure, nozzle designs, carrier type
and depending on technique of delivery, cell containing droplet size [276, 277, 281, 285].
Further research should take into account the importance of preventing cell damage, since
this could reflect poor proliferation [276, 278]. Hydrogels could potentially serve as a
mechanical protection for the cells during transplantation and provide structural support
once transplanted. Although in vitro studies have shown good short term cell survival
post aerosol delivery, clinical studies have not been able to show similar results as yet.
The challenge for researchers is to develop a feasible spray delivery system with acceptable
cell viability and proliferation which can be translated to clinical studies. Also, current
clinical cell spray devices could potentially benefit from these optimized features.
1.10 Thesis overview
Spray cell delivery to enhance wound healing is limited by its carrier causing cell spillage.
In this thesis a biocompatible hydrogel as cell carrier has been developed aiming to im-
prove uniformity of the spray distribution and adherence to the receiving surface while
maintaining cell viability as graphically illustrated in Figure 1.10. The development and
material characteristics of a suitable cell carrier for spray delivery are presented in Chap-
ter 2. E↵ects of encapsulation and spraying on cell viability and function have been
investigated in Chapter 2 and Chapter 3. Chapter 4 presents the formulation of a gellan
hydrogel wound dressing containing acetic acid to treat burn wound infection. Finally,
Chapter 5 provides a summary of the findings, limitations and directions of future work
based on the presented results in this thesis.
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GELLAN-BASED FLUID GEL CARRIER
The following chapter includes work that was also presented in the published paper A
gellan-based fluid gel carrier to enhance topical cell spray delivery 2.
Autologous cell transplantation was introduced to clinical practice nearly four
decades ago to enhance burn wound re-epithelialisation. Autologous cultured
or uncultured cells are often delivered to the surface in saline-like suspensions.
This delivery method is limited because the sprayed suspension forms droplets
upon deposition that run across the wound bed, leading to uneven coverage
and cell loss. A way to circumvent this problem would be to use a gel-based
material to enhance surface retention. Fibrin systems have been explored as
co-delivery system with keratinocytes or as adjunct to ‘seal’ the cells following
spray delivery, but the high costs and need for autologous blood has impeded
widespread use. Aside from fibrin gel, which can exhibit variable properties,
it has not been possible to develop a gel-based carrier that solidifies on the
skin surface. This is because it is challenging to develop a material that is
sprayable but gels on contact with the skin surface. This study reports the
use of an engineered carrier device to deliver cells via spraying, to enhance
retention upon a wound. The device involves shear-structuring of a gelling
biopolymer, gellan, during the gelation process; known as a fluid gel. The
formulation of gellan gum fluid gels are reported, formed with 0.75 or 0.9%
(w/v) polymer and varying salt concentrations. The rheological properties and
the propensity of the material to wet a surface were determined for polymer
modified and non-polymer modified cell suspensions. The gellan fluid gels had
a significantly higher viscosity and contact angle when compared to the non-
polymer carrier. The shear thinning property of the material enabled it to
be applied using an airbrush and spray angle, distance and air pressure were
optimised for coverage and cell viability. Viability of human fibroblasts was
not impeded by encapsulation in the gellan fluid gel or spraying, platelets were




Large surface area wounds, such as those seen in burns patients, compromise the bar-
rier function of skin and when coupled with extensive fluid loss causes an impairment
of vital bodily functions which can result in death. Rapid epithelialisation is essential
to restoring the function of the skin and in the longer-term, to reduce the likelihood of
scarring [286]. Current clinical practice includes transplantation of autologous skin from
a healthy site of the body, however, challenges arise when a limited number of donor
sites are available. One approach to overcome this issue is to deliver autologous skin cells
(usually keratinocytes) in suspension following a period of culture, or directly after har-
vest from the patient, to the wound [287]. Cell transplantation techniques have evolved
from syringe-dripping to spraying systems [47]. The major advantage of the spray tech-
nique is rapid delivery to large and geometrically complex areas of the body. For medical
applications, a minimum distance of 10 cm from the body is necessary to allow safe appli-
cation without the risk of an air embolus, this is easily achieved in topical application (in
comparison with endoscopic surgery). Even though spraying presents great potential for
topically applying cells in suspension, there are still many drawbacks, including: spillage
of cells from the wound bed and uneven spreading [47, 288]. This results in the applica-
tion of dressing materials around the wound as a means to retain as many cells on the
wound bed as possible [289]. Although poor retention is considered a critical disadvantage
of the cell spraying methodology amongst clinicians, it has not as of yet received much
attention within the published literature. Autologous fibrin sprays similar to fibrin glue
have been proposed to retain sprayed epithelial cells at the wound [229, 288]. High costs
and the need for patient’s own blood-derived fibrin, however, have impeded widespread
use of this technique to date. While hydrogels have gained huge and sustained interest for
therapeutic delivery systems, development of a practical system for topical spray delivery
is technically challenging; requiring either in-situ gelation on the surface of the wound or
a su ciently high viscosity to be retained on the wound but not clog the spray nozzle.
Fluid gels have shown continued promise to address these issues, whereby at rest act
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in a pseudo-solid fashion but can be made to flow under shear [269]. This is derived
through the processing of a hydrogel during its sol to gel transition. The application of
shear during the sol-gel transition has been previously shown to support the formation
of discrete gel particles, which in close proximity interact with one another in suspension
to give reversible shear thinning and solid-like behaviours. Furthermore, fluid gels have
been previously shown to demonstrate yield stresses once at rest [290]. The presence of
yield stresses and yielding behaviours has generated much debate within the rheological
literature, due to a long understanding that “everything flows” [291]. However, it is gen-
erally accepted that in practise, within timescales relevant to the material in question, a
material has a yield stress if it does not flow below a defined threshold [292]. The im-
portance of engineering yield-stresses into fluids has been recently highlighted by Nelson
and Ewoldt [292] demonstrating a clear set of design principles for such materials. Here
they have highlighted the synergistic link between customer need/material specification
and the materials microstructure, allowing for its application, an example of this would
be paint where the presence of a dynamic yield stress allows it to “stick” to the wall
without running [293, 294]. Such principles were used to design a biopolymer hydrogel
with viscoelastic properties that allow the material to liquefy when passing through the
nozzle, but restructure to a weak gel on the receiving surface. Thus, facilitating reten-
tion of cells on the receiving surface and not impair the spraying process itself (Figure 2.5).
Biopolymer hydrogels are widely used in burn wound care as dressings, and tissue-
engineered sca↵olds with or without bioactive compounds [127]. These gel systems can
mimic the 3D architecture of native extracellular matrix (ECM)[127]. The ability of
these gels to entrap relatively large volumes of water per %wt of polymer is beneficial for
maintaining a moist wound environment and allows for rapid di↵usion of nutrients and
metabolites [295]. Gellan gum was used as the biopolymer of choice in this study because
it can be processed into a hydrogel with highly tunable mechanical properties [269]. Gellan
gum hydrogels can be designed for many biomedical applications [296] and in many forms
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including shear-thinning gels named ‘fluid gels’ [297, 298]. To date, surprisingly little
research has focused on quantifying the uniformity of sprayed solutions for wound coverage
and the influence of spraying on mammalian cell survival after transplantation [276, 278].
This study addresses some of the problems of current spray delivery systems and proposes
gellan fluid gel as a material that could be utilised to enhance cell retention on a surface
following spraying.
2.2 Material and methods
2.2.1 Fluid gel preparation and characterisation
Low acyl gellan gum stock solutions 1% (w/v) and 0.83% (w/v) were prepared by the
addition of gellan powder [Kelcogelr obtained from Azelis, Hertford, UK] to sterile water
at 65 °C under constant agitation. Following, stocks of NaCl cross-linker solutions were
prepared to concentrations of 0.1, 0.2, 0.3, 0.4 and 0.5 M in sterile water. Final polymer
sols were subsequently formed by mixing aliquots of both gellan with cross-linker stock
solutions (9:1) at 65 °C, resulting in final concentrations of either 0.9% (w/v) or 0.75%
(w/v) polymer - 10 mM, 20 mM, 30 mM, 40 mM and 50 mM NaCl. Gellan sols were then
added to the cup of a couette (Cup diameter 28 mm, vane diameter, 26 mm) rheometry
set-up (Kinexus Ultra, Malvern Pananalytical, UK) at 60 °C. After allowing thermal
equilibrium to be reached, the system was cooled at a rate of 1 °C min 1 to 20 °C under
constant shearing, 450 s 1; unless stated otherwise. Post-production shear was removed,
and fluid gels stored at 4 °C until further testing/use.
2.2.2 Rheological measurements
All rheological measurements were performed at 25 °C using a Kinexus Ultra rheometer
(Malvern Pananalytical, UK) equipped with 40 mm parallel plates (1 mm gap height), 48
hours post-processing.
Small deformation rheometry was undertaken varying both amplitude and frequency.
51
Amplitude data was obtained in strain-controlled mode, ranging from 0.1 to 500% log-
arithmically at a constant frequency of 1 Hz. Linear viscoelastic regions (LVRs) were
determined and a common strain of 0.5% was found to be common across all systems.
This strain was then used for all frequency sweeps ranging between 0.1 and 10 Hz. Single
frequency data was collected as a function of temperature at 0.5% strain and 1 Hz. Tem-
perature ramps were applied at 1 °C min 1 and moduli (G’ and G”) obtained.
Non-linear rheology was determined using shear ramps in shear rate mode. Ramps
were undertaken from 0.1 to 600 s 1 logarithmically over a 3-minute timescale. Hysteresis
of the systems was probed by undertaking a second sweep immediately after the first, from
600 s 1 back to 0.1 s 1. Data from the second ramp was fitted to the Herschel-Bulkley
model (Equation 2.1) to determine the dynamic yield stress ( y).
  =  y +K ̇n (2.1)
Where  y is the yield stress, K is the consistency factor,  ̇ is the shear rate and n is
the flow index.
The yield stress was compared to the maximum stress on the material at an inclining
substrate to investigate whether flow is induced. Maximum stress was determined by
Equation 2.2
 max = ⇢⇥ g ⇥ h⇥ (sin ) (2.2)
Where  max is the maximum stress on the material, ⇢ the material density (kg m 3),
g the gravitational acceleration of 9.807 m s 1, h is the height (m) and   the angle of
inclined substrate.
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2.2.3 Microscopy of fluid gels
Micrographs of the fluid gel systems were undertaken using a Leica DM6000 microscope
(Leica Microsystems, UK). Firstly, fluid gels were diluted at a ratio of 4:1 in PEG400, via
slow addition of the PEG under constant agitation. Post-dilution, one drop of the system
was dispensed onto a microscope slide and coverslip placed over the top. Images were
obtained at x20 magnification using phase contrast to distinguish between the continuous
and particulate phases. ImageJ was used to add scale bars. Images presented are typical
representations of the systems, compared against a minimum of 5 other micrographs.
2.3 Contact angle measurements
The static contact angle of sodium chloride and gellan fluid gel droplets on a variety of
surfaces at room temperature were determined by imaging and subsequent measurement
with ImageJ software using the DropSnake Plugin [299]. A 60 µl droplet was dropped
onto the test surfaces and imaged. Three repetitions were performed, each sample was
measured three times and the mean contact angle was calculated. Substrates used in-
cluded: gelatin 5% w/v (prepared with deionized water and bovine gelatin, stirred and
allowed to set at 4 °C for a minimum of 60 minutes), alumina ceramic (referred to as
ceramic), porcine epidermis and porcine subcutis. Porcine skin (Arun Meats & Lifestock
LTD, UK) was kept frozen and thawed before use.
2.4 Spray methods
Materials were delivered through an airbrush with external mixture and a standard
medium size nozzle of 750 µm in diameter (Badger, Universal 360 model, US) as il-
lustrated in Figure 2.1A. An oil-free air compressor (Badger BA1100, US) was used as
the air source with air pressure regulator. Air pressure at delivery (10-15 psi), nozzle
diameter (750 µm), application distance (10-15 cm) and spray angle from spray tip to
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receiving surface (45°) were standardized (Figure 2.1B). The airbrush system was cleaned
and the nozzle rinsed thoroughly with ethanol 70% and allowed to air dry in the lam-
inar flow hood before each spray cell experiment. Between experiments the nozzle was
purged with 1 ml ethanol 70% and 1 ml culture media to ensure no cells from a previous
application remained.
(A) (B)
Figure 2.1: Airbrush spray device and standardised set up
2.5 Spray analysis using water sensitive paper
For investigation of uniform distribution following spraying the individual droplet size,
droplet size distribution and area covered by the gel was compared to control liquid
(water or sodium chloride). Water-sensitive paper (WSP) of 26 mm x 76 mm (John
Rhodes AS Ltd, Evesham, UK) was utilized to compare gellan fluid gel to the control
liquid in a standardized fashion (Figure 2.2). Yellow coloured spray cards coated with
bromoethyl blue dye turn blue when in contact with water. Measurements included: the
percentage area covered by sprayed volume (%coverage), droplet size and droplet size
distribution. Volumes of 50 µl or 25 µl were sprayed with an airbrush onto the WSP and
allowed to dry for up to 60 min. A minimum of 3 repetitions was performed. Images
were obtained directly following spray application, dried spray cards were scanned at
600x600 dpi (Konica Minolta scanner, bizhub c3350). Images were analysed with ImageJ
Software, a colour threshold was set and the image was converted to a binary image.
Then, percentage of coverage was calculated by the ratio of original (white pixels) to
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Figure 2.2: Water-sensitive paper (WSP) sprayed with gellan and water
For droplet size the ‘Particle Analysis plugin’ was used. Obtained parameters include
droplet diameter (D) in mm, droplet area (A) in mm2 and total sprayed area (TSA) in
mm2. A value where 50% of the total sprayed volume consists of drops with diameter
larger than the median value and 50% smaller than the median value (DA50) could be
obtained from the data. Next, DA10 and DA90 were obtained, similar to DA50, but for
10% and 90%. Relative Span factor (RSF), a single number reflecting the uniformity of





2.5.1 HDF cell culture
Human dermal fibroblasts (HDF) were grown in Dulbecco’s Modified Eagle’s medium –
high glucose (DMEM) (Sigma, UK), supplemented with 10% fetal bovine serum (FBS),
1.5% penicillin-streptomycin and 2.5% L-glutamine. Culture media was changed every
2-3 days. Culture media was changed every 2-3 days and cells were harvested when they
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reached 80% confluence. Cells until passage 10 were used. All cultures were maintained
in the incubator under stable conditions of 5% humidity, temperature of 37 °C and 100
% humidity.
2.5.2 Fluid gel encapsulation
HDFs were detached from cell culture flask using TryplE solution (Sigma, UK), bu↵ered
with fibroblast culture media and centrifuged at 1000 rpm for 3 min. Cells were suspended
in gellan fluid gels (0.9% or 0.75% (w/v)) at a concentration of 1-2 × 106 cells/ml. Cell
solutions were pipetted on culture petri dishes or sprayed with the airbrush device into
cell culture treated 24-well plates and fresh culture media was added before samples
were incubated (at 5% CO2, temperature 37 °C, 100% humidity) for later experiments or
directly stained for imaging.
2.5.3 Live/Dead assay
Calcein acetocymethylester (Calcein AM) (Invitrogen, UK) was used to stain live cells
and Propidium Iodide (PI) (Invitrogen, UK) was used to stain dead cells. Calcein AM/PI
stain was added to 1 ml of DMEM, samples were immersed in 100 µl/ml of this solution
for 20 min in the incubator. Samples were visualized using confocal microscopy (Olympus,
Fluoview FV100), showing viable cells green (Calcein AM) and non-viable cells red (PI).
Laser setting 488 nm and 543 nm for Calcein AM and PI respectively. Cell viability was
measured with ImageJ software, images were split in the colour channels red (dead cells)
and green (live cells). For each sample, cells were automatically counted by using the
particle size plugin of ImageJ. Percentage of viable cells were calculated by Equation 2.5.
viable cells(%) =
number of viable cells
total number of cells (live+ dead cells)
⇥ 100 (2.5)
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2.5.4 Alamar Blue Metabolic Activity
Encapsulated and control HDFs were seeded or sprayed into 24-well tissue cultured plates
at a density of 5 x104 per well for cells in gel and 1 x104 for cells in medium. Fresh
growth medium at a volume of 1 ml was added, cells were then incubated for a minimum
of 24 hr (at 5% CO2, temperature 37 °C, 100% humidity) together with negative control
wells including medium and gellan fluid gel. Metabolic activity was assessed at day 1, 3
and 7 for all 4 conditions by incorporating 10% Alamar Blue reagent (Life Technologies,
UK) into the culture medium. After an incubation time of 4 hours, absorbance was read
at 570nm and 600nm using a microplate reader (Multiskan FC, Thermo Scientific, UK).
Percentage reduction was calculated by comparing absorbance to negative control wells
with Equation 2.6.
Percentage reduced(%) =
(✏ox2 ⇥ A1)  (✏ox1 ⇥ A2)
(✏red1 ⇥ B2)  (✏red2 ⇥ B1)
⇥ 100 (2.6)
A1 = absorbance at 570 nm test well
A2 = absorbance at 600 nm test well
B1 = absorbance at 570 nm control well
B2 = absorbance at 600 nm control well
Standard molar extinction coe cients for oxidized (✏ox) and reduced (✏red) form of
AlamarBluer were used:
✏ox1 = 80,586 at 570 nm
✏ox2 = 117,216 at 600 nm
✏red1 = 155,677 at 570 nm
✏red2 = 14,652 at 600 nm
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2.5.5 Statistical Methods
Mean values and standard deviations are plotted unless stated otherwise. Unpaired t-tests
and two-way ANOVA were performed using Prism 7 (GraphPad software, CA, USA) with
a significance of p<0.05.
2.6 Results
2.6.1 Fluid gel material and characterisation
Fluid gel production
The preparation of fluid gels has been depicted in Figure 2.3a using a schematic of the cup
and vane set-up. Here a constant shearing force is applied to a gellan sol as it is forced,
thermally as the system is cooled, through a sol-gel transition: as such the gelation
becomes confined by degree of shear applied, resulting in the formation of a particulate
suspension of microgel particles Figure 2.3b and Figure 2.3 [297]. The formation of such
systems was monitored via changes in viscosity as a function of temperature (Figure 2.3d).
Figure 2.3d highlights that at a critical temperature an increase in the system viscosity was
observed, dependent on the concentration of crosslinker in agreement with data published
for quiescent gels [300]. The increase in viscosity results from the formation of particles
which trap the continuous aqueous phase resulting in an e↵ective change in the particle
volume until a plateau is reached [301, 302]. Such particles were studied using optical
microscopy, showing anisotropic particles with varying length to width ratios (visually
observed) dependent on the salt concentration (Figure 2.3b and 2.3c, 50 and 10 mM
NaCl respectively).
Mechanical responses have been shown in Figures 2.3e and 2.3f, demonstrating the
typical viscoelastic properties of the fluid gel. Figure 2.3e compares the flow profile of the
fluid gel against that of the current standard used for cell spraying (0.9% saline solution).
The saline solution demonstrated a linear relationship between the shear stress and rate,
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Figure 2.3: Manufacture process and characteristics of gellan fluid gel. a) Fluid gel man-
ufacture process as adapted from Cooke et al, 2018 with permission [269]. Micrographs
of diluted 0.75% fluid gels in 4:1 PEG:gellan ratio, manufactured with 50 mM NaCl (b)
and 10 mM NaCl (c), scale bar = 100 µm. d) Flow profiles for the formation of gellan
fluid gel (0.75% (w/v), 10 mM and 50 mM NaCl) gelation of fluid gel occurs as tem-
perature is decreasing under a constant shear rate of 450 s 1. Values presented are of
one representative measurement. e) Flow profiles of post-production of gellan 0.9%, 20
mM NaCl demonstrated a non-Newtonian shear thinning behaviour with higher viscosity
at low shear compared to 200mM sodium chloride showing a linear relationship typical
of a Newtonian fluid. N=3 for gellan and N=2 for NaCl. Mean values presented, error
bars are SD (smaller than icon and therefore not visible). f) Frequency dependence of
0.9% (w/v) gellan fluid gel (20 mM NaCl) with gradually increasing G’ and G” modulus
under increasing frequency typical of a weak gel system. Mean values of 3 individual
measurements presented, error bars are SD (smaller than icon and therefore not visible)
typical of a Newtonian system where the viscosity is independent of the shear rate. In
contrast, the fluid gel exhibited a shear thinning profile, typical of such systems [297],
with a much greater viscosity in comparison to the saline. Linear rheology was further
probed using frequency dependent measurements to better understand the materials be-
haviour at rest (Figure 2.3f). Data suggests the formation of a weakly gelled network,
both dependent on frequency and displaying large values of Tan   (ratio of loss to storage
modulus; G”/G’) [303, 304], again previously reported as typical characteristics of such
59
systems [269, 297, 304]. The calculated loss tangent was >0.1 for all gels, as shown in
Table 2.1.
Table 2.1: Rheological properties of gellan fluid gels. All gels were fabricated with low
acyl gellan gum powder and cross-linked with sodium chloride (NaCl) until a final con-
centration of 0.75% (w/v) or 0.9% (w/v) with a constant shear rate (450 s 1) during the
gelation process. Flow profiles for 3 individual samples per gel composition was measured
at 25 °C and viscosity at a shear rate of 205 s 1shown, mean with standard deviation (SD)
is presented. Viscosity of all gels is higher than control liquid (NaCl) and dependent on
cross-linker and polymer concentration. G’ at frequency of 1 Hz is presented, %strain at
which loss of storage modulus occurs indicating the end of the LVR, loss tangent (G”/G’),
a loss tangent of >0.1 indicates a weak gel [304], as shown here all fluid gels compositions
can be considered weak gels. *1 sample of 200 mM NaCl was tested, viscosity measured




















10 mM 0.085 (0.001) 5.99 (0.17) 15.87 1.03
20 mM 0.076 (0.000) 10.45 (0.42) 12.00 0.70
30 mM 0.086 (0.002) 36.46 (3.42) 6.39 0.35
40 mM 0.110 (0.002) 105.74 (5.48) 4.02 0.21
50 mM 0.118 (0.005) 215.03 (35.89) 2.52 0.16
0.90% (w/v)
10 mM 0.117 (0.001) 12.54 (0.29) 12.00 0.84
20 mM 0.125 (0.003) 36.81 (1.28) 22.26 0.45
30 mM 0.135 (0.006) 94.45 (7.97) 6.39 0.27
40 mM 0.143 (0.002) 171.23 (10.36) 4.02 0.21
50 mM 0.177 (0.011) 388.47 (100.14) 2.52 0.17
Sodium chloride 200 mM - 0.004* - - -
Modulation of fluid gel properties
Manipulation over the material properties of the fluid gels was probed systematically as
a function of both polymer and cross-linker concentrations; with a view to improve the
characteristics required for enhanced “spray-ability”. Flow behaviour and viscosity for
the fluid gel systems have been shown in Figure 2.4a Figure 2.4b. All systems showed a
high degree of shear thinning as the shear rate was increased from 0.1 to 600 s 1 (Figure
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2.4a). Shear profiles were used to estimate the behaviour of the fluid during spraying.
This was achieved by comparing data. As previously described by Hendriks et al.[277]
the expected shear rate  ̇ encountered during spraying can be estimated by calculating





•  ̇ = shear rate in s 1
• V = velocity of liquid (m s 1)
• DN = diameter of nozzle (m)
Standard nozzle diameter of the airbrush is 750 µm (7.5 x 10 4 m). Flow velocity (v)
was calculated by Equation 2.8
Q = v ⇥ A (2.8)
• Q = volumetric flow rate (m3 s 1)
• v = flow velocity (m s 1)
• A = column cross-sectional area (m2)
For the standard nozzle size of 750 µm, the nozzle induced shear rate of gellan 0.9% hy-
drogel was estimated at 223 s 1. Viscosities were obtained and compared at the calculated
shear rate were derived from rheology testing (Figure 2.4b). For airbrush application, the
estimated viscosity of the material was shown to be a function of both polymer and NaCl
concentration. At comparative cross-linking concentrations, the higher polymer systems
resulted in increased fluid gel viscosities. Additionally, a linear correlation between cross-
linker concentration and viscosity was observed, again where higher concentrations of the
cross-linker formed more viscous suspensions. However, ultimately all systems were char-
acterised by a low spraying viscosity, 8.4 x 10 2 Pa.s (± 6.7 x 10 4) to 1.8 x 10 1 Pa.s (±
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Figure 2.4: Modulation of fluid gel properties. a) Demonstrates that gellan fluid gels
behave as shear-thinning materials (non-Newtonian), since viscosity decreased as shear
rate increased. Four compositions of gellan fluid gel (0.9% (w/v), 20 mM and 50 mM
NaCl and 0.75% (w/v), 20 mM and 50 mM NaCl) presented. b) Increasing crosslinker
or polymer concentration results in higher viscosity as demonstrated here. Data is mean
viscosity at shear rate 205 s 1 c) Amplitude dependence of storage and loss moduli in
gellan 0.9%, 20 mM as representative gel shows that under increasing strain eventually
G’ and G” will cross-over resulting in a G” dominated system indicating more liquid
like behaviour under high strain. Storage modulus as a function of the polymer and
salt concentration of 0.75% fluid gels (d) and 0.9% fluid gels (e) shows an earlier loss of
storage modulus (shorter LVR’s) in higher salt-concentrations. f) Frequency dependence
of four systems is shown here to illustrate influence of salt-concentration on viscoelastic-
properties, from viscoelastic-solids at 10 mM NaCl concentrations to gel-like behaviours at
50 mM NaCl concentrations. G” (open signs) and G’ (closed signs) values are presented.
Unless stated otherwise, mean values of three independent measurements are presented,
error bars represent the standard deviation. Mean values of 3 individual measurements
presented, error bars are SD (smaller than icon and therefore not visible).
1.2 x 10  2). Although such viscosities are considered in this case low, they are still over
an order of magnitude greater than the viscosity of the current standard delivery medium
used for cell spraying.
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The amplitude dependence (reflected in percentage strain) of the storage and viscous
moduli are presented in Figure 2.4c. Under increasing strain all tested compositions of
gellan fluid gels eventually underwent a cross over showing a transition in G’ dominance
to systems governed by G” (full data range shown in supplementary Figure A.3 panel
of gels). The data highlights one of the important properties of the fluid gels, where at
large deformations the suspensions act as liquid-like materials, enabling flow. Changes
in the degree of bulk suspension elasticity (G’) as a function of the polymer and salt
concentration has been demonstrated in Figure 2.4d and Figure 2.4e. Here both the
magnitude of G’ and length of the LVR were observed to be a function of the polymer
and cross-linker concentrations, with the LVR shortening and modulus increasing with
elevated salt concentrations.
Frequency data obtained for the fluid gel formulations highlighted a change in me-
chanical behaviour with frequency sweeps of 10 mM NaCl systems demonstrating initial
G’ dominated systems with clear cross-overs to G” domination Figure 2.4f and Figure
2.4g. However, at higher salt concentrations (>20 mM to 50 mM) plots showed G’ domi-
nance over the whole frequency range studied, with both G’ and G” demonstrating some
frequency dependence, typical of viscoelastic gel-like fluids. Gel strength was observed to
increase, described by a reduction in tan   (Table 2.1 and supplementary Figure A.1) as
a function of both salt and polymer concentration.
A simple experiment to demonstrate the clinical challenge of spray run-o↵ has been
shown in Figure 2.5a, in which the control (sodium chloride) instantly flows on vertical
tilted porcine skin surface in comparison to the retained fluid gel. Fluid gel hysteresis
was probed to study the time dependent behaviours of the systems post spraying, using
consecutive shear ramps: increasing and decreasing in shear rate (0.1- 600 s 1 and 600
to 0.1 s 1). Direct comparison of the flow profiles suggests little change, with a large
degree of the initial viscosity of the system is recovered almost instantaneously, Figure
2.5b. The rheological phenomenon known as the dynamic yield stress was examined to
describe the ability of the fluid gel to be maintained upon the skin without flowing. The
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Herschel-Bulkley model can be used to determine the yield stress of a fluid [305]. Data
fitted to the model presented for the second sweep (example shown in Figure 2.5c and
supplementary Figure A.2). Yield stress plotted as a function of the fluid gel formulations
have been presented in figure 2.5d (full data presented in Table 2.2). Fitting to the 10
mM NaCl systems for both polymer concentrations resulted in negative values, indicating
an inadequate means of describing the yield-stress fluid. However, a linear correlation
between NaCl concentration and yield stress was observed for the higher concentrations.
A simple gravitational model described for “sagging” was used to assess fluid gel resistance
to flow on an inclined plane. The gravitational forces, described as ‘maximum stress on
the material at an inclined surface’ were calculated with Equation 2.2 using the following
values: material density of 1020 kg m 3 for fluid gel (0.9%, 20 mM NaCl), assuming a
fluid gel thickness of 1.0 x 10 4 m and a substrate angle of 45°. The calculated maximum
stress was observed to be lower than the yield stress of the gel, with values of 0.85 Pa and
1.777 Pa respectively.
Spray-ability of the fluid gel carrier
Spreading properties of the fluid gels in comparison to saline solution were investigated
to gain further information of both coverage and run-o↵. The contact angles for the fluid
gel and control (NaCl) were measured on a variety of substrates, comparing their wetting
ability. Gellan fluid gels exhibited a significantly higher mean contact angle than NaCl
on gelatin (63.3° vs 44.4°, p<0.001), porcine epidermis (54.8° vs 25.37°, p<0.001) and
porcine dermis (59.7° vs 36.6°, p<0.001) describing lower wettability, resulting in reduced
spreading. There was no significant di↵erence found for contact angles on ceramic, with
a mean contact angle of 37.5° for gellan fluid gel and 35.8° for NaCl (Figure 2.6a).
Flow and spreading due to the thermo-responsive properties of the gellan was also
investigated. The e↵ect of increasing temperature on the degree of structure within the
fluid gels system was investigated as a function of G’ and G” (Figure 2.6b). Increasing
temperature resulted in a reduction in the storage modulus, as the junction zones that
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Table 2.2: Fitting parameters from the Herschel-Bulkley model for gellan fluid gels. Values
presented are mean of 3 individual measurements, yield stress (+ SD), K is the consistency
index, n is the flow index. E is standard error, presented for each fitting value and R square




















































1.600 2.921 1.454 0.423 0.030 0.9624
create the 3D matrix began to break down, resulting in fluid-like behaviour of the gels. In
general, a reduction in storage modulus appeared to occur between 30 – 40 °C for all gels,
as shown in (Figure 2.6c), this range includes peripheral skin temperature. Based on the
rheological data, gellan fluid gel with 0.9% polymer concentration and 20 mM NaCl cross-
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Figure 2.5: Determination of fluid gel retention. a) gellan fluid gel (0.9% (w/v), 20 mM
NaCl) and sodium chloride (200mM) were dyed with acrylic black ink (Daler Rowney
Bracknell, UK). Gellan fluid gel (left) and sodium chloride (right) droplets applied to
tilted porcine skin at the same time. A low rate of spreading of the gellan fluid gel
compared to sodium chloride was macroscopically observed. b) Viscosity of gellan fluid
gel under increasing (ramp 1) and decreasing (ramp 2) shear rates over a known time
frame. Plotted data includes mean viscosity of 0.9% (w/v), 20 mM NaCl prepared under
same conditions, error bars represent SD. Increase in shear rate leads to shear thinning
(decrease in viscosity) and decreasing the shear rate allows the gellan fluid gel to recover,
demonstrated as increased viscosity resulting in a small thixotropy. Mean values of 3
individual measurements presented, error bars are SD (smaller than icon and therefore not
visible) c) Herschel-Bulkley model fitted for 0.9%, 20 mM NaCl gel showing an excellent
fit to the model represented in a R2 of 0.9969. d) Yield stresses determined using the
Herschel-Bulkley model for 0.75% and 0.9% fluid gels with 20, 30, 40 and 50 mM NaCl.
Yield stress was found to increase in higher polymer concentration gels and in higher
salt-concentrations. Mean values of 3 individual measurements presented, error bars are
SD.
linker concentration was considered most suitable for the cell spray application (further
discussed later), and thus used for further studies.
Spray coverage (% coverage) is the proportional area of receiving surface covered by
sprayed material (gellan hydrogel or control liquid). A higher percentage of area was
covered with water compared to gellan hydrogel, although these di↵erences were not sta-
tistically significant 2.7c and Figure 2.7d. As expected, a higher percentage coverage was
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Figure 2.6: Structural stability on the receiving surface. a) Mean contact angles of gellan
fluid gel (0.9% (w/v), 20 mM) compared with control liquid (sodium chloride, 200 mM)
on a variety of surfaces. Three repetitions for each surface and three measurements per
repetition were performed. Error bars represent SD. Gellan fluid gel demonstrates larger
contact angles on all tested surfaces compared to control liquid. b) Thermo-responsive
properties of gellan (0.9%, 20 mM NaCl) was probed by investigating viscoelastic proper-
ties under increasing temperature. Increasing temperature resulted in a reduction in the
storage modulus, resulting in fluid-like behaviour of the gel. Tc denotes the critical tem-
perature at which the elastic structure starts to rapidly break down. Values presented are
of one representative measurement. c) The storage modulus against rising temperatures
in a panel of gellan fluid gels is presented. Gels with higher cross-linker concentrations
de-structure (show fluid like behaviour) at higher temperature levels. Mean values of 2
individual measurements presented, error bars are SD.
achieved when sprayed volume was increased, however, this was not proportional, i.e.
doubling the volume did not double the area covered 2.7d. There was a non-statistically
significant positive correlation between sprayed volume and percentage coverage for gel-
lan hydrogel (p=0.301, 95%CI: 33.09, 11.86; Pearson correlation 0.820) and water (p=
0.065, CI95%: -34.066, 1.308; Pearson correlation 0.723). This could be explained by
the observed accumulation of droplets (especially in the centre of the sprayed area) with
increasing volumes.
Individual droplet size was determined for all sprayed cards with ImageJ Software.
The minimum cut o↵ droplet size was set at 0.01 mm2. Mean droplet size of water (5.5 x
10 2 mm2) and gellan fluid gel (5.2 x 10 2 mm2) was not found to be significantly di↵erent
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Figure 2.7: Spray features of gellan gum fluid gel. 0.9% (w/v) gellan fluid gel with 20
mM NaCl cross-linker was used for all spray experiments presented in this figure. Mean
values are presented, error bars represent SD. a) Schematic illustration of airbrush and
its nozzle. b) Schematic of standardized airbrush spray experiment set up. c) Illustration
of water-sensitive paper with area coverage demonstrated for sprayed gellan fluid gel and
control (volume of 50 µl). d) percentage of area covered seems higher with sprayed water
compared to gellan fluid gel, but no statistically significant di↵erence was found. e-f) A
lower mean relative span factor was calculated for gellan fluid gels (gellan) in comparison
to control liquid (water) for both sprayed volumes together (e) and separated (f), this
di↵erence was more profound when looking at low sprayed volumes of 25 µl, indicating a
more uniformly spray distribution for the gel, but no statistical di↵erence was found.
(p=0.326, 95%CI: -0.011, 0.004). On the other hand, the gellan fluid gel has a lower mean
relative span factor (RSF) of 8.57 indicating a more uniform drop size distribution com-
pared to the water (11.84). However, this di↵erence was not found statistically di↵erent
(p=0.457, 95% CI: -8.77, 2.23). Droplet size distribution dependence on sprayed volume
was investigated by comparing the RSF of two sprayed volumes per material. Gellan fluid
gel showed a smaller decline in RSF when a smaller volume is sprayed compared to water,
but this di↵erence was not found significant (p=0.854, 95% CI: -12.00, 4.62 for 25 µl and
p=0.654, 95%CI: -33.24889, -4.89256 for 50 µl). (Figure 2.7e and Figure 2.7f).
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2.6.2 Biological response to fluid gel spray delivery
HDF cell viability
Limited evidence of airbrush cell spray systems has been published, with most data pre-
senting moderate cell viability (69%-70% survival) following spraying in Hank’s Balanced
Salt Solution [280] or cell culture media [75]. As investigated by Hendriks et al. [277]
certain spray conditions impact on cell viability such as receiving tissue/substrate sti↵-
ness, viscosity of cell carrier, nozzle-surface distance and delivery pressure. Therefore, all
these conditions were standardised to reduce bias as described in the methods section.
The study aimed to develop a cell carrier with maintaining a cell viability comparable to
current spray systems. Cell viability of sprayed encapsulated human dermal fibroblasts
was evaluated at days 1, 3, and 7 using live/dead assay as demonstrated in Figure 2.8.
Cells remained viable in the gellan fluid gel up to at least day 7, with a mean cell viabil-
ity of 88.0% (range 80.6% - 96.9%). Encapsulated HDFs attached to the bottom of the
culture disks at day 7 (Figure 2.9c) and spreading of the cells was observed at day 14
(Figure 2.9d). Therefore, it can be assumed that cells are able to leave the gel, whether
this is by active migration or passive sedimentation needs to be confirmed. Sprayed HDFs
encapsulated in gellan fluid gel maintained similar high viability throughout the studied
period, there was no statistically significant di↵erence between the application methods
(Figure 2.8b).
The e↵ects of spraying and encapsulation were also investigated for platelets derived
from whole blood. The results are less promising in terms of viability post-spraying or
encapsulation, however, a potentially interesting finding of platelet activation upon spray-
ing could be further explored for topical platelet applications. The preliminary results of
this work are presented in Appendix B.
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Figure 2.8: Human dermal fibroblast response to fluid gel spray delivery. ai-axii) Fluo-
rescence cell viability assay of encapsulated human dermal fibroblasts (HDF) before (i-iii)
and after (iv-vi) spraying shows similar high cell viability. Similar for good viability is
seen in sprayed cells (x-xii) in control medium compared to non-sprayed cells (vii-ix). b)
No significant di↵erences between the two groups on each timepoint was found. Present-
ing data is mean cell viability and SD. c,d) Alamar blue assay of encapsulated and control
HDFs. %Reduction of encapsulated sprayed and control cells did not change significantly
over the studied period. Statistically significant di↵erences were found for cells sprayed in
medium, comparing day 1 to day 4 and day 7 and in non-sprayed cells also between day
4 and day 7. Significant di↵erences found by two-way ANOVA and post-hoc statistical
testing is indicated by *(p < 0.05), **(p < 0.01), and ***(p < 0.001), which correspond
to p values in brackets. Data are presented as the means (+SD) from one experiment,
performed in triplicate.
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Figure 2.9: Live/dead assay of HDFs encapsulated in gellan fluid gel. Z-stack image of
fluorescence cell viability assay of human dermal fibroblasts (HDF) after 1 day (a), 3
days (b), 7 days (c) and 14 days (d) of encapsulation in gellan fluid gel (live cells stained
green, dead cells stained red). Cells are viable and attach to the bottom of the well and
seem to migrate out of the gel. Position of cells within the gel is shown in micrographs
of encapsulated cells in gellan fluid gel (e) stained with fluorescence live/dead dye and in
PEG diluted fluid gel (f). Images were obtained at day of encapsulation.
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Metabolic activity
Alamar blue, a non-toxic reagent used to quantify the cellular metabolic activity, was
used to investigate metabolic activity of encapsulated and sprayed cells. Data shown
in Figure 2.8c-d shows metabolic activity directly measured via absorbance, expressed
by percentage of reduction. Percentage reduction of encapsulated cells remained stable
over the tested period of 7 days. Whereas cells in culture medium showed a significant
increase in percentage reduction indicating a proliferation of the cells following delivery
Figure 2.8d. No statistically significant di↵erences of sprayed cells compared to non-
sprayed cells were found. Data implies that proliferation capacity of encapsulated cells is
limited, while cell viability remains high.
2.7 Discussion
Cell spraying techniques have been translated to clinical practice, but limited success
finds them not routinely used within burns care [101]. Several features of the cell solution
could be compromising the full potential of the technology: e.g. cell-spillage, non-uniform
distribution [47] and decrease in cell viability following transplantation [278].
This study aimed to remedy this clinical problem by engineering a sprayable gellan-
based fluid gel, to enable cells to be transplanted to the receiving surface without spillage
and/or loss of cell viability. The polymer used to prepare the hydrogel was gellan
gum, a polysaccharide derived from the bacterium Pseudomonas elodea, comprised of
D-glucuronic acid, L-rhamnose and D-glucose subunits. This natural polymer is FDA
approved as a food additive, however, has also found its way to the pharmaceutical and
biomedical industry due to its biocompatibility in a range of tissues - demonstrating non-
cytotoxic behaviour. A plethora of biomedical applications for gellan gum have been
reported, such as regeneration of cartilage [181, 306], neural tissue [307] or intervertebral
discs [308] and topical applications to enhance wound healing [309], have arisen from its
diverse nature lending it to applications such as injectables, films/dressings, eye drops
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and cell culture matrices [182].
Cross-linking of gellan gum can be achieved using ionic cross-linkers with monovalent
cations (Na+ or K+) resulting in the formation of weaker gels than comparative divalent
cations [298, 300, 310]. Strong gels, although they do not disintegrate easily upon the
wound bed like weak gels, do not easily conform to the body resulting in poor bioavailabil-
ity. Even though on a bulk scale weaker gels are prone to breaking-up, the ability to get
them to conform and disintegrate on a microscale presents an advantage for sprayed cell
applications; as a gradual form of degradation is desired to release the cells and eventually
remove the foreign material. The lack of cell binding capacity of gellan also means that
cells do not necessarily attach to the material readily [311], which is again beneficial for
rapid cell release from the gel to tissue. Furthermore, adhesive cells such as fibroblasts and
keratinocytes are dependent on adhesion to exhibit di↵erentiation, therefore adhesive cells
can be encapsulated in gellan hydrogel while potentially preserving their di↵erentiation
potential.
Fluid gels formulated with gellan therefore propose an ideal matrix for cell delivery,
via spraying; demonstrating key rheological properties needed for both spraying and con-
touring to the wound surface for the release of cells in situ (Figure 2.3). Fluid gels are
formed via the application of constant confinement (mechanical shear) to a biopolymer
undergoing a sol-gel transition [297, 312]. Applying this technique to gellan results in the
restriction of ordering during the random coil to helix transition, preventing the forma-
tion of a continuous gelled network, and forming a particulate suspension; where particle
growth is governed ultimately by the interplay between gelation kinetics and degree of
confinement acting within the system [313] (Figure 2.3a). This was demonstrated by the
change in gelling profiles for the 0.75% (w/v) fluid gels prepared using either 10 or 50
mM NaCl. Here, for the same degree of confinement applied (a shear rate of 450 s 1),
systems resulted in very di↵erent gelling temperatures and final viscosities (although it
is key to note that these viscosities are found well within the systems shear thinning re-
gion). In this case the heightened concentration of crosslinker has prompted gelation at
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higher temperatures, as expected from literature, as the salt ions promote the formation
of helices with tighter binding and stronger junction zones [314]. Changes in the viscosity
of the two systems is described in a similar way, where tighter binding and stronger junc-
tion zones between polymer chains results in more rigid particles [314] and a subsequent
increase in suspension viscosity as demonstrated by Adams et al. [315] in accordance
with Snabre and Mills [316]. Micrographs of the systems suggested changes in particle
morphology (Figure 2.3b and Figure 2.3c). Di↵erences in particles formed under the same
degree of shear are likely to reflect a change in the mechanism of formation, as detailed
by Fernández Farrés et al. [290]: who demonstrated that at faster gelation kinetics large
gelled entities were initially formed that became broken down in flow, whereas as when
gelation is much slower, particles were formed within the elongation flow itself - within
the rheometer geometry [290, 297, 317] (although further characterisation of the systems
here is needed to qualitatively address key parameters including particle size and degree
of anisotropy to draw stronger conclusions on this area).
Systematic modulation of the fluid gel properties, in order to optimise the system
for spray applications was achieved through careful control over the formulation; varying
both the biopolymer and cross-linker concentrations. Changes in the microstructure were
probed using small deformation rheology. Frequency dependence sweeps of low salt con-
centration systems demonstrated an initial G’ domination with a clear cross-over to G”
domination. Whereas at higher salt concentrations, these cross-overs did not occur and
G’ dominated over the whole frequency range studied, but both G’ and G” are demon-
strating some frequency dependence, with decreasing values for the loss tangent (tan  )
as a function of increasing salt concentrations. Gel-like mechanical spectra arise from the
restriction of polymer movement preventing the polymers from relaxing. However, within
the gel systems, polymer re-arrangement results in viscous dissipation of energy (G”)
[318, 319]. The reduction in tan   suggested increased hinderance within the gelled ma-
trix, as polymer re-arrangement becomes increasing prohibited, due to a higher crosslink
density at higher salt concentrations. This has also been seen in the frequency depen-
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dence data which indicates that the fluid gels became sti↵er at a high frequency due to
the rapid relaxation time of short chain segments. On a bulk scale, this results in the
formation of sti↵er particles, with suspensions exhibiting increased storage moduli [315].
Meanwhile G” also increased with increasing frequency, contributing to recoverable de-
formation and energy dissipation, especially in fluid gels with a low crosslinking degree
(10 mM NaCl). However, it is key to note that although the suspension rheology is
governed primarily through the sti↵ness of the particles, weak interactions between parti-
cles [269, 290, 297, 313] e↵ectively resulted in the suspensions demonstrating mechanical
spectra which fall someway between those typical of entangled polymers and strong-gels
[297].
Strain sweeps were used to explore the nature of the weak forces between suspended
particles. It has previously been proposed that during the conformational change of
the biopolymer during cooling (coil to helix formation) complete polymerisation at the
particle interface becomes prevented [297, 313]. This results in points of weak association
between particles. On deformation the fluid gel suspensions reached a critical strain
at which they no longer act linearly. This critical strain is principally related to the
proximity of gellan chains to each other and the number of weak interactions (hydrogen
bonds etc.) at both the particle interfaces, and interstitial gellan remaining within the
aqueous phase [320]. At larger deformations physical debonding between particle-particle
and particle-interstitial gellan can occur resulting in a reduction in storage modulus.
Reduced deformation of the fluid gel particles as a function of the increased sti↵ness (at
higher salt concentrations) results in a shortening of the contact zones between particles,
e↵ectively reducing the degree of interactions between polymer chains [315]. This explains
the reduction in LVR with increasing salt concentrations. Furthermore, it is hypothesised
that changes in particle morphology (smaller discrete through to long ribbon-like particles)
may also play a role within the particle contact time; as the longer “ribbon-like” particles
remain in contact across much larger strains (deformations) before the systems begin
to breakdown [317, 321]. Again, such inferences require further quantification of the
75
micrographs obtained.
The e↵ects of formulation on suspension viscosity were studied in respect to spray-
ability. The e↵ect of salt concentration has been previously described within the manuscript,
however, viscosity modulation was also achieved by changing the concentration of poly-
mer. Once gelled under shear, the formation of particulates resulted in entrapment of the
continuous aqueous phase, e↵ectively increasing the volume occupied by the particles. In
correspondence with work published by Adams et al. [315], a direct correlation between
the initial polymer weight fraction and particle phase volume can be assumed, as such the
increase in viscosity thus becomes a function of the particle packing fraction; with rhe-
ologies typical of highly concentrated systems [322]. However, at shear rates comparable
to those expected during spraying, all systems resulted in a degree of shear thinning that
allowed application.
Fluid gel systems exhibited very little thixotropy, recovering much of their original vis-
cosity once shear had been removed. Flow profiles were compared to the Herschel-Bulkley
equation, which highlighted the presence of a yield stress for all systems formulated with
> 20 mM NaCl. Again, similar trends to the small deformation rheology were observed,
where increases in both salt and polymer concentrations, tended towards larger yield
stresses. Such overlap implies a common mechanism, whereby increased crosslink density
and subsequent interactions (increased G’), results in connected particles that require
a critical stress in order to induce flow. Yielding values were compared to gravitational
stresses, as a simple force balance. In all cases where yielding behaviour was observed, the
fluid gel yield stress surpassed that of the gravitational stress, suggesting long residence
times on the skin, where many of the surfaces are contoured. Clinically this means the
finite gelled layer would remain in situ until mechanically removed, likely during dressing
changes or other cleaning processes.
Following the ability to spray, spreading of the material post-application is also impor-
tant: as large degrees of spreading lead to vast amounts of run-o↵ and too little prevents
the formation of a continuous layer. Complete wetting of a material to the surface occurs
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when the contact angle is near to 0° as high wetting requires small contact angles <90°,
while large contact angles refer to low wettability >90° [323]. Contact angles obtained for
the fluid gel systems across a variety of materials including biological substrates encoun-
tered within a burn environment: epidermis and subcutaneous fat (Figure 2.5a). The
gellan-based systems showed a significant increase in contact angle (p<0.001) across the
gelatin, epidermis and subcutaneous fat substrates. This is a result of enhanced viscosity
which strongly influences the liquid-surface. Fluid gels are enriched with the presence of
polar groups, long polymer chains and possibly additional side chains causing a slower
spreading, and less spillage. Whereas the low-viscosity saline solutions (such as sodium
lactate and sodium chloride solutions), currently used as the delivery vehicle of choice in
sprayed cell systems, exhibit low cohesive forces suggesting stronger adhesive forces to the
substrate resulting in high wettability.
Spreading as a result of the thermo-reversible nature of the gellan gels was also probed,
in respect to temperatures associated with burns wounds. Average peripheral skin tem-
peratures lie around 34 °C [324], but can vary greatly in critically ill patients, especially
following burn injuries p<0.001 when room and body temperatures are deliberately in-
creased [324, 325]. Upon heating, the gels showed weakening of the interactions between
the particles as demonstrated by a reduction in G’ at a critical temperature, Tc (Figure
2.5b). This loss of storage modulus is caused by the gel melting (initially by melting of
residual unaggregated helices and secondly by melting of the aggregated double helices
[298]), with Tc correlating closely with literature obtained using as di↵erential scanning
calorimetry (DSC) [? ]. Structural weakening was shown to be influenced by salt con-
centration as expected from literature. As such, delayed onset of gel breakdown could be
achieved by increasing the cross-linker concentration (Figure 2.5c), corresponding to data
by Morris et al [298]. Ultimately the balance between the mechanical behaviour of the gels
and weakening is important as a certain degree of gel breakdown is desired, so cells are
easily able to be released from the gel. Also, to improve patient experience the remaining
polymer can be taken o↵ the skin with cleaning solution warmed to skin temperature.
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The fluid gel composition can be tuned to these specific needs and highlighted the 0.9%
(w/v), 20 mM NaCl formulation as the optimal system to trial as the cell delivery vehicle.
Current cell spray delivery systems have been used clinically by manufacturers guid-
ance only. Quantifying the total area covered by the cell sprays has been investigated
sparsely [81]. Furthermore, uniformity of the sprayed solutions could provide information
on even cell distribution indirectly informing on required cell density. In this study, spray
coverage and uniformity of distribution was quantified using water-sensitive paper (WSP)
%(Figure 2.7c). The technique was used to quantify sprayed gellan fluid gel in terms
of percentage coverage and droplet size by a similar method utilizing ImageJ software
described by Ferguson et al. [326, 327]. A trend towards lower coverage of the gellan hy-
drogel was seen (Figure 2.7d), likely explained by preserved droplet stability (shape) as a
result of larger contact angles, however, such di↵erences were not statistically significant.
The high cell viability following encapsulation in this study is supported by the current
literature, with successful encapsulation of numerous cell types reported in quiescent
gellan hydrogels [181, 296, 307, 328]. After 7 days of culturing within the fluid gel, cell
attachment to the bottom of the well was noted, suggesting movement of the fibroblasts
(Figure 2.9). Adherence, elongation and spreading of the fibroblasts over the plastic was
also observed. Data suggested that the fluid gel support migration of the cells whilst
preserving their cell function. Such observation correspond to the findings by Ferris et
al. reporting cell settling of mouse myoblasts in gellan fluid gel [180]. It is proposed that
such movement is facilitated either by passive sedimentation through the gelled particles
or active migration of the cells out of the gel as seen in alginate-based fluid gels [329]:
however, further study on environmental conditions that might influence this migration
is needed.
Cell viability post-spraying is an important factor to consider, as numerous mechan-
ical stresses during the spraying process can be detrimental to the cell’s integrity [278];
causing structural cell damage such as membrane elongation, adverse cell responses (e.g.
some cell di↵erentiation processes are mechanically activated) or diminished cell viabil-
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ity after deposition. Several parameters influence the shear stresses exerted on the cell
systems during spraying such as nozzle diameter, viscosity of the material and velocity
at delivery [277]. Previous studies based on saline carrier systems demonstrate a sur-
vival rate of >90% when a low air pressure and large nozzle sizes were used [276]. This
study demonstrates a comparable level of viability when spray nozzles with similar di-
ameters and air pressure were used, compared to current commercially available spray
systems. Modification of viscosity provided by the fluid gel system can be crucial to
protecting the cells, providing a cushioning e↵ect during delivery [277]. Data has shown
that metabolic activity of encapsulated sprayed cells is similar to non-encapsulated cells
at day 1 and remains stable for 7 days (tested period). Because the metabolic activity of
non-encapsulated cells increases over time following spraying whereas encapsulated cells
expressed a steady level metabolic activity, it is possible that the proliferation capacity of
encapsulated cells is restricted in the fluid gel. But the introduction of a structured fluid
gel has not compromised cell viability following spraying in an in vitro setting. Although
demonstrated in vitro, within a clinical setting, cells are sprayed into a hostile wound
environment, potentially exposed to further mechanical trauma by wound dressings. It is
suggested that the fluid gel carrier may provide extended shielding, enhancing the poten-
tial of the cells by allowing time for migration and adhesion within the local tissues. The
findings of this study support that gellan fluid gel is a promising cell carrier for fibroblast
spray delivery, but further research is needed to investigate this technique in an in vivo
model.
2.8 Conclusion
The work presented here demonstrates the development of a gellan-based fluid gel system,
with flexible viscoelastic properties that can be tuned to facilitate spray delivery require-
ments such as: liquefying at high shear during spraying, self-structuring post-spraying
and resistance to flow once in situ. Spray assessment of the gellan fluid gel demonstrated
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higher contact angles and limited runo↵ of the receiving surfaces when compared to a
current clinically available cell carrier. Furthermore, cell compatibility to the gellan fluid
gel was high, with good cell viability over a 7-day timescale. Additionally, viability of
the encapsulated cells was not compromised following the spraying process. Therefore,
gellan fluid gels provide a promising candidate for cell encapsulation, bridging the clinical
need for sprayed systems and allowing retention to the wound site. However, future work
will need include other cell types and focus on functional and proliferation behaviour of




Spray delivery of epidermal cells has successfully translated to clinical prac-
tice to treat burn wounds. However, the technique has not yet been widely
accepted due to limited retention and disputable cell viability and function in
the wound. This study has evaluated a method for delivering cells with an
aerosol device using a gellan-based ’fluid gel’ (a shear-thinning gel system).
The viscoelastic properties allow the material to liquefy upon spraying and
restructure rapidly on the surface. Our results demonstrate that both spray-
ing and encapsulation of human epidermal keratinocytes have some adverse
e↵ects on cell viability and function, but cells are recoverable to a certain
extent. A cumulutive e↵ect occurs when combining both spraying and en-
capsulation in gellan fluid gel, with detrimental e↵ects to cell viability and
function. These findings indicate that encouraging results from earlier work
with encapsulated fibroblasts could not be readily adopted for keratinocytes,
suggesting a cell-type dependent response to this delivery technique.
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3.1 Introduction
Skin damage can occur as a result of burns, skin blistering diseases, ulcers, trauma and
other skin diseases. Any breach of the skin barrier can introduce microbial infection and
delayed healing can cause scarring. Early wound closure of large defects is critical and can
be achieved by traditional skin grafting, however, to cover extensive injuries large areas
of autologous donor skin are required. Donor skin sparing techniques that achieve rapid
wound healing have received much attention and improvements are ungoing. Examples
include: cultured epithelial autografts (CEA) [44], artificial skin with cells incorporated
[283] and skin cell spray techniques [105, 211]. Single cell delivery of (sub)confluent cells
in solution via an aerosol system was introduced to overcome the issues of conventional
grafting techniques by reducing donor site area, enhance fast re-epithelialisation and to
reduce/eliminate culture time. Positive clinical outcomes of keratinocyte spray delivery
have been published in the literature [105, 211, 330]. However, suprisingly little research
has focused on in vitro cell viability and function after spray-delivery. Available research
has shown moderate to high viability of sprayed keratinocytes with no statistical di↵er-
ences when compared to non-sprayed cells after 3 days [106], 7 days [41] and up to 14 days
[278]. Results of these studies should be compared with caution as di↵erent spray appli-
cators, cell types and/or spray methods were used. In this study the spraying method
was standardized.
In this study, a previously engineered biopolymer based cell carrier is used to enhance
retention upon a wound [269]. A sprayable hydrogel must have a certain low viscosity
to facilitate homogeneous cell distribution and yet, solidify rapidly to retain cells on the
wound. This is achieved by applying shear during the gelation process, forming a fluid gel
with shear-structuring properties that allowed for delivery of cells via spraying. Previous
work showed that the viability of encapsulated human dermal fibroblasts in gellan gum
fluid gel was not compromised, in agreement with data published for other cell types
encapsulated in gellan hydrogels [181, 182, 307, 308]. These promising results have not
yet been established in keratinocytes, but with a successful cell-spray application already
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in place, this could open the possibility for improving current keratinocyte spray systems
rapidly. Furthermore, expanding controlled cell deposition with gellan fluid gel-based car-
rier system to other clinical application systems including endoscopic, arthroscopic and
laparoscopic procedures, is an opportunity to enhance minimally invasive cell therapy
for tissue regeneration. Therefore, the aim of this study was to examine the e↵ect of
encapsulation and spray delivery of human epidermal keratinocytes in gellan fluid gel in
terms of cell viability, proliferation, cell migration and di↵erentiation in comparison to
non-encapsulated cells.
3.2 Methods
3.2.1 Fluid gel preparation and characterisation
Low acyl gellan gum stock 1% (w/v) solution was prepared by the addition of gellan
powder [Kelcogelr obtained from Azelis, Hertford, UK] to sterile water at 65 °C un-
der constant agitation. Following, a NaCl cross-linker solution (0.2 M concentration)
was prepared with sterile water. Then, polymer sols were formed by mixing gellan with
cross-linker (9:1 ratio) in a cell stirrer and autoclaving at (at 121 °C,) resulting in a final
concentration of 0.9% (w/v) polymer - 20 mM NaCl. Gels were then cooled to 20 °C
under continuous stirring and stored at 4 ￿ until further use. Gel temperatures were
raised to 37 °C for cell encapsulation.
Rheological measurements were performed with a Kinexus Ultra rheometer (Malvern
Pananalytical, UK) equipped with 40 mm parallel plates and a gap height of 1 mm.
To determine the viscoelastic behaviour, small deformation rheometry was undertaken:
an amplitude sweep from 0.1 to 700% was applied at an angular frequency of 1 Hz and
the linear viscoelastic region (LVR) was determined. Frequency sweeps (!=0.1–10 Hz)
were carried out to investigate the ‘strength’ of the gel [318]. All measurements were
taken at 25 °C and 0.5% strain within the linear viscoelastic region (LVR), informed by
amplitude sweep measurements. Further, flow behaviour was studied by increasing the
83
shear rate from 0.1 to 600 s 1 over a 3 minute timescale. To probe hysteresis, shear rate
was immediately reduced back from 600 s 1 to 0.1 s 1.
3.2.2 Keratinocyte culture and encapsulation
Adult human epidermal keratinocytes (HEKa) were obtained from Gibco (lot nr 1781895
and 1989906). Keratinocyte culture media was prepared from EpiLifeKitr medium with
60 µM calcium chloride (Gibco, UK) and supplemented with Human Keratinocyte Growth
Supplement (HKGS) containing 0.2% v/v bovine pituitary extract (BPE), 5 µg/ml bovine
insulin, 0.18 µg/ml hydrocortisone, 5 µg/ml bovine transferrin; and 0.2 ng/ml human
epidermal growth factor (all from Gibco, UK). Culture media was changed according
to suppliers’ guidelines and only cells of passage 2 to 4 were used. All cultures were
maintained in the incubator under stable conditions of 5% humidity, temperature of 37
°C and 100 % humidity. Cells were harvested when they reached approximately 80%
confluence.
Then, cells were resuspended in gellan fluid gel and delivered at a seeding density of 4.0
x 104 viable cells/cm2 or in culture media, with a seeding density of 2.0 x 104 (sprayed)
and 1.0 x 104 (non-sprayed) viable cells/cm2. Directly following mixing, cell solutions
were pipetted or sprayed with the airbrush device (Badger, US) into tissue culture 24-
well plates as described in Chapter 2 - Spray methods, fresh culture media was added and
samples were incubated (at 5% CO2, temperature 37 °C, 100% humidity) until further
testing.
3.2.3 Cell sedimentation in fluid gel
Chemotactic migration of keratinocytes towards a layer of dermal fibroblasts was investi-
gated with a modified Boyden well chamber technique using a ThinCertTM 12-well tran-
swell system with 8 µm pore size (Greiner bio-one,UK). Human dermal fibroblasts were
seeded in 12-well tissue culture plates in HDF media (prepared as described in Chapter
2-Cell culture). After 3 hours, HDF culture media was changed to keratinocytes media.
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Then, control and encapsulated keratinocytes were either sprayed or pipetted into 0.8 µm
pore size transwells and placed into wells with or without HDF seeded on the bottom. A
total of 4 conditions were tested as illustrated in Figure 3.1. After 2 days, the inserts were
gently removed and placed in 3 subsequent baths of sterile PBS to wash and then fixed
with 4% paraformaldehyde for 20 min and permeabilised with 0.5% Triton-X dissolved in
PBS for 30 min, both at room temperature. Finally, 3 washes with PBS before inserts
were cut out and mounted on coverslips with DAPI-mounting media. The number of cells
present on the underside of the coverslip were imaged with a Zeiss Axiovert fluorescence
microscope.
Figure 3.1: Transwell assay. Human epidermal keratinocytes were seeded in a 8 µm pore
size transwell insert in either gel (A) and (B) or keratinocyte culture media (C) and (D).
Chemotaxis in the presence (A and C) or absence (B and D) of human dermal fibroblasts
was assessed. Migration of keratinocytes through the pore membrane was imaged at day
2.
3.2.4 Cell viability
Green-fluorescent Calcein Acetocymethylester (Calcein AM) (Invitrogen, UK) was used
to stain live cells and red-fluorescent Ethidium Homodimer-1 (EH) (Thermofisher, UK)
was used to stain dead cells. Live/dead stain was added to 1 ml of cell specific culture
medium, samples were immersed in 100 µl/ml of this solution and incubated for 20 min.
Samples were then visualized using confocal microscopy (Olympus, Fluoview FV100) and
images produced with Imaris software (Bitplane, UK) or fluorescent microscope (Cytation
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5, Biotek, UK), showing viable cells green (Calcein AM) and non-viable cells red (PI or
EH). Laser setting 488 nm and 543 nm for green and red fluorescent respectively.
Cellular analysis
Automated cellular analysis was performed using Cytation 5 fluorescent microscope with
Genzyme5 3.04 software (Biotek, UK). Figure 3.2 gives an example of automated live/dead
cell counting by masking the individual green or red channels. Identical settings based on
cell size (5µm to max 160 µm) were used for all samples to select cells. Cell count and
average cells size was automatically obtained.
Figure 3.2: Example of live/dead assay cell count of human epidermal keratinocytes.
The generated image of entire 24-well stained with green (live) and red (dead) fluorescent
stains (A), both the green (B) and red (C) fluorescent cells are masked for counting. Scale
bars are 3000 µm.
Based on live and dead cell counts, the percentage of viable cells could be calculated
with Equation 3.1.
viable cells(%) =
number of viable cells
total number of cells (live+ dead cells)
⇥ 100 (3.1)
3.2.5 Morphology
Cells were washed using sterile PBS and subsequently fixed with 4% paraformaldehyde for
20 min at room temperature. Next, cell were permeabilised with 0.5% Triton-X dissolved
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in PBS for 30 min at room temperature. Samples were washed several times with PBS in
between all steps. Cells were stained with Alexa Fluor 488 phalloidin (Thermo Fisher, UK)
and DAPI at 0.5-1 µg/ml for F-actin and cell nucleus respectively. Fixed and stained cells
were visualised directly with confocal microscopy or fluorescent microscopy, laser settings
for excitation: 495 nm and emission: 518 nm and stored at 7 ￿ protected from light until
testing. Images were then analysed with either ImageJ software, using the particle size
plugin [299] or with Genzyme 5 3.04 software. Individual cell shape was analysed with
shape descriptors as graphically illustrated in Figure 3.3. The circularity is derived from
area and perimeter measurements with a value of 1 indicating a perfect circle, Equation
3.2.
Circularity (0  1) = 4⇡ Area
Perimeter2
(3.2)
Figure 3.3: Diagram of cell shape descriptors illustrates the normal shape of a human
epidermal keratinocytes (A), measurements of cell size (Area in µm2) (B), the maximum
cell length (Feret in µm) (C), cell circumference (Perimeter in µm)(D) and circularity on
a scale of 0-1 (E).
3.2.6 Alamar Blue Metabolic Activity
Encapsulated and control HEKa were seeded or sprayed into 24-well tissue cultured plates
at a density of 4.0 x 104 viable cells/cm2 in gellan fluid gel or 2.0 x 104 (sprayed) and 1.0
x 104 (non-sprayed) viable cells/cm2 in culture media. Metabolic activity of keratinocytes
was investigated by incorporation of 10% Alamar Blue. Experiments were performed in
24-well culture tissue plates over a study period of 14 days as described in detail in Chap-
ter 2 - Alamar Blue Metabolic Assay. Absorbance was measured at 570nm and 600nm.
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Results are presented as the percentage reduction (Equation 2.6) and as percentage dif-
ference in reduction between treated and untreated cells (Equation 3.3).
Percentage difference(%) =
(✏ox2 ⇥ A1)  (✏ox1 ⇥ A2)
(✏ox2 ⇥ B1)  (✏ox1 ⇥ B2)
⇥ 100 (3.3)
A1 = absorbance at 570 nm test well
A2 = absorbance at 600 nm test well
B1 = absorbance at 570 nm control well
B2 = absorbance at 600 nm control well
Standard molar extinction coe cients for the oxidized (✏ox) form of AlamarBluer were
used:
✏ox1 = 80,586 at 570 nm
✏ox2 = 117,216 at 600 nm
3.2.7 In-Cell Western
In-Cell Western assay is a technique that allows cellular protein quantification without
the need for cell lysis (as in original Western blot assays). This technique was preferred
here as retrieving cells from the 3D gel matrix might be accompanied with (further)
cell damage and cell loss. Sprayed and non-sprayed cells in 24 well plates were washed
carefully with PBS and fixed with 10% v/v formaldehyde/PBS with 2% sucrose for 15
min at 37 °C. Cells were permeabilized (10.3g sucrose, 0.292 g NaCl, 0.006 g MgCl2, 0.476
g Hepes in 100 ml PBS, adjusted to pH 7.2 with 0.5 ml Triton X) at 4 °C for 4 minutes.
Then, cells were blocked in blocking bu↵er, 1% milk protein in 0.1% Tween 20/PBS
(PBST) at room temperature for 1,5 hours on a shaker. Cells were incubated for at least
2.5 hours with primary antibodies diluted in PBST. Primary antibodies: anti-involucrin
88
antibody (abcam, ab68) at 1 mg/ml and anti-laminin 5 antibody (abcam, ab14509) at
10 µg/ml in blocking bu↵er at room temperature. Followed by 5x 5 min washes with
wash bu↵er (0.1% PBST). Then, cells were incubated with 1:800 diluted infra-red labeled
secondary antibodies; IRDyer 800 CW Goat anti-Mouse (LI-COR 926-32210) , IRDyer
800CW Goat anti-Rabbit (LI-COR 926-32211) and 1:500 diluted CellTag 700 stain (LI-
COR 926-41090) for 1 hour at room temperature, followed by 5x 5 min washes with wash
bu↵er (0.1% PBST). Plates with 2D samples were then dried for at least 2 hours and
PBS was added to 3D sample plates to avoid drying out of the gel. Samples were stored
at 4 °C until subjected to LI-COR Odysseyy Sa scanner equipped with ImageStudioLite
software to read the protein of interest with infrared signal at 800 nm and CellTag at
700 nm. Data presented is fluorescent intensity of the protein of interest (Laminin 5 or
Involucrin), normalized against cell number as detected with CellTag 700 stain.
3.2.8 Scratch assay
Monolayers of HEKa cells passage 2 were grown in 24 well tissue culture plates until
confluent. Monolayers were fluorescently labeled red with CellMaskTM Deep Red Plasma
membrane stain (Thermofisher, UK). Briefly, stock solution of the stain was prepared in
DMSO (1000x). Monolayers grown to confluence were incubated with 100 µl stain per well
for 10 min at 37 °C and 5% CO2. Then, stain was removed and samples washed 3 times
with PBS. Fresh media was added and samples were imaged immediately or placed in
incubator. A total of 5 conditions were tested on top of the monolayers and compared to
control wells with only HEKa monolayers. Conditions included: cell-free gel seeded on top,
HEKa encapsulated in gel sprayed, HEKa encapsulated non-spray, HEKa sprayed in media
and HEKa in media non-spray. Cells added on top of monolayers were pre-labeled with 5-
chloromethylfluorescein diacetate (CMFDA), CellTrackerTM Green (ThermoFisher, UK),
in order to track whether delivered cells would contribute to wound healing. Conditions
were added and cultures were incubated for 2 hours. Then, wells were scored using a 200
µm sterile pipette tip in a linear fashion to leave a 0.5-0.7 mm wide wound area. Four
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repetitions of each condition were performed. Culture medium was removed immediately
and replaced with fresh medium and cultures were maintained at 37 °C and 5% CO2.
Wells were imaged up to 4 days post-scratch.
Imaging
Wound closure was monitored by collecting images at set time points (2 hrs, 24 hrs, 48
hrs, 96 hrs and 120 hours) after the scratch was performed using Cytation 5 equipped
with Genzyme5 3.04 software (Biotek, UK). Images of the entire scratch were made at
timepoint zero (2 hours after scratch) and the area of scratch was selected (region of
interest) and an automated cell count with total object area (µm2) within this region
was obtained. In following timepoints the object area was compared to the previously
determined scratch area to analyse cell infiltration into the wound. Automated cell count
and object area measurement for red and green fluorescently stained cells was performed
with the cellular analysis plug in as shown in Figure 3.4. Data presented as the extent
of wound closure of the scratch by measuring wound width and rate of closure (Equation
3.4) over the studied period.
Rate of cell migration (nm/hour) =
(Wi   Wf )
t
(3.4)
• Wi = initial wound width (nm)
• Cf = final wound with (nm)
• t = time (duration of migration in hours)
To account for changes in cell density due to proliferation the data has also been
presented as percentage wound confluence, calculated with the following Equation 3.5:
wound confluence (%) =




Figure 3.4: In vitro scratch assay wound density analysis method. The scratch was
identified in the total image (A) and a rectangle closely surrounding the wound edges was
selected (B), within this region the total object area of fluorescently stained red (RFP)
and green (GFP) cells was measured. Scale bars are 2000 µm.
• Object areat = Density of the wound area at time (t) in µm
• Object area0 = Density of the wound area at time point zero in µm
• Areatotal = Total area of region of interest (µm2)
3.3 Results
3.3.1 Material characteristics
Fluid gel production and characterisation
Gellan fluid gels were prepared by applying a constant shear during the sol-gel transition
phase as previously described [269, 297, 301, 312]. Viscoelastic properties of gellan fluid
gel were examined by rheology.
The frequency sweep measurements (obtained within LVR) allowed for investigation
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of the elastic and viscous moduli at variable frequencies, an example is demonstrated in
Figure 3.5A. Frequency dependence of gellan fluid gel demonstrates a weak gel system
with gradually increasing G’ and G” modulus under increasing frequency, typical of fluid
gels [297]. Weakly associated single helices are not destroyed hence G’ remains greater
than G” at higher frequencies. Additionally, the calculated loss tangent (tan  = G”/G’)
is > 0.1, as seen in weak gels (data not shown)[304].
The amplitude dependence of the elastic and viscous moduli are presented in Figure
3.5B. Under increasing strain, a cross-over from an elastic (G’) to viscous (G”) dominated
system was observed. Thus, at large deformations the suspension acts as a liquid-like
material, which enables flow, a typical property of a fluid gel.
In order to estimate the behaviour during spraying, the system was subjected to
increasing shear ramps starting from 0.1 to 700 s 1 and a second sweep immediately after
to test hysteresis. Results demonstrated a high degree of shear thinning at increasing
shear rates and once shear was removed the system recovered to its original viscosity.
Figure 3.5: Viscoelastic properties of gellan fluid gel used for keratinocyte encapsulation.
Sedimentation
Sedimentation velocity of cells through the gel was estimated using Stokes’ law as calcu-
lated by Equation 3.6, where the sedimentation velocity is given by the force acting upon
the particle influenced by gravity and particle density in comparison to liquid density.







· (g · r2) (3.6)
• v = sedimentation velocity (m/s)
• ⇢p = particle density (kg/m3)
• ⇢f = fluid density (kg/m3)
• ⌘ = viscosity fluid (Pa·s)
• g = gravitational acceleration (m/s)
• r = particle radius (m)
Cell density of 1.05 kg/m3 [331] was used for fibroblasts, keratinocytes and platelets.





• ⇢ = density of gel [0.9%, 20 mM NaCl] (kg/m3)
• M = mass of the gel (kg)
• V = volume of the gel (m3)
Viscosity (within the range of gellan fluid gels as presented in Chapter 2) was plotted
against the expected time for particles (eg cells) to settle in 1 mm thick layer of the fluid
gel. The gravitational acceleration is a given value of 9.81 m/s2. Lastly, the particle
radius was derived from the average cell size: for fibroblasts 15 µm, keratinocytes 10 µm
and platelets 0.2 µm.
As shown in Figure 3.6E, the estimated time of cells to sediment in the gel is depen-
dent on the size of the particle, with longer sedimentation time for smaller particles (eg
platelets) compared to larger cell types (keratinocytes and fibroblasts). It is important
to note that cell size can di↵er according to di↵erentiation status[332].
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Low sedimentation rate implies that the particle (eg cell) has a tendency to float and
high sedimentation rate indicates that the particle sinks quicker in the fluid. The Stokes’
law assumes a laminar flow, spherical particles, a homogeneous material with smooth
surfaces and that particles do not interfere with each other. Furthermore, a potential
active migration of cells towards chemoattractants present in either medium or towards
the air-liquid interface (as seen in keratinocytes) can not be taken into account.
Transwell assay
Since mobilization of cells out of the gel is required to contribute to wound healing, we
next determined whether keratinocytes seeded in the gel could migrate in a chemotactic
transwell assay toward dermal fibroblasts. As expected, keratinocyte migration through
the gel is restricted in comparison to cells in culture media. Keratinocyte migration was
highest in wells without gel (Figure 3.6), however, no statistical significant di↵erences
were found between presence or absence of dermal fibroblasts in the well. Therefore,
soluble factors excreted by the fibroblasts do not seem to have a chemoattractive e↵ect in
this experiment. Likewise, in the presence of fibroblasts, encapsulated keratinocytes do
not migrate quicker. However, the potential e↵ect of robust chemoattractants present in
in vivo wound environments might facilitate active migration of the cells out of the gel.
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Figure 3.6: Keratinocyte migration assay with presence or absence of human dermal
fibroblasts as chemoattractant. Keratinocytes in medium (A, D) have a higher number of
cells migrating through the insert compared to keratinocytes seeded in gel (B, C). In A
and C, HDFs were seeded at the bottom as chemoattractant. Four representative images
of each condition are presented, scale bars are 100µm. (E) Estimated time to sediment in 1
mm layer of fluid gel in 3 cell types, derived from sedimentation velocity calculated based
on Stokes’ Law. (F) Cell count of keratinocytes migrated through the inserts. Values
represent mean, errrorbars are SD. Significant di↵erences found by one-way ANOVA with





Growth of HEKa was systematically investigated at set time points by trypan blue ex-
clusion. Figure 3.7 shows the 3 phases of cell growth over a period of 7 days. Cells were
subcultured when still in exponential phase, usually around day 4 or 5.
Figure 3.7: Growth curve of adult human epidermal keratinocytes. Green area indicates
exponential phase. Experiments were performed in tripliclates per timepoint. Values
presented are mean + SEM.
The population doubling time was approximately 13 hours (SD 0.30) for cells in ex-
ponential phase as calculated with Equation 3.8.




• Xb = cell number at beginning of incubation time
• Xe = cell number at end of incubation time
• T = incubation time (hours)
Live/dead assay
Cell viability of sprayed and non-sprayed human epidermal keratinocytes was evaluated at
days 1, 4, 7, 10 and 14 using live/dead assay as demonstrated in Figure 3.12. Percentage
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viability of sprayed cells was lower than non-sprayed cells up to day 7, however these
di↵erences were not found to be statistically significant. At day 10 and day 14 sprayed
cells showed a higher percentage viability (probably due to overconfluence of control wells
causing cell death). Average viability of sprayed cells dropped from 77.4% at day 1 to
40.7% at day 4, but then increased again to 88.9% on day 10. Probably due to proliferation
of viable cells at the bottom of the well.
It was found that cells encapsulated in gellan fluid gel had a lower mean cell viability
at day 1 than non-sprayed cells in medium (77.3% and 93.9% respectively) (Figure 3.13).
The viability of encapsulated cells remained high up to day 4 with a mean of 68.6% viable
cells. But, a significant decline of mean cell viability to 28.6% was seen at day 7, by then
the cells that have di↵used out of the gel adhered to the bottom of the culture plastic
and show normal morphology. However, it seems that those cells that remain in the gel
environment die (Figure 3.13B). A sharp incline in mean percentage of viable cells is again
seen at day 10 with approximately 78% viable cells, this percentage is constant until the
end of the studied period (day 14). Likewise, probably explained by the proliferation of
viable adherent cells.
The e↵ect of spraying fluid gel encapsulated keratinocytes on cell viability follows a
similar trend with significantly lower percentage of viability in sprayed cells compared
to non-sprayed cells at all timepoints. Interestingly, the negative e↵ect of spraying is
more profound when cells are encapsulated in the gellan fluid gel when compared to cells
sprayed in normal culture medium. This result is in contrast with our previous reported
outcomes of spray delivery of encapsulated fibroblasts in Chapter 2.
From these results it is clear that encapsulation of cells in the fluid gel system is less
successful in terms of cell viability than in normal cell culture medium, however, a majority
of cells still remain viable and are able to multiply when di↵used out of the gel. Spray
delivery of encapsulated cells was detrimental for cells, with a very limited amount of
cells surviving in the gel. Interestingly, previous reports suggested an increased survival
of cells delivered in higher viscosity environments as the gel was expected to work as
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cushioning e↵ect [277]. Perhaps what happens is that sprayed cells respond di↵erently
to the stress response than non-encapsulated cells. With cells being entrapped in the
gel experiencing solely autonomic feedback and no feedback from surrounded cells. Lack
of cell to cell interactions as well as attachment to ECM components might have forced
keratinocytes into committing to di↵erentiation or apoptosis. Furthermore, keratinocyte
size is related to the level of di↵erentiation, with non-multiplaying cells being larger and
more likely to stay trapped in the 3D gel system. Non-sprayed cells that are unable to
di↵use out of the gel stay rounded and also become unviable by day 7. Despite addition
of cell specific culture medium on top, the gel system does not seem to provide the ideal
culture environment for these kind of cells. Incorporation of cell media or growth factors
into the gel might be benificial and worth exploring in future studies. However, when
used as rapid delivery method with applying a thin layer of gel, this system could still be
of benefit for cell delivery.
3.3.3 Morphological changes in sprayed cells
Morphological features of the cell can give clues on its physiological state and 2D mea-
surements are commonly used as quantative measures of cell shape. To examine the
morphological changes occuring following spray delivery, cells were fixed, permealised and
stained for F-actin and DAPI to visualise the cytoskeleton and cell nucleus respectively.
As shown in Figure 3.8, at 24 hours following delivery, the sprayed cells are smaller and
have a more rounded phenotype with actin fibre accumulation at the cell borders. Al-
though, average cell size, circumference and circularity of sprayed cells seemed di↵erent
from non-sprayed cells at day 1, no statistically significant di↵erences were found which
might be related to low numbers of non-sprayed cells that could be examined due to
overlap of individual cells (Figure 3.8B). These results suggest a stress response of cells
delivered with the airbrush system. To examine whether spraying has a long term e↵ect
on cell shape, cells were again examined following a culture period of 2 weeks as shown in
Figure 3.8. Non-sprayed cells show a cobble stone morphology typical for keratinocytes,
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but also elongated cells can be found. Cell shape of sprayed cells was not significantly
di↵erent after 2 weeks of culturing, however, the sprayed cells were significantly smaller
than non-sprayed as reflected by area, cell circumference and feret outcomes at week 2
(Figure 3.8B). Thus, spraying induces morphological changes in keratinocytes which can
still be observed after two weeks of culturing.
Figure 3.8: Cytoskeleton (f-actin) and nucleus (DAPI) staining of non-sprayed and
sprayed keratinocytes (A). Scalebars are 100 µm for day 1 images and 1000 µm for week
2 images. (B) Cell shape measurements of sprayed and non-sprayed human epidermal
keratinocytes in medium per parameter at day 1 and week 2. Data presented as indi-
vidual values and mean with SD. Significant di↵erences found by one-way ANOVA with





The Alamar blue assay was implemented to quantitavely investigate the metabolic activity
of sprayed HEKa. This assay allowed for continuation of cell culture, giving the opportu-
nity to assess viability (with live/dead staining) on the same cell population. As shown
in Figure 3.9 A and B, metabolic activity of sprayed cells is reduced in comparison to
non-sprayed cells. Interestingly, this e↵ect is more profound in cells encapsulated in fluid
gel as is in agreement with the viability assay. In all groups except sprayed encapsulated
cells, the metabolic activity increases again over time, indicating that viable delivered
cells are able to recover and proliferate. From this data, cell proliferation seems restricted
by encapsulation and spraying with lower percentage reduction at all timepoints when
compared to control keratinocytes, especially since a lower number of cells was delivered
to the control wells.
When comparing sprayed and non-sprayed conditions directly, sprayed cells under-
perform in terms of metabolic activity as demonstrated in Figure 3.9C. The amount of
reduction of encapsulated cells in the sprayed wells is less than 50% of that of the non-
sprayed wells for all timepoints. In cells delivered in media the percentage di↵erence is
initially 71%, meaning that the metabolic activity in the sprayed wells is inhibited by
29% when compared to non-sprayed wells.
Figure 3.9: Metabolic activity of HEKa as determined by alamar blue. Percentage reduc-
tion for sprayed and non-sprayed HEKa in culture medium (A) and gel (B) was compared.
Percentage di↵erence between treated (i.e. sprayed) and non-treated (i.e. pipetted) cells
delivered in gel or media (C). Values are mean percentage (2 individual experiments,
minimal 4 repetitions), errorbars are SD.
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Wound healing
In vitro wound healing was assessed by a scratch assay of HEKa monolayers combined
with 5 conditions: cell-free fluid gel, sprayed and non-sprayed keratinocytes in medium
and sprayed and non-sprayed keratinocytes in fluid gel. For distinction between wound
healing from the existing wound edges and cells delivered on top; cells in the monolayer
were stained red and cells applied on top of the monolayer stained green. In general,
cells delivered on top of the monolayers did not seem to contribute significantly to wound
healing as only few green stained cells were found in the wounded area in comparison to
red stained cells infiltrating from the wound edges. Di↵erences between cell densities of
sprayed cells in gel or media are shown in Figure 3.10C.
Theoretically, soluble factors secreted by spray delivered cells could impact on wound
healing of the monolayers underneath. When looking solely at the monolayers, Figure
3.10B demonstrates a higher mean object area (i.e. cell density) for monolayers with cells
sprayed in media compared to cells sprayed in gel at all timepoints except at 2 hours.
However, no statistical significant di↵erences were found for the mean cell density between
gel and media groups.
Figure 3.10: In vitro wound scratch assay of sprayed human epidermal keratinocytes.
Representative micrographs of a monolayer of HEKa (red) with sprayed keratinocytes in
culture medium (green)(Ai-iii) or encapsulated in fluid gel (Aiv-vi) taken at 2 hours, 96
hours and 120 hours after scratch. Cell density measured as the mean object area (µm2)
of monolayer cells fluorescently stained red (B) and sprayed cells, fluorescently stained
green(C). Scalebars are 1000 µm.
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Furthermore, the presence of cell-loaded fluid gel did not seem to enhance healing rates
of the monolayers as reflected in the rate of wound closure as calculated from repeated
wound width measurements (Figure 3.11A). Sprayed cells delivered in medium had a
smaller mean wound width at 120 hours after the scratch (Figure 3.11A), but despite
near or complete closure of 3 out of 4 wounds, no significant di↵erences of wound healing
rate could be found when compared to cells sprayed in gel (Figure 3.11B).
(A) (B)
Figure 3.11: Scratch assay of control and encapsulated sprayed keratinocytes. Wound
width (A) and wound healing rate (B). Values presented are mean and standard deviation.
t
Di↵erentiation
Keratinocytes express distinctive marker genes at each di↵erentiation stage [287]. Here,
we examined expression of two keratinocyte di↵erentiation markers 3 days and 1 week fol-
lowing spray-application. A marker for basal keratinocytes is laminin 5 (LM-5). Laminin
5 is an important component of the basement membrane and plays a role in regulating
cell adhesion as well as cell migration in wound healing [333].
A higher level of laminin-5 was expressed by keratinocytes delivered in medium when
compared to encapsulated cells (Figure 3.14A). All cells came from the same population
and cultured under identical conditions, thus, encapsulation in fluid gel has a restrictive
e↵ect on LM-5 expression at day 3. At a later timepoint, expression of LM-5 has increased
in encapsulated cells, especially in sprayed keratinocytes. Likewise, sprayed keratinocytes
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Figure 3.12: Cell viability of sprayed and non-sprayed human epidermal keratinocytes.
Both conditions eventually reach confluence as shown in representative images taken for
each condition and timepoint (A), but images of the entire well obtained by capturing of
8x6 individual images (montage) show that pipetted cells reach confluence earlier com-
pared to sprayed cells (B). C) Automated cell count of live and dead cells presented as
percentage viable cells in the entire well. Data presented as mean of duplicate measure-
ment with SD.
103
Figure 3.13: Cell viability of encapsulated sprayed and non-sprayed human epidermal
keratinocytes. Representative images taken for each condition and timepoint (A) show a
high viability of pipetted encapsulated cells, however poor survival of sprayed encapsulated
cells was noted. Z-stack confocal images are demonstrating that pipetted cells maintain
good viability during the studied period, while sprayed cells have poor viability from day
1 with little recovery (B). (C) Automated cell count of live and dead cells presented as
percentage viable cells in the entire well. Data presented as mean duplicate measurement,
errorbars represent SD.
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in medium having higher LM-5 expression could indicate a cell response to trauma (Fig-
ure 3.14C).
Keratinocytes that have left the basal layer and are enlarging synthesise involucrin, a
marker for terminal di↵erentiation. Higher values of involucrin were found in encapsu-
lated cells, especially those that were sprayed, at day 6 following application, indicating
that encapsulated cells can commit to di↵erentiation (Figure 3.14B and D). In contrast,
involucrin levels in cells delivered in medium were very low at 1 week after delivery, with
no di↵erence between sprayed and non-sprayed cells. Migratory keratinocytes do not usu-
ally commit to di↵erentiation, cells at the wound edge proliferate and migrate to close the
wound before restoring the barrier function by stratification (eg di↵erentiation). Since
keratinocytes delivered in medium are not confined by a matrix like encapsulated cells, a
more migratory behaviour is expected.
3.4 Discussion
The clinical outcomes of spray delivery of autologous human keratinocytes have been
investigated widely, with variable results in terms of graft take and healing time. But
in vitro cell studies on long term e↵ect of spraying are lacking. Furthermore, current
clinically adopted spray systems struggle to retain cells on the wound, cell spillage is an
unadressed clinical problem that could be circumvented by the introduction of a gellan -
fluid gel based cell carrier, as investigated here.
Gellan gum is an anionic heteropolysaccharide derived from the bacterium Pseudomonas
elodea, consisting of D-glucuronic acid, L-rhamnose and D-glucose subunits, it can form
a thermo-reversible gel in the presence of ions upon temperature decrease. FDA and
European Union (E418) approved as food additive and for medical use, making it also an
attractive agent for a wide range of pharmaceutical and biomedical applications. For ex-
ample, as encapsulating agent in controlled drug delivery systems [334] and more recently,
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Figure 3.14: In-Cell Western assay for the keratinocyte di↵erentiation markers laminin 5
(A) and involucrin (B) in sprayed and non-sprayed encapsulated and control keratinocytes.
LM-5 = laminin 5, INV = involucrin. Normalized fluorescent intensity of laminin 5 (C)
and involucrin (D). Data presented as mean (n=4), errorbars represent SD (not visible
when smaller than icon).
as a material for tissue engineered sca↵olds[179], injectables[181] and bio-inks[180, 335].
A gellan fluid gel system was prepared by applying shear during the gelation process,
producing a shear-thinning system referred to as ’fluid gel’. In gellan, applying shear
during the random coil to helix transition restricts the orderly formation of a contineous
gelled network, instead, a particulate suspension is formed with weak associations between
the particles (typical for fluid gels [269, 297]). Rheological characterization demonstrated
that gellan fluid gel has specific viscoelastic properties that behaves as a liquid under
high shear (when passing through the spray nozzle), but restructures to a weak gel on the
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receiving surface facilitating retention of cells on the surface (Figure 3.5).
Following the investigation into the mechanical properties of the fluid gel, the cell viabil-
ity of encapsulated cells was compared to that of non-encapsulated cells. As described
in other cell depositing technologies such as 3d bioprinting, cell viability can be jeopar-
dized by harsh extrusion methods such as large pressure drops in extrusion bioprinting
disrupting cell membranes causing cell death [336] or laser-assisted printing with thermal
damage to cells occuring[337]. Taken these challenges into account, researchers have now
shown encouraging results with highly viable and di↵erentiating cells, for example Fu et
al. showed that bioprinted epithelial progenitors in a gelatin-based porous construct can
form glandular morphology [338]. Cubo et al. bioprinted a two-layered skin equivalent
including a fibrin-based layer with dermal fibroblasts embedded and a keratinocytes layer
on top, in vivo formation of stratified skin was found in a murine model [339]. These
exciting developments potentially pave the way for 3D printed skin[340]. Moreover, these
advances are particularly interesting as similarities between nozzle based bioprinting and
spray-assisted cell delivery exist. For example, knowledge on printer extrusion settings
(such as pressure, shear and temperature at delivery), nozzle diameters and bio-ink fab-
rication could be translated to other cell-deposition applications such as cell-spraying.
In this study, it was found that keratinocytes encapsulated in fluid gel remained vi-
able initially, but eventually seemed to die. Encapsulated cells kept a rounded phe-
notype as shown in Figure 3.13B-Day 1 and their metabolic activity was lower than
non-encapsulated cells. However, an increasing proliferative capacity was observed at
later timepoints indicating either proliferation of remaining viable cells in the gel or more
likely, proliferation of cells that were able to di↵use out of the gel and attached to the
bottom of the well as captured with confocal microscopy at day 7 (Figure 3.13B). As a re-
sult, viable cell numbers are again increasing after day 7 (3.13C) as the viable multiplying
cells will soon outnumber the unviable cells entrapped in the gel. These results indicate
the importance of cells to reach the wound bed and therefore migration of the cells to-
wards a chemoattractant was tested in a transwell assay. As expected from the estimated
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sedimentation rate, di↵usion of cells through the porous membrane was restricted by the
gel with significant di↵erences between cells seeded in the gel and in culture medium
(Figure 3.1F). Interestingly, the presence of a chemoattractant (HDFs in this case) did
not influence the di↵usion or migration of keratinocytes through the membrane.
Likewise, the e↵ect of spray delivery on viability and function of keratinocytes was inves-
tigated. In contrast with previous work based on encapsulated fibroblast spray-delivery
(Chapter 2), it was found that low pressure spray delivery was compromising viability
and function of encapsulated keratinocytes as reflected in decreasing viable cell numbers
(Figure 3.13C) and low metabolic activity (Figure 3.9B) throughout the studied period.
This e↵ect was less evident in non-encapsulated cells, with cell viability again increasing
after day 4 and confluence was reached by day 10-14. Also, metabolic activity of sprayed
cells recovered to >50% reduction by two weeks of cells culturing. A possible explana-
tion for low cell viability following spraying of encapsulated cells is the use of a high cell
density. With cells in close proximity of each other the local stress on a cell is increased
during delivery as shown in a computional model by Nair et al. [341] and by a 3D alginate
model from the same group [342].
The morphology of sprayed cells was examined by visualizing filamentous actin (f-actin),
a major constituent of the cytoskeleton network [343]. The actin cytoskeleton interacts
with focal complexes at the edge of the cell generating traction forces that facilitate cell
migration and f-actin is part of the lamellipodia that enhance matrix adhesion[333]. Ker-
atinocytes are robust cells that can endure higher compression forces than other cell types
[344], however, it is possible that pressure at spray delivery can induce some cell membrane
disruption. In this study, di↵erences in organization of the f-actin cytoskeleton between
sprayed and non-sprayed cells were found, confirming a level of stress with smaller cells
and more f-actin deposition at the cell borders at day 1 (Figure 3.8A). Accumulation of
contractile stress fibers as observed in sprayed cells on day 1 could lead to apoptosis, likely
explaining the significant drop of viable cells on day 4 (Figure 3.12C). In addition, the
potential lack of cell-to-cell contact and cell matrix adherence could drive keratinocytes
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into a specific type of programmed cell death: anoikis [345]. The significantly smaller
cell size found in sprayed cells after 2 weeks of culturing, indicate a potential slower or
incomplete recovery following spraying (Figure 3.8). Indeed, proliferation (as measured
by metabolic activity) of sprayed cells stayed behind that of non-sprayed cells (Figure 3.9.
Next, we examined whether cells delivered to a wound contribute to wound healing and
can be found in the wound bed. In the medium group one well showed limited healing,
whereas the 3 other wells were nearly or completely healed within 120 hours. In contrast,
the gel group, showed less evident healing for 3 out of 4 wells, but, 1 well did show com-
plete confluence of the wounded area within 120 hours. Despite consistent experiment
conditions, these results seems to reflect that wound healing is not always reproducible.
Although some di↵erences between the groups were observed, no statistically significant
di↵erences were found, most likely due to the large standard deviations given by wide
varying outcomes within the groups. Therefore, di↵erences between the groups cannot be
guaranteed to cause the di↵erences seen in this experiment.
The di↵erentiation capacity of sprayed and encapsulated keratinocytes was investigated
by measuring laminin-5 and involucrin expression. LM-5 deposition appears to be crit-
ical for the organisation of the basal membrane zone and for cell migration during re-
epithelialization[346]. Cells delivered in medium expressed high levels of LM-5 after 3
days of culturing (Figure 3.14), this may indicate that cells start upregulating LM-5 as a
response to cell delivery, whether this is caused by a response to inflammatory cytokines
released following trauma or because cells are actively migrating, needs further investiga-
tion. As there are no other ECM products or cells available in the system, keratinocytes
rely on autocrine signaling pathways for response to trauma and subsequently stimulation
of repair via migration (re-epithelialization) and proliferation[347]. Interestingly, cells en-
capsulated in fluid gel do not express high levels of LM-5 at day 3, but a slight increase
is observed in sprayed cells which might indicate some attempt to migratory behaviour
of activated keratinocytes.
When cells leave the basal layer and commit to di↵erentiation, markers such as keratin 1,
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10 and involucrin are expressed [287]. Here, di↵erentiation of keratinocytes was probed
by measurement of involucrin, a marker for terminal di↵erentiation synthesized in the
spinous layer of the epidermis. Involucrin expression of all groups was similar at day 3,
but a marked raise of expression was noted for cells encapsulated in fluidgel after one
week of culturing.
Involucrin expression is linked to increased cell size and change in cell shape to a more
flattened phenotype as part of the di↵erentiation process, cells lose ECM connection and
upward migration occurs[348]. As the gellan gel-network does not provide ECM-like
binding sites, the encapsulated cells cannot bond to either the ECM or other cells and
as a result, the onset of terminal di↵erentiation and thus premature involucrin expression
might occur [349]. Furthermore, cells in single-cell suspension are prone to early di↵er-
entiation [350]. Interestingly, in vitro cultured keratinocytes on plastic can synthesize
involucrin immediately above the basal layer [351]. However, at one week of culturing,
involucrin levels of cells delivered in medium was very low, suggesting that cells did not
commit to terminal di↵erentiation at that point, but perhaps were still in a migratory
state.
Gels formulated with gellan gum have previously shown to be a promising candidates
for cell encapsulation [269, 311, 352]. Our earlier work has demonstrated benificial ma-
terial characteristics of gellan fluid gel with good spray-ability and limited run-o↵ from
the wound area, this material was compatible for HDF encapsulation. However, these
encouraging results can not directly be translated to keratinocytes. As this study has
shown that spray-delivery of keratinocytes changed the cell morphology and has an im-
pact on cell function in terms of metabolic activity and protein expression. Furthermore,
when encapsulated in gellan fluid gel, keratinocytes remain initially viable, but soon show
altered behaviour in terms of decreased metabolic activity, remain a rounded phenotype
when entrapped in the gel and eventually lose viability. As a result, migratory behaviour




By using a previously engineered biopolymer fluid gel to encapsulate human epidermal
keratinocytes, we aimed to address the issue of poor retention of cells to the wound bed - a
limitation in current cell-spray systems. The response of human epidermal keratinocytes
to encapsulation in a biopolymer fluid gel and subsequently spray delivery was investi-
gated. Spray delivery itself, has a negative e↵ect on keratinocytes as shown by changes
in the morphology and reduced metabolic activity in comparison to non-sprayed cells.
However, recovery seems to occur with a confluent monolayer being formed after 10 days
of culturing. Encapsulated cells also showed recovery following delivery, as measured by
an increase in percentage viable cells and metabolic activity over a timescale of 2 weeks.
However, spray delivery of encapsulated keratinocytes has a significant detrimental e↵ect
on cell viability and cell function in terms of metabolic activity, wound healing and dif-
ferentiation.
Therefore, gellan fluid gel in the current formulation did not seem to be an ideal in vitro
3D culture system for keratinocytes, but the potentially positive e↵ects of in vivo wound
environment conditions on keratinocyte function were not taken into account here. Thus,
when used as rapid delivery method by applying a thin layer of gel, this system could
still be of benefit for cell delivery as it facilitates homogenous coverage of complex wound
areas. Data presented suggests that cells used for cell-spraying applications must not
only be robust enough to survive the process, but also be able to recover from mechanical
and/or physiological stresses once transplanted, to ensure highly proliferative and func-
tional cells that contribute to the wound healing process. Future work should focus on




FORMULATION OF ACETIC ACID - GELLAN
HYDROGEL DRESSING
Antimicrobial skin dressings to treat infected (burn) wounds without causing
antibiotic resistance are in great demand. Acetic acid is a known antimicrobial
agent to treat wound infections, acetic acid soaked in sterile gauze can be
applied to infected wounds, however, rapid drug release and adherence to the
woundbed leading to traumatic removal are considered disadvantageous.
In the present study, a gellan-based hydrogel film is used to deliver diluted
acetic acid to the wound bed. The gellan films are rehydrated in acetic acid
solutions prior to application and compared to medical gauze. The prepared
gellan films are transparant, anti-adherent and could possibly improve patient
comfort when compared to gauze. The results of this study show that by
increasing the acetic acid content in rehydration fluids, the swelling capacity
and thickness of the gellan films decrease, which is not observed in gauze.
However, the mechanical properties in terms of tensile strength increase in
higher concentrations of acetic acid rehydration fluids. When compared to
gauze, the gellan films have similar release kinetics but seem to dehydrate
slower. Microbial action was probed using a disk di↵usion test on a blood agar
plate seeded with Pseudomonas Aeruginosa, the gellan films provided anti-
microbial action when rehydrated in 3-5 % acetic acid with zone of inhibitions
up to 5 mm.
Taken together, the capacity of the gellan films to absorb and release diluted
acetic acid was shown and the physical properties are superior to medical
gauze. The gellan films have shown promising results to be used as wound
dressing application, but further studies are needed optimize release kinetics.
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4.1 Introduction
4.1.1 Burn wound infection
Burn wound infections (BWI) can cause delayed healing, poor scarring and invasive in-
fection leading to sepsis which can result in death of the patient [353, 354]. Burn wound
infection and secondary sepsis are considered the most serious complications in thermally
injured patients [355]. The major cause of death in severely burned patients (>40%
TBSA) is sepsis secondary to inhalation injury or any form of infection such as BWI
[355]. Burn wound infections account for approximately 9% -17% of all burn injury re-
lated complications [356, 357]. Pruitt et al. reports that invasive burn wound infections
account for 5% of all burn treatment complications in a healthy patient population (U.S.
Army Burn Center between 1986-1995)[353]. Invasive BWI undoubtedly requires intra-
venous or oral antibiotics; however, nosocomial BWI can also be targeted with a wide
variety of topical agents such as silver nitrate, povidone iodine, topical antibiotics or
acetic acid. To date, no consensus regarding superiority of a certain topical agent for the
prevention or treatment of BWI has been reached (European Burn Association guidelines)
[358]. Because bacterial resistance is an increasing worldwide concern, antimicrobial ef-
fective topical agents that do not increase the risk of resistance and are non-toxic to cells
involved in the wound healing process are required.
4.1.2 Acetic Acid in burn wound treatment
Acetic Acid is a simple carboxylic acid that consists of an acetyl group and a hydroxyl
group. It is a product of ethanol oxidation and wood distillation (Figure 4.1) [359].
Figure 4.1: Chemical structure of acetic acid - C2H4O2.
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Cells naturally contain acetic acid at a low level. Acetic acid is also found in human
vaginal lubrication, probably playing a role in reducing microbicidal activity [360]. Acetic
acid has been used as an antibacterial and antifungal agent for thousands of years, more
recently acetic acid has been a widely used topical antiseptic agent for the treatment
of burns wounds and has been shown to have activity against Gram-negative organisms
including Pseudomonas Aeruginosa [361]. The common application method is to soak
gauze in a 1-5% w/v acetic acid solution and place this directly on the cleaned burn wound
or on top of a protective layer such as para n gauze. These dressings are then protected
with more layers of (para n) gauze. Changing dressings is required to observe, clean and
redress the wound; patients often require additional analgesia during these procedures
[362]. It is documented that many patients complain of stinging and pain on application of
acetic acid to wounds, in particular if a strength of 5% is used [363]. Higher concentrations
can lead to severe complications and induce skin injury [364]. During the treatment of
colonised burn wounds it is important to maintain a balance between microbicidal activity
and tolerability. In vitro studies have been conducted examining the minimum inhibitory
concentrations (MIC) of acetic acid before and after evaporation and exposure to gauze.
These showed that the methicillin-susceptible strain of S. Aureus (MSSA) had an MIC
of 0.312% and a methicillin-resistant strain was less susceptible, MIC = 0.625%. Strains
of A. baumannii also had a MIC of 0.312% and all strains of Pseudomonas Aeruginosa
were susceptible, MIC = 0.166% [365]. The mechanism of action in wounds is still unclear
[366] but could be related to lowering the pH level of the wound milieu, which can inhibit
growth of many pathogenic bacteria and their protease activity. Another e↵ect of low
pH at the infection site is the induced release of oxygen towards the cells resulting in
higher concentration of reactive oxygen species that is known to promote wound healing
[367]. However, Bjarnsholt et al treated P. Aeruginosa cultures with hydrochloric acid
(HCL) and acetic acid with the same low pH (range 4.33-6.0) and found a beneficial e↵ect
of acetic acid in comparison to HCL, indicating that the mechanism of action of acetic
acid is not merely due to an acidic e↵ect. Interestingly, a pH dependency for acetic acid
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was found with samples treated with low pH (<4.76) being significantly more e↵ective
than higher pH treatment (>4.76) [368]. Acetic acid can di↵use through the cell wall of
bacteria and acidify the cytoplasm causing disruption of the cell function [369, 370].
4.1.3 Acetic acid delivery systems
Diluted acetic acid is routinely applied to infected wounds in clinical practice. The es-
tablished method is to drench a compress in the solution and apply to the wound [366].
Other medical applications of diluted acetic acid include its use in ear drops to treat otitis
externa [371], as urological irrigation solution [372], or as acidic vaginal gel for the treat-
ment of bacterial vaginosis [373]. In more concentrated dilutions (up to 50%) it has been
used in sclerotherapy for renal cysts [374, 375] and as ultra-sound guided percutaneous
acetic acid injection therapy (PAIT) for hepatocellular carcinoma [376].
4.1.4 Study rationale
Acetic acid can be used as an antimicrobial agent to treat wound infections (especially
known for P. Aeruginosa treatment). E↵ectiveness of acetic acid in concentrations of
0.3-5% has been proven in vitro against several bacteria [365] and fungi [377]. Numer-
ous clinical studies investigating e↵ectiveness of acetic acid against wound infection have
supported these results [361, 363, 366, 378, 379]. Currently, a pilot trial comparing the
antimicrobial e↵ectiveness and tolerability of acetic acid 0.5% versus 2% in patients with
burn wounds is performed (ongoing study).
Clinically adopted protocols advise to soak the diluted acetic acid in sterile gauze and
apply this to the wound. The dressings are usually changed to ensure an active dose of
diluted acetic acid in the wound. As dressing changes are related to discomfort and pain
for patients [380], minimizing these dressing and improving the comfort of the dressings
is key. These issues can be addressed by applying a hydrogel based dressing hydrated
with diluted acetic acid to the wound. In this way, a slower release of the acetic acid
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can be achieved resulting in fewer dressing changes. Furthermore, comfort of the dressing
material is improved by using a soft hydrogel compared to gauze that is known to adhere
to the woundbed.
The aim of this study is to optimise the composition of gellan gum hydrogel film for the
uptake and release of acetic acid in wounds.
4.2 Methods
4.2.1 Preparation gellan gel films
Low-acyl gellan gum (kelcogel LOT #: 5C1623A ) was used for preparation of all gellan
films. A 2 % (w/v) gellan solution was prepared by adding gellan powder to deionised
water, the solution was heated until 70 °C. Solution was allowed to cool until 60 °C, if
applicable, at this stage PBS was added. Next, gellan solutions were casted in 10x10
cm square culture plates on a low speed orbital shaker to enhance even distribution and
were then dried in a pre-heated vacuum oven (Thermo Scientific; VT 6060 M) set on
40-42 °C for a total duration of 17 hours. In the last 2 hours a vacuum was applied to
remove moisture. Films were harvested and stored individually in sealed bags in a dry
environment at room temperature until further use.
4.2.2 Material characterisation gellan patches
Swellability
Five di↵erent rehydration fluids were used including deionized water (H2O), 5% acetic
acid solution (w/v) (Huddersfield Pharmacy Specials, UK), 1% acetic acid solution (w/v),
sodium chloride 0.9% (w/v) and acetic acid diluted in sodium chloride until a final concen-
tration of 1% acetic acid (w/v) and 0.72% NaCl (w/v). Dry weight of all gellan patches
was measured. Next, gellan patches prepared with and without PBS were immersed for 5
minutes in rehydration fluids at room temperature. Excess fluid was lightly wiped by filter
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paper and weighted (PM460 Delta Range balance, Mettler-Toledo Ltd, UK) immediately,






• Wd = Weight of dry polymer (g)
• Ws = weight of swollen polymer (g)
Thickness
Thickness of gellan films was measured with a digital caliper following 5 min rehydration
in the dedicated fluid, for each sample 3 measurements from di↵erent sections of the film
were obtained.
Tensile strength
The gellan films were rehydrated for 5 minutes and cut into dogbone shaped samples using
a 3D-printed cutter with specified dimensions [381] as shown in (Figure 4.2A and Figure
4.2B). Samples were directly loaded onto the testing machine (Bose ElectroForce 5500,
TA Instruments) equipped with WinTestr software package as shown in Figure 4.2C. All
tests were run with a crosshead speed of 0.1 mm/s at room temperature until breakage
of specimens occured.
The tensile stress (Equation 4.2) and strain (Equation 4.3) were calculated from dis-
placement (mm) and load (N). Youngs modulus was calculated from the linear region of





With   is stress (Pa), Force being the load in (N) and the Area (mm2) was determined
by the width (4 mm) times the depth (thickness) of the tested sample.
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• ✏ = strain
•  L = displacement (mm)





• E = Young’s modulus (N/mm2)
• ✏ = strain (%)
•   = stress (Pa)
4.2.3 Release
Di↵usion through agarose gel
Gellan patches were rehydrated into H2O 1%, 3% and 5% acetic acid solutions (w/v) and
cut into squares to fit cuvettes. An agarose 1% (w/v) gel was prepared by addition of
agarose (Fisher Scientific, UK) to H2O heated to 80 – 90 °C under constant mechanical
stirring, gel formation occured upon cooling to room temperature and an pH indicator was
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added to the cooling gel. Rehydrated gellan-only patches were placed on top of agarose
gel filled cuvettes and photographs were taken at 5 min and 14 hours after application.
Release into wound bed
Release of acetic acid was quantified with an enzymatic detection kit, K-ACETAK(Megazyme),
based on the following reactions:
1. Acetate + ATP (acetate kinase)
            !
acetyl-phosphate + ADP
2. ADP + PEP (pyruvate kinase)
             !
ATP + pyruvate
3. Pyruvate + NADH + H+ (D   lactate dehydrogenase)
                      !
D-lactic acid + NAD+
ATP= Adenosine triphosphate, ADP= Adenosine diphosphate, PEP = Phosphoenolpyru-
vate , NADH= Nicotinamide adenine dinucleotide (reduced form), NAD+ = Nicotinamide
adenine dinucleotide (oxidized form) Reagents were prepared following suppliers’ guide-
lines. Briefly, reagent 1 contained NADH, ATP, PEP and PVP mixed with H2O and
reagent 2 contained a bu↵er, preservative, acetate kinase, pyruvate kinase and D-lactate
dehydrogenase suspension. The absorbance was measured at 340 nm with a Sparkr
microplate reader before (A0) and after the reaction (A1), the di↵erence ( A) was cal-
culated. First, a calibration curve was performed with acetic acid concentration ranging
from 0 - 1.8 g/L as shown in Figure 4.3. Good linearity is shown for concentrations up
to 0.9 g/L (R2 = 0.9701) and less so when the full range of concentrations was included
(R2 = 0.9274), attempts to improve accuracy of the reading included: decreasing volumes
to allow for better mixing, prolonging the reaction time and lowering the amount of NADH
in the reaction, these attempts did not improve accuracy and the initial method was used
for further experiments. However, lowering the amount of NADH in the reaction resulted
in lower absorbance values, now clearly within the detection limits of the platereader and
therefore the adapted reagent 1 was used for further experiments.
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Figure 4.3: Acetic acid detectection calibration curve. Values represent absorbance dif-
ference of A0 and A1 both measured at 340 nm.
Then, the release of acetic acid was measured in an ex vivo porcine skin wound model
as illustrated in Figure 4.4. Porcine skin wounds were created by scoring patches of 1x1
cm2 with a scalpel in 4 directions, each 10 times. Then the skin was hydrated in H2O
for 2 hours, excess fluid was removed from the epidermis and the skin was incubated at
34 °C and 5% CO2 while hydrated with H2O for another 2 hours. Samples of gellan-only
dressing and gauze were cut in 1x1 cm2 square patches, rehydrated in 0%, 1%, 3% and
5% w/v acetic acid solutions for 5 min and placed on top of porcine wounds. Weight of
dry and wet (before application to pig skin) was measured. Samples were removed after
1, 6, 12 and 24 hrs and diluted in 50 ml H2O for 24 hours. Then, aliquots of diluted
dressings were taken and acid acid was detected as described above.
Figure 4.4: Porcine wound model method
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4.2.4 Agar disk di↵usion assay
Antimicrobial e↵ect of the gellan films and gauze were compared. The disk di↵usion assay
was performed with blood agar prepared by the clinical microbiology lab at UHB1 and
plated with Pseudomonas Aeruginosa for 24 hours. Then, 6 mm diameter round punch
biopsies were taken from the gellan patches and multiple layers of medical gauze cut in
similar shape samples. All samples were rehydrated for 5 minutes in the test agents (1%,
2%, 3%, 4%, 5% acetic acid solutions (w/v) and H2O). When the solution has an anti-
microbial e↵ect, a clear zone around the sample can be observed (=zone of inhibition),
here, measured after 24 hours of incubation.
4.3 Results
4.3.1 Visual appearance of dressings
All the investigated gellan films are transparant with a square shape and smooth surface,
with dry gellan films being thin and delicate. After rehydration the gellan films remained
transparant and exhibited a softer touch, especially those rehydrated in H2O and low-
acetic acid concentration fluids. All films were non-adhesive to skin when rehydrated, but
preparations rehydrated in H2O were more fragile to handle. Rehydration increased the
thickness of the films and a higher concentration of acetic acid present in the rehydration
fluid resulted in dressings with a firmer consistency.
4.3.2 Thickness
Transparant gellan films were prepared with low-acyl gellan gum and the thickness of
hydrated systems was measured. Table 4.1 shows the mean thickness (SD) of di↵erent
compositions of gellan patches per rehydration fluid. In general, it was found that thick-
ness of the systems is highly dependent on the type of rehydration fluid used with systems
1with help from Dr. Fenella Halstead, NIHR SRMRC Clinical Scientist - Microbiology
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rehydrated in H2O being significantly thicker than other rehydration fluids. Gellan films
prepared with PBS (GGPBS) (Figure 4.5B) have thicknesses ranging from 0.17 mm (5%
AA w/v) to 0.59 mm (H2O rehydration). Overall mean thickness of gellan patches pre-
pared without PBS (GG) was thinner and ranged from 0.14 mm until 0.46 mm when
rehydrated in 5% AA w/v and H2O respectively (Figure 4.5A). In both types of films, the
amount of acetic acid added to the rehydration fluid negatively influenced the thickness,
with a statistically significant di↵erence found in gellan only systems.
Table 4.1: Gellan film thickness. All measurements are performed in triplicates, values
are mean thickness in mm (SD).
Rehydration fluid
H2O 1% Acetic acid (w/v) 5% Acetic acid (w/v) 0.9% NaCl (w/v)
1% Acetic acid (w/v)
in 0.72% NaCl (w/v)
Gellan - PBS 0.59 (0.05) 0.21 (0.01) 0.17 (0.00) 0.27 (0.03) 0.20 (0.01)
Gellan 0.46 (0.04) 0.23 (0.01) 0.14 (0.01) 0.20 (0.01) 0.16 (0.01)
Figure 4.5: Mean thickness (mm) and standard deviations of gellan films prepared with
PBS (B) or without (A) following rehydration. Significant di↵erences found by one-way
ANOVA with post-hoc statistical significance analysis indicated by p values of *<0.05 ,
** <0.01 and ***<0.001.
4.3.3 Swelling capacity
Dry weight of gellan patches and medical gauze (Synergy, UK) was measured. Sub-
sequently, the weight was measured directly following rehydration of the samples and
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swelling rate (in %) was calculated as shown in Figure 4.6. All preparations showed a
positive swelling capacity that ranged from 582% to 2234% with the maximum value at-
tained for gellan films rehydrated in H2O. Swelling capacity of the fabricated films follows
a similar pattern as the thickness outcomes, with a lower percentage of swelling for films
rehydrated in higher acetic acid concentration fluids, except for gellan patches without
PBS that were rehydrated in 1% AA sodium chloride solution. Furthermore, only those
preparations rehydrated in H2O reached a higher swelling capacity than medical gauze
as shown in Figure 4.6. It was found that swelling of medical gauze was not influenced
by the type of rehydration fluid. Whereas both the gellan patches have a large range
of swelling with largest increase in weight found for systems rehydrated in H2O and a
decrease in swelling capacity noticed with increasing concentrations of acetic acid present
in the solvent fluid. Hence, solvent composition influences the swellability of the gellan
patches strongly. Swelling is increased when lower concentrations of acetic acid are used
in the rehydration fluid.
Figure 4.6: Mean swelling (%) of gellan films compared to gauze following rehydration.
4.3.4 Dehydration
In order to evaluate the ability of gellan films to retain water following application, gellan
films were allowed to dry and weight was measured 30 min, 90 min and 20 hours after
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rehydration at ambient conditions as shown in Figure 4.7. Gellan films showed a larger
water holding capacity than gauze with slower decrease of weight loss as calculated by
percentage mass loss of swollen state. In a physiological environment the dressings would
be exposed to a moist woundbed and covered with a secondary dressing, it can be expected
that the preparations are able to absorb wound exudate. This is of great value because
besides releasing the acetic acid in the wound, the gellan films are able to retain water
for longer, resulting in a moist wound environment necessary for wound healing.
Figure 4.7: Mean dehydration (%) of gellan films compared to gauze at 30 min, 90 min
and 20 hours after rehydration. Values presented are mean percentage dehydration of 3
individual measurements, errorbars are SD.
4.3.5 Tensile strength
The mechanical strength of the gellan films was determined by measuring the amount
of tensile stress needed for the gellan films to rupture. A general correlation is evident
between amount of acetic acid in the solvent fluid and Young’s modulus; preparations
rehydrated in 5% AA endured highest stress before failure (tensile strength) 4.8A,B and
had the largest Young’s modulus 4.8E. As expected, the lowest maximum stress upon
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failure and lowest Young’s modulus were measured for gellan films rehydrated in H2O,
resulting in dressings that are less practical as they rupture easily upon handling. How-
ever, the greatest elongation properties were seen in dressing rehydrated in 0.9% NaCl,
followed by gellan-PBS films rehydrated in 1% AA NaCl (Figure 4.8C,D).
Figure 4.8: The tensile stress-strain curves for gellan only (A) and gellan-PBS films (B)
show a relationship between solvent formulation and tensile strength. Mean values of 3
individual experiments are shown. Elongation as measured by maximum extension (mm)
at point of failure of gellan-only (C) gellan-PBS dressings(D). Young’s modulus of gellan
films prepared with (GG) and without PBS (GGPBS) (E). Values presented are mean
Young’s modulus and individual measurements, errorbars are SD.
4.3.6 Release
Release of acetic acid into the wound should occur in a controlled manner instead of
rapid release seen in gauze soaked in acetic acid. Mechanical properties of gellan films
indicate that the solvent formulation influences swelling ratio and strength of the prepa-




Di↵usion of acetic acid through a higher viscosity environment was tested by placing the
rehydrated dressings on pH indicating agarose gel. As expected, when dressings are re-
hydrated in higher concentrations of acetic acid, a larger di↵usion grade was observed
(Figure 4.9). Whether this e↵ect can similarly be observed as a concentration of acetic
acid in the wound was examined by a wound model based on porcine skin.
Figure 4.9: Acetic acid di↵usion into agarose gel.
4.3.8 Porcine wound model
The e↵ect of acetic acid loading on the release rates was investigated for gauze and
gellan-only formulations. It was hypothesized that the concentration release for formula-
tions containing lower concentration of acetic acid would be low, while the release should
increase with increasing amount of acetic acid absorbed in the dressings. However, it was
found that when normalized against H2O, the absorbance di↵erences in all samples were
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extremely low with many negative values in the gellan group (Figure 4.10). Absorbance
di↵erences from gauze samples were low at all timepoints and concentrations, but mainly
positive values were found, indicating a trace of acetic acid left in the dressing.
Figure 4.10: Acetic acid release form porcine wound model normalized against H2O sam-
ple. Data presented is mean of 3 individual measurements per timepoint with standard
deviation. Significance tested with two-way ANOVA.
4.3.9 Antimicrobial e↵ect
Anti-microbial activity of acetic acid rehydrated gellan patches was compared to medical
gauze. Larger zones of inhibition were present for gauze samples rehydrated in acetic
acid when compared to the gellan patches for the full range of acetic acid concentrations
tested. However, the gellan patches could be accurately cut into 6 mm round (punch
biopsy) samples, whereas, the gauze was cut in similar samples, but due to di culty
to handle and frail edges, larger samples were used (Figure 4.11). Acetic acid has an
anti-microbial e↵ect as growth was only observed under/on gellan patches rehydrated in
H2O. Gellan patches provided anti-microbial action when rehydrated in 3-5 % acetic acid
with zone of inhibitions up to 5 mm (Table 4.2). Although no growth was seen under
the samples rehydrated in lower concentrations (1-2% acetic acid), no zone of inhibition
was present either. These preliminary results indicate that acetic acid released from the
dressings has an anti-microbial e↵ect against Pseudomonas Aeruginosa, however, further
studies with larger numbers are needed to validate these results.
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Table 4.2: Anti-microbial activity (zone of inhibition) of gellan dressings
H2O 5% AA 4% AA 3% AA 2% AA 1% AA
Gellan only no zone* 5.0 3.2 no zone no zone no zone
Gellan - PBS no zone* 3.6 2.4 1.2 no zone no zone
Gauze no zone 10.3 13.1 9.4 5.1 3.5
AA = acetic acid. *growth under disk. All values presented are zone of inhibition in mm.
Figure 4.11: Gellan patches anti-microbial activity against Pseudomonas Aeruginosa
4.4 Discussion
With antibiotic resistance rising worldwide [382], the need to treat infections with an-
timicrobial e↵ective topical agents that do not increase the risk of resistance and are
non-toxic to cells involved in the wound healing process are required. Patients su↵ering
from burn injuries have a disrupted skin barrier which substantially increases the risk of
developing hospital-associated infections[383]. Acetic acid has been used in health care
as an antimicrobial agent to treat chronic and burn wound infections. Beneficial results
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have been shown with acetic acid solutions up to 5% [361, 366, 368]. However, nowadays
lower concentrations seem to be preferred to avoid burning sensations and complications
at the wound site [364]. It is known that wound dressing changes cause significant pain to
patients resulting in administration of pain medication and in extensive wounds sedatives
are often required to minimize discomfort [384]. Furthermore, the current application
technique can result in painful removal due to incorporation of the dressing material into
the wound, this can be avoided by applying a protective layer underneath the acetic acid
gauze. However, this additional barrier will most likely decrease the amount of acetic acid
released in the wound. Therefore, a non-adhesive soft dressing that can absorb acetic acid
solution and subsequently release it into the woundbed is desired.
In this study, the composition of a transparant gellan gum hydrogel film for the uptake
and release of acetic acid has been designed and its properties investigated. Gellan gum
is an exopolysaccharide that is produced through aerobic fermentation by the bacterium
Pseudomonas elodea, it consists of D-glucuronic acid, L-rhamnose and D-glucose subunits.
Mostly known in the food industry as a thickener, this natural polymer has also gained
interest for the use in biomedical applications because it can form a thermoreversible gel,
is biocompatible and has highly tunable mechanical properties. In terms of tissue engi-
neering purposes, gellan-based materials have been investigated for the use in ocular or
oral drug delivery [385, 386], reconstruction of cartilage [181], neural tissue [307], interver-
tebral discs [308] and intra-abdominal anti-adhesion barrier [183]. As a wound dressing,
gellan has been found to be non-toxic, stimulate healing and reduced scarring in a rodent
study [387].
A particular advantageous property is the transparance of the prepared gellan films as
transparant dressings give the clinician an opportunity to review the wound without hav-
ing to remove or replace the dressing allowing for frequent wound examinations and early
intervention if needed. The results of this study have shown that gellan films have a good
swelling capacity resulting in soft and pliable films when rehydrated. Although lacking the
transparancy, anti-adhesiveness and soft surface of gellan films, gauze is also an e↵ective
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delivery vehicle for acetic acid solutions with a constant swelling rate for all rehydration
fluids studied (Figure 4.6). In contrast, the swelling capacity and thickness of the films
decreases upon increase of acetic acid concentration in the solvent. Similarly, mechan-
ical strength as measured by the amount of tensile stress required for films to rupture,
was increased when gellan films were soaked in increasing concentrations of acetic acid.
The increased mechanical strength was expected since low-acetyl gellan is known to be
acid-sensitive [388, 389]. Norton et al. showed gellan gel strengthening following acid
(HCL) soaks resulting in a transition from fluid to solid gels. [390], it is suggested that
the cross-linking between the polymer chains is strengthened by exposure to acid [391].
Furthermore, it was found that rehydrated gellan films demonstrated a slower decrease
of weight loss at ambient temperatures when compared to gauze, especially at the early
timepoint of 30 minutes (Figure 4.7). This is clinically relevant as dressing changes often
take some time to complete depending on the size of the wound, dressings that dehydrate
- due to evaporation of the solvent - are more likely to adhere to the woundbed as is seen
in medical gauze.
Next, the release of acetic acid into the wound bed was probed using a porcine wound
model. From the gellan films tested, only at one timepoint (6 hours) acetic acid detection
was higher than the control (H2O). Gauze samples did produce slightly higher values,
with the highest mean value measured of 0.06 for 5% acetic acid following 1 hour appli-
cation. These results could indicate a couple of things; first, the majority of the acetic
acid is released into the wound bed and therefore values are low; secondly, the samples
have been overdiluted resulting in barely detectable values or thirdly, performance of the
assay was not optimized. Other drug release studies focussing on gastrointestinal tract
drug-delivery have used gellan beads as delivery vehicle, they have shown sustained drug
release properties when carefully selecting cation-induced ionotropic gelation strategies
[334, 392]. Agnihotri et al. prepared beads in high (pH 9) and low (pH 5) media, low pH
media created more porous beads leading to a rapid release of the drug (cephalexin)[334].
Babu et al. formulated gellan macrobeads with Amoxicillin encapsulated, they found that
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increase of drug concentration, decrease of polymer concentration and lower electrolyte
concentration (calcium chloride) in the crosslinker solution a↵ected the drug release rate
positively [392]. Thus, by controlling the degree of hydrogel swelling through crosslinking
either during or after hydrogel preparation, the release of drugs can be controlled [393].
However, with acetic acid being a very small molecule, it is likely that di↵usion through
pores happens rapidly despite adjusting the swelling kinetics.
A proof of concept study was conducted to examine antimicrobial e cacy of the gellan
films compared to gauze. Although gauze showed larger zones of inhibition, this is likely
contributed to the larger samples used in this study. Therefore, further studies should
aim to eliminate di↵erences between tested and control dressings for example by stan-
dardizing the dry weight of each sample. However, the preliminary results of this study
have demonstrated that gellan films rehydrated in acetic acid solutions of 3-5%, have
an antimicrobial e↵ect against Pseudomonas Aeruginosa. Further studies are needed to
validate these results and investigate the anti-microbial e↵ects on other bacterial strains.
4.5 Conclusion
The work presented here demonstrates the formulation of a gellan film rehydrated in
acetic acid for the treatment of wound infections. The physical properties of the gellan
film; high water holding capacity, transparancy and anti-adhesiveness to the woundbed
facilitate clinical needs such as close wound monitoring and painless dressing removal.
Tensile strength assessment of the gellan films demonstrated higher resistance to rupture
and increased Young’s modulus when higher concentrations of acetic acid solutions were
used. Similarly, swelling capacity (%) of the gellan films was dependent on acid concen-
tration, but less swelling was observed when compared to medical gauze. Furthermore,
acetic acid release was measured by an enzymatic assay showing low values for both gellan
films and gauze, indicating a potentially high early release of acetic acid in the woundbed.
However, further studies are needed to investigate the release kinetics in more detail to
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confirm current results.
Overall, gellan films are a promising candidate for topical wound applications to deliver
acetic acid, but future work is needed to finetune the delivery vehicle in order to confirm
sustained release of acetic acid in the woundbed and validate prelimineray results regard-
ing antimicrobial e↵ect. In vivo studies comparing the gellan film to current standards
will eventually need to confirm e↵ectiveness and practicality in the clinical setting.
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CHAPTER 5
CONCLUSIONS AND FUTURE WORK
5.1 Conclusions
5.1.1 Chapter 1: Introduction
This chapter provided the reader with an updated overview on cell spray techniques for
skin wounds and natural polymer based materials to enhance skin wound healing. Skin
wounds and in particularly burn wounds can leave disabling and disfiguring scars on the
outside and inside. Skin grafting has been the gold standard treatment to cover large body
surface area wounds, however, with more people surviving devastating injuries, quality and
appearance of the healed tissue becomes more important. There is currently no adequate
engineered sca↵old that results in complete regeneration of the full function of the skin
that can replace autologous skin grafts entirely. E↵orts have been made to minimize
the grafted area by developing a method of isolating skin cells that can subsequently be
cultured in the lab into a cell sheet (CEA) or delivered to the wound via spraying in a
single cell solution. Cell spraying presents great potential for topically applying cells in
suspension, but poor retention of the material on the wound results in cell spillage.
The aim of this thesis was to develop a carrier capable of spraying cells to the surface of
a wound while maintaining cell viability and improving cell retention. This was achieved
by identifying a suitable polymer and formulating a shear thinning gel that is spray-able
and self-structuring.
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5.1.2 Chapter 2: Gellan-based fluid gel carrier
The formulation and characterisation of a gellan-based fluid gel carrier were presented in
this chapter. All the systems were found to have a degree of shear thinning that allowed
spray application and recovered much of their original viscosity once shear had been
removed with reduced run-o↵. The viscoelastic properties of the systems were dependent
on both polymer and cross-linker concentrations and the properties of the gel could be
modulated based on these variables. Furthermore, cell compatibility was not compromised
by encapsulation or spraying as shown by good viability, however, proliferation capacity
of encapsulated fibroblasts might be limited.
5.1.3 Chapter 3: Keratinocyte spray delivery
Following the encouraging results from encapsulating fibroblasts, this chapter investigated
the e↵ect of encapsulation and spraying of human epidermal keratinocytes on viability and
function. Results indicate that a combination of spraying and gellan fluid gel encapsula-
tion has a negative e↵ect on keratinocyte viability and function. The current gel carrier
was less e↵ective for spray delivery of encapsulated keratinocytes, suggesting a cell-type
dependent response to this delivery technique. However, keratinocytes can recover from
spraying itself, forming a confluent monolayer with normal morphology. Similar, once
retrieved from the gel, cells could form a viable confluent monolayer after one week of
culturing. The carrier system could potentially be used as rapid delivery system in its
current form, but optimizing the gel to improve outcomes is thought to be feasible.
5.1.4 Chapter 4: Formulation of acetic acid - gellan hydrogel
dressing
The final chapter focusses on a di↵erent topical application method using the same poly-
mer. Chapter 4 describes the work involved formulating a gellan film that can be rehy-
drated in acetic acid for the treatment of wound infections. This work is in continuation
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of earlier work by our department, when a gellan film was developed for the delivery of
decorin to reduce scarring in burn wounds. Gellan films were superior to the conven-
tional delivery vehicle (gauze) in terms of having a high water holding capacity, being
transparant and anti-adhesive to the woundbed, but not for swelling capacity, release ki-
netics and anti-microbial outcomes. Furthermore, a general correlation is evident between
concentration acid in the solvent fluid and the swelling index; gellan films rehydrated in
high pH achieved higher water absorption capacity than low pH solvents. A similar rela-
tion was found for mechanical strength, this can be explained by the increased crosslinking
of gellan under acidic conditions.
In conclusion, the gellan films have favourable properties for topical wound application,
but further work is needed to confirm preliminary results found in this study and the
dressing could potentially be further developed to enhance sustained release of acetic acid
without compromising practicality in a clinical setting.
5.2 Limitations and future investigations
The findings of Chapter 2 support that gellan fluid gel is a promising cell carrier for
fibroblast spray delivery. It would be interesting to investigate whether this material is
beneficial for the use of other delivery techniques such as spreading, injection, bio-printing
or in the form of a wound dressing. Based on the desired application features, this could
be achieved by altering the formulation of the gel as discussed in Chapter 2, for example
by changing polymer and cross-linker concentrations and the shear rate during produc-
tion. Further work could also focus on investigating fluid gel properties of other (natural)
polymers and polymer blends, some promising candidates that have showed improved
wound healing when used in topical applications are discussed in Chapter 1. Although
the main focus of this study was the formulation of a hydrogel carrier, the biological
response of fibroblasts to the system could have been further explored. Further studies
could investigate fibroblast function in terms of migration capacity, growth factor release,
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interaction with other cell types and this technique should eventually be tested in an in
vivo wound healing model.
The results of Chapter 3 pave the way for future research directions exploring cell-matrix
interactions for example by studying focal adhesion expression in sprayed and encap-
sulated keratinocytes. The ability of cells to create focal adhesions has possibly been
compromised by the spraying, in combination with the lack of ECM components in the
matrix; anoikis could have occured as the cells have lost integrin-dependent achorage. Vi-
ability and adhesion of cells could potentially be improved by optimizing the gel system
by incorporating ECM-like components and addition of culture media into the system.
Spraying onto culture plastic is not a good representation of the physiological wound en-
vironment, a next step would involve creating a substrate more similar to skin in terms
of sti↵ness and providing cell-anchoring sites on protein-coated surfaces or more complex
3D cell- or tissue derived matrices.
Furthermore, it would be interesting to investigate the response of keratinocyte spray de-
livery in an in vivo wound model, the natural occuring growth factors, ECM components,
other cell types and cytokines might stimulate keratinocyte to migrate out of the gel and
contribute to wound healing.
Chapter 4 describes the formulation of a gellan hydrogel dressing for the release of
acetic acid in the wound. Initial results encourage the use of gellan as a topical wound
dressing, but future work is needed to validate the current outcomes in terms of anti-
microbial e↵ect against a variety of common microbes. Besides disk di↵usion assays,
other approaches such as determination of the minimum inhibitory concentration (MIC)
and the ability to prevent biofilm formations is required for more robust evidence to justify
In vivo studies. Eventually, In vivo clinical trials comparing the gellan film to current
standards will need to confirm e↵ectiveness and practicality in the clinical setting.
The e↵ect of acetic acid concentration on the materials’ properties could be investigated in
further detail, for example by examining the average pore size and pore size distribution,
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as this might give further clues to permeability and release kinetics of the drugs loaded into
the hydrogel matrix. Regarding the release kinetics of acetic acid, it would be worthwhile
to optimize the use of the commercial detection kit (K-ACETAK, Megazyme) to provide
more reliable outcomes. Furthermore, the release of acetic acid in a wound bed is expected
to be very di↵erent than in a bu↵er solution due to presence of electrolytes, protein-rich
wound exudate and additional dressing material etc, yet, the use of more standardized
drug release assays such as a dialysis method[394], could provide more insight in release
dynamics of the dressing. An alternative approach to adjust release kinetics is to develop
a more complex dressing design with multiple layers that release for example with multiple
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[194] C E Schanté, G Zuber, C Herlin, and T F Vandamme. Chemical modifications
of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical
applications. Carbohydrate Polymers, 85:469–489, 2011.
[195] I P Monteiro, D Gabriel, B P Timko, M Hashimoto, S Karajanagi, R Tong, A P
Marques, R L Reis, and D S Kohane. A two-component pre-seeded dermal-epidermal
sca↵old. Acta Biomater, 10(12):4928–4938, 2014.
155
[196] R Bennett and M Taher. Restylane persists for 23 months found during Mohs
Micrographic Surgery - a source of confusion with hyaluronic acid surrounding basal
cell carcinoma. Dermatol Surg, 31:1366–1369, 2005.
[197] S Bowman, M E Awad, M W Hamrick, M Hunter, and S Fulzele. Recent ad-
vances in hyaluronic acid based therapy for osteoarthritis. Clinical and Translational
Medicine, 7(1):6, 2018.
[198] K T Dicker, L A Gurski, S Pradhan-Bhatt, R L Witt, M C Farach-Carson, and
X Jia. Hyaluronan: A simple polysaccharide with diverse biological functions. Acta
Biomaterialia, 10:1558–1570, 2014.
[199] C Law, J Li, H Chou, Y Chen, and H Chan. Hyaluronic acid-dependent protection
in H9C2 cardiomyocytes: A cell model of heart ischemia–reperfusion injury and
treatment. Toxicology, 303:54–71, 2013.
[200] C L Wu, H C Chou, J M Li, Y W Chen, J H Chen, Y H Chen, and H L Chan.
Hyaluronic acid-dependent protection against alkali-burned human corneal cells.
Electrophoresis, 34(3):388–396, 2013.
[201] A D’Agostino, A Stellavato, L Corsuto, P Diana, R Filosa, A La Gatta, M De Rosa,
and C Schiraldi. Is molecular size a discriminating factor in hyaluronan interaction
with human cells? Carbohydrate Polymers, 157(157):21–30, 2017.
[202] S Misra, V C Hascall, R R Markwald, and S Ghatak. Interactions between hyaluro-
nan and its receptors (CD44, RHAMM) regulate the activities of inflammation and
cancer, may 2015.
[203] S R King, W L Hickerson, and K G Proctor. Beneficial actions of exogenous
hyaluronic acid on wound healing. Surgery, 109(1):76–84, jan 1991.
[204] M T Cerqueira, L P da Silva, T C Santos, R P Pirraco, V M Correlo, R L Reis,
and A P Marques. Gellan gum-hyaluronic acid spongy-like hydrogels and cells
from adipose tissue synergize promoting neoskin vascularization. ACS Appl Mater
Interfaces, 6(22):19668–19679, 2014.
[205] Z Wu, L Fan, B Xu, Y Lin, P Zhang, and X Wei. Use of Decellularized Sca↵olds
Combined with Hyaluronic Acid and Basic Fibroblast Growth Factor for Skin Tissue
Engineering. Tissue Engineering Part A, 21(1-2):390–402, 2015.
[206] H Wang, M Ho, C Chen, Y Chou, Z Wen, and Z Wang. Novel Biodegradable Porous
Sca↵old Applied to Skin Regeneration. PLoS ONE, 8(6):e56330, 2013.
156
[207] M Kuroyanagi, A Yamamoto, N Shimizu, A Toi, T Inomata, A Takeda, and
Y Kuroyanagi. Development of anti-adhesive spongy sheet composed of hyaluronic
acid and collagen containing epidermal growth factor. Journal of Biomaterials Sci-
ence, Polymer Edition, 25(12):1253–1265, 2014.
[208] Y K Lin, Y Matsumoto, Y Kuroyanagi, and S Kagawa. A bilayer hyaluronic acid
wound dressing to promote wound healing in diabetic ulcer. Journal of Bioactive
and Compatible Polymers, 24(5):424–443, 2009.
[209] R Simman, W Mari, S Younes, and M Wilson. Use of Hyaluronic Acid-Based
Biological Bilaminar Matrix in Wound Bed Preparation: A Case Series. Eplasty,
18:e17, 2018.
[210] A Faga, G Nicoletti, F Brenta, S Scevola, G Abatangelo, and P Brun. Hyaluronic
acid three-dimensional sca↵old for surgical revision of retracting scars: A human
experimental study. International Wound Journal, 10(3):329–335, 2013.
[211] G Gravante, D Delogu, N Giordan, G Morano, A Montone, and G Esposito. The
use of hyalomatrix PA in the treatment of deep partial-thickness burns. Journal of
Burn Care and Research, 28(2):269–274, 2007.
[212] S K Han, S Y Kim, R J Choi, S H Jeong, and W K Kim. Comparison of tissue-
engineered and artificial dermis grafts after removal of basal cell carcinoma on face
- A pilot study. Dermatologic Surgery, 40(4):460–467, 2014.
[213] S J Delatte, J Evans, A Hebra, W Adamson, H B Othersen, and E P Tagge.
E↵ectiveness of beta-glucan collagen for treatment of partial-thickness burns in
children. Journal of Pediatric Surgery, 36(1):113–118, 2001.
[214] H Ismail, M Irani, and Z Ahmad. Starch-Based Hydrogels: Present Status and
Applications. International Journal of Polymeric Materials and Polymeric Bioma-
terials, 62(7):411–420, 2013.
[215] J Ngoenkam, A Faikrua, S Yasothornsrikul, and J Viyoch. Potential of an injectable
chitosan/starch/beta-glycerol phosphate hydrogel for sustaining normal chondro-
cyte function. Int J Pharm, 391(1-2):115–124, 2010.
[216] N Sperelakis. Cell physiology sourcebook, volume XXXIII. 2012.
[217] S Van Vlierberghe, P Dubruel, and E Schacht. Biopolymer-based hydrogels as scaf-
folds for tissue engineering applications: a review. Biomacromolecules, 12(5):1387–
1408, 2011.
157
[218] M Garcia-Fuentes, A J Meinel, M Hilbe, L Meinel, and H P Merkle. Silk fi-
broin/hyaluronan sca↵olds for human mesenchymal stem cell culture in tissue engi-
neering. Biomaterials, 30(28):5068–5076, 2009.
[219] U J Kim, J Park, C Li, H J Jin, R Valluzzi, and D L Kaplan. Structure and
properties of silk hydrogels. Biomacromolecules, 5(3):786–792, 2004.
[220] S Kapoor and S C Kundu. Silk protein-based hydrogels: Promising advanced ma-
terials for biomedical applications. Acta Biomater, 31:17–32, 2016.
[221] R Ghassemifar, S Redmond, Zainuddin, and T V Chirila. Advancing towards a
tissue-engineered tympanic membrane: silk fibroin as a substratum for growing
human eardrum keratinocytes. J Biomater Appl, 24(7):591–606, 2010.
[222] B Kundu and S C Kundu. Silk sericin/polyacrylamide in situ forming hydrogels for
dermal reconstruction. Biomaterials, 33(30):7456–7467, 2012.
[223] H Teramoto, T Kameda, and Y Tamada. Preparation of gel film from Bombyx mori
silk sericin and its characterization as a wound dressing. Biosci Biotechnol Biochem,
72(12):3189–3196, 2008.
[224] Z Wang, Y Zhang, J Zhang, L Huang, J Liu, Y Li, G Zhang, S C Kundu, and
L Wang. Exploring natural silk protein sericin for regenerative medicine: an in-
jectable, photoluminescent, cell-adhesive 3D hydrogel. Sci Rep, 4:7064, 2014.
[225] K Tsubouchi, Y Igarashi, Y Takasu, and H Yamada. Sericin enhances attachment of
cultured human skin fibroblasts. Biosci Biotechnol Biochem, 69(2):403–405, 2005.
[226] D S A Hickman, C L Pawlowski, U D S Sekhon, J Marks, and A S Gupta. Biomate-
rials and Advanced Technologies for Hemostatic Management of Bleeding. Advanced
Materials, 30(4):1–40, 2018.
[227] PJ M Bouten, M Zonjee, J Bender, S T K Yauw, H Van Goor, J C M Van Hest, and
R Hoogenboom. The chemistry of tissue adhesive materials. Progress in Polymer
Science, 39:1375–1405, 2014.
[228] K Foster, D Greenhalgh, R L Gamelli, D Mozingo, N Gibran, M Neumeister, S Z
Abrams, E Hantak, L Grubbs, B Ploder, N Schofield, and L H Riina. E cacy
and Safety of a Fibrin Sealant for Adherence of Autologous Skin Grafts to Burn
Wounds: Results of a Phase 3 Clinical Study. Journal of Burn Care & Research,
29(2):293–303, mar 2008.
158
[229] L J Currie, R Martin, J R Sharpe, and S E James. A comparison of keratinocyte
cell sprays with and without fibrin glue. Burns, 29(7):677–685, 2003.
[230] CRYOSEAL ® FS SYSTEM, 2007.
[231] K Yamamoto and L DeJoseph. E cacy and Safety of Artiss Fibrin Tissue Sealant
Use in Rhytidectomy: A Review of 120 Cases. The Surgery Journal, 03(02):e69–e74,
2017.
[232] C M Bhamidipati, J S Coselli, and S A LeMaire. BioGlue in 2011: what is its role
in cardiac surgery? The Journal of extra-corporeal technology, 44(1):P6–12, 2012.
[233] H K Chenault, S K Bhatia, W G Dimaio, G L Vincent, W Camacho, and A Behrens.
Sealing and healing of clear corneal incisions with an improved dextran aldehyde-
PEG amine tissue adhesive. Current Eye Research, 36(11):997–1004, 2011.
[234] D Miki, K Dastgheib, T Kim, A Pfister-Serres, K A Smeds, M Inoue, D L Hatchell,
and M W Grinsta↵. A photopolymerized sealant for corneal lacerations. Cornea,
21(4):393–399, 2002.
[235] J M G Reyes, S Herretes, A Pirouzmanesh, D A Wang, J H Elissee↵, A Jun, P J
McDonnell, R S Chuck, and A Behrens. A modified chondroitin sulfate aldehyde ad-
hesive for sealing corneal incisions. Investigative Ophthalmology and Visual Science,
46(4):1247–1250, 2005.
[236] D Eyrich, F Brandl, B Appel, H Wiese, G Maier, M Wenzel, R Staudenmaier,
A Goepferich, and T Blunk. Long-term stable fibrin gels for cartilage engineering.
Biomaterials, 28(1):55–65, jan 2007.
[237] Y Li, H Meng, Y Liu, and B P Lee. Fibrin gel as an injectable biodegradable sca↵old
and cell carrier for tissue engineering. Scientific World Journal, 2015.
[238] O Gsib, J Duval, M Goczkowski, M Deneufchatel, O Fichet, V Larreta-Garde,
S Bencherif, and C Egles. Evaluation of Fibrin-Based Interpenetrating Polymer Net-
works as Potential Biomaterials for Tissue Engineering. Nanomaterials, 7(12):436,
2017.
[239] F Lee and M Kurisawa. Formation and stability of interpenetrating polymer net-
work hydrogels consisting of fibrin and hyaluronic acid for tissue engineering. Acta
Biomaterialia, 9(2):5143–5152, 2013.
159
[240] C Han, L Zhang, J Sun, H Shi, J Zhou, and C Gao. Application of collagen-
chitosan/fibrin glue asymmetric sca↵olds in skin tissue engineering. Journal of
Zhejiang University SCIENCE B, 11(7):524–530, 2010.
[241] S Cox, M Cole, and B Tawil. Behavior of human dermal fibroblasts in three-
dimensional fibrin clots: dependence on fibrinogen and thrombin concentration.
Tissue Eng, 10(5-6):942–954, 2004.
[242] J Kopp, M G Jeschke, A D Bach, U Kneser, and R E Horch. Applied tissue
engineering in the closure of severe burns and chronic wounds using cultured human
autologous keratinocytes in a natural fibrin matrix. Cell Tissue Bank, 5(2):89–96,
2004.
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Supplementary Figure A.1:
Figure A.1: Frequency dependence of a panel of gellan fluid gels. Frequency dependence
of a panel of gellan fluid gels illustrates that all compositions behave as weak gels. In
both polymer concentrations (0.75% and 0.9%) there is an evident increase in both G’ and
G” with increasing cross-linker concentration. Mean values of 3 individual measurements
presented, error bars are SD (not visible when smaller than icon).
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Supplementary Figure A.2:
Figure A.2: Amplitude dependence of a panel of gellan fluid gels fitted for Herschel-
Bulkley model. The shear rate dependence of gellan fluid gel plotted against shear stress
fitted the Herschel-Bulkley equation good with a mean R square value of 0.98229 (range:
0.9387-0.9995). The individual fitting parameters and R2 are shown in Table 2.2. Mean




Figure A.3: Amplitude sweeps of a panel of gellan fluid gels. The elastic modulus of gellan
fluid gels remains linear until about 10% strain, structure breakdown outside the LVR is
indicated by decreasing G’ in higher percentage strains. In both polymer concentration
gels (0.75% and 0.9%) there is an earlier loss of elastic modulus with increasing cross-
linker concentration. Mean values of 3 individual measurements presented, error bars are
SD (not visible when smaller than icon).
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SPRAY DELIVERY OF PRP
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B.1 Introduction
Platelet-Rich-Plasma (PRP) is derived from whole blood and gained increasing interest in
regenerative medicine and has been used topically to enhance wound healing as it releases
growth factors that stimulate tissue repair and can serve as a tissue sealant [395, 396].
PRP is prepared by centrifugation to concentrate platelets, since a variety of preparation
methods are available, PRP can be classified based on several factors:
• Platelet concentration
• Leucocyte count
• Red blood cell count
• Activation
• Preparation technique
Recently, a new classification system has been proposed based on the above mentioned
factors resulting in 4 main categories [397]:
• P-PRP (pure platelet-rich-plasma)
• L-PRP (leucocyte platelet-rich-plasma)
• P-PRF (pure platelet-rich-fibrin)
• L-PRF (leucocyte platelet-rich-fibrin)
PRP delivery is usually accompanied by activation via stimulus such as thrombin
and calcium chloride in order to release their growth factors[396]. However, it is known
that mechanical trauma can activate platelets as well, activation techniques based on
this principle include: freeze-thawing cycles or use of tissue homogenizer [398]. It was
hypothesised that spraying could induce a similar response and potentially pre-empt the
activation via potential harmful exogenous calcium or thrombin. In this study, the e↵ect
of spraying on platelet activation and viability was investigated.
Besides topical application of concentrated platelets, tranfusion of platelets has become
an established practice in the treatment of active hemorrhage. Readily available donor
platelets are required to meet the clinical need of treating trauma patients with major
bleeding. Platelets can be stored under specific conditions (constant agitation at room
temperature) for 5 days prior to transfusion, sometimes extended to 7 days[399]. During
storage, changes occur in both platelets and medium, limiting the shelf life of platelet
products. The negative impact of prolonged storage on platelet function and transfusion
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outcomes have recently been highlighted [399–401]. Research into methods to prolong
platelet storage and development of novel platelet products have not yet led to readily
available platelets with extended shelf life [402]. The second aim of this study was to
examine the e↵ect of fluid gel encapsulation on platelets to investigate possible methods
to prolong storage.
B.2 Methods
This work was performed with the help of Dr P. Harrison for flowcytometry analysis
and LTA assays, all the basic experimental work, imaging and results analysis has been
performed by BTH.
B.2.1 Platelet rich plasma preparation
Platelet rich plasma (P-PRP): whole blood from 1 healthy volunteer donor was collected
in EDTA and citrate blood tubes (BD vacutainer, UK). Directly following collection, cit-
rate tubes were agitated to allow mixing of anticoagulant and blood. Baseline platelet
count was determined with Sysmex XN-1000 hematology analyzer (Sysmex UK, Milton
Keynes, UK). Platelet rich plasma (PRP) was prepared by centrifugation of whole blood
at 200 g for 10 min. PRP was carefully collected into fresh tubes without disturbing red
blood cells underneath as illustrated in Figure B.1a.
Leucocyte rich PRP (L-PRP): was prepared from whole blood as described above, but
centrifugation protocol adjusted to 1500 g for 20 min. The tube consisted of clear platelet-
poor plasma at the top, a bu↵y coat containing white blood cells and platelets in the mid-
dle and red blood cells at the bottom as illustrated in Figure B.1b. The bu↵y coat was
carefully obtained with minimal disturbance of the red blood cells. Full blood count in-
cluding platelet count was performed with Sysmex XN-1000 (Sysmex UK, Milton Keynes,
UK), for both PRP and L-PRP and platelet fold increase was calculated. Samples were
kept at room temperature until testing.
B.2.2 PRP fluid gel encapsulation
Platelet count of PRP was determined prior to mixing. A PRP to gel ratio of 1:5 was
used to come to an approximate concentration of 8 x 104 platelets/µl. Fresh PRP was
gently mixed into the gellan fluid gel (0.9% gellan, 20 mM NaCl) with careful pipetting
using a large orifice pipette tip to reduce mechanical cell stress. Samples were kept at
room temperature until testing.
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Figure B.1: Preparation of PRP. Two distinctive layers can be observed; a cloudy yellow
layer of plasma including platelets on top and a deep red layer of erythrocytes at bottom
(a). The L-PRP tube (b) has 3 distinct layers of clear yellow plasma on top, the bu↵y
coat containing leucocytes and platelets in the middle indicated with (*) and red blood
cells at the bottom. [Source: Britt ter Horst].
B.2.3 PRP viability
For this study, 4 conditions were compared: control PRP, sprayed PRP, encapsulated non
sprayed PRP and encapsulated sprayed PRP. A volume of 0.5-1 ml of PRP was sprayed
with an airbrush device (as described in section 2‘spray methods’ onto cover slips in a 6
well plate and 0.5-1 ml of control PRP was pipetted into the wells. All samples were im-
mersed in PBS until testing. Live/dead assay was performed with calcein-acetoxymethyl
ester (Calcein-AM), a cell permeable substrate that is not cell specific and stains viable
cells. FM4-64 was used to stain non-viable platelets as previously described [403]. Stains
were handled in a dark environment.
Encapsulated PRP: samples were immersed in a working solution of 100 nM Calcein-
AM and 5 µm FM4-64 in calcium-free Hanks’ balanced salt solution (HBSS) for 20 min.
Coverslips were placed onto microscope slides and visualised using confocal microscopy
(Olympus, Fluoview FV100), showing viable platelets green (Calcein AM) and non-viable
platelets red (FM4-64).
Non-encapsulated PRP: platelets were diluted in HBSS (1:100) and 5 µl of Calcein-AM
(final concentration of 100 nM) and 5 µl of FM4-64 (final concentration of 5 µM) was
added. Samples were incubated for 10 min at room temperature before analysing with
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flowcytometry. Unstained samples were used as control for autofluorescence.
B.2.4 Platelet activation
Platelets were labeled with CD62P-FITC (P selectin) to measure activation before and
after induced activation by the thrombin receptor activity peptide (TRAP). Sprayed PRP
and non-sprayed PRP were diluted to 100 x 109/L in calcium free HBSS. IgG1 (mouse)
FITC was used as control antibody and CD62P-FITC as platelet antibody. In non acti-
vated sample tubes, 5 µl of platelet solution was added with 5 µl of IgG1 (control) or 5
µl of CD62-P (test) without mixing. Mixing of the solution was achieved by adding 40 µl
of PBS. In activated sample tubes, the mixing solution consisted of 5 µl TRAP and 35 µl
PBS. All tubes were incubated for 15 min at room temperature prior to flowcytometric
analysis. Accuri C6 flow cytometer equipped with CFlow software (BD Biosciences) was
used for analysis. A minimum of 10.000 events were collected and a logarithmic gain was
used. The platelet population was identified by their characteristic forward and side scat-
ter signals and a manual gate drawn. Background fluorescence was set with the isotype
control (IgG1 FITC) and the percentage and median fluorescence intensity of positive
events recorded using the anti-CD62P FITC. Data is presented as percentage activation.
B.2.5 Platelet aggregation
Platelet aggregation of platelets encapsulated in fluid gel with flowcytometry is not pos-
sible due to higher viscosity of gel with risk of clogging. Therefore, platelet aggregation
was assessed by Light Transmission Aggregometry, the addition of activation factors like
thrombin, collagen, adenosine 5’-diphosphate (ADP), TRAP or von Willebrand factor
(vWf) causes aggregation. Aggregated platelets allow more light to be transmissed com-
pared non-aggregated platelets in suspension, ligth intensity is measured and presented
as percentage light transmission. Samples were loaded on a PAP 8 aggregometer and
TRAP was used as aggregation agonist. A total volume of 500 µl per tube consisted of
50% PPP (Platelet poor plasma) and 50% PBS or gellan fluid gel as blank test. Test




P-PRP and L-PRP were prepared, the mean blood values obtained are presented in Table
B.1. P-PRP was chosen for further spraying and encapsulation work as the addition of
white blood cells was not needed at this stage.
Table B.1: Mean blood values of P-PRP and L-PRP preparations
P-PRP L-PRP
Mean SD N Mean SD N
WBC (109/L) 0.248 0.468 6 32.535 2.100 2
RBC (1012/L) 0.032 0.008 6 3.505 0.474 2
PLT-F (109/L) 408.833 53.019 6 1936.500 242.538 2
WBC= white blood count, RBC= red blood count, PLT-F= platelet count (obtained with
Sysmex), SD= standard deviation, N= number of preparations.
B.3.2 Spray delivery of PRP
Platelet activation
Platelet activation following spraying was measured by labeling activated platelets with
P-selection, the sprayed and non-sprayed groups were compared and in a second group
the response to induced activation by TRAP was measured by flowcytometry. It was
found that sprayed platelets get slightly activated upon spraying, but do not respond well
to induced activation (Figure B.2).
Platelet viability
Next, we examined whether this poor response of sprayed cells to activation is due to
cell death by staining live platelets with Calcein AM and apoptotic/dead platelets by
the plasma membrane binding FM4-64 stain as previously described [404]. Results of
flowcytometry demonstrate a reduction of viable platelets from 97.6% (control) to 39.4%
following spraying (Figure B.3A). When visualized with confocal microscopy it was indeed
clear that sprayed platelets had a low percentage of viable cells. Furthermore, pseudopodia
were noted on viable cells in both the sprayed and non-sprayed groups as shown in Figure
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Figure B.2: Platelet activation following spray delivery. Natural and TRAP-induced
platelets activation following spray delivery compared to control (non-spray delivery).
B.3B. Presence of pseudopodia indicates the start of platelets aggregation, these changes
are irreversible.
B.3.3 Fluid gel encapsulation of PRP
Platelet aggregation
Because flowcytometers are not equipped to run gel samples, activation of plateletes
was investigated by light transmission aggregometry (LTA). Aggregation of platelets was
induced by adding an activation factor (TRAP). It was found that no sponteneous ag-
gregation occured when platelets were encapsulated in fluid gel. Furthermore, platelets
responded to TRAP activation in 2 out of 3 experiments by aggregation (expressed by
increased light transmission) when encapulsated in gellan fluid gel, as shown in Figure
B.4.
Platelet viability
Clustering of platelets was also observed on day 1 with confocal microscopy where live cells
were stained green and dead cells stained red. The cell clusters exhibited and although
mainly stained green, a red ‘shell’ around individual cells was observed meaning that
the aggregated cells take up FM4-64 early while potentially still viable (Figure B.5), this
vesicle morphology is seen in apoptotic platelets[405]. Thus, encapsulation in fluid gel
results in platelet activation in non-sprayed samples with some formation of pseudopodia
and induces apoptosis. However, spontaneous aggregation was not observed in the LTA
assay. This di↵erence is potentially explained by the duration of encapsulation; platelets
assessed for viability were kept in the gel for a longer period of time before imaging and
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clustering might have occurred in that time frame, whereas LTA platelet aggregation was
assessed immediately after mixing PRP and gel.
Figure B.3: Platelet viability following spray delivery. A) Flowcytometry results of
live/dead stain of platelets following spray delivery compared to non-sprayed (pipetted)
platelets. B) Confocal images of FM4-64 stained dead cells (red) and green viable platelets
(stained by Calcein AM). Yellow arrows indicate pseudopodia, seen in both non-sprayed
and sprayed cells.
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Figure B.4: Platelet aggregation in fluid gel. Control PRP in PBS showed activation
upon activation with TRAP as indicated by E. Percentage light transmission increases in
2 out of 3 PRP-gel samples upon stimulation by TRAP.
B.4 Conclusion and future work
In this study, the e↵ect of spraying concentrated platelets (P-PRP) on platelet activation,
viability and morphology was investigated. Although, PRP spray devices are already used
in clinic [406], but evidence on platelet viability following spraying is lacking[407]. The
preliminary results showed that spraying induced platelet activation slightly, however,
sprayed platelets were less receptive to induced activation (by TRAP) than non-sprayed
platelets indicating a change in behaviour of sprayed cells. Airbrush spray systems al-
low for adjusting the airpressure at delivery; determining whether higher airpressure at
delivery (increased mechanical stress) might be related to an increased rate of activation
may help to understand the mechanism of platelet activation and be interesting for clin-
ical applications. Furthermore, as platelet viability following spraying was reduced, the
activation seen could be an early sign of apoptosis. It would be interesting to investi-
gate whether this spray-induced activation would lead to similar growth factor release as
non-sprayed platelets.
Secondly, encapsulation of platelets in gellan fluid gel was investigated in order to
determine whether the gel could potentially be used as a storage medium. The results seem
to indicate that platelets form clusters when encapsulated in the fluid gel. Interestingly,
aggregation did not always occur when mixing platelets and gel in the LTA assay. This
might be related by the duration of encapsulation. Current platelet storage medium
includes additives such as glucose, acetate, potassium, magnesium, and phosphate in
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Figure B.5: Platelet viability following encapsulation in gellan fluid gel. FM4-64 stained
dead cells red and green platelets are viable (stained by Calcein AM). Clustering of
platelets was observed at all magnifications (A, B, C) and pseudopodia were observed
(B).
order to inhibit the storage lesion (and activation)[408]. Future studies could aim to
include these additives in the gel and engineer the fluid gel in such a way that it is closer
to low viscosity fluids reducing aggregation and investigate platelet storage properties in
more detail. This could be achieved by looking at activation, viability and growth factor
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This review gives an updated overview on keratinocyte transplantation in burn wounds concentrating on appli-
cationmethods and future therapeutic cell delivery optionswith a special interest in hydrogels and spray devices
for cell delivery.
To achieve faster re-epithelialisation of burnwounds, the original autologous keratinocyte culture and transplan-
tation technique was introduced over 3 decades ago. Application types of keratinocytes transplantation have im-
proved from cell sheets to single-cell solutions delivered with a spray system. However, further enhancement of
cell culture, cell viability and function in vivo, cell carrier and cell delivery systems remain themes of interest.
Hydrogels such as chitosan, alginate, fibrin and collagen are frequently used in burnwound care and have advan-
tageous characteristics as cell carriers.
Future approaches of keratinocyte transplantation involve spray devices, but optimisation of application tech-
nique and carrier type is necessary.
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1. Introduction
Burn injuries are complicated wounds to manage with a relative
high mortality rate in especially large area burns and elderly patients
[1]. Substantial tissue damage and extensive fluid loss can cause
impaired vital functions of the skin. Rapid epithelialisation ismandatory
to restore the barrier function of the skin and enhance healing. Patho-
logical scar formation (hypertrophic scarring) can occur as a long
term sequelae of delayed wound healing. When healing is delayed,
the potential short term common complications include wound infec-
tion affecting the local healing process or systemic inflammatory and
immunological responses which subsequently can cause life threaten-
ing sepsis and multi-organ failure. In the United states, approximately
400,000 fire/burn injuries were recorded in 2014 in a population of
about 300 million, including a total of 3196 (0.78%) fatal injuries (data
from CDC in WISQARS Injury Mortality Report) [2].
Fortunately, survival rates have improved drastically over the last
century due to advancements in burn care such as early surgical inter-
vention, critical care support and wound care [3,4]. However, despite
further technological advancements in the last 30 years, survival rates
have not improved significantly over the last three decades and now
seem to be plateauing in countries with high-standard burn care [5–7].
Furthermore, since modern standard burn care allows the majority
of patients to survive thermal injury, other outcome measurements
aiming to improve quality of life become more relevant. For example,
shortening length of hospital stay, decreasing the number of trips to
the operating theatre and optimizing the quality of restored tissue.
Functional and aesthetic outcome of the restored tissue are reflected
by scar quality in terms of pigmentation, pliability, sensation, hair
growth and function (prevention of scar contraction).
All of these factors require a specialized approach aiming on regen-
eration of tissue instead of tissue repair. Progress in short term results
(lifesavingwound coverage) remains essential. Subsequently, advances
of long term results are desired to facilitate the need for quality of life
improvement of the increasing population of burn survivors. Answers
to these challenges are sought in the field of tissue engineering. Al-
though, advances in engineered skin equivalents and cell-delivery to
the wound bed are emerging in burn care, they currently do not meet
the expected results and translation to clinical practice is challenging.
Keratinocyte delivery was the first skin cell transplantation successfully
translated to the clinical burn care. In the last four decades this method
has been investigated widely and numerous researchers have contrib-
uted to a variety of improvements. This review gives an updated over-
view on applications of keratinocyte delivery in burns and wound
healing and future therapeutic cell delivery optionswith a special inter-
est in hydrogels and spray devices for cell delivery.
2. Skin
2.1. Epidermis
The skin is the largest organ of the body and has a barrier function,
preventing the passage of water, electrolytes and pathogens (Fig. 1).
The epidermis is predominantly formed from highly specialized epithe-
lial cells called keratinocytes. Other cells which can be found in the epi-
dermis include Langerhans' cells, melanocytes and Merkel cells, which
are responsible for immune regulation, pigmentation and sensory func-
tion. Keratinocytes play a key role in epidermal restoration following
injury through proliferation and re-epithelialisation (Fig. 2). Solely epi-
dermal injuries will achieve re-epithelialisation from proliferated
keratinocytes and heal by regeneration without scarring [8,9]. Differen-
tiated keratinocytes perform their barrier function through the provi-
sion of a mechanical barrier in the formation of a keratinised layer and
by reacting to invasion of pathogens via release of pro-inflammatory
mediators which subsequently attract leukocytes to the site of invasion.
2.1.1. Keratinocyte differentiation and proliferation markers
Keratinocytes proliferate from the basal cells of the innermost
layer of the skin (stratum basale). The epidermal stem cells are at-
tached by hemi-desmosomes to the stratum basale and can divide
into either more stem cells, which persist indefinitely and to maintain
the layer's regenerative capacity, or into transit amplifying cells which
have limited division potential. As the transit amplifying cells continue
to divide and proliferate, differentiation occurs. Throughout this differen-
tiation process, the keratinocytes migrate upwards towards the stratum
spinosum and stratum granulosum to eventually become corneocytes
which form a relatively impermeable outer layer, the stratum corneum.
Once fully differentiated, these corneocytes lose their nucleus and cyto-
plasmic organelles and will eventually be shed off via desquamation.
The estimated time for turnover from epidermal stem cell to desquama-
tion in healthy human skin is around 39 days [10].
During this process, keratinocytes express several differentiation
proteins including keratins which are intermediate filament proteins
in epithelial cells. Keratins play a host of important function including
the provision of structural support, protection of epithelial cells from
mechanical and non-mechanical stress and the regulation of apoptosis
and protein synthesis [11]. There are 37 known functional human epi-
thelial keratin genes, divided in type 1 and 2 genes. Mutations in these
genes are associated with skin diseases such as epidermolysis bullosa
simplex (keratin 5, 14) with structural weak epidermal basal cells or
epidermolytic hyperkeratosis (keratin 1 and 10) [12]. Keratin expres-
sion is frequently used as a marker for epidermal proliferation and dif-
ferentiation in cell culture, with keratin 14 (K14) being used for the
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basal layer and keratin 10 for the spinous layer. Other differentiation
markers starting at the basal layer are K5, and K15, spinous layers K1
and K10, transglutaminase and involucrin, at the granular layer.
Filagrine, loricrin and caspase-14 activation are hypothesised to play a
role in terminal keratinocyte differentiation [13–15]. (Fig. 2).
2.1.2. Factors promoting keratinocyte differentiation
Amajor regulator of keratinocyte differentiation is the calcium gra-
dient. Extracellular calcium concentration is lowest in the stratum
basale and gradually increases until the stratum granulosum. Elevated
levels of extracellular calcium concentrations stimulate formation of
intercellular contacts and the increase of intracellular free calcium con-
centrations via transmembrane calcium influx, which subsequently
initiates differentiation via stimulation of the calcium receptor (CaR)
[14]. This has consequences for the culture technique of keratinocytes
in vivo, high calcium concentration induces differentiation, whereas
in low calcium concentration keratinocytes remain proliferative [14–
16].
E-cadherin provides adherens junctions for adhesion between cells
which is crucial for keratinocyte differentiation. In addition, following
a signalling pathway e-cadherin can increase the intracellular calcium
concentration [14]. Furthermore, 1,25-Dihydroxyvitamin D3 (Vitamin
D3) is known to influence keratinocyte differentiation by regulating
gene expression and modulating calcium concentrations [17,18].
Logically, factors that promote proliferation will inhibit differen-
tiation of keratinocytes. Factors known to promote proliferation are
TGF-α, vitamin A, transcription factor p63 and epidermal growth
factor (EGF).
2.1.3. Keratinocyte interaction with other epidermal cells
Within the epidermis, keratinocytes interact with other surrounding
cell types for example, melanocytes. Melanin production (melanogene-
sis), occurs in the melanocytes and protects the DNA of melanocytes
and keratinocytes from ultraviolet radiation and contributes to the
colouration of the skin. Keratinocytes take up melanin via the melanin
containing melanosomes produced by melanocytes [19].
The interactions between keratinocytes and fibroblasts in wound
healing have been well described in literature, where a double para-
crine signalling concept is proposed. Keratinocytes instruct fibro-
blasts to produce growth factors and cytokines such as keratinocyte
growth factor, fibroblast growth factor-7, GM-CSF and IL-6 [20]. Con-
sequently, expression of these growth factors initiates keratinocyte
proliferation. The transcription factor activator protein-1 seems to
play an important role in this process [21]. Furthermore, under the
control of keratinocytes, fibroblasts can obtain a myofibroblast phe-
notype, which is important for wound contraction [20].
2.2. Dermis and basement membrane
Underneath the epidermis, the dermal layer acts a support net-
work, providing strength and elasticity to the skin. Fibroblasts are
the key cells of the dermis. Fibroblasts are responsible for the pro-
duction andmaintenance of the extracellular matrix which is formed
by fibrous components (collagen and elastin) embedded in non-fi-
brous elements such as proteoglycans and glycosaminoglycans
(GAGs). Collagens are the main structural element of the extracellular
matrix (ECM) and provide tensile strength, regulate cell adhesion and
Fig. 1. Layers and function of the skin. The uppermost layer of the skin is the epidermis. The epidermis consists of 5main layers described fromdeep to superficial: stratumbasale, stratum
spinosum, stratum granulosum, stratum lucidum and stratum corneum. The epidermis has two distinct functions: a protective barrier function against trauma and fighting off pathogens
as well as a controlling function regulating body temperature, fluid and electrolyte balance. Other functions of the epidermis include production of vitamin D, pigmentation, providing
mechanical strength and it has a role in cutaneous immune function.
[Source: histology image provided by Dr. GM Reynolds PhD CSci FIBMS, Liver Unit of Queen Elizabeth Hospital Birmingham, UK. Image adapted by Britt ter Horst, with permission from G
M Reynolds.]
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support migration. Other cellular components include endothelial cells,
smoothmuscle cells andmast cells [22]. The vascular deep and superfi-
cial plexus lie within the upper and lower part of the reticular dermis
respectively and supply the dermis and epidermis. The epidermis and
dermis are firmly connected by the basement membrane, and the epi-
dermal-dermal junction is bordered and stabilized by the anchoring of
keratinocyte-derived collagen (type VII) fibrils into the dermis. Addi-
tionally, collagen XVII, a structural component of hemidesmosomes,
mediates the anchoring of basal epithelial cells to the basement mem-
brane [23]. If this junction is disrupted, serious morbidity such as seen
in epidermolysis bullosa can occur [12].
Several structures originate in the dermis and extend into the epi-
dermis such as sensory nerves, sweat glands and hair follicles. Hair fol-
licles are lined with epidermal keratinocytes and contain multipotent
stem cells [24]. Therefore, if the dermis is only partially injured these ad-
nexal structures can deliver cells that can proliferate, migrate and re-
generate the epidermis. However, the dermis lacks the intrinsic
capability of regeneration and heals by fibrosis and scar formation. Sen-
sory nerves are responsible for mediating pain and itch, control inflam-
mation and there is evidence that shows that they may also influence
the remodeling phase [9]. After skin injury the body starts a remarkable
healing process which often results in complete regeneration.
3. Wound healing and keratinocytes
3.1. The role of keratinocytes in wound healing
The skin barrier function can be disrupted by trauma such as a ther-
mal injury. Wound healing usually occurs via four overlapping phases;
haemostasis, inflammation, proliferation and remodeling. Normally
this process is sufficient to allow the skin to repair itself after injury.
However, extensive skin loss, as seen in burn victims, requires interven-
tion to allow for tissue restoration. Burn injuries are often caused by
heat, however, electricity, radiation, chemicals or friction can also result
in similar injuries clinically [25]. Following thermal injury, a complex
healing processwill start with the involvement of numerous specialized
and interacting cells, molecules and pathways. The cellular response in-
volves macrophages, platelets, fibroblasts, epithelial and endothelial
cells. In addition to the various cellular interactions, proteins and glyco-
proteins such as growth factors, cytokines, chemokines, inhibitors and
their receptors can also influence healing. Although, burns heal differ-
ently from normal wound healing, the phases of healing remain the
same [26]. Keratinocytes and fibroblasts play an important role in the
proliferative phasewhich is focused on the replacement of the damaged
ECM and restoration of tissue structure and function. Activation of
keratinocytes and fibroblasts by macrophages via cytokine and growth
factor release causes angiogenesis, collagen production, ECM produc-
tion and epithelialisation [27].
3.1.1. Angiogenesis
The restoration of the vascular network is essential as angiogenesis
supports cell activity by providing oxygen and nutrients to the wound
bed. Once endothelial cells are activated by macrophages, they loosen
their cell to cell junctions in order tomigrate. This process aswell as en-
dothelial proliferation is encouraged by a hypoxic and acidotic environ-
ment which is typically found in wounds. Finally, revascularisation
occurs when sprouted vessels organise into capillary networks. Vascu-
larisation consequently neutralizes the hypoxic and acidotic wound en-
vironment and leads to decreased production of angiogenic factors. This
eventually results in reduction of endothelial cell migration and prolif-
eration [8,28].
3.1.2. Epithelialisation
Within hours of injury re-epithelialisation starts with a vital role
being played by keratinocytes. The quantity of epidermal stem cells re-
siding in stem cell niches such as in the hair follicles, sebaceous glands
Fig. 2.Keratinocyte differentiation andmarkers. Diagram is showing differentiation of keratinocytes in the epidermiswith expression of stratificationmarkers. Basal keratinocytes express
Keratin 5, keratin 14 and keratin 15.When keratinocytes differentiate theymove upwards into the suprabasal layers: stratumspinosum, stratumgranulosumand finally stratumcorneum.
Differentiating keratinocytes express specific markers in each epidermal layer.
[Source: Britt ter Horst].
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and basal layers of the interfollicular epidermis determines the regener-
ative capability of the skin [8,24].
Activated by growth factors released bymacrophages, keratinocytes
migrate to the wound bed and fill the defect (Fig. 3). In order for
keratinocytes to start their migration they undergo phenotypical alter-
ations by loosening of intercellular adhesions, although some desmo-
some contacts are sustained [8]. Furthermore, cells can separate from
the basal layer once hemidesmosomes are disrupted which allows
them tomigrate laterally [8,29].When integrin receptors are expressed,
the keratinocytes flatten and the altered basal keratinocytes migrate
over the granulation tissue to form a monolayer of epithelial cells, but
remain under the non-viable eschar of the burn wound. While moving
they secrete proteolytic enzymes that enable the degradation of provi-
sionalmatrix and promotes further cell migration [30]. After a confluent
sheet of cells covers the wound bed, the cells then divide to form a
multi-layered stratified epithelium and mature under the influence of
TGF-β1 and TGF- β2 [31].
Keratinocytes play a vital role in especially the proliferative phase of
burn wound healing leading to epithelialisation and restoration of the
vascular network. For this reason and the possibility of in vitro
keratinocyte culture, keratinocytes are considered an excellent candi-
date for cell transplantation.
3.2. Pathophysiology of burn injury
Major burn injury, defined as approximately 20% of the total body
surface area (TBSA) burned, causes burn shock due to severe haemody-
namic and haematopoietic dysfunction [26] secondary to immediate
evaporative and direct fluid losses [32], extensive loss of proteins, re-
duced colloid oncotic pressure andwound oedema development.With-
out intervention the fluid loss will result in desiccation of deeper tissues
and further cell death leading to an increase in wound depth. A moist
wound bed is necessary for epithelial cell movement and therefore for
successful re-epithelialisation [9]. Furthermore, with disruption of the
barrier function of the skin, microorganisms have easy access and
when entering the microcirculation can cause systemic infection.
Presence of these acute systemic responses are related with increased
morbidity and mortality numbers [33,34], especially in the elderly [1].
3.3. Rational for keratinocyte transplantation
Traditional therapy for severe burns is surgical debridement and
autologous skin graft. However, with extensive burn injury healthy
donor site is scarce and alternatives to restore skin function are nec-
essary. When rapid epithelialisation can be achieved the skin barrier
function is restored and this can determine a patient's likelihood of
survival. Clearly, it is important in the treatment of a burn injury to
focus on quick re-epithelialisation. Therefore, development of success-
ful and efficient autologous skin replacement techniques is highly
desirable. Wound closure will not occur without epithelialisation and
epithelialisation will not occur without the presence of keratinocytes
in thewound bed [8]. To achieve faster re-epithelialisation, keratinocyte
transplantation was introduced as part of the burn wound care arsenal
over 30 years ago. However, the original autologous keratinocyte trans-
plantation technique has several disadvantages which has spurred re-
searchers to seek for improvements in cell culture technique, delivery
systems and also the optimisation of the timing of keratinocyte trans-
plantation [35].
4. Cell transplantation technology
4.1. Cell source
Keratinocytes and their progenitor cells can be sourced locally from
stem cell niches in hair follicles. Several stem cell niches are known:
mesenchymal stem cells (MSC) resident in the dermal papilla and
multipotent hair follicle stem cells (HFSC) and melanocyte stem cells
in the superior bulge [36]. HFSCs are essential for normal morphogene-
sis of hair follicles, sebaceous glands and contribute to formation of the
three epithelial cell lines [37]. Progenitor cells also reside in the bone
marrow and could arise from embryonic cell lines [38].
Fig. 3. Role of keratinocytes in re-epithelialisation. Schematic illustration of a skin injury with keratinocytes as key cells. Keratinocytes are activated via pro-inflammatory cytokines and
growth factors released in thewound bed. Once activated, keratinocytes from thewound edges and dermal appendagesmigrate over theprovisionalmatrix andfinally close the defect in a
process called epithelization. When the basal layer is spared from injury, basal keratinocytes can support this process by upward migration as occurs in non-injured skin. Activated
keratinocytes communicate with other cell types present in the epidermis. Epithelial cells proliferate and differentiate to achieve a stratified epithelium with restoration of the barrier
function of the skin. Maturation of the wound continues over a period of several months with fibroblasts remodeling the underlying dermis.
[Source: Britt ter Horst].
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4.2. Methods of human keratinocyte cell culture
4.2.1. Historical development of keratinocyte culture
The first successful in vitro human keratinocyte expansion, achieved
by Rheinwald and Green in 1975, paved the way towards autologous
cell transplantation in burn care [39]. Keratinocytes were successfully
cultured in the presence of fibroblast feeder cells. However, to prevent
these fibroblasts fromoutgrowing the keratinocyte population, irradiat-
ed murine 3T3 fibroblast feeder cells, which have lost their mitotic abil-
ity but remain metabolically active, were used [39]. Besides the use of
feeder cells, culture media often contains fetal calf serum with growth
factors, hormones and antibiotics [39–41]. Keratinocytes are able to be
grown into colonies and subsequently form a stratified epithelium and
human keratinocyte stem cells were proven to have an enormous pro-
liferation potential. Subsequently, small cell sheets of two or three
layers of confluent keratinocytes were produced and not long after,
the first human transplantation became a reality [42,43].
Keratinocytes cultured for clinical use must have the regenerative
capability to form an effective epidermis after transplantation. It is
thought that in vitro differentiating keratinocytes do not contribute sig-
nificantly to regeneration in vivo [44]. Instead, keratinocyte stem cells
and their transient amplifying cells seem to have excellent regenerative
capacities [45]. Thus, culturing keratinocytes that keep the ability to
produce progeny once transplanted, seems key for successful epidermis
formation following transplantation.
The degree of differentiation in vitro can be controlled by the
method of culture. Fully differentiated keratinocytes (confluent) mul-
tilayers aswell as pre-confluent single cells can be produced and deliv-
ered to thewound bed [16,46]. In a histological comparison of cultured
pre-confluent and uncultured keratinocytes seeded on a collagen-GAG
matrix in a pigmodel, both provided a fully differentiated epidermis in
14 days. A thicker and confluent cell layer, however, was obtained
more rapidly with the cultured cells [47]. The original culture method
has been the subject of much debate, because the murine fibroblast
feeder layers can potentially result in transplantation of animal com-
ponents with the keratinocyte product. Due to the serious risk of ani-
mal-derived disease transmission to human epithelium in the
transplantation process, it is not advised to use undefined xenogeneic
materials in the treatment of patients. Additionally, radioactive irradi-
ation of murine fibroblasts in this technique is accompanied with
higher costs and potential uptake of irradiated DNA via the murine fi-
broblasts into the transplanted keratinocytesmight cause cell destruc-
tion [48].
4.2.2. Progress towards xenobiotic free culture techniques
To limit or exclude the transmission risk, other keratinocyte culture
protocols without feeder cells and limited or no use of xenogeneic
media products have been developed [16,49]. Jubin et al. showed that
human keratinocytes can be successfully expanded in co-culture with
non-irradiated autologous human fibroblasts in Rheinwald and Green
but still required medium supplemented with fetal bovine serum
(FBS) to maintain their proliferative phenotype in vitro [50]. A further
approach to minimise xenogeneic products in culture media was intro-
duced when serum free medium was used for the expansion of
keratinocytes with non-irradiated human fibroblasts on several sub-
strates [49]. However, FBS still had to be used to expand the human fi-
broblasts initially.
Although the culture media are free of serum, often other prod-
ucts used in the culture media still contain animal-derived proteins.
This could be solved by the use of only human material, however the
risk of infection remains and high costs in an already expensive pro-
cess makes this option less favourable. Successful culture of human
keratinocytes in a serum-free and feeder-free culture was demon-
strated in vitro in a skin equivalent model by Coolen et al. With the
addition of collagen type IV, serum substitute and keratinocyte
growth factor (KGF) a differentiated epidermis could be formed
[51]. Lamb et al. demonstrated that although keratinocytes grown
in serum-free and feeder-free conditions did show sufficient propa-
gation, these cells were not able to support mature epidermis forma-
tion in an in vitro skin model. However, when re-introduced to a
serum-containing media they then did form a stratified epidermis.
Moreover, when heat-inactivated serum was used an improved
stratified epidermis was formed, indicating that serum-products
also contains (heat-sensitive) factors that can inhibit in vitro epider-
mis formation [52].
Lenihan et al. compared three commercially available feeder-free
media systems; CnT-07 medium (CellnTech, Bern, Switzerland),
EDGS (Gibco), S7 (Gibco) with the original Rheinwald and Green
method [39] for expansion of human keratinocytes for clinical usage.
A maximum of 3 weeks culture time (passaged twice) was allowed, as
the ideal transplantation window was considered between 4 and
20 days. They found that all three feeder free culture media supported
keratinocyte growth. However, the only fully xenobiotic free media
(S7) had a low cumulative population doubling time and therefore
did not reach sufficient cell numbers to be considered for clinical
usage at day 21 and was therefore excluded from further analyses [53].
Using feeder free and serum free media is less labour intensive and
beneficial for use in the clinical setting, further research will have to
show whether keratinocytes maintain their proliferative potential in
vivo. Besides elimination of xenobiotic materials from culture media,
the elimination of antibiotics is a further goal to improve keratinocyte
cell expansion for usage in the clinical setting [54].
4.2.3. Additions to keratinocyte culture
To further encourage and optimise skin regeneration following
burn injury, improvements have been made to the keratinocyte
transplantation process. These have included the addition of multi-
ple other cell types and growth factors during keratinocyte culture
or transplantation.
The addition of melanocytes in the keratinocyte culturing process
has been proposed to solve the problem of potential irregular pig-
mentation of the post burn scar. Co-culturing of keratinocytes with
melanocytes has been investigated in patients with vitiligo and in
full thickness wound healing in animal models [55–58]. In humans,
more evidence is available for uncultured cell suspensions containing
keratinocytes and melanocytes for the treatment of hypopigmented le-
sions [59–62]. However, these pilot studies are limited by small sample
sizes and lack of controls. Controlled clinical studies are needed to sup-
port the findings before this technique can be accepted as standard clin-
ical practice.
Cultured epithelial autografts lack a vascular plexus and burn
wounds often have insufficient vascularisation due to the disruption
of the dermal layer. Therefore, approaches to promote angiogenesis
via the addition of autologous or allogenic endothelial cells into
skin grafts have been proposed [63,64]. Also, adipose derived stem
cells (ASCs) have received attention with respect to their potential
to enhance wound healing. Huang et al. seeded human ASCs onto a
dermal acellular skin substitute in vitro to enhance vascularisation.
When transplanted to full thickness wounds in nude mice, an increase
in blood vessel densitywas found twoweeks post transplantation com-
pared to controls [65]. Another approach is to add growth factors like
epidermal growth factor (EGF) [66]. Additionally, co-delivery of cul-
tured keratinocytes with EGF in a fibrin matrix demonstrated improve-
ment of epidermal regeneration in full thickness wounds in a murine
model [67]. Furthermore, Supp et al. genetically modified keratinocytes
with an overexpression of vascular endothelial growth factor (VEGF) to
stimulate angiogenesis in skin substitutes in animal studies [68,69]. Be-
sides adding factors, modifications of the 3D structure of skin substi-
tutes to stimulate faster ingrowth of vascular structures have also
been proposed [70]. Of interest from a tissue engineering perspective,
is whether transplanted cells actually survive and function in vivo.
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4.3. Keratinocyte viability after transplantation
Cell survival of transplanted keratinocytes in vivo is of great interest
for tissue engineering purposes. Vernez et al. evaluated the cell viability
and apoptosis balance in clinical samples taken from cultured epidermal
autografts prior to transplantation [71]. Although, all samples showed
high levels of cell viability and low levels of apoptosis, variable biological
activity of certain parameters between samples of different patientswas
observed. It was suggested that this could impact on therapeutic effica-
cy [71]. In a pigmodel Navarro et al. found no altered cell viability before
and after spraying a suspension of cultured keratinocytes to full thick-
nesswounds [72]. Duncan et al. examined cultured human keratinocyte
proliferation measured with the MTT assay after spray delivery to a de-
epidermalised dermis (DED) in vitro and found no significant cell death
or reduced cell proliferation [73]. These studies seem to support that
cells remain viable and maintain proliferative capability after spray
cell delivery to a wound bed.
5. Application types of keratinocytes transplantation
5.1. Introduction: grafting of burn wounds
Ambroise Paré (1510–1590 CE) was probably the first to describe
the surgical intervention for early excision of burnwounds [74]. Surgical
burn care has progressed tremendously since then and methods which
have nowbecomewell established in burn care include early excision of
burn wounds, the development of autologous and allogenic skin grafts
and the use of skin substitutes [75].
Techniques involving transplantation of healthy human skin to dam-
aged areas are still the gold standard in deep or full thickness burn
wounds. However, challenges arise when large areas are affected and
donor sites are scarce. Subsequently, many skin graft expansion tech-
niques have been developed to reduce donor site size, these techniques
include meshing of the graft (maximum expansion ratio of 1:9), modi-
fiedmeek technique (expansion ratio of 1:9), epidermal blister grafting
(expansion ratio of 1:1) and several techniques ofmicro grafting such as
epidermal CelluTome™ micro-grafting (expansion ratio: 1:6), or
Xpansion® micro-grafting (maximum expansion ratio: 1:100). Devel-
opers of cellular based techniques claim to deliver even higher expan-
sion rates, such as cultured epithelial sheets (expansion rate 1:1000)
and uncultured cell suspensions (maximum expansion rate 1:100)
[76,77]. However, to the knowledge of the authors no other studies
have been able to support these findings.
Furthermore, procedures to harvest skin are time consuming, can
lead to longer healing timeswith prolonged hospital stay and can be ac-
companied by donor site complications. Additionally, skin grafts do not
always meet the desired cosmetic outcomes.
Therefore, methods to enhance the results of skin grafting and alter-
natives to it have been subject of much research in the last few decades.
Specifically, progress towards a permanent epidermal replacement or
its improved regeneration is the main goal of cellular based therapy.
In Fig. 6 different methods of autologous keratinocyte transplantation
are schematically summarized.
5.2. Cultured keratinocyte sheets
5.2.1. Cultured autologous keratinocyte sheets
In 1981, O'Connor et al. reported the first transplant of cultured au-
tologous keratinocytes to treat a burn injury [43]. Cultured epithelial au-
tografts (CEA) were developed to replace the epidermis and restore the
Fig. 4. Burn wound coverage with cultured epithelial autografts applied in sheets. In this example, successful burn wound healing in about 2 weeks was achieved when the sheets were
removed a week after application. a) Deep second degree burn in the back of a 29-year old patient after excision of the burn b) application of cultured keratinocyte sheets c) removal of
sheets 8 days after surgery and d) complete healing 16 days after surgery.
[Reprinted fromBurns Volume 41, Issue 1, Pages 71–79, Cultured autologous keratinocytes in the treatment of large anddeep burns: A retrospective study over 15 years, Celine Auxenfans,
Veronique Menet, Zulma Catherine, Hristo Shipkov, Pierre Lacroix, Marc Bertin-Maghit, Odile Damour, Fabienne Braye, Copyright (2017), with permission from Elsevier.]
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barrier function of the skin [78,79]. In the last three decades CEAs have
been adapted and introduced to the clinical setting (Fig. 4).
Nowadays, several commercialised bioengineered skin products de-
rived from autologous cells are available. In general, clinicians harvest
autologous skin and the company produces a graftable substrate seeded
with the autologous cells for clinical use in approximately 2 weeks
(Epicel, Genzyme, Cambridge, MA and Laserskin, Fidia, Italy). The
timeframe wherein viability of the grafts can be ascertained (shelf-
life) is 24–48 h. These serviceswill often involve high costs and a certain
waiting time and narrow application timeframe.
In 2007, the FDA approved the use of CEAs for use in patients with
deep dermal or full thickness burns greater than, or equal to 30% TBSA
(Epicel, Genzyme, Cambridge, MA) [43,80,81]. The main advantage of
cultured epithelial autografts is that large areas of the body can be cov-
ered with autologous cells derived from a small biopsy and improve-
ment in the speed of re-epithelialisation has been reported. In terms
of cosmetic results, CEA seems to have better results when compared
to wide mesh autograft in extensive burns [82]. However, several au-
thors who have reviewed the use of cultured epithelial autografts in
burn care have found variability in terms of graft take and cosmetic out-
comes [46,83,84].
A major disadvantage of this technique is the long time-interval
between biopsy and grafting. Although the average culture time has im-
proved from 5 [43] to about 3 weeks [85,86], variability among patients
has been described, especially among different age groups [87]. Follow-
ing burn excision, the wound can be temporary covered with allograft
and/or xenograft dressings for several weeks until CEA is ready. Howev-
er, this is related to a higher risk of wound colonization and infection
[46]. The ideal timing for keratinocyte transplantation is difficult to de-
termine as it is dependent on several factors including hospital facilities
and patient conditions [86,88].
Furthermore, both short and long term clinical limitations such as
the formation of bullae, poor take rates, fragility of the sheets and
wound contractures have been reported [88–90]. These may be due to
the lack of a dermal component that is necessary to support the new
epidermal layer.
The restoration of the dermis is important for the skin to regain
mechanical strength and to facilitate adherence of the new or
transplanted epidermis [36]. Although in one study, an advanced ap-
plication technique with allograft wound bed preparation and com-
bination of CEA with wide meshed autograft seems to improve take
rates up to 84% [91].
Cell culture is an expensive process and the cost/benefit relationship
of this method is heavily debated [92]. Finally, the potential of graft site
malignancy after keratinocyte transplantation has been highlighted [93,
94]. However, the type of malignancy reported, squamous cell carcino-
ma, is also known to occur in burn wounds and scars in the absence of
keratinocyte transplantation [95].
5.2.2. Introduction of dermal substitutes including cultured keratinocytes
With a complete absence of a dermal component, the cultured
keratinocytes are thought to be of limited value in treating full-thick-
ness burns due to the poor quality of the resulting epidermis. Conse-
quently, this has led researchers to optimise the wound bed via the
use of allogenic or artificial substitutes prior to keratinocyte transplan-
tation. A further approach is to grow or seed the cultured keratinocytes
on a (dermal) substitute to facilitate secure transplantation and im-
prove healing potential [96]. This concept was introduced by
Hansbrough and Boyce in 1989 [97]. Many types of delivery systems
have since followed, and have been extensively discussed in the litera-
ture throughout the years [98–100].
Limitations in keratinocyte cell culture methods and transplantation
have impeded the widespread use of this technique in the clinical set-
ting. The use of single-cell suspension was introduced predominantly
to shorten the culture time.
5.3. Autologous keratinocyte transplantation in suspension
To overcome the main negative features of epidermal sheets which
are the long culture times and poor cell adhesion to thewound bed, de-
livery of cells in suspension form has been investigated.
While epidermal sheets contain cultured confluent cells that are
passed the phase of exponential growth, cell suspension delivery
systems can be designed to contain pre-confluent cells. Ideally,
these cells are harvested or passaged when reaching a 70–80% cover-
age of culture dishes to ensure their proliferative capability and
avoid confluence, hence the term pre- or sub confluent cells. When
a sufficient cell number is reached (after approximately 2 weeks of
culture), the cells are detached and suspended in a saline solution for
clinical use. As differentiation in vitro is not desirable, keratinocytes in
a pre-confluent suspension form is often preferred for transplantation
(Fig. 5).
Nowadays, several commercially available spray cell delivery prod-
ucts are used clinically to enhance burn wound healing. These tech-
niques can be categorised by the type and level of confluence of the
transplanted cells.
5.3.1. Pre-confluent keratinocytes suspension
The use of pre-confluent cells can shorten culturing time and facili-
tate more rapidly available cellular grafts, which in theory is likely to
Fig. 5. Spray delivery of cultured keratinocytes to enhance burn wound healing. In this
example, a mixed depth burn to the abdomen was treated with solely sprayed cultured
keratinocytes (no additional mesh grafting) 27 days after injury. The wound was
considered to have healed completely 10 days after treatment. Unfortunately, long term
outcomes in terms of scar quality were not available for this patient.
[Reprinted from Burns Volume 36, Issue 3, Pages e10–e20, Sprayed cultured autologous
keratinocytes used alone or in combination with meshed autografts to accelerate wound
closure in difficult-to-heal burns patients, S. Elizabeth James, Simon Booth, Baljit Dheansa,
Dawn J. Mann, Michael J. Reid, Rostislav V. Shevchenko, Philip M. Gilbert, Copyright
(2017), with permission from Elsevier.]
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reduce the risk of wound infections and consequently the length of hos-
pital stay [101,102]. A commercial suspension consisting of autologous
pre-confluent keratinocytes has been available since 2007 for aerosol
delivery. Hartman et al. treated 19 patients with deep dermal face and
neck burns with a spray apparatus with an estimated spray pressure
of 8.2 mm Hg, which seems to be a surprisingly low delivery pressure
using autologous cultured epithelial cells of 80–90% confluence at the
end of passage 0 [103].
An alternative commercially available cell spray system is
Kerahealtm, which was developed by MCTT, Korea. This system uti-
lises an autologous non-differentiated pre-confluent keratinocyte
suspension, which is sprayed to the burn wound followed by fibrin
spray application. The Kerahealtm methodology is similar to conven-
tional CEA and requires 2–3 weeks of culture time, but the cells are
provided in a suspension instead of sheet. To date, two single centre
retrospective studies have evaluated the clinical outcomes of the
sprayed cell suspension in combination with wide meshed skin
grafts in a total of 39 (6 patients who died or were lost to follow up
were excluded from follow up analyses) patients with severe
burns. Graft take rate two weeks after application is surprisingly dif-
ferent between the studies, but after 8 weeks the take rates are both
above 90%. A follow up of 1–2 years was achieved in both studies
with a Vancouver scar scale (VSS) assessment. Scar evaluation
12 months after surgery was lower in Lee et al. with an average VSS
of 3 compared to an average VSS of 5 in Yim et al. [101,102].
Various developers have introduced adjustments to the technique in
terms of the application device, cell detachment process, confluency of
transplanted cell and application setting in order to meet clinical needs.
5.3.2. Uncultured keratinocytes suspension
A further approach is the use of uncultured autologous cells for di-
rect application onto burn wounds without pre-processing in a tissue
culture lab. In a single procedure, a small piece (2× 2 cm) of skin is har-
vested by the surgeon and then placed in an enzymatic solution follow-
ed by manual scraping of the epidermal layer, the skin specimen is
placed in a buffer solution and subsequently filtered before use. The
company provides a kit which allows the clinical team to process the
cells in a single treatment session without the need for a lab technician
or transport of the cells elsewhere [83,104]. The use of an uncultured
mixture of autologous epidermal cells (keratinocytes,melanocytes, der-
mal fibroblasts and Langerhans cells)was introduced to clinical practice
in 2005 as a standardized spray device under the name ReCell (Avita
Medical Europe Ltd., Melbourne, UK).
The purported benefits of this system are the elimination of lengthy
culture times and the delivery of a mixture of autologous epidermal
cells.
Since its introduction, several studies have demonstrated promising
outcomes with the use of ReCell for acute burn wounds or in the treat-
ment of hypopigmentation. These studies ranged from case reports to
larger comparative studies [105,60,106–109]. Although most papers
have shown promising results, the potential value of spray cell trans-
plantation in burns is difficult to evaluate due to the heterogeneity of
the studies in terms of clinical outcomes explored, patient population,
wound characteristics, type of treatment and study design [99]. Gerlach
et al. used a similar approach with direct application of an uncultured
autologous epidermal suspension on thewound bed using a fine needle
spray in a single treatment session. Although, a small number of pa-
tients was treated and results were not compared to controls [110,
111]. The question arises whether a large wound area can be covered
by the harvest of cells without expansion from a small skin specimen.
In an in vitro study an expansion ratio of over 1:100 was calculated
for uncultured cells sprayed with a density of 104 cells/cm2 for an esti-
mated surface coverage [112]. However, there is no other literature to
support the claimed expansion rate.
Fig. 6.Methods of autologous keratinocyte transplantation to burn wounds. In patients with burn injury keratinocytes can be isolated from a small skin biopsy as illustrated above. The
autologous keratinocytes can be cultured and delivered to the wound bed of the patient by several methods. First to be developed was a sheet of cultured epithelial cells, thereafter a
single cell suspension applied to the wound by dripping from a syringe and latest development is application of cultured or uncultured cells in single-suspension with a spray device.
[Source: Britt ter Horst].
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To allow the comparison of clinical data, it has been recommended
by the National Institute for Health and Clinical Excellence (NICE) that
studies evaluating spray delivery of uncultured cells need to include at
least: the time to 95% healing of the burn wound, length of hospital
stay, scar assessment, physical function and cosmetic appearance of
the burned area and compare these results with the current standard
of care [69]. To date, randomized controlled clinical trials and non-com-
mercial studies investigating effectiveness compared to conventional
treatment are lacking. Challenges arise in consistent assessment for
burn wound healing as objective non-invasive assessment tools have
not yet been incorporated widely in routine burn care and might not
be superior to visual expert assessment [26]. Therefore, researchers
rely on subjective clinical assessments for acute burn wound healing
and late outcomes in terms of scarring [113].
5.3.3. Allogeneic neonatal keratinocytes suspension
Several research groups have explored the possibility of the trans-
plantation of fetal allogenic cells with the purpose of stimulating regen-
eration of residual cells in the wound. Neonatal foreskin derived
allogenic cells have low immunogenic properties which is preferred in
tissue transplantation. This work has resulted in the creation of skin
substitutes that have been seeded with allogenic cells such as Apligraf
(Organogenesis, Canton, MA) and Orcel (Ortec International, Inc., New
York, New York).
Similar to the developments in autologous cells delivery, allogenic
cell suspensions have also been investigated as an alternative method
of cell delivery. A cell suspension, code named HP802–47, which con-
tains allogenic neonatal non-proliferating human keratinocytes and fi-
broblasts in thrombin was developed for the use in chronic wounds.
Multi-centre randomized controlled phase IIa and IIb studies were con-
ducted and have demonstrated promising outcomes in wound closure
of venous leg ulcers [114–118]. Subsequently, a double blinded Phase
III study followed in North America and Europe comparing wound clo-
sure after HP802-247 treatment or placebo in venous leg ulcers. Howev-
er, the study was unexpectedly halted in the preliminary stages due to
disappointing results [119]. To the knowledge of the authors, no clinical
studies have been conducted for the treatment of burn wounds with
HP802-247.
5.3.4. Other clinical studies using cell sprays
Delivery of mesenchymal stem cell (MSC) to (burn) wounds is con-
sidered very promising due their capacity to differentiate into multiple
lineages and potential beneficial effects on the immune response [54].
However, only few clinical studies investigated the use of mesenchymal
stem cells to treat burn wounds have been performed so far [120–122].
Ueda conducted a pilot study of 10 patients treated with cultured epi-
thelial autograft (CMEA) delivered to deep dermal burn wounds with-
out adverse events and a healing time of approximately 12 days
(range 7–14 days) [123].
Iman et al. compared spray delivery versus intradermal injection of
autologous cultured keratinocyte-melanocyte suspension to treat
hypopigmented burn scars in a total of 28 patients. Although patients
might show a beneficial result with pigmentation, no statistical differ-
ence in type of application was found [59].
Cell transplantation techniques have changed significantly after the
introduction of different cell-carriers and various forms of cell spray
techniques. Nevertheless, some shortcomings of the suspension appli-
cation technique have yet to be addressed.
For example, spraying on an uneven wound bed that often also
occurs on a curved body contour, can result in uneven spreading of
the of the cell suspension or dripping off the wound bed [46,124]. A
potentially useful development of keratinocyte transplantation is to
improve the method of delivery in order to optimise cell delivery to
the designated area and stimulate cell adherence to the wound
bed. More recently, cell transplantation exploiting hydrogel carriers
have gain interest among researchers. In the past decade
biomaterials to mediate cell delivery and accommodate cells in a
3Dmicroenvironment have been investigated. A plethora of synthet-
ic and natural polymers which may form hydrogels have been stud-
ied as potential cell delivery vehicles due to their ability to integrate
with healthy tissue.
5.4. Hydrogels
Hydrogels are defined as polymer networks with the ability to swell
and absorbwaterwithin their structure. Due to their hydrophilic nature
and flexibility they are very similar mechanically to human soft-tissue.
Both natural and synthetic hydrogels could be considered for tissue en-
gineering. Natural hydrogels benefit from high biological affinity and
are often easily degradable, but the risk of infection transmission and
difficulties with purification has increased the popularity of synthetic
hydrogels.
[125,126] Biopolymer gels can be formed out of polysaccharides or
proteins. For example, polysaccharides obtained from plants (gum aca-
cia, guar gum, starch, psyllium [127]), seaweeds (alginate, agarose, car-
rageenans), micro-organisms (dextran, gellan gum) or animal derived
(chitosan, chitin) (hyaluronic acid) and proteins gained from animal
or human tissue (collagen, fibrin, gelatin, elastin) or animal products
(silk sericin, silk fibroin) [128].
5.4.1. Hydrogels in burn care
Hydrogels currently available for patient care have been reviewed by
many clinicians, but a skin substitute that is able to achieve complete
skin regeneration has not yet been reported [79,129-131]. However,
hydrogels play a promising role in the development of next generation
skin substitutes in burn care and are often used as wound dressings
[132,133], regenerative scaffolds or delivery devices for cells and thera-
peutic e.g. drugs, growth factors etc. Hydrogels have several characteris-
tics to promote skin healing such as the ability to absorb and release
water, which is useful in regulating burn wound exudate. Furthermore,
the architecture of hydrogels can be modified to mimic the body's own
extracellular matrix and their tunable mechanical properties can pro-
vide customised elasticity and flexibility [125] and make them suitable
candidates for skin regeneration [66,134-139].
5.4.1.1. Chitosan. Chitosan is a hydrophilic, non-toxic polysaccharide de-
rived from de-acetylated chitin, obtained from crustaceans or fungi
[140]. Due to its numerous advantageous characteristics such as the
ability to encourage haemostasis, the ability to be modified so that it
can be degraded by human enzymes and availability of a variety of for-
mulation forms [141], chitosan hydrogels have been widely used in
many biomedical applications. Topical forms of chitosan are used as
wound healing stimulating dressings, for haemostasis [142-143] and
specifically for use in the treatment of burn wounds [144-145].
Furthermore, the positive influence of chitosan on keratinocyte pro-
liferation and adhesion has been described previously [146] and chito-
san as a bio-active polymer is suggested as a promising candidate for
tissue regeneration [147.
5.4.1.2. Alginate. Alginate is a negatively charged polysaccharide derived
from the cell walls of brown algae (seaweed) and has hydrophilic prop-
erties. Besides its widespread use in the food and paper-printing indus-
try, it has gained much popularity as a biomaterial due to its non-
immunogenicity, low cost, and simple gelation method. Alginate is
FDA approved for medical applications and is commercially available
as alginate based dressings such as Kaltostat® which are widely used
in burn treatment [9,148] Alginate dressings are also commonly used
for the coverage of donor sites post-skin harvest and has also been suc-
cessful in the treatment of paediatric burn patients [149].
5.4.1.3. Fibrin. Fibrin is a protein which can be derived from human or
animal blood. It can naturally form a gel and acts as a haemostatic
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agent in the body after tissue injury. For this reason,fibrin has been used
as a sealant (fibrin glue) in the medical field [150]. For wound healing,
fibrin sealants and gels have been used for the delivery of several cell
types such as fibroblasts [151-152], mesenchymal stem cells [121] and
keratinocytes [153-155]. Specifically, in keratinocyte spray delivery, ad-
ditional fibrin sealant seems beneficial for adhesion of the suspension to
the (artificial) wound bed [40,124,156]. In contrast, Currie et al. per-
formed a histological and immunohistological analysis and did not
show a difference when adding fibrin glue to a keratinocyte spray deliv-
ery system in terms of epithelialisation [157].
Furthermore, fibrin has also been explored for keratinocyte trans-
plantation in combination with a dermal substitute. For example, en-
capsulated keratinocytes seeded in alloderm [158], keratinocytes
seeded on a fibrin based dermal matrix containing fibroblasts [153,
159] or as a glue to enhance adhesion of human dermis [160] or Integra
[161]. More recently, angiogenesis stimulating factors have been added
to fibrin scaffolds to improve regeneration of ischemic tissue [162].
5.4.1.4. Collagen. Collagen is the most abundant protein in the human
body, it is the main structural protein of the extracellular matrix and
has a key role in wound healing [163]. Therefore, many tissue
engineered collagen based products have been developed. In 1981,
Burke and Yannas developed an artificial dermal replacement based
on collagen, which has eventually led to the production of the
commercialised dermal substitute Integra [164]. In the same decade,
Hansbrough et al. used a collagen-glycosaminoglycan scaffold with at-
tached cultured autologous keratinocytes and fibroblasts in burn
wound treatment [97]. Since then, collagen matrices in different forms
have been investigated thoroughly inwound healing; as (a)cellular der-
mal replacements [163-168] or as a bilayered skin substitutes such as
Orcel [166], Transcyte [169], Apligraft [170], Integra [171] and
Matriderm [63]. Also, collagen hydrogels have been developed for tissue
regeneration [64] with autologous cells incorporated to improve burn
wound healing [139]. Although widely investigated and used in clinical
practice, collagenmatrices and hydrogels have a fast degradation when
applied to human tissuewhich can have anundesirable effect. However,
the rapid degradation of collagen-based biomaterials can be stabilized
through chemical cross-linking [172].
Examples of other hydrogels used for cell delivery in wound healing
or specifically burn care are gelatin [173], hyaluronic acid [81,174], silk
sericin [70,175] and dextran [66,176].
All the above mentioned hydrogels have been successfully translat-
ed to clinical practice and some are part of the standard burn wound
treatment arsenal. Hydrogels have advanced burn care as part of tissue
engineered skin substitutes, incorporated in dressings, topical creams or
as sprayable substance.
6. Methods of spray deposition
6.1. Spray parameters and cell viability
Cell transplantation can be achieved by several techniques. In this
chapter the focus lies on cell transplantation to the tissue via aerosol
or spray delivery.
Sprayed cells are expected to bedamaged at time of impact to the re-
ceiving surface. Following impact, the cell membrane can elongate and
deform. Cell rupture and subsequently cell death can occur in largely
overstretched cell membranes [177]. More precisely, cells can tolerate
a cell membrane area stretch of up to 5% before it becomes detrimental
to cell survival. Cell elongation, deformation and subsequent cell surviv-
al depends onmany variables such as target surface characteristics, vis-
cosity of the transporting fluid/media and velocity of the delivered cell
containing droplet, nozzle distance and diameter.
Veazey et al. investigated the cell viability of xenogeneic 70% conflu-
encefibroblasts immediately after aerosol deliverywith anairbrush sys-
tem and their growth behaviour in a culture model [178]. The airbrush
system used could be adjusted for different nozzle diameters (312,
494, 746 μm) and air pressure at delivery (ranging from 41 kPa to
124 kPa). It was found that cell viability directly measured post aerosol
delivery significantly decreased with higher pressure and smaller noz-
zle diameter. For cell proliferation studies, only the highest pressure
with smallest nozzle diameter combination showed a delayed popula-
tion doubling time and the time to reach confluence was doubled [178].
In another in vitro studywith 80% confluence neonatal dermal rat fi-
broblasts an analytical model was proposed to describe the impact of
several spray parameters in a droplet-based spray application to the
cell viability. Stiffness of the tissue surface, high cell-viscosity and cell-
velocity had a negative influence on cell viability post spray impact,
whereas a larger cell-containing droplet diameter had a positive effect
on cell viability. The latter was explained as a cushioning effect of the
droplet to the surface protecting the cell within the droplet [179].
In other words, cell viability is expected to be highest in large and
low-viscosity single cell-containing droplets sprayed with low-velocity
onto a soft tissue surface.
Wounds would serve as a soft receiving surface for cell transplanta-
tion and can be expected to be highly viscous when hydrogels are used.
Hence, tailored spray devices, with pressures and nozzle diameters op-
timized for cell survival can play an important role in improving cell
delivery.
6.2. Spray systems
Spray systems are beingwidely used inmany industries. Surprising-
ly little research has focused on the influence of the type of aerosol de-
vice on mammalian cell survival after transplantation.
6.2.1. Low and high pressure spray nozzle
Fredriksson et al. evaluated 7 different application techniques for
cell transplantation on cell viability and proliferation in an in vitro
study. Based on current clinical practice they included commercially
available spray systems: spray nozzle systems such as the Harvest
SK/S Spray Applicator Kit®, high and low pressure Tissomat applica-
tor in combination with a Duploject™ spray nozzle, a Duploject™
spray nozzle without additional pressure control and two non-
spray systems: pipetting and paintbrushing. This study showed an
approximate 50% drop in viable cell count immediately after trans-
plantation when using a high pressure device (200 kPa) and a fur-
ther decline to nearly 40% viable cell count after 2 weeks of
culturing, which was comparable to the paintbrush [180]. In contrast,
Harkin et al. measured a 20% higher post aerosol delivery cell survival
with similar pressures [156]. The immediate cell survival is comparable
with other studies utilising low pressure delivery methods/systems
[178]. Although no statistically significant differences were displayed,
the poorest cell viability after 2weekswas seen in the high pressure de-
vice and paintbrush [180]. Fredriksson et al. hypothesised that an addi-
tional application of fibrin sealant might improve cell survival.
Furthermore, the authors emphasized the importance of measuring
the proliferation capacity of cells post aerosolisation, since a large differ-
ence was seen in their data among the different devices. Interestingly,
the delivery pressure and nozzle diameter of clinically used manual
cell spray devices is unclear and might impact on cell viability and pro-
liferation capacity.
Aerosol delivery with handheld airbrush systems with adjustable
air pressure supply have also been previously investigated and stud-
ies have demonstrated consistent acceptable cell viability of above
80% with low delivery pressure (below 69 kPa) [171,178]. According
to Veazey et al., this system should also be compatible with alginate-,
gellan, hyaluronic and hyaluronate-based hydrogel cell carriers [68].
However, to date, there is no published data to support this
statement.
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6.2.2. Liquid atomizer
Liquid atomizers or nebulizers originally designed for aerosol drug
delivery to the trachea have also been explored for cell delivery. In
burns, inhalation injury can occur with damage to the trachea and
drug- or cell delivery could be used to improve the healing of these in-
jured areas. Sosnowski et al. investigated the use of 5 different atom-
izers for cell delivery to the trachea in terms of cell viability. However,
a droplet size below 20 μm was found to be incompatible for fibroblast
encapsulation and 3 nebulizer devices had to be excluded. The nasal at-
omizer (NA) andMicrosprayer Aerosolizer (MSA) had above 90% viable
cells post spraying, but the viable cell count in the NA group declined to
65% 48h after spraying, indicating that it was amore destructive aerosol
technique [181].
All spray cell delivery techniques have been investigated in vitro or
rodent studies, which has led to the development of commercial spray
devices that are now available in clinical practice for burn wound
treatment.
7. Potential therapeutic applications
7.1. Future approaches keratinocyte transplantation
Several reviews in the last decade have discussed the future implica-
tions of skin tissue engineering and/or specifically keratinocyte cell
transplantation in the treatment of burns [35,36,54,131,182].
Larger burnwounds often requiremesh grafting. Autologous epider-
mal cell transplantation can complement mesh grafting by stimulating
rapid epithelialization, which is highly desirable to improve patient's
chance of survival and eventually improve scarring. Burns specific clin-
ical studies investigating keratinocyte transplantation are available, but
due to heterogeneity of the studies and different outcome parameters
the evidence remains low. Comparative trials with standardized out-
comes and ideally randomized treatment for available cell transplanta-
tion techniques are required.
Due to the disadvantages of CEA sheets, future research is focused on
optimizing keratinocyte proliferation by transplantation of pre- or sub
confluence cells. Further improvement of keratinocyte culture method
in terms of culture time, reducing infection risk and elimination of xe-
nobiotic products and also antibiotics needs to be further investigated.
Graft attachment in keratinocyte transplantation remains an im-
portant focus for research. Boyce and Supp developed a cultured skin
substitute containing cultured human keratinocytes and fibroblasts
attached to a collagen-glycosaminoglycan matrix which seems to
form a basement membrane at the dermal-epidermal junction in
vitro [183]. Importance of basement membrane formation and
rapid epithelialisation has to be taken into account in novel cell
spray or carrier delivery methods [183,184].
7.2. Future spray cell delivery systems for burns wound care
Spray cell delivery to burnwounds can overcome themajor issues of
conventional grafting techniques by reducing donor site and enhance
fast re-epithelialisation. The available delivery systems can be improved
by optimizing spray features to aim for high cell viability and prolifera-
tion. This should be tailored according to cell type and receiver surface.
Spray features to optimise might be: air delivery pressure, nozzle de-
signs, carrier type and depending on technique of delivery, cell contain-
ing droplet size [178,179,181 ]. Further research should take into
account the importance of preventing cell damage, since this could re-
flect poor proliferation [178,180]. Hydrogels could potentially serve as
amechanical protection for the cells during transplantation and provide
structural support once transplanted. Although in vitro studies have
shown good short term cell survival post aerosol delivery, clinical stud-
ies have not been able to show similar results as yet. The challenge for
researchers is to develop a feasible spray delivery system with accept-
able cell viability and proliferation which can be translated to clinical
studies. Also, current clinical cell spray devices could potentially benefit
from these optimized features.
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a b s t r a c t
Autologous cell transplantation was introduced to clinical practice nearly four decades ago to enhance
burn wound re-epithelialisation. Autologous cultured or uncultured cells are often delivered to the sur-
face in saline-like suspensions. This delivery method is limited because droplets of the sprayed suspen-
sion form upon deposition and run across the wound bed, leading to uneven coverage and cell loss. One
way to circumvent this problem would be to use a gel-based material to enhance surface retention. Fibrin
systems have been explored as co-delivery system with keratinocytes or as adjunct to ‘seal’ the cells fol-
lowing spray delivery, but the high costs and need for autologous blood has impeded its widespread use.
Aside from fibrin gel, which can exhibit variable properties, it has not been possible to develop a gel-
based carrier that solidifies on the skin surface. This is because it is challenging to develop a material that
is sprayable but gels on contact with the skin surface. The manuscript reports the use of an engineered
carrier device to deliver cells via spraying, to enhance retention upon a wound. The device involves
shear-structuring of a gelling biopolymer, gellan, during the gelation process; forming a yield-stress fluid
with shear-sensitive behaviours, known as a fluid gel. In this study, a formulation of gellan gum fluid gels
are reported, formed with from 0.75 or 0.9% (w/v) polymer and varying the salt concentrations. The rhe-
ological properties and the propensity of the material to wet a surface were determined for polymer mod-
ified and non-polymer modified cell suspensions. The gellan fluid gels had a significantly higher viscosity
and contact angle when compared to the non-polymer carrier. Viability of cells was not impeded by
encapsulation in the gellan fluid gel or spraying. The shear thinning property of the material enabled it
to be applied using an airbrush and spray angle, distance and air pressure were optimised for coverage
and viability.
Statement of significance
Spray delivery of skin cells has successfully translated to clinical practice. However, it has not yet been
widely accepted due to limited retention and disputable cell viability in the wound. Here, we report a
method for delivering cells onto wound surfaces using a gellan-based shear-thinning gel system. The vis-
coelastic properties allow the material to liquefy upon spraying and restructure rapidly on the surface.
Our results demonstrate reduced run-off from the surface compared to currently used low-viscosity cell
carriers. Moreover, encapsulated cells remain viable throughout the process. Although this paper studies
the encapsulation of one cell type, a similar approach could potentially be adopted for other cell types.
Our data supports further studies to confirm these results in in vivo models.
Crown Copyright ! 2019 Published by Elsevier Ltd on behalf of Acta Materialia Inc. All rights reserved.
1. Introduction
Large surface area wounds, such as those seen in burns patients,
compromise the barrier function of skin. When coupled with
extensive fluid loss, an impairment of vital bodily functions can
arise, which can result in death. Rapid epithelialisation is essential
to restoring the function of the skin and in the longer-term, to
reduce the likelihood of scarring [1]. Current clinical practice
includes transplantation of autologous skin from a healthy site of
the body, however, challenges arise when a limited number of
donor sites are available.
https://doi.org/10.1016/j.actbio.2019.03.036
1742-7061/Crown Copyright ! 2019 Published by Elsevier Ltd on behalf of Acta Materialia Inc. All rights reserved.
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One approach to overcome this issue is to deliver autologous
skin cells (usually keratinocytes) to the wound; either in suspen-
sion following a period of culture, or directly after harvest from
the patient [2]. Over recent years, cell transplantation techniques
have evolved from syringe-dripping to spraying systems [3]. The
major advantage of the spray techniques is the rapid delivery to
large and geometrically complex areas of the body. For medical
applications, a minimum distance of 10 cm from the body is neces-
sary to allow safe application without the risk of an air embolus,
this is easily achieved in topical application (in comparison with
endoscopic surgery). Even though spraying presents great poten-
tial for topically applying cells in suspension, there are still many
drawbacks, including: spillage of cells from the wound bed and
uneven spreading [3,4]. This results in the application of dressing
materials around the wound as a means to retain as many cells
on the wound bed as possible [5]. Although poor retention is con-
sidered a critical disadvantage of the cell spraying methodology
amongst clinicians, it has not as of yet received much attention
within the published literature. Autologous fibrin sprays, similar
to fibrin glue, have been proposed to retain sprayed epithelial cells
at the wound [4,6]. However, high costs and the need for patient’s
own blood-derived fibrin, have impeded widespread use of this
technique to date. While hydrogels have gained huge and sus-
tained interest for therapeutic delivery systems, development of
a practical system for topical spray delivery is technically challeng-
ing; requiring either in-situ gelation on the surface of the wound or
a sufficiently high viscosity to be retained on the wound but not
clog the spray nozzle.
Fluid gels have shown continued promise to address these
issues, whereby at rest act in a pseudo-solid fashion but can be
made to flow under shear [7] This is derived through the process-
ing of a hydrogel during its sol to gel transition. The application of
shear during the sol-gel transition has been previously shown to
support the formation of discrete gel particles, which in close prox-
imity interact with one another in suspension to give reversible
shear thinning and solid-like behaviours. Furthermore, fluid gels
have been preciously shown to demonstrate yield stresses once
at rest [8]. The presence of yield stresses and yielding behaviours
has generated much debate within the rheological literature, due
to a long understanding that ‘‘everything flows” [9]. However, it
is generally accepted that in practise, within timescales relevant
to the material in question, a material has a yield stress if it does
not flow below a defined threshold [10]. The importance of engi-
neering yield-stresses into fluids has been recently highlighted
by Nelson and Ewoldt [10] demonstrating a clear set of design
principles for such materials. Here they have highlighted the syn-
ergistic link between customer need/material specification and
the materials microstructure, allowing for its application, an exam-
ple of this would be paint where the presence of a dynamic yield
stress allows it to ‘‘stick” to the wall without running [11,12]. Such
principles were used to design a biopolymer hydrogel with vis-
coelastic properties that allow the material to liquefy when passing
through the nozzle, but restructure to a weak gel on the receiving
surface. Thus, facilitating retention of cells on the receiving surface
without impairing the spraying process itself (Fig. 3).
Biopolymer hydrogels are widely used in burn wound care as
dressings, and tissue-engineered scaffolds with or without bioac-
tive compounds [13]. Hydrogels offer ideal systems often mimick-
ing the 3D architecture of native extracellular matrix (ECM) [13].
The ability of these gels to entrap relatively large volumes of water
at low percentages (%wt) of polymer is beneficial for maintaining a
moist wound environment, allowing rapid diffusion of nutrients
and metabolites [14]. Gellan gum was used as the biopolymer of
choice in this study due to its highly tuneable mechanical proper-
ties [13]. Gellan gum hydrogels can be designed for many biomed-
ical applications [15] using many forms including fluid gels [16,17].
To date, surprisingly little research has focused on quantifying the
uniformity of sprayed solutions for wound coverage and the influ-
ence of spraying on mammalian cell survival after transplantation
[18,19]. This study addresses some of the problems of current
spray delivery systems and proposes gellan fluid gel as a material
that could be utilised to enhance cell retention upon a surface fol-
lowing spraying.
2. Material and methods
2.1. Fluid gel preparation
Low acyl gellan gum stock solutions (1% (w/v) and 0.83% (w/v))
were prepared by the addition of gellan powder [Kelcogel"
obtained from Azelis, Hertford, UK] to sterile water at 65 #C under
constant agitation. Following, stocks of NaCl cross-linker solutions
were prepared to concentrations of 0.1, 0.2, 0.3, 0.4 and 0.5 M in
sterile water. Final polymer sols were subsequently formed by
mixing aliquots of both gellan with cross-linker stock solutions
(9:1) at 65 #C, resulting in final concentrations of either 0.9% (w/
v) or 0.75% (w/v) polymer ! 10 mM, 20 mM, 30 mM 40 mM and
50 mM NaCl. Gellan sols were then added to the cup of a couette
(Cup diameter 28 mm, vane diameter, 26 mm) rheometry set-up
(Kinexus Ultra, Malvern Pananalytical, UK) at 60 #C. After allowing
thermal equilibrium to be reached, the system was cooled at a rate
of 1 #C min!1 to 20 #C under constant shearing, 450 s!1; unless sta-
ted otherwise. Post-production shear was removed, and fluid gels
stored at 4 #C until further testing/use.
2.2. Rheological measurements
All rheological measurements were performed at 25 #C using a
Kinexus Ultra rheometer (Malvern Pananalytical, UK) equipped
with 40 mm parallel plates (1 mm gap height), 48 h post-
processing.
Small deformation rheometry was undertaken varying both
amplitude and frequency. Amplitude data was obtained in strain-
controlled mode, ranging from 0.1 to 500% logarithmically at a con-
stant frequency of 1 Hz. Linear viscoelastic regions (LVRs) were
determined and a common strain of 0.5% was found to be common
across all systems. This strain was then used for all frequency
sweeps ranging between 0.1 and 10 Hz. Single frequency data
was collected as a function of temperature at 0.5% strain and
1 Hz. Temperature ramps were applied at 1 #C min!1 and moduli
(G’ and G’’) obtained.
Non-linear rheology was determined using shear ramps in
shear rate mode. Ramps were undertaken from 0.1 to 600 s!1 log-
arithmically over 3-minute timescale. Hysteresis of the systems
was probed by undertaking a second sweep immediately after
the first, from 600 s!1 back to 0.1 s!1. Data from the second ramp
was fitted to the Herschel-Bulkley model (Equation (1)) to deter-
mine the dynamic yield stress (ry).
r ¼ ry þ K _cn ð1Þ
where ry is the yield stress, K is the consistency factor, _c is the shear
rate and n is the flow index.
The yield stress was compared to the maximum stress on the
material at an inclining substrate to investigate whether flow is
induced. Maximum stress was determined by the following
formula:
rmax ¼ qghðsinbÞ ð2Þ
where rmax is the maximum stress on the material, q the material
density (kg m!3), g the gravitational acceleration of 9.807 m s!1, h
is the height (m) and b the angle of inclined substrate.
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2.3. Microscopy of fluid gels
Micrographs of the fluid gel systems were undertaken using a
Leica DM6000 microscope (Leica Microsystems, UK). Firstly, fluid
gels were diluted at a ratio of 4:1 in PEG400, via slow addition of
the PEG under constant agitation. Post-dilution, one drop of the
systemwas dispensed onto a microscope slide and coverslip placed
over the top. Images were obtained at x20 magnification using
phase contract to distinguish between the continuous and particu-
late phases. ImageJ was used to add scale bars. Images presented
are typical representations of the systems, compared against a
minimum of 5 other micrographs.
2.4. Contact angle measurements
The static contact angle of sodium chloride and gellan fluid gel
droplets on a variety of surfaces at room temperature were deter-
mined by imaging and subsequent measurement with ImageJ soft-
ware using the DropSnake Plugin [20]. A 60 ll droplet was dropped
onto the test surfaces and imaged. Three repetitions were per-
formed, each sample was measured three times and the mean con-
tact angle was calculated. Substrates used included: gelatin 5% (w/
v) (prepared with deionized water and bovine gelatin, stirred and
allowed to set at 4 #C for a minimum of 60 min), alumina ceramic
(referred to as ceramic in this paper), porcine epidermis and por-
cine subcutis. Porcine skin (Arun Meats & Lifestock LTD, UK) was
kept frozen and thawed before use.
2.5. Spray methods
Materials were delivered through an airbrush with external
mixture and a standard medium size nozzle of 750 lm in diameter
(Badger, Universal 360 model, US) as illustrated in Fig. 5a. An oil-
free air compressor (Badger BA1100, US) was used as the air source
with air pressure regulator. Air pressure at delivery (15 psi), nozzle
diameter (750 lm), application distance (10–15 cm) and spray
angle from spray tip to receiving surface (45#) were standardised
(Fig. 5b). The airbrush system was cleaned and the nozzle rinsed
thoroughly with ethanol 70% and allowed to air dry in the laminate
flow hood before each spray cell experiment. Between experiments
the nozzle was purged with 1 ml ethanol 70% and 1 ml culture
media to ensure no cells from a previous application remained.
2.6. Spray analysis using water sensitive paper
For investigation of uniform distribution following spraying the
individual droplet size, droplet size distribution and area covered
by the gelwas compared to control liquid (water or sodiumchloride)
(Fig. 5). Water-sensitive paper (WSP) of 26 mm & 76 mm (John
Rhodes AS Ltd, Evesham, UK) was utilized to compare gellan fluid
gel to the control liquid in a standardized fashion (Fig. 5c). Yellow
coloured spray cards coated with bromoethyl blue dye turn blue
when in contact with water. Measurements included: the percent-
age area covered by sprayed volume (%coverage), droplet size and
droplet size distribution. Volumes of 50 ml or 25 ml were sprayed
with an airbrush onto the WSP and allowed to dry for up to
60 min. A minimum of 3 repetitions was performed. Images were
obtained directly following spray application, dried spray cards
were scanned at 600x600 dpi (Konica Minolta scanner, bizhub
c3350). Images were analysed with ImageJ Software, a colour
threshold was set and the image was converted to a binary
image. Then, percentage of coverage was calculated by the
ratio of original (white pixels) to covered area (black pixels)
(%coverage = (Areacovered/Areaoriginal)*100). For droplet size the
‘Particle Analysis plugin’ was used. Obtained parameters include
droplet diameter (D) in mm, droplet area (A) in mm2 and total
sprayed area (TSA) in mm2. A value where 50% of the total sprayed
volume consists of drops with diameter larger than the median
value and 50% smaller than the median value (DA50) could be
obtained from thedata. Next, DA10 andDA90were obtained, similar
to DA50, but for 10% and 90%. Relative Span factor (RSF), a single
number reflecting the uniformity of the droplet size distribution
was calculated in accordance with Eq. (3):




Human Dermal Fibroblasts (HDFs) were used for all experi-
ments. Fibroblast culture media was prepared from Dulbecco’s
modified Eagle’s medium – high glucose (DMEM) (Sigma, UK), sup-
plemented with 10% fetal bovine serum (FBS), 1.5% penicillin-
streptomycin and 2.5% L-glutamine. Cultures were maintained in
the incubator (5% CO2, temperature 37 #C, 100% humidity) and cul-
ture media changed every 2–3 days. Cells were harvested when
they reached approximately 80% confluence.
2.8. Encapsulation of human dermal fibroblasts
HDFs were detached from cell culture flask using TryplE solu-
tion (Sigma, UK), buffered with fibroblast culture media and cen-
trifuged at 1000 rpm for 3 min. Cells were suspended in gellan
fluid gels (0.9% or 0.75% (w/v)) at a concentration of 1–2 & 106
cells/ml. Cell solutions were pipetted on culture petri dishes or
sprayed with the airbrush device into cell culture treated 24-well
plates and fresh culture media was added before samples were
incubated (at 5% CO2, temperature 37 #C, 100% humidity) for later
experiments or directly stained for imaging.
2.9. Live/Dead assay
Calcein acetocymethylester (Calcein AM) (Invitrogen, UK) was
used to stain live cells and Propidium Iodide (PI) (Invitrogen, UK)
was used to stain dead cells. Calcein AM/PI stain was added to
1 ml of DMEM, samples were immersed in 100 ml/ml of this solu-
tion for 20 min in the incubator. Samples were visualized using
confocal microscopy (Olympus, Fluoview FV100), showing viable
cells green (Calcein AM) and non-viable cells red (PI). Laser setting
488 nm and 543 nm for Calcein AM and PI respectively. Cell viabil-
ity was measured with ImageJ software, images were split in the
colour channels red (dead cells) and green (live cells). For each
sample, cells were automatically counted by using the particle size
plugin of ImageJ. Percentage of viable cells were calculated by the
following formula (Eq. (4)):
viable cells %ð Þ ¼ number of viable cells
total number of cells ðliveþ dead cellsÞ x 100
ð4Þ
2.10. Alamar blue metabolic activity
Encapsulated and control HDFs were seeded or sprayed into 24-
well tissue cultured plates at a density of 5 x104 per well for cells in
gel and 1 & 104 for cells in medium. Fresh growth medium at a vol-
ume of 1 ml was added, cells were then incubated for a minimum
of 24 hr (at 5% CO2, temperature 37#, 100% humidity) together with
negative control wells including medium and gellan fluid gel.
Metabolic activity was assessed at day 1, 3 and 7 for all 4 condi-
tions by incorporating 10% Alamar Blue reagent (Life Technologies,
UK) into the culture medium. After an incubation time of 4 h,
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absorbance was read at 570 nm and 600 nm using a microplate
reader (Multiskan FC, Thermo Scientific, UK). Percentage reduction
was calculated by comparing absorbance to negative control wells
with the following equation:
percentage reduced ð%Þ ¼ ðeox2xA1Þ ! ðeox1xA2Þ
ðered1xB2Þ ! ðered2xB1Þ
x 100 ð5Þ
A1 = absorbance at 570 nm test well; A2 = absorbance at
600 nm test well; B1 = absorbance at 570 nm control well and
B2 = absorbance at 600 nm control well.
Standard molar extinction coefficients for oxidized eoxð Þ and
reduced eredð Þ form of alamarBlue" were used:
eox1 = 80,586 at 570 nm; eox2= 117,216 at 600 nm; ered1= 155,677
at 570 nm and ered2 = 14,652 at 600 nm
2.11. Statistical methods
Mean values and standard deviations are plotted unless stated
otherwise. Unpaired t-tests and two-way ANOVA were performed
using Prism 7 (GraphPad software, CA, USA) with a significance of
p < 0.05.
3. Results
3.1. Fluid gel material and characterisation
3.1.1. Fluid gel production
The preparation of fluid gels has been depicted in Fig. 1a using a
schematic of the cup and vane set-up. Here a constant shearing
force is applied to a gellan sol as it is forced, thermally as the sys-
tem is cooled, through a sol-gel transition: as such the gelation
becomes confined by degree of shear applied, resulting in the for-
mation of a particulate suspension of microgel particles (Fig. 1b
and c) [16]. The formation of such systems was monitored via
changes in viscosity as a function of temperature (Fig. 1d).
Fig. 1d highlights that at a critical temperature an increase in the
system viscosity was observed, dependent on the concentration
of crosslinker in agreement with data published for quiescent gels
[21]. The increase in viscosity results from the formation of parti-
cles which trap the continuous aqueous phase resulting in an effec-
tive change in the particle volume until a plateau is reached
[22,23]. Such particles were studied using optical microscopy,
showing anisotropic particles with varying length to width ratios
(visually observed) dependent on the salt concentration (Fig. 1b
and c, 50 and 10 mM NaCl respectively).
Mechanical responses have been shown in Fig. 1e and f,
demonstrating the typical viscoelastic properties of the fluid gel.
Fig. 1e compares the flow profile of the fluid gel against that of
the current standard used for cell spraying (0.9% saline solution).
The saline solution demonstrated a linear relationship between
the shear stress and rate, typical of a Newtonian system where
the viscosity is independent of the shear rate. In contrast, the
fluid gel exhibited a shear thinning profile, typical of such sys-
tems [16], with a much greater viscosity in comparison to the sal-
ine. Linear rheology was further probed using frequency
dependent measurements to better understand the materials
behaviour at rest (Fig. 1f). Data suggests the formation of a
weakly gelled network, both dependent on frequency and dis-
playing large values of Tan d (ratio of loss to storage modulus;
G”/G’) [24,25], again previously reported as typical characteristics
of such systems [7,16,24] (The calculated loss tangent was >0.1
for all gels, as shown in Table 1).
Fig. 1. Manufacture process and characteristics of gellan fluid gel. a) fluid gel manufacture process as adapted from Cooke et al, 2018 with permission [17]. Micrographs of
diluted 0.75% fluid gels in 4:1 PEG:gellan ratio, manufactured with 50 mM NaCl (b) and 10 mM NaCl (c), scale bar = 100 lm. d) Flow profiles for the formation of gellan fluid
gel (0.75% (w/v), 10 mM and 50 mM NaCl) gelation of fluid gel occurs as temperature is decreasing under a constant shear rate of 450 s-1. Values presented are of one
representative measurement. e) Flow profiles of post-production of gellan 0.9%, 20 mM NaCl demonstrated a non-Newtonian shear thinning behaviour with higher viscosity
at low shear compared to 200 mM sodium chloride showing a linear relationship typical of a Newtonian fluid. N = 3 for gellan and N = 2 for NaCl. Mean values presented, error
bars are SD (smaller than icon and therefore not visible). f) Frequency dependence of 0.9% (w/v) gellan fluid gel (20 mM NaCl) with gradually increasing G’ and G” modulus
under increasing frequency typical of a weak gel system. Mean values of 3 individual measurements presented, error bars are SD (smaller than icon and therefore not visible).
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3.1.2. Modulation of fluid gel properties
Manipulation over the material properties of the fluid gels was
probed systematically as a function of both polymer and cross-
linker concentrations; with a view to improve the characteristics
required for enhanced ‘‘spray-ability”. Flow behaviour and viscos-
ity for the fluid gel systems have been shown in Fig. 2a and b. All
systems showed a high degree of shear thinning as the shear rate
was increased from 0.1 to 600 s!1 (Fig. 2a). Shear profiles were
used to estimate the behaviour of the fluid during spraying. This
was achieved by comparing data. As previously described by Hen-
driks et al. [26] the expected shear rate ( _c) encountered during
spraying can be estimated by calculating the nozzle-induced shear




( _c = shear rate in s!1, V = velocity (m s!1) of liquid and DN =
diameter of nozzle (m). Standard nozzle diameter of the airbrush
is 750 lm (7.5 & 10!4 m). Flow velocity (v) was calculated by the
following equation:
Q ¼ v x A ð7Þ
Volumetric flow rate (Q) in m3 s!1, flow velocity (v) in m/s, col-
umn cross-sectional area (A) in m2.
For the standard nozzle size of 750 lm, the nozzle induced
shear rate of gellan 0.9% hydrogel was estimated at 223 s!1. Vis-
cosities were obtained and compared at the calculated shear rate
were derived from rheology testing (Fig. 2b). For airbrush applica-
tion, the estimated viscosity of the material was shown to be a
function of both polymer and NaCl concentration. At comparative
cross-linking concentrations, the higher polymer systems resulted
in increased fluid gel viscosities. Additionally, a linear correlation
between cross-linker concentration and viscosity was observed,
again where higher concentrations of the cross-linker formed more
viscous suspensions. However, ultimately all systems were charac-
terised by a low spraying viscosity, 8.4 & 10!2 Pa.s (±6.7 & 10!4) to
1.8 & 10!1 Pa.s (±1.2 & 10!2). Although such viscosities are consid-
ered in this case low, they are still over an order of magnitude
greater than the viscosity of the current standard delivery medium
used for cell spraying.
The amplitude dependence (reflected in percentage strain) of
the storage and viscous moduli are presented in Fig. 2c. Under
increasing strain all tested compositions of gellan fluid gels even-
tually underwent a cross over showing a transition in G’ domi-
nance to systems governed by G” (full data range shown in
Supplementary Data: panel of gels). The data highlights one of
the important properties of the fluid gels, where at large deforma-
tions the suspensions act as liquid-like materials, enabling flow.
Changes in the degree of bulk suspension elasticity (G’) as a func-
tion of the polymer and salt concentration has been demonstrated
in Fig. 2d and e. Here both the magnitude of G’ and length of the
LVR were observed to be a function of the polymer and cross-
linker concentrations, with the LVR shortening and modulus
increasing with elevated salt concentrations.
Frequency data obtained for the fluid gel formulations high-
lighted a change in mechanical behaviour with frequency sweeps
of 10 mM NaCl systems demonstrating initial G’ dominated sys-
tems with clear cross-overs to G’’ domination (Fig. 2f and g). How-
ever, at higher salt concentrations (>20 mM to 50 mM) plots
showed G’ dominance over the whole frequency range studied,
with both G’ and G’’ demonstrating some frequency dependence,
typical of viscoelastic gel-like fluids. Gel strength was observed
to increase, described by a reduction in tand (Table 1 and Supple-
mentary Fig. 2) as a function of both salt and polymer
concentration.
A simple experiment to demonstrate the clinical challenge of
spray run-off has been shown in Fig. 3a, in which the control
(sodium chloride) instantly flows on vertical tilted porcine skin
surface in comparison to the retained fluid gel. Fluid gel hysteresis
was probed to study the time dependent behaviours of the systems
post spraying, using consecutive shear ramps: increasing and
decreasing in shear rate (0.1–600 s!1 and 600 to 0.1 s!1). Direct
comparison of the flow profiles suggests little change, with a large
degree of the initial viscosity of the system is recovered almost
instantaneously, Fig. 3b. The rheological phenomenon known as
the dynamic yield stress was examined to describe the ability of
the fluid gel to be maintained upon the skin without flowing. The
Herschel-Bulkley model can be used to determine the yield stress
of a fluid [27]. Data fitted to the model presented for the second
sweep (example shown in Fig. 3c and Supplementary Fig. 3). Yield
stress plotted as a function of the fluid gel formulations have been
presented in Fig. 3d (full data presented in Table 2). Fitting to the
10 mM NaCl systems for both polymer concentrations resulted in
negative values, indicating an inadequate means of describing
the yield-stress fluid. However, a linear correlation between NaCl
concentration and yield stress was observed for the higher concen-
trations. A simple gravitational model described for ‘‘sagging” was
used to assess fluid gel resistance to flow on an inclined plane. The
Table 1
Rheological properties of gellan fluid gels. All gels were fabricated with low acyl gellan gum powder and cross-linked with sodium chloride (NaCl) until a final concentration of
0.75% (w/v) or 0.9% (w/v) with a constant shear rate (450 s!1) during the gelation process. Flow profiles for 3 individual samples per gel composition was measured at 25 #C and
viscosity at a shear rate of 205 s!1 shown, mean with standard deviation (SD) is presented. Viscosity of all gels is higher than control liquid (NaCl) and dependent on cross-linker
and polymer concentration. G’ at frequency of 1 Hz is presented, %strain at which loss of storage modulus occurs indicating the end of the LVR, loss tangent (G”/G’), a loss tangent






Mean viscosity (Pa.s) (SD) G’ (Pa) (SD) Strain end LVR (%) Loss tangent (G”/
G’)
Gellan 0.75% (w/v) 10 0.085 (0.001) 5.99 (0.17) 15.87 1.03
20 0.076 (0.000) 10.45 (0.42) 12.00 0.70
30 0.086 (0.002) 36.46 (3.42) 6.39 0.35
40 0.110 (0.002) 105.74 (5.48) 4.02 0.21
50 0.118 (0.005) 215.03 (35.89) 2.52 0.16
0.90% (w/v) 10 0.117 (0.001) 12.54 (0.29) 12.00 0.84
20 0.125 (0.003) 36.81 (1.28) 22.26 0.45
30 0.135 (0.006) 94.45 (7.97) 6.39 0.27
40 0.143 (0.002) 171.23 (10.36) 4.02 0.21
50 0.177 (0.011) 388.47
(100.14)
2.52 0.17
Sodium chloride 200 mM – 0.004* – – –
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gravitational forces, described as ‘maximum stress on the material
at an inclined surface’ were calculated with Eq. (2) using the fol-
lowing values: material density of 1020 kg m!3 for fluid gel
(0.9%, 20 mM NaCl), assuming a fluid gel thickness of 1.0 & 10!4
m and a substrate angle of 45#. The calculated maximum stress
was observed to be lower than the yield stress of the gel, with val-
ues of 0.85 Pa and 1.777 Pa respectively.
3.1.3. Spray-ability of the fluid gel carrier
Spreading properties of the fluid gels in comparison to saline
solution were investigated to gain further information of both cov-
erage and run-off. The contact angles for the fluid gel and control
(NaCl) were measured on a variety of substrates, comparing their
wetting ability. Gellan fluid gels exhibited a significantly higher
mean contact angle than NaCl on gelatin (63.3# vs 44.4#,
p < 0.001), porcine epidermis (54.8# vs 25.37#, p < 0.001) and por-
cine dermis (59.7# vs 36.6#, p < 0.001) describing lower wettability,
resulting in reduced spreading. There was no significant difference
found for contact angles on ceramic, with a mean contact angle of
37.5# for gellan fluid gel and 35.8# for NaCl (Fig. 4a).
Flow and spreading due to the thermos-responsive properties of
the gellan was also investigated. The effect of increasing tempera-
Fig. 2. Modulation of fluid gel properties. a) demonstrates that gellan fluid gels behave as shear-thinning materials (non-Newtonian), since viscosity decreased as shear rate
increased. Four compositions of gellan fluid gel (0.9% (w/v), 20 mM and 50 mMNaCl and 0.75% (w/v), 20 mM and 50 mMNaCl) presented. b) Increasing crosslinker or polymer
concentration results in higher viscosity as demonstrated here. Data is mean viscosity at shear rate 205 s–1 c) Amplitude dependence of storage and loss moduli in gellan 0.9%,
20 mM as representative gel shows that under increasing strain eventually G’ and G” will cross-over resulting in a G” dominated system indicating more liquid like behaviour
under high strain. Storage modulus as a function of the polymer and salt concentration of 0.75% fluid gels (d) and 0.9% fluid gels (e) shows an earlier loss of storage modulus
(shorter LVR’s) in higher salt-concentrations. f) Frequency dependence of four systems is shown here to illustrate influence of salt-concentration on viscoelastic-properties,
from viscoelastic-solids at 10 mM NaCl concentrations to gel-like behaviours at 50 mMNaCl concentrations. G” (open signs) and G’ (closed signs) values are presented. Unless
stated otherwise, mean values of three independent measurements are presented, error bars represent the standard deviation. Mean values of 3 individual measurements
presented, error bars are SD (smaller than icon and therefore not visible).
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ture on the degree of structure within the fluid gels system was
investigated as a function of G’ and G’’ (Fig. 4b). Increasing temper-
ature resulted in a reduction in the storage modulus, as the junc-
tion zones that create the 3D matrix began to break down,
resulting in fluid-like behaviour of the gels. In general, a reduction
in storage modulus appeared to occur between 30 and 40 #C for all
gels, as shown in Fig. 4c, this range includes peripheral skin tem-
perature. Based on the rheological data, gellan fluid gel with 0.9%
polymer concentration and 20 mM NaCl cross-linker concentration
was considered most suitable for the cell spray application (further
discussed later), and thus used for further studies.
Spray coverage (% coverage) is the proportional area of receiving
surface covered by sprayed material (gellan hydrogel or control liq-
uid). A higher percentage of area was covered with water compared
to gellan hydrogel, although these differences were not statistically
significant (Fig. 5c and d). As expected, a higher percentage cover-
age was achieved when sprayed volume was increased, however,
this was not proportional, i.e. doubling the volume did not double
the area covered (Fig. 5d). There was a non-statistically significant
positive correlation between sprayed volume and percentage cov-
erage for gellan hydrogel (p = 0.301, 95%CI: 33.09, 11.86; Pearson
correlation 0.820) and water (p = 0.065, CI95%: !34.066, 1.308;
Pearson correlation 0.723). This could be explained by the observed
accumulation of droplets (especially in the centre of the sprayed
area) with increasing volumes.
Individual droplet size was determined for all sprayed cards
with ImageJ Software. The minimum cut off droplet size was set
at 0.01 mm2. Mean droplet size of water (5.5 & 10!2 mm2) and gel-
lan fluid gel (5.2 & 10!2 mm2) was not found to be significantly dif-
ferent (p = 0.326, 95%CI: !0.011, 0.004). On the other hand, the
gellan fluid gel has a lower mean relative span factor (RSF) of
8.57 indicating a more uniform drop size distribution compared
to the water (11.84). However, this difference was not found
statistically different (P = 0.457, 95% CI: !8.77, 2.23). Droplet size
Fig. 3. Determination of fluid gel retention. a) gellan fluid gel (0.9% (w/v), 20 mM NaCl) and sodium chloride (200 mM) were dyed with acrylic black ink (Daler Rowney
Bracknell, UK). Gellan fluid gel (left) and sodium chloride (right) droplets applied to tilted porcine skin at the same time. A low rate of spreading of the gellan fluid gel
compared to sodium chloride was macroscopically observed. b) Viscosity of gellan fluid gel under increasing (ramp 1) and decreasing (ramp 2) shear rates over a known time
frame. Plotted data includes mean viscosity of 0.9% (w/v), 20 mM NaCl prepared under same conditions, error bars represent SD. Increase in shear rate leads to shear thinning
(decrease in viscosity) and decreasing the shear rate allows the gellan fluid gel to recover, demonstrated as increased viscosity resulting in a small thixotropy. Mean values of
3 individual measurements presented, error bars are SD (smaller than icon and therefore not visible) c) Herschel-Bulkley model fitted for 0.9%, 20 mM NaCl gel showing an
excellent fit to the model represented in a R2 of 0.9969. d) Yield stresses determined using the Herschel-Bulkley model for 0.75% and 0.9% fluid gels with 20, 30, 40 and 50 mM
NaCl. Yield stress was found to increase in higher polymer concentration gels and in higher salt-concentrations. Mean values of 3 individual measurements presented, error
bars are SD.
Table 2
Fitting parameters from the Herschel-Bulkley model for gellan fluid gels. Values presented are mean of 3 individual measurements, yield stress (+SD), K is the consistency index, n
is the flow index. E is standard error, presented for each fitting value and R square as value for goodness of fit.
Gellan concentration (% w/v) Final NaCl concentration (mM) Mean Yield Stress (SD) EY K EK n En R2
0.75% 10 !0.655 (0.005) 0.072 2.508 0.049 0.360 0.004 0.9995
20 0.250 (0.018) 0.156 1.945 0.108 0.377 0.010 0.9965
30 2.130 (1.306) 0.208 1.657 0.125 0.409 0.016 0.9928
40 3.854 (0.084) 0.436 1.405 0.302 0.466 0.021 0.9848
50 5.231 (0.227) 0.608 1.247 0.461 0.496 0.023 0.9804
0.90% 10 !0.848 (0.016) 0.291 3.844 0.060 0.340 0.070 0.9387
20 1.777 (0.091) 0.226 2.860 0.156 0.383 0.010 0.9969
30 4.446 (0.098) 0.305 2.508 0.184 0.413 0.015 0.9934
40 5.357 (0.072) 0.806 2.166 0.653 0.441 0.023 0.9775
50 7.036 (0.572) 1.600 2.921 1.454 0.423 0.030 0.9624
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distribution dependence on sprayed volume was investigated by
comparing the RSF of two sprayed volumes per material. Gellan
fluid gel showed a smaller decline in RSF when a smaller volume
is sprayed compared to water, but this difference was not found
significant (p = 0.854, 95% CI: !12.00, 4.62 for 25 ml and
p = 0.654, 95%CI: –33.24889, !4.89256 for 50 ml). (Fig. 5e and f).
3.2. Biological response to fluid gel spray delivery
3.2.1. Cell viability
Limited evidence of airbrush cell spray systems has been pub-
lished, with most data presenting moderate cell viability (69%-
70% survival) following spraying in Hank’s Balanced Salt Solution
[28] or cell culture media[29]. As investigated by Hendriks et al.
[26] certain spray conditions impact on cell viability such as
receiving tissue/substrate stiffness, viscosity of cell carrier,
nozzle-surface distant and delivery pressure. Therefore, all these
conditions were standardised to reduce bias as described in section
2.4. The study aimed to develop a cell carrier with maintaining a
cell viability comparable to current spray systems. Cell viability
of sprayed encapsulated human dermal fibroblasts was evaluated
at days 1, 3, and 7 using live/dead assay as demonstrated in
Fig. 6. Cells remained viable in the gellan fluid gel up to at least
day 7, with a mean cell viability of 88.0% (range 80.6% ! 96.9%).
Encapsulated HDFs attached to the bottom of the culture disks at
day 7 (Fig. 7c) and spreading of the cells was observed at day 14
(Fig. 7d). Therefore, it can be assumed that cells are able to diffuse
out of the gel, whether this is by active migration or passive sedi-
mentation needs to be confirmed. Sprayed HDFs encapsulated in
gellan fluid gel maintained similar high viability throughout the
studied period, there was no statistically significant difference
between the application methods (Fig. 6b).
Alamar blue, a non-toxic reagent used to quantify the cellular
metabolic activity, was used to investigate metabolic activity of
encapsulated and sprayed cells. Data shown in Fig. 7 shows that
metabolic activity directly measured via absorbance and is
expressed by percentage of reduction. Percentage reduction of
encapsulated cells remained stable over the tested period of
7 days. Whereas cells in culture medium showed a significant
increase in percentage reduction indicating a proliferation of the
cells following delivery (Fig. 7d). No statistically significant differ-
ences of sprayed cells compared to non-sprayed cells were found.
Data implies that proliferation capacity of encapsulated cells is
limited, while cell viability remains high.
4. Discussion
Cell spraying techniques have been translated to clinical prac-
tice, but limited success finds them not routinely used within
burns care [30]. Several features of the cell solution could be com-
promising the full potential of the technology: e.g. cell-spillage,
non-uniform distribution [3] and decrease in cell viability follow-
ing transplantation [18].
This study aimed to remedy this clinical problem by engineer-
ing a sprayable gellan-based fluid gel, to enable cells to be trans-
planted to the receiving surface without spillage and/or loss of
cell viability. The polymer used to prepare the hydrogel was gellan
gum, a polysaccharide derived from the bacterium Pseudomonas
elodea, comprised of D-glucuronic acid, L-rhamnose and D-
glucose subunits. This natural polymer is FDA approved as a food
additive, however, has also found its way to the pharmaceutical
Fig. 4. Structural stability on the receiving surface. a) Mean contact angles of gellan fluid gel (0.9% (w/v), 20 mM) compared with control liquid (sodium chloride, 200 mM) on
a variety of surfaces. Three repetitions for each surface and three measurements per repetition were performed. Error bars represent SD. Gellan fluid gel demonstrates larger
contact angles on all tested surfaces compared to control liquid. b) Thermo-responsive properties of gellan (0.9%, 20 mM NaCl) was probed by investigating viscoelastic
properties under increasing temperature. Increasing temperature resulted in a reduction in the storage modulus, resulting in fluid-like behaviour of the gel. Tc denotes the
critical temperature at which the elastic structure starts to rapidly break down. Values presented are of one representative measurement. c) The storage modulus against
rising temperatures in a panel of gellan fluid gels is presented. Gels with higher cross-linker concentrations de-structure (show fluid like behaviour) at higher temperature
levels. Mean values of 2 individual measurements presented, error bars are SD.
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and biomedical industry due to its biocompatibility in a range of
tissues - demonstrating non-cytotoxic behaviour. A plethora of
biomedical applications for gellan gum have been reported, such
as regeneration of cartilage [31,32], neural tissue [33] or interver-
tebral discs [34] and topical applications to enhance wound heal-
ing [35], have arisen from its diverse nature lending it to
applications such as injectables, films/dressings, eye drops and cell
culture matrices [31].
Cross-linking of gellan gum can be achieved using ionic cross-
linkers with monovalent cations (Na+ or K+) resulting in the forma-
tion of weaker gels than comparative divalent cations [211736].
Strong gels, although they do not disintegrate easily upon the
wound bed like weak gels, do not easily conform to the body
resulting in poor bioavailability. Even though on a bulk scale
weaker gels are prone to breaking-up, the ability to get them to
conform and disintegrate on a microscale presents an advantage
for sprayed cell applications; as a gradual form of degradation is
desired to release the cells and eventually remove the foreign
material. The lack of cell binding capacity of gellan also means that
cells do not necessarily attach to the material readily [37], which is
again beneficial for rapid cell migration from the gel to tissue. Fur-
thermore, adhesive cells such as fibroblasts and keratinocytes are
dependent on adhesion to exhibit differentiation, therefore adhe-
sive cells can be encapsulated in gellan hydrogel while potentially
preserving their differentiation potential.
Fluid gels formulated with gellan therefore propose an ideal
matrix for cell delivery, via spraying; demonstrating key rheologi-
cal properties needed for both spraying and contouring to the
wound surface for the release of cells in situ (Fig. 1). Fluid gels
are formed via the application of constant confinement (mechani-
cal shear) to a biopolymer undergoing a sol–gel transition [16,38].
Applying this technique to gellan results in the restriction of order-
ing during the random coil to helix transition, preventing the for-
mation of a continuous gelled network, and forming a particulate
suspension; where particle growth is governed ultimately by the
interplay between gelation kinetics and degree of confinement act-
ing within the system [39] (Fig. 1a). This was demonstrated by the
change in gelling profiles for the 0.75% (w/v) fluid gels prepared
using either 10 or 50 mM NaCl. Here, for the same degree of con-
finement applied (a shear rate of 450 s!1), systems resulted in very
different gelling temperatures and final viscosities (although it is
key to note that these viscosities are found well within the systems
shear thinning region). In this case the heightened concentration of
crosslinker has prompted gelation at higher temperatures, as
expected from literature, as the salt ions promote the formation
of helices with tighter binding and stronger junction zones [40].
Changes in the viscosity of the two systems is described in a similar
way, where tighter binding and stronger junction zones between
polymer chains results in more rigid particles [40] and a subse-
quent increase in suspension viscosity as demonstrated by Adams
et al. [41] in accordance with Snabre and Mills [42]. Micrographs of
the systems suggested changes in particle morphology (Fig. 1b and
c). Differences in particles formed under the same degree of shear
are likely to reflect a change in the mechanism of formation, as
detailed by Fernández Farrés et al.[8]: who demonstrated that at
faster gelation kinetics large gelled entities were initially formed
that became broken down in flow, whereas as when gelation is
much slower, particles were formed within the elongation flow
itself - within the rheometer geometry [8,16,43] (although further
characterisation of the systems here is needed to qualitatively
address key parameters including particle size and degree of aniso-
tropy to draw stronger conclusions on this area).
Systematic modulation of the fluid gel properties, in order to
optimise the system for spray applications was achieved through
Fig. 5. Spray features of gellan gum fluid gel. 0.9% (w/v) gellan fluid gel with 20 mMNaCl cross-linker was used for all spray experiments presented in this figure. Mean values
are presented, error bars represent SD. a) Schematic illustration of airbrush and its nozzle. b) Schematic of standardized airbrush spray experiment set up. c) Illustration of
water-sensitive paper with area coverage demonstrated for sprayed gellan fluid gel and control (volume of 50 ll). d) percentage of area covered seems higher with sprayed
water compared to gellan fluid gel, but no statistically significant difference was found. e-f) A lower mean relative span factor was calculated for gellan fluid gels (gellan) in
comparison to control liquid (water) for both sprayed volumes together (e) and separated (f) This difference was more profound when looking at low sprayed volumes of
25 ll, indicating a more uniformly spray distribution for the gel, but no statistical difference was found.
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careful control over the formulation; varying both the biopolymer
and cross-linker concentrations. Changes in the microstructure
were probed using small deformation rheology. Frequency depen-
dence sweeps of low salt concentration systems demonstrated an
initial G’ domination with a clear cross-over to G’’ domination.
Whereas at higher salt concentrations, these cross-overs did not
occur and G’ dominated over the whole frequency range studied,
but both G’ and G’’ are demonstrating some frequency dependence,
with decreasing values for the loss tangent (tan d) as a function of
increasing salt concentrations. Gel-like mechanical spectra arise
from the restriction of polymer movement preventing the poly-
mers from relaxing. However, within the gel systems, polymer
re-arrangement results in viscous dissipation of energy (G’’)
[44,45]. The reduction in tan d suggested increased hinderance
within the gelled matrix, as polymer re-arrangement becomes
increasing prohibited, due to a higher crosslink density at higher
Fig. 6. Human dermal fibroblast response to fluid gel spray delivery. ai-axii) Fluorescence cell viability assay of encapsulated human dermal fibroblasts (HDF) before (iiii) and
after (iv-vi) spraying shows similar high cell viability. Similar for good viability is seen in sprayed cells (x-xii) in control medium compared to non-sprayed cells (vii-ix). b) No
significant differences between the two groups on each timepoint was found. Presenting data is mean cell viability and SD. Airbrush spray set up was standardized with air
pressure at delivery of 15 psi, nozzle diameter (750 lm), consistent angle and distance to receiving surface. c,d) Alamar blue assay of encapsulated and control HDFs. %
Reduction of encapsulated sprayed and control cells did not change significantly over the studied period. Statistically significant differences were found for cells sprayed in
medium, comparing day 1 to day 4 and day 7 and in non-sprayed cells also between day 4 and day 7. Significant differences found by two-way ANOVA and post-hoc statistical
testing is indicated by *(p < 0.05), **(p < 0.01), and ***(p < 0.001), which correspond to p values in brackets. Data are presented as the means (+SD) from one experiment,
performed in triplicate. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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salt concentrations. This has also been seen in the frequency
dependence data which indicates that the fluid gels became stiffer
at a high frequency due to the rapid relaxation time of short chain
segments. On a bulk scale, this results in the formation of stiffer
particles, with suspensions exhibiting increased storage moduli
[41]. Meanwhile G’’ also increased with increasing frequency, con-
tributing to recoverable deformation and energy dissipation, espe-
cially in fluid gels with a low crosslinking degree (10 mM NaCl).
However, it is key to note that although the suspension rheology
is governed primarily through the stiffness of the particles, weak
interactions between particles [7,8,16,39] effectively resulted in
the suspensions demonstrating mechanical spectra which fall
someway between those typical of entangled polymers and
strong-gels [16].
Strain sweeps were used to explore the nature of the weak
forces between suspended particles. It has previously been pro-
posed that during the conformational change of the biopolymer
during cooling (coil to helix formation) complete polymerisation
at the particle interface becomes prevented [16,39]. This results
in points of weak association between particles. On deformation
the fluid gel suspensions reached a critical strain at which they
no longer act linearly. This critical strain is principally related to
the proximity of gellan chains to each other and the number of
weak interactions (hydrogen bonds etc.) at both the particle inter-
faces, and interstitial gellan remaining within the aqueous phase
[46]. At larger deformations physical debonding between
particle-particle and particle-interstitial gellan can occur resulting
in a reduction in storage modulus. Reduced deformation of the
fluid gel particles as a function of the increased stiffness (at higher
salt concentrations) results in a shortening of the contact zones
between particles, effectively reducing the degree of interactions
between polymer chains [41]. This explains the reduction in LVR
with increasing salt concentrations. Furthermore, it is hypothe-
sised that changes in particle morphology (smaller discrete
Fig. 7. Live/dead assay of HDFs encapsulated in gellan fluid gel. Z-stack image of fluorescence cell viability assay of human dermal fibroblasts (HDF) after 1 day (Fig. a), 3 days
(Fig. b), 7 days (Fig. c) and 14 days (Fig. d) of encapsulation in gellan fluid gel (livecells stained green, dead cells stained red). Cells are viable and attach to the bottom of the
well and seem to migrate out of the gel. Position of cells within the gel is shown in micrographs of encapsulated cells in gellan fluid gel (e) stained with fluorescence live/dead
dye and in PEG diluted fluid gel (f). Images were obtained at day of encapsulation. (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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through to long ribbon-like particles) may also play a role within
the particle contact time; as the longer ‘‘ribbon-like” particles
remain in contact across much larger strains (deformations) before
the systems begin to breakdown [43,47]. Again, such inferences
require further quantification of the micrographs obtained.
The effects of formulation on suspension viscosity were studied
in respect to spray-ability. The effect of salt concentration has been
previously described within the manuscript, however, viscosity
modulation was also achieved by changing the concentration of
polymer. Once gelled under shear, the formation of particulates
resulted in entrapment of the continuous aqueous phase, effec-
tively increasing the volume occupied by the particles. In corre-
spondence with work published by Adams et al. [41], a direct
correlation between the initial polymer weight fraction and parti-
cle phase volume can be assumed, as such the increase in viscosity
thus becomes a function of the particle packing fraction; with rhe-
ologies typical of highly concentrated systems [48]. However, at
shear rates comparable to those expected during spraying, all sys-
tems resulted in a degree of shear thinning that allowed
application.
Fluid gel systems exhibited very little thixotropy, recovering
much of their original viscosity once shear had been removed. Flow
profiles were compared to the Herschel-Bulkley equation, which
highlighted the presence of a yield stress for all systems formu-
lated with >20 mM NaCl. Again, similar trends to the small defor-
mation rheology were observed, where increases in both salt and
polymer concentrations, tended towards larger yield stresses. Such
overlap implies a common mechanism, whereby increased cross-
link density and subsequent interactions (increased G’), results in
connected particles that require a critical stress in order to induce
flow. Yielding values were compared to gravitational stresses, as a
simple force balance. In all cases where yielding behaviour was
observed, the fluid gel yield stress surpassed that of the gravita-
tional stress, suggesting long residence times on the skin, where
many of the surfaces are contoured. Clinically this means the finite
gelled layer would remain in situ until mechanically removed,
likely during dressing changes or other cleaning processes.
Following the ability to spray, spreading of the material post-
application is also important: as large degrees of spreading lead
to vast amounts of run-off and too little prevents the formation
of a continuous layer. Complete wetting of a material to the surface
occurs when the contact angle is near to 0# as high wetting
requires small contact angles < 90#, while large contact angles
refer to low wettability > 90# [49]. Contact angles obtained for
the fluid gel systems across a variety of materials including biolog-
ical substrates encountered within a burn environment: epidermis
and subcutaneous fat (Fig. 4a). The gellan-based systems showed a
significant increase in contact angle (p < 0.001) across the gelatin,
epidermis and subcutaneous fat substrates. This is a result of
enhanced viscosity which strongly influences the liquid-surface.
Fluid gels are enriched with the presence of polar groups, long
polymer chains and possibly additional side chains causing a
slower spreading, and less spillage. Whereas the low-viscosity sal-
ine solutions (such as sodium lactate and sodium chloride solu-
tions), currently used as the delivery vehicle of choice in sprayed
cell systems, exhibit low cohesive forces suggesting stronger adhe-
sive forces to the substrate resulting in high wettability.
Spreading as a result of the thermo-reversible nature of the gel-
lan gels was also probed, in respect to temperatures associated
with burns wounds. Average peripheral skin temperatures lie
around 34 #C [50], but can vary greatly in critically ill patients,
especially following burn injuries p < 0.001 when room and body
temperatures are deliberately increased [50,51]. Upon heating,
the gels showed weakening of the interactions between the parti-
cles as demonstrated by a reduction in G’ at a critical temperature,
Tc (Fig. 4b). This loss of storage modulus is caused by the gel melt-
ing (initially by melting of residual unaggregated helices and sec-
ondly by melting of the aggregated double helices [17]), with Tc
correlating closely with literature obtained using as differential
scanning calorimetry (DSC) [52]. Structural weakening was shown
to be influenced by salt concentration as expected from literature.
As such, delayed onset of gel breakdown could be achieved by
increasing the cross-linker concentration (Fig. 4c), corresponding
to data by Morris et al [17]. Ultimately the balance between the
mechanical behaviour of the gels and weakening is important as
a certain degree gel breakdown is desired, so cells are easily able
to be released from the gel. Also, to improve patient experience
the remaining polymer can be taken off the skin with cleaning
solution warmed to skin temperature. The fluid gel composition
can be tuned to these specific needs and highlighted the 0.9% (w/
v), 20 mM NaCl formulation as the optimal system to trial as the
cell delivery vehicle.
Current cell spray delivery systems have been used clinically by
manufacturers guidance only. Quantifying the total area covered
by the cell sprays has been investigated sparsely [53]. Furthermore,
uniformity of the sprayed solutions could provide information on
even cell distribution indirectly informing on required cell density.
In this study, spray coverage and uniformity of distribution was
quantified using water-sensitive paper (WSP) (Fig. 5). The tech-
nique was used to quantify sprayed gellan fluid gel in terms of per-
centage coverage and droplet size by a similar method utilizing
ImageJ software described by Ferguson et al [54,55]. A trend
towards lower coverage of the gellan hydrogel was seen (Fig. 5d),
likely explained by preserved droplet stability (shape) as a result
of larger contact angles, however, such differences were not statis-
tically significant.
The high cell viability following encapsulation in this study is
supported by the current literature, with successful encapsulation
of numerous cell types reported in quiescent gellan hydrogels
[15,32,33,56]. After 7 days of culturing within the fluid gel, cell
attachment to the bottom of the well was noted, suggesting move-
ment of the fibroblasts (Fig. 7). Adherence, elongation and spread-
ing of the fibroblasts over the plastic was also observed. Data
suggested that the fluid gel support migration of the cells whilst
preserving their cell function. Such observation correspond to the
findings by Ferris et al reporting cell settling of mouse myoblasts
in gellan fluid gel [57]. It is proposed that such movement is facil-
itated either by passive sedimentation through the gelled particles
or active migration of the cells out of the gel as seen in alginate-
based fluid gels [58]: however, further study on environmental
conditions that might influence this migration needs to be further
addressed.
Cell viability post-spraying is an important factor to consider, as
numerous mechanical stresses during the spraying process can be
detrimental to the cell’s integrity [18]; causing structural cell dam-
age such as membrane elongation, adverse cell responses (e.g.
some cell differentiation processes are mechanically activated) or
diminished cell viability after deposition. Several parameters influ-
ence the shear stresses exerted on the cell systems during spraying
such as nozzle diameter, viscosity of the material and velocity at
delivery [26]. Previous studies based on saline carrier systems
demonstrate a survival rate of > 90% when a low air pressure and
large nozzle sizes were used [19]. This study demonstrates a com-
parable level of viability when spray nozzles with similar diame-
ters and air pressure were used, compared to current
commercially available spray systems. Modification of viscosity
provided by the fluid gel system can be crucial to protecting the
cells, providing a cushioning effect during delivery [26]. Data has
shown that metabolic activity of encapsulated sprayed cells is sim-
ilar to non-encapsulated cells at day 1 and remains stable for
7 days (tested period). Because the metabolic activity of non-
encapsulated cells increases over time following spraying whereas
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encapsulated cells expressed a steady level metabolic activity, it is
possible that the proliferation capacity of encapsulated cells is
restricted in the fluid gel. But the introduction of a structured fluid
gel has not compromised cell viability following spraying in an
in vitro setting. Although demonstrated in vitro, within a clinical
setting, cells are sprayed into a hostile wound environment, poten-
tially exposed to further mechanical trauma by wound dressings. It
is suggested that the fluid gel carrier may provide extended shield-
ing, enhancing the potential of the cells by allowing time for migra-
tion and adhesion within the local tissues. The findings of this
study support that gellan fluid gel is a promising cell carrier for cell
spray delivery, but further research is needed to investigate this
technique in an in vivo model.
5. Conclusions
The work presented here demonstrates the development of a
gellan-based fluid gel system, with flexible viscoelastic properties
that can be tuned to facilitate spray delivery requirements such
as: liquefying at high shear during spraying, self-structuring
post-spraying and resistance to flow once in situ. Spray assessment
of the gellan fluid gel demonstrated higher contact angles and lim-
ited runoff of the receiving surfaces when compared to a current
clinically available cell carrier. Furthermore, cell compatibility to
the gellan fluid gel was high, with good cell viability over a 7-
day timescale. Additionally, viability of the encapsulated cells
was not compromised following the spraying process. Therefore,
gellan fluid gels provide a promising candidate for cell encapsula-
tion, bridging the clinical need for sprayed systems and allowing
retention to the wound site. However, future work will need to
focus on functional and proliferation behaviour of transplanted
epithelial cells with a view to translation of the technique within
in vivo models.
Permission Note
Permission to publish an adapted version of Fig. 1a has been
received from John Wiley and Sons.
Funding
This work was supported by the Scar Free foundation. The fund-
ing source had no involvement in designing the study, data collec-
tion, interpretation of data and decision to submit the article for
publication. None of the authors has a financial interest in any of
the products, devices, or drugs mentioned in this manuscript.
Disclosures
The authors state no conflict of interest.
Acknowledgements
This study was funded by a Medical Research Council Develop-
mental Pathway Funding 517 Scheme (MR/N019016/1) and by the
Scar Free Foundation Birmingham Burn Research Centre.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.actbio.2019.03.036.
References
[1] C.D. Marshall, M.S. Hu, T. Leavitt, L.A. Barnes, H.P. Lorenz, M.T. Longaker,
Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions,
Adv. Wound Care. 7 (2018) 29–45, https://doi.org/10.1089/wound.2016.0696.
[2] B. Ter Horst, G. Chouhan, N.S. Moiemen, L.M. Grover, Advances in keratinocyte
delivery in burn wound care, Adv. Drug Deliv. Rev. (2017), https://doi.org/
10.1016/j.addr.2017.06.012.
[3] D.L. Chester, D.S. Balderson, R.P. Papini, A review of keratinocyte delivery to the
wound bed, J. Burn Care Rehabil. 25 (2004) 266–275.
[4] P. Johnstone, J.S. Kwei, G. Filobbos, D. Lewis, S. Jeffery, Successful application of
keratinocyte suspension using autologous fibrin spray, Burns 43 (2017) e27–
e30, https://doi.org/10.1016/j.burns.2016.05.010.
[5] A. Allouni, R. Papini, D. Lewis, Spray-on-skin cells in burns: a common practice
with no agreed protocol, Burns 39 (2013) 1391–1394, https://doi.org/10.1016/
j.burns.2013.03.017.
[6] L.J. Currie, R. Martin, J.R. Sharpe, S.E. James, E. James, A comparison of
keratinocyte cell sprays with and without fibrin glue, Burns 29 (2003) 677–
685, https://doi.org/10.1016/S0305-4179(03)00155-4.
[7] M.E. Cooke, S.W. Jones, B. ter Horst, N. Moiemen, M. Snow, G. Chouhan, L.J. Hill,
M. Esmaeli, R.J.A. Moakes, J. Holton, R. Nandra, R.L. Williams, A.M. Smith, L.M.
Grover, Structuring of Hydrogels across Multiple Length Scales for Biomedical
Applications, Adv. Mater. 30 (2018), https://doi.org/10.1002/adma.201705013.
[8] I. Fernández Farrés, R.J.A. Moakes, I.T. Norton, Designing biopolymer fluid gels:
A microstructural approach, Food Hydrocoll. 42 (2014) 362–372, https://doi.
org/10.1016/j.foodhyd.2014.03.014.
[9] H.A. Barnes, The yield stress-a review or ’greek’-everything flows?, J
Nonnewton. Fluid Mech. 81 (1999) 133–178, https://doi.org/10.1016/S0377-
0257(98)00094-9.
[10] A.Z. Nelson, R.H. Ewoldt, Design of yield-stress fluids: a rheology-to-structure
inverse problem, Soft Matter 13 (2017) 7578–7594, https://doi.org/10.1039/
c7sm00758b.
[11] Q.D. Nguyen, D.V. Boger, Measuring the Flow Properties of Yield Stress Fluids,
Annu. Rev. Fluid Mech. 24 (1992) 47–88, https://doi.org/10.1146/annurev.
fl.24.010192.000403.
[12] E.C. Bingham, H. Green, Paint, a plastic material and not a viscous liquid; the
measurement of its mobility and yield value, Proc. Am. Soc. Test. Mater. (1920)
640–675.
[13] M. Madaghiele, C. Demitri, A. Sannino, L. Ambrosio, Polymeric hydrogels for
burn wound care: advanced skin wound dressings and regenerative templates,
Burn. Trauma 2 (2015) 153–161, https://doi.org/10.4103/2321-3868.143616.
[14] N.E. Fedorovich, J. Alblas, J.R. de Wijn, W.E. Hennink, A.J. Verbout, W.J.A. Dhert,
Hydrogels as Extracellular Matrices for Skeletal Tissue Engineering: State-of-
the-Art and Novel Application in Organ Printing, Tissue Eng. 13 (2007) 1905–
1925, https://doi.org/10.1089/ten.2006.0175.
[15] D.F. Coutinho, S. Sant, H. Shin, J.T. Oliveira, M.E. Gomes, N.M. Neves, A.
Khademhosseini, R.L. Reis, Modified Gellan Gum hydrogels with tunable
physical and mechanical properties, Biomaterials 31 (2010) 7494–7502,
https://doi.org/10.1016/j.biomaterials.2010.06.035.
[16] D.A. Garrec, I.T. Norton, Understanding fluid gel formation and properties, J.
Food Eng. 112 (2012) 175–182, https://doi.org/10.1016/j.jfoodeng.2012.04.001.
[17] E.R. Morris, K. Nishinari, M. Rinaudo, Gelation of gellan - a review, Food
Hydrocoll. 28 (2012) 373–411, https://doi.org/10.1016/j.foodhyd.2012.01.004.
[18] C. Fredriksson, G. Kratz, F. Huss, Transplantation of cultured human
keratinocytes in single cell suspension: a comparative in vitro study of
different application techniques, Burns 34 (2008) 212–219, https://doi.org/
10.1016/j.burns.2007.03.008.
[19] W.S. Veazey, K.J. Anusavice, K. Moore, Mammalian cell delivery via aerosol
deposition, J. Biomed. Mater. Res. Part B Appl. Biomater. 72B (2005) 334–338,
https://doi.org/10.1002/jbm.b.30159.
[20] W. Rasband, ImageJ: Image processing and analysis in Java, Astrophys. Source
Code Libr. 1 (2012) 06013, https://doi.org/10.1016/j.molcel.2006.04.003.
[21] H. Grasdalen, O. Smidsrød, Gelation of gellan gum, Carbohydr. Polym. 7 (1987)
371–393, https://doi.org/10.1016/0144-8617(87)90004-X.
[22] A. Gabriele, F. Spyropoulos, I.T. Norton, Kinetic study of fluid gel formation and
viscoelastic response with kappa-carrageenan, Food Hydrocoll. 23 (2009)
2054–2061, https://doi.org/10.1016/j.foodhyd.2009.03.018.
[23] P.A. Williams, Gums and Stabilisers (2002) 384.
[24] Assunta Borzacchiello, Luigi Ambrosio, in: Hydrogels, Springer Milan, Milano,
2009, pp. 9–20, https://doi.org/10.1007/978-88-470-1104-5_2.
[25] X. Xin, A. Borzacchiello, P.A. Netti, L. Ambrosio, L. Nicolais, Hyaluronic-acid-
based semi-interpenetrating materials, J. Biomater. Sci. Polym. Ed. 15 (2004)
1223–1236, https://doi.org/10.1163/1568562041753025.
[26] J. Hendriks, C. Willem Visser, S. Henke, J. Leijten, D.B.F. Saris, C. Sun, D. Lohse,
M. Karperien, Optimizing cell viability in droplet-based cell deposition, Sci.
Rep. 5 (2015) 11304, https://doi.org/10.1038/srep11304.
[27] P. Coussot, Yield stress fluid flows: a review of experimental data, J.
Nonnewton. Fluid Mech. 211 (2014) 31–49, https://doi.org/10.1016/j.
jnnfm.2014.05.006.
[28] W.S. Veazey, K. Moore, K.J. Anusavice, K. Moore, Mammalian cell delivery via
aerosol deposition, J. Biomed. Mater. Res. B Appl. Biomater. 72 (2003) 334–338.
[29] F.A. Navarro, M.L. Stoner, C.S. Park, J.C. Huertas, H.B. Lee, F.M. Wood, D.P. Orgill,
Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine
microwound model, J. Burn Care Rehabil. 21 (2000) 513–518, https://doi.org/
10.1097/00004630-200021060-00007.
178 B. ter Horst et al. / Acta Biomaterialia 89 (2019) 166–179
[30] J.N. McHeik, C. Barrault, G. Levard, F. Morel, F.X. Bernard, J.C. Lecron, Epidermal
healing in burns: autologous keratinocyte transplantation as a standard
procedure: update and perspective, Plast Reconstr Surg Glob Open. 2 (2014),
https://doi.org/10.1097/gox.0000000000000176.
[31] S.R. Moxon, A.M. Smith, Controlling the rheology of gellan gum hydrogels in
cell culture conditions, Int. J. Biol. Macromol. 84 (2016) 79–86, https://doi.org/
10.1016/j.ijbiomac.2015.12.007.
[32] J.T. Oliveira, L.S. Gardel, T. Rada, L. Martins, M.E. Gomes, R.L. Reis, Injectable
gellan gum hydrogels with autologous cells for the treatment of rabbit
articular cartilage defects, J. Orthop. Res. 28 (2010) 1193–1199, https://doi.
org/10.1002/jor.21114.
[33] J.T. Koivisto, T. Joki, J.E. Parraga, R. Paakkonen, L. Yla-Outinen, L. Salonen, I.
Jonkkari, M. Peltola, T.O. Ihalainen, S. Narkilahti, M. Kellomaki, Bioamine-
crosslinked gellan gum hydrogel for neural tissue engineering, Biomed. Mater.
12 (2017) 25014, https://doi.org/10.1088/1748-605X/aa62b0.
[34] J. Silva-Correia, J.M. Oliveira, S.G. Caridade, J.T. Oliveira, R.A. Sousa, J.F. Mano, R.
L. Reis, Gellan gum-based hydrogels for intervertebral disc tissue-engineering
applications, J Tissue Eng Regen Med. 5 (2011) e97–e107, https://doi.org/
10.1002/term.363.
[35] M.W. Lee, H.F. Tsai, S.M. Wen, C.H. Huang, Photocrosslinkable gellan gum film
as an anti-adhesion barrier, Carbohydr. Polym. 90 (2012) 1132–1138, https://
doi.org/10.1016/j.carbpol.2012.06.064.
[36] K. te Nijenhuis, Thermoreversible Networks, Viscoelastic Properties and
Structure of, Gels (1997).
[37] Biomater. Sci. 4 (9) (2016) 1276–1290, https://doi.org/10.1039/C6BM00322B.
[38] G. Sworn, G.R. Sanderson, W. Gibson, Gellan gum fluid gels, Top. Catal. 9 (1995)
265–271, https://doi.org/10.1016/S0268-005X(09)80257-9.
[39] I.T. Norton, D.A. Jarvis, T.J. Foster, A molecular model for the formation and
properties of fluid gels, Int. J. Biol. Macromol. 26 (1999) 255–261, https://doi.
org/10.1016/S0141-8130(99)00091-4.
[40] Food Hydrocolloids 4 (6) (1991) 495–507, https://doi.org/10.1016/S0268-
005X(09)80200-2.
[41] J. Rheol. 48 (6) (2004) 1195–1213, https://doi.org/10.1122/1.1795193.
[42] P. Snabre, P. Mills, Rheology of concentrated suspensions of viscoelastic
particles, Colloids Surf. A Physicochem. Eng. Asp. 152 (1999) 79–88, https://
doi.org/10.1016/S0927-7757(98)00619-0.
[43] R.J.A. Moakes, A. Sullo, I.T. Norton, Preparation and characterisation of whey
protein fluid gels: the effects of shear and thermal history, Food Hydrocoll. 45
(2015) 227–235, https://doi.org/10.1016/j.foodhyd.2014.11.024.
[44] S.B. Ross-Murphy, Rheological characterization of polymer gels and networks,
Polym. Gels Networks 2 (1994) 229–237, https://doi.org/10.1016/0966-7822
(94)90007-8.
[45] A.M. Grillet, N.B. Wyatt, L.M. Gloe, Polymer Gel Rheology and Adhesion,
Rheology (2012), https://doi.org/10.5772/36975.
[46] N. Altmann, J.J. Cooper-White, D.E. Dunstan, J.R. Stokes, Strong through to
weak ‘‘sheared” gels, J. Nonnewton. Fluid Mech. 124 (2004) 129–136, https://
doi.org/10.1016/j.jnnfm.2004.07.013.
[47] D.A. Garrec, B. Guthrie, I.T. Norton, Kappa carrageenan fluid gel material
properties. Part 1: Rheology, Food Hydrocoll. 33 (2013) 151–159, https://doi.
org/10.1016/j.foodhyd.2013.02.014.
[48] J. Rheol. 29 (6) (1985) 739–775, https://doi.org/10.1122/1.549808.
[49] D. Li, A.W. Neumann, Equation of State for Interfacial Tensions of Solid-Liquid
Systems, Adv. Colloid Interface Sci. 39 (1992) 299–345.
[50] B. Ibsen, Treatment of shock with vasodilators measuring skin temperature on
the big toe. Ten years’ experience in 150 cases, Dis. Chest. 52 (1967)
425–429.
[51] A.M. Kholoussy, S. Sufian, C. Pavlides, T. Matsumoto, Central peripheral
temperature gradient. Its value and limitations in the management of critically
iii surgical patients, Am J Surg. 140 (1980) 609–612.
[52] E. Dickinson, Food polymers, gels and, colloids (1991).
[53] R. Esteban-Vives, M.T. Young, T. Zhu, J. Beiriger, C. Pekor, J. Ziembicki, A.
Corcos, P. Rubin, J.C. Gerlach, Calculations for reproducible autologous skin
cell-spray grafting, Burns 42 (2016) 1756–1765, https://doi.org/10.1016/j.
burns.2016.06.013.
[54] J.C. Ferguson, R.G. Chechetto, C.C. O’Donnell, B.K. Fritz, W.C. Hoffmann, C.E.
Coleman, B.S. Chauhan, S.W. Adkins, G.R. Kruger, A.J. Hewitt, Assessing a novel
smartphone application - SnapCard, compared to five imaging systems to
quantify droplet deposition on artificial collectors, Comput. Electron. Agric.
128 (2016) 193–198, https://doi.org/10.1016/j.compag.2016.08.022.
[55] C. Nansen, J.C. Ferguson, J. Moore, L. Groves, R. Emery, N. Garel, A. Hewitt,
Optimizing pesticide spray coverage using a novel web and smartphone tool,
SnapCard, Agron. Sustain. Dev. 35 (2015) 1075–1085, https://doi.org/10.1007/
s13593-015-0309-y.
[56] J. Silva-Correia, B. Zavan, V. Vindigni, T.H. Silva, J.M. Oliveira, G. Abatangelo, R.
L. Reis, Biocompatibility evaluation of ionic- and photo-crosslinked
methacrylated gellan gum hydrogels: In vitro and in vivo study, Adv.
Healthc. Mater. 2 (2013) 568–575, https://doi.org/10.1002/adhm.201200256.
[57] C.J. Ferris, K.J. Gilmore, S. Beirne, D. McCallum, G.G. Wallace, M., in het
Panhuis, Bio-ink for on-demand printing of living cells, Biomater Sci. 1 (2013)
224–230, https://doi.org/10.1039/C2BM00114D.
[58] M.E. Cooke, M.J. Pearson, R.J.A. Moakes, C.J. Weston, E.T. Davis, S.W. Jones, L.M.
Grover, Geometric confinement is required for recovery and maintenance of
chondrocyte phenotype in alginate, APL Bioeng. 1 (2017), https://doi.org/
10.1063/1.5006752 016104.
B. ter Horst et al. / Acta Biomaterialia 89 (2019) 166–179 179
Natural polymers: biomaterials
for skin scaffolds 6
Britt ter Horst 1,2,3, Naiem S. Moiemen 2, Liam M. Grover 4
1School of Chemical Engineering, University of Birmingham, Birmingham, United Kingdom;
2University Hospital Birmingham Foundation Trust, Birmingham, United Kingdom;
3The Scar Free Foundation Birmingham Burn Research Centre, Birmingham,
United Kingdom; 4University of Birmingham, Birmingham, United Kingdom
6.1 Introduction
Polymer-based biomaterials are widely used in wound treatment as wound dressings
and regenerative scaffolds. Polymers are commonly used to form hydrogels, as the
ability of hydrogels to absorb and release water is very useful in regulating excessive
wound exudates while maintaining a moist wound environment to allow healing [1].
Polymers derived from natural sources have most frequently been used for the
development of next generation skin substitutes due to their similarities with the
extracellular matrix. In contrast with some of their synthetic counterparts, natural
hydrogels are biocompatible, biodegradable, and of low cytotoxity. However, effort
into modifying synthetic polymers has resulted in promising biomaterials for
wound healing [2,3]. Natural polymers can support several aspects of wound heal-
ing: some natural hydrogels are known for their hemostatic properties (chitosan,
fibrin), others for their antimicrobial properties [4] or for stimulation of reepitheli-
zation when seeded with skin cells. Some disadvantages of natural hydrogels such
as structural weakness and rapid degradation have been addressed by researchers.
For example, strength of a cellulose hydrogel was increased by introducing
carboxyl and aldehyde groups to the surface of cellulose nanofibrils [5] and degra-
dation of collagen can be slowed down by chemical cross-linking [6]. Source vari-
ability is another disadvantage that is difficult to address, but Gomez et al. showed
that selecting the appropriate alginate purification method can optimize the yield
and can influence polymer properties [7].
However, care must be taken with products derived from natural materials, since
they may be immunogenic, transmit pathogens, and difficult to purify and sterilize.
Modifications to natural hydrogels to make them suitable for clinical use have been
widely investigated over the last decades, and this has resulted in an increased
availability of hydrogel systems for skin repair and regeneration purposes. To date,
however, no natural polymerebased skin substitute has been able to achieve complete
skin regeneration.
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6.2 Definition and classification of natural
polymerederived materials
Hydrogels are polymer networks with high water holding capabilities [8] with an abil-
ity to absorb and release water. The polymer chains in a hydrogel can be held together
through weak ionic interactions, physical entanglement, or through covalent binding
between the polymer chains within the gel structure. The “cross-linked” structure
enables the hydrogel to swell with water and create a solid that will eventually fail
if placed under increasing loads.
Hydrogels can be classified according to their source, as being either natural or syn-
thetic. Natural hydrogels are those hydrogels that consist of a polymer network based
on natural products such as proteins (e.g., collagen or gelatin) and polysaccharides
(e.g., starch, alginate, or agarose). When a single polymer is cross-linked, a homopol-
ymeric hydrogel can be formed. A blend of two and multiple polymers are named
copolymeric and multipolymeric hydrogels, respectively. Mixing two or more
polymers can result in several types of bonds; polymers can bond back to back (block
copolymers), bonding of end of polymer 1 to a portion of the backbone of polymer 2
(graft copolymer), and if no bonding occurs a polymer blend is formed. A mixture of
two or more polymers with partially interlacing networks without covalent bonds are
interpenetrating polymeric network (IPN) or semiIPN (consisting of a cross-linked
polymer and a non cross-linked polymer) [9].
Frequently used natural polymers are negatively charged (alginate, hyaluronic acid)
due to their carboxyl or sulfate groups. Although cell interactions based on electro-
static charge of polymers is not fully understood, it has been postulated that positively
charged polymers allow for cell attachment. Brodaczewska et al. have shown that
chitosan (a cationic polymer) attracted inflammatory cells in vivo [10]. Baxter et al.
found that a chitosan dressing initially stimulated the expression of TGF-b1 in
mice, but that the expression was decreased after the initial inflammatory phase in a
burn wound model [11]. Several classification systems for hydrogels are available
as shown in Table 6.1 [8].
Table 6.1 Polymers can be classified using different systems depending on source, physical







Polymeric bonding Polymer blend
Graft copolymer
Block copolymer
Interpenetrating polymeric network (IPN)
Semi-IPN (cross-linked polymer and noncross-linked polymer).
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Natural polymers can be designed to enable wound healing as bioactive materials
(fibrin glue), or as vehicles for cell or drug delivery, 3D networks that stimulate
and/or organize local tissue to recover or regenerate. An overview of applications is
given in Fig. 6.1. The selection of polymer materials for biomedical applications is
based on features such as solubility, architecture, pore size, water absorption capacity,
degradability, electrical charge, etc. In this chapter the importance of these features for
the development of scaffolds aimed to heal wounds will be discussed, as well as the
currently available or promising natural polymerebased materials for skin repair
and regeneration.
6.3 Natural polymers in wound healing
6.3.1 Polysaccharides
Polysaccharides are often used in wound dressings as shown in Table 6.2, examples
are calcium alginate, cellulose, and chitosan-based dressings. The use of polysaccha-
rides has also found its way in tissue engineering for wound healing. Polysaccharides
consist of linked monosaccharides and are sourced from renewable resources such as
plants and animals. As these resources are widely available in nature, polysaccharides
are an attractive candidate for researchers. The most commonly used polysaccharides
and proteins for skin repair applications are listed in Table 6.2.
6.3.1.1 Alginate
Alginate is a linear anionic polymer that consists of mannuronic acid, referred to as




Semicrystalline (mixture of amorphous and crystalline phases)
Crystalline
Type of cross-linking Chemical
Physical
Electronical charge Nonionic (neutral)
Ionic (anionic or cationic groups)
Amphoteric (both acid and basic groups)
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G blocks are easier to process and seem to have lower immunogenicity and therefore
are more suitable for biomaterials [14]. Alginate is usually sourced from the cell wall
of brown algae but can also be synthesized by certain bacteria. Its widespread use in
biomedical applications is due to beneficial properties like biocompatibility, nonim-
munogenity, simple gelation process, ability to control its degradation, and relatively
low cost. Alginate is a versatile polymer; its mechanical properties can be tuned by the
type and concentration of cross-linker [15]. Alginate can form hydrogels by ionic
cross-linking with cations such as Ca2þ. The divalent cations will bind exclusively
to the G blocks. Covalent cross-linking is another approach, but as the reagent can
be cytotoxic a secondary cleaning step is often required. While covalent cross-
linking is permanent, ionic cross-linking can be reversed. Also, photo-cross-linking
under mild conditions has been introduced for in vivo gelation of alginate onto the
eye [16]. Lack of cell adhesion ligands and its poorly controlled natural degradation
have limited its suitability for some applications. However, alginate can be modified
to gain higher cell adhesivity by peptide coupling such as arginyl-glycyl-aspartic
acid (RGD) to the polymer [17,18]. Degradation can be influenced by the amount



























Figure 6.1 Applications of natural polymer scaffolds in skin repair and regeneration.
Permission to publish obtained from (a) author (unpublished work) (b) John Wiley and Sons,
E.A.B. Hughes, S.C. Cox, M.E. Cooke, O.G. Davies, R.L. Williams, T.J. Hall, L.M. Grover,
Interfacial mineral fusion and tubule entanglement as a means to harden a bone augmentation
material, Adv Healthc Mater 7 (2018) 1e9. doi:10.1002/adhm.201701166. (c) author’s own
work (d) American Chemical Society, J. Rnjak-Kovacina, L.S. Wray, K.A. Burke, T.
Torregrosa, J.M. Golinski, W. Huang, D.L. Kaplan, Lyophilized silk sponges: a versatile
biomaterial platform for soft tissue engineering, ACS Biomater Sci Eng 1 (2015) 260e270. doi:
10.1021/ab500149p.
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Table 6.2 Natural polymers and their properties commonly used for skin repair and regeneration.
Type Polymer Source Degradation Biodegradable
Cell
binding
Polysaccharides Agarose Red algae Nondegradable No Low
Alginate Brown algae Ion exchange Noa Low
Carrageenan Red algae Ion exchange, enzymatic cleavage No Low
Starch Plants Enzymatic cleavage Yes Highb
Cellulose Plants, wood Enzymatic cleavage No Low
Chitosan Crustaceans, fungi Ion exchange Yes High
Hyaluronic acid ECM (animal derived), bacterial
fermentation
Enzymatic cleavage Yes High
Gellan gum Bacteria Thermal, enzymatic cleavage, ion
exchange (hydrolytic degradation)
Yes High
Dextran Bacteria Phagocytosis Yesc Low
Bacterial
cellulose
Bacteria Enzymatic cleavage No Low
Proteins Collagen ECM (animal derived) Enzymatic cleavage Yes High
Fibrin Blood (heterologous, autologous) Enzymatic cleavage Yes High
Gelatin ECM, collagen Enzymatic cleavage Yes High
Elastin ECM Enzymatic cleavage Yes High
Silk sericin Bombyx mori Thermal, pH responsive Yes High
Silk fibroin Bombyx mori Proteolytic Yes High
ECM, extracellular matrix.
aPolymer can be modified to be biodegradable.










of photo-cross-linked alginate prior to methacrylation has shown to speed up biodeg-
radation due to a higher susceptibility to hydrolysis [19].
Commercially available alginate-based wound dressings such as Kaltostat and
AlgiSite are widely used in acute burn care, donor wound site coverage [20,21],
venous leg ulcers [22], and pressure ulcers [23]. Although (calcium) alginate dressings
have been used for many years in wound care, clinical data is still poor as not many
well-designed clinical trials have been conducted [24].
Numerous researchers have demonstrated that cells can be successfully encapsu-
lated in alginate hydrogels [25,26]. Alginate as culture matrix can improve prolifera-
tion of microencapsulated human pluripotent stem cells [27] and supports viability and
function of other cell types [15,18,28]. Alginate-based macroporous systems for cell
culture are now commercially available with different pore sizes to suit specific cell
types. These sterile scaffolds are ionically gelated and then dried. After rehydration
and cell seeding they turn into hydrogels [18]. The first transplantation of alginate
beads with encapsulated pancreatic cells into the human body happened in the
1980s [29]. Despite attempts to encapsulate skin cells into alginate scaffolds [28], a
similar development for alginate-based cellular regenerative scaffolds to treat wounds
has not been established.
6.3.1.2 Cellulose
Cellulose is the most abundant biopolymer in nature and can be derived from a variety
of organisms such as plants (vascular plants or algae) and bacteria (Acetobacter xyli-
num). Biosynthesis of bacterial cellulose fibrils eventually results in the development
of a large nanofibrous network on the outer side of the bacterium with a macroscop-
ically gelatinous appearance [30]. These fibers are around 20e100 nm thick and ori-
ented in a unidirectional fashion [31]. Cellulose derived from plants or specifically
wood generally have a smaller diameter (3e5 nm) forming bundles of 20e50 nm
thick [32,33]. Other differences are the higher water holding capacity and lower
crystallinity of bacterial cellulose [30]. Cellulose hydrogels can be formed by
cross-linking solutions of cellulose derivates such as methylcellulose and sodium
carboxymethylcellulose [34].
Hydrogels can also be formed by ion-cross-linking of negatively charged nano-
fibrillated cellulose (wood-derived) with divalent or trivalent cations [32,35].
Bacterial cellulose has gained interest for the development of skin replacement
therapy because of its 3D architecture with high mechanical strength, high water
holding capacity, and biocompatibility. Interestingly, its natural negatively charged
surface can be altered with or without [36] the use of matrix ligands to improve cell
attachment.
Clinically available acellular products such as Biofill (Fibrocel) or Nanocell
(Thai Nano Cellulose Co Ltd.) are available for the treatment of a variety of wounds
(burns, chronic ulcers, following excision of skin cancers, and as donor site dres-
sing) [37,38].
Recently, a bacterial cellulose hydrogel was proposed as cell carrier and wound
dressing to stimulate wound healing in a full thickness mice model. Bacterial cellulose
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hydrogel was mixed with an acrylic acid solution and cells (human keratinocytes and
dermal fibroblasts) were seeded into the hydrogel. The results, as shown in Fig. 6.2,
indicate that this scaffold seems to be suitable as cell carrier and full thickness wound
healing in a mice model was achieved, but no compare treatment was given [39].



























































































Figure 6.2 Bacterial cellulose cellular scaffold. Live and dead stain of dermal fibroblasts (DF)
and epidermal keratinocytes (EK) on the bacterial cellulose hydrogel and on culture plastic at
day 1 and day 3 (a). MTT assay results for proliferation of cells on the hydrogel at day 1 and
day 7 showed no significant differences between any of the groups (b). Percentage of wound
healing of full thickness punch biopsy wounds in rats treated with bacterial cellulose hydrogel
with and without cells and no treatment control. Significant differences with the no treatment
group are marked with (*), (**), (***) for (P < .05), (P < .01), and (P < .001), respectively.
(c). Clinical photos were taken at day 0, 7, 9, 11, 13 (d).
Figures were adapted from E. Yun, X. Loh, N. Mohamad, M.B. Fauzi, M.H. Ng, S.F. Ng, M.
Cairul, I.M. Amin, Development of a bacterial cellulose-based hydrogel cell carrier containing
keratinocytes and fibroblasts for full-thickness wound healing, Sci Rep (2018). doi:10.1038/
s41598-018-21174-7, open access article, published under Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/).
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6.3.1.3 Chitosan
Chitosan is a polysaccharide obtained from deacetylated chitin which is the structural
component in the exoskeleton of crustaceans or fungi [40]. The polymer is named chi-
tosan when over 50% of chitin is deacetylated. It is a weak base that can be dissolved in
acidic solutions; this could be a limitation for applications where solubility in a pH
neutral environment is desired. Chitosan has unique characteristics, as it is one of
few cationic natural polymers and can form polyelectrolyte complexes with polymers
of the opposite charge [41]. Chitosan has gained interest for tissue engineering pur-
poses due to its many advantageous properties: it is nontoxic, promotes hemostasis,
high cell adhesivity, and is biodegradable [14,42]. A relatively rapid biodegradation
in vitro has been described with the use of lysozyme [43]. Degradability of chitosan
can be influenced by a higher degree of deacetylation [43] and molecular weight
[44], resulting in slower degradation in the body. However, its degradation in the
body is not yet fully understood [45].
Cross-linking techniques that successfully formed hydrogels include ionic [46],
chemical [47], physical cross-linker [48] and photopolymerization [49]. But chitosan
on its own has weak mechanical properties and modifications or blending with other
polymers is often required.
The positive charge of chitosan is of particular interest for researchers as adherence
to negatively charged surfaces or cells is increased [50].
As a wound dressing chitosan has shown to be hemostatic and antimicrobial and
improves wound healing [51], especially in burn wounds [52]. Its antimicrobial prop-
erties are thought to be caused by the ionic bonding of chitosan onto negatively
charged bacteria surfaces leading to altered permeability with intracellular content be-
ing released and ultimately cell death [53]. The influence of chitosan on platelets is not
well understood, but platelets seem to adhere to chitosan derivates and aggregates
causing a thrombogenic effect [54].
The hemostatic effect of chitosan has led to commercially available dressings
such as HemCon bandage (HemConMedical Technologies, Inc.) and Celox gauze
(MedTrade) marketed for the local treatment of bleeding wounds [55]. Chitosan is a
bioactive polymer that has a promise as scaffold for tissue regeneration as it is cyto-
compatible toward many cell types [56]. Hilmi et al. described the use of a chitosan
3D culture scaffold with incorporation of human dermal fibroblasts and reported
cell survival up to 14 days. The interconnected pores that were formed were consid-
ered to support fibroblast attachment to the scaffold (Fig. 6.3BeD) [58]. Keratinocytes
and especially fibroblasts seem to adhere better onto chitosan with a lower degree of
deacetylation as shown in Fig. 6.3A [59].
6.3.1.4 Gellan
Gellan gum is an FDA approved product that is regularly used in the food industry as a
thickener. It is a hydrophilic anionic polysaccharide produced by the bacterium
Pseudomonas elodea [60]. The favorable physicochemical features of gellan has
generated much interest for its use in pharmaceutical and biomedical applications
[61]. The enzyme galactomannanase can degrade gellan [62], but also common human
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Figure 6.3 Cell compatibility of chitosan scaffolds. Cell adhesion of keratinocytes and
fibroblasts to chitosan decreases when degree of acetylation (DA%) increases (a). Scanning
electron microscope of a porous chitosan scaffold with interconnected pores, scale bars
140 mm (b). Confocal microscopy images of the scaffold used as 3D templates for human
dermal fibroblasts culture showed homogenously spread and viable cells, scale bars
100 mm (c,d).
Permission to publish adapted figures obtained from Elsevier, (a) C. Chatelet, O. Damour, A.
Domard, C. Chatelet, O. Damour, A. Domard, Influence of the degree of acetylation on some
biological properties of chitosan films, Biomaterials. 22 (2001) 261e268. Figures (bed) were
adapted from A.B.M. Hilmi, A.S. Halim, A. Hassan, C.K. Lim, K. Noorsal, I. Zainol, In vitro
characterization of a chitosan skin regenerating template as a scaffold for cells cultivation,
SpringerPlus. 2 (2013) 1e9. doi:10.1186/2193-1801-2-79, open access article published under
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).
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enzymes such as lysozyme or trypsin [63]. The rate of degradation is slower in low
acyl group gellan as shown by Lee et al. [64]. However, it remains unclear whether
gellan completely degrades in the body as Ferris et al. noted degradation in terms of
mass loss up to 28 days, but no further degradation in the following 140 days [65].
In terms of tissue engineering, gellan-based injectable materials have previously
been used for cartilage reconstruction [66]. Various autologous cell types such as
preosteoblasts, fibroblasts, and chondrocytes were successfully encapsulated within
a hydrogel [66,67]. Furthermore, a topical application of gellan in the form of an
antiadhesive and nontoxic dressing was found to stimulate healing and improved
the scarring outcome in a rodent study [68]. However, no gellan-based skin scaffolds
are available for clinical use at the moment.
6.3.1.5 Dextran
Dextran is a hydrophilic natural polysaccharide produced by bacteria and its degrada-
tion occurs via phagocytosis [69]. Dextran-derived hydrogels can be formed by chem-
ical or physical cross-linking or via radical polymerization. Since dextran-based
hydrogels have a limited cell adhesivity and do not seem to affect cell viability,
they have been used in drug delivery. These features in combination with slow degra-
dation have limited its use for tissue engineering in wound healing. Therefore, research
groups have attempted to tailor the properties of dextran hydrogels to improve its cell
adhesion [70] and biocompatibility [71] and have modified its degradation profile [72]
to ultimately enhance functionality in tissue engineered scaffolds for burn wound
healing [73]. The application of an acellular dextran hydrogel has been investigated
in full thickness burns in mice and was found to stimulate angiogenesis and skin regen-
eration [73]. Similar results were seen in a full thickness porcine model, and addition-
ally an improved dermal reconstruction and reinnervation were observed [74]. More
recently, a hypoxiaeinducible dextran hydrogel promoting neovascularization has
been proposed by the same research group [75].
In terms of cell delivery to wounds, keratinocytes have been seeded into collagen-
coated dextran microspheres transplanted as micrografts to full thickness wounds in
athymic nude mouse model, but intradermal epithelial cysts were formed possibly
due to high carrier adhesivity and slow degradation of the microspheres [76].
6.3.1.6 Hyaluronic acid
Hyaluronic acid (HA) is an anionic, linear polymer that is present in all living organ-
isms and can be found in connective tissue especially in the dermis of the skin, but it is
also abundant in vitreous humor of the eye and synovial fluid. It can be derived from
many tissues via extraction and enzyme digestion methods or by bacterial synthesis.
HA is an important glycosaminoglycan consisting of D-glucuronic acid and N-
acetyl-D-glucosamine. Degradation in natural tissue occurs by enzymatic cleavage
with different types of enzymes among tissues [77]. Rapid biodegradation is found
to be problematic in certain biomedical applications, for example, in a rodent study
a half-life of only 24 h following joint and skin injection was found [78]. Hence,
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for biomedical applications HA requires modification to be able to form a hydrogel
and also to reduce biodegradation in vivo [79] which then can be administered by
injection or incorporated in dressings [80]. Examples of HA hydrogels formed by
chemical cross-linking are dermal fillers with prolonged durability; histological
studies have reported HA presence in the skin for up to 9e23 months [81]. As a
highly hydrophilic polymer, its use as lubricant and biological absorber injected
to deteriorating joints has been widely explored [82]. A variety of biological func-
tions of HA have been recognized such as its role in cell motility, adhesion, and
regulation [83].
The chain length and molecular weight of hyaluronic acid plays an important role in
its biological function. In an in vitro cell study, rat cardiomyocytes underwent
ischemic-reperfusion injury and were incubated with low molecular weight HA
(LMW-HA, 100 kDa) or high molecular weight HA (HMW-HA 1000 kDa), and it
was found that cell viability and wound healing (scratch wound assay) of HMW-
HA pretreated cells were significantly improved. Proteomic expression assays demon-
strated a significant recovery of cytoskeleton regulation proteins in samples following
injury when pretreated with HMW-HA and not with LMW-HA, suggesting cytoskel-
etal rearrangement by HMW-HA [84]. Likewise, Wu et al. investigated the effect of
HA in chemically burned (alkali) human corneal cells and suggested superior cell
viability and more rapid wound healing in cells treated with HMW-HA (1525 kDa)
when compared to LMW-HA (127 kDa) [85].
However, in other studies focusing on wound healing, small HA fragments seem to
have a beneficial effect on wound healing [86], potentially due to its role in stimulating
proinflammatory mediators [87]. Advantages of LMW-HA is its solubility in serum,
making it suitable for systemic distribution. Furthermore, HA can bind to CD44 and
receptor for HA-mediated motility (RHAMM) cell surface receptors. Binding of HA
to CD44 triggers internalization; because CD44 is overexpressed in cancer cells it
can be used in anticancer drug delivery [87].
Cell surface RHAMM is implicated in mediation of cell migration and cell focal
adhesion in response to degraded HA activation [9].
HA interaction with RHAMM is linked to cell motility and cell focal adhesion and
interplays with CD44. HA can be functionalized with cell adhesion peptides to
enhance cell attachment to other cell types [80]. The diversity in chemical modification
techniques offers opportunities for copolymeric biomaterials and makes HA a versatile
polymer for use in tissue engineering.
Cells that are naturally surrounded by HA rich connective tissue in the body have
commonly been encapsulated into HA scaffolds such as chondrocytes and dermal
fibroblasts. A plethora of biomedical materials based on hyaluronic acid derivates
has been commercialized for deteriorating joints, (commercial) skincare, and wound
healing purposes.
For wound healing specifically, rodent full thickness skin wound models have
suggested a beneficial effect of HA to wound healing [88] using scaffolds containing
HA [89e93]. A scaffold available for human use is Hyalomatrix (Anika therapeutics,
former Fidia Advanced Biopolymers, Padua, Italy), a sterilized matrix based on
hyaluronic acid derivate (benzyl ester of hyaluronic acid) with an outer layer of
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semipermeable silicone. The scaffold can be directly delivered to the wound bed and
aims to attract cellular ingrowth of fibroblasts and ECM components and promote
vascular ingrowth. It has been used as dermal replacement in serious surgical wounds
[94] and following scar release in adult patients with final autologous skin graft applied
to most patients in 2e4 weeks after scaffold placement [95]. Gravante et al. used
Hyalomatrix in pediatric burn patients as dermal replacement therapy following derm-
abrasion debridement and considered it safe to use and reported no adverse events [96].
However, no large good quality control studies in humans are available that focus on
wound healing.
Hyalograft is an HA scaffold seeded with autologous human dermal fibroblasts.
Han et al. compared the use of an acellular HA scaffold (Hyalomatrix) to the same
scaffold seeded with human dermal fibroblasts (Hyalograft) in terms of wound healing
in 35 patients with a soft tissue defect to the face following basal cell carcinoma
removal. Although the study lacks statistical power, the outcomes were in favor of
the cellular scaffold with less scar contracture and a flatter scar compared to the
acellular scaffold [97].
6.3.1.7 Starch
Starches can be derived from widespread available plant sources such as potato, corn,
rice, oat [98], or wheat [99]. Thermosensitive starch hydrogels can be formed by
b-glycerol phosphate cross-linking [100]. Chemically modified starches have been
used for drug delivery and tissue engineering. For example, an injectable starch-
chitosan hydrogel was developed for the delivery of chondrocytes by Viyoch et al.
Due to the nonionic nature of starch, it can easily blend with other polymers and in
this study, starch was found to increase the pore size and water absorption ability of
the resulting polymer blend [100]. Although starch-based hydrogels are easily avail-
able and degraded by enzymatic degradation, it has not been widely explored for
wound healing purposes [99].
6.3.2 Proteins
A protein is a linear polymer made up from amino acids. DNA in cells produce pro-
teins, the type and composition of the amino acids determine its final structure and
function [101]. Proteins can be derived from blood products (fibrin), mammalian tissue
(collagen, gelatin, and elastin), or other animal products (silk fibroin and silk sericin).
Advantages in using proteins are that they are biodegradable and usually enhance cell
adhesion to the scaffold. Some disadvantages are a low mechanical strength of protein
skin scaffolds and the availability and costs of human/animal products. The properties
of proteins for the use in skin scaffolds are listed in Table 6.2. The most abundant pro-
tein in the human body and the main structural component of the dermal layer of the
skin is collagen. Therefore, many bioengineered skin scaffolds consist of collagen.
However, researchers have been exploring other proteins for the development of
skin scaffolds. Here, we describe those proteins that have most commonly been incor-
porated in cellular and acellular skin scaffolds.
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6.3.2.1 Silk proteins
Silk produced by the silk worm Bombyx mori contains two major proteins named silk
sericin and silk fibroin. Due to its mechanical strength and biocompatibility, fibroin has
been widely used in textiles, drug delivery, and as a biomaterial [102]. For example,
a fibroin/hyaluron scaffold supporting mesenchymal stem cell adhesion has been
developed [103].
Alterations to fibroin degradability and surface modification have been successfully
performed to meet biomedical needs [104]. Fibroin fiber ropes have been used as su-
ture material for closure of surgical wounds for many years, and this clinical success
has paved the way for its use in other different biomedical applications such as solu-
bilized fibers to produce sponges, films, and hydrogels used in wound healing and
tissue engineering [105]. For example, in the development of a tympanic membrane
replacement, a fibroin substrate that stimulates human keratinocyte growth was
engineered [106].
In contrast, silk sericin has not yet been explored that extensively, and for many
years silk sericin was discarded as a waste product in the derivation of fibroin. Sericin
is the glue that is found between the fibroin fibers. Its positive features such as non-
immunogenity; serum-dependent cell-adhesivity; and its specific antioxidant, antibac-
terial, and anticoagulative features make sericin a promising candidate for biomedical
applications such as in skin regeneration [107e109]. Teramoto et al. described a low
cell adhesivity where other studies have shown a high cell adhesivity in different cell
types [108e110]. These contrasting results might be explained by a serum-dependent
cell adhesivity of sericin.
6.3.2.2 Fibrin
Fibrin is an insoluble protein, a product from fibrinogen found in blood plasma.
Upon tissue injury the proteolytic thrombin is activated which cleaves the soluble
fibrinogen into the insoluble protein fibrin. Because it naturally forms a fibrous
mesh that acts as blood clotting agent, it has been widely investigated for wound
healing applications. Especially, as a hemostatic tissue sealant [111] in surgical
wound closure where a hydrogel can be dripped or sprayed onto a wound surface
to enhance healing or as glue when subsequently a skin graft is applied on top.
Fibrin has been translated to clinical practice successfully in the form of a spray,
powder, or sheet consisting of fibrin, thrombin, calcium ions, factor VIII, and a pro-
tease [112]. This tissue sealant has shown to enforce engraftment of autologous skin
grafts in burn wound care [113] and skin substitutes [114]. Because activation by
thrombin is required; these products are usually provided in a dual syringe system
that can mix upon application to the body. Some products such as Cryoseal (Ther-
mogenesis, US) [115] and Vivostat (Vivolution A/S, Denmark) utilize autologous
blood plasma for onsite preparation of the sealant; however, this can be a disadvan-
tage in patients that are potentially hemodynamic unstable. An alternative is the use
of FDA approved human pooled plasma (Artiss). However, the high costs of the
system limit its widespread use globally [113,116]. Other proteins that have been
used as tissue sealants are gelatin and albumin; however, gelatin has not been
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used for skin wounds. Although albumin-based tissue adhesives are FDA approved
for cardiac and vascular surgery [117], no reports in skin wounds have been found.
Also polysaccharides like chitosan, chitin, dextran, chondroitin sulfate, hyaluronic
acid can be used to form tissue adhesives [112]. Chitosan as a positively charged
polymer is thought to attract red blood cells which accelerate blood clotting. A
sponge form of chitosan is on the market as hemostatic, adhesive material in acute
wound care [55]. Although dextran, chondroitin sulfate, and hyaluronic acid show
promise as tissue adhesive in corneal [118e120] defects, their use in skin wounds
has not been explored yet.
Fibrin is easily degraded by proteolytic enzymes in the body and therefore fibrin
hydrogels or scaffolds usually have weak mechanical properties. Improving these
mechanical properties can be achieved by optimizing cross-linker concentration and
pH [121], or utilizing degradation regulators and fibrin stabilizers such as aprotinin
and tranexamic acid [122]. Additionally, to reinforce fibrin scaffolds they can be com-
bined with other polymers to form interpenetrating polymer networks (IPN) [123].
Encouraging results have been established by a fibrin-hyaluronic network with
increasing structural stability of the gel, but decreased proliferation of encapsulated
fibroblasts occurred in stiffer materials [124].
Besides its role in blood clotting, the fibrin network is also a nest for cells to attach,
proliferate, and migrate through. Fibrin as a sealant has also been used to coat scaffolds
for improved cell adhesion [125] and in bilayered substitutes as a natural barrier to
separate the epidermal and dermal layer. Due to its high biocompatibility and high
affinity to cells, a variety of cell types have been encapsulated in fibrin carriers such
as fibroblasts [126], keratinocytes [127,128], mesenchymal stem cells [129], and com-
binations of cells seeded into or onto fibrin scaffold [130] or gels [80,131].
Although, degradation of autologous fibrin is rapid, no toxic byproducts are
released in the natural degradation process and no rejection occurs upon transplanta-
tion. Fibrin gel in its natural form seems most suitable for applications that do not
require a high mechanical strength or long duration in situ.
Recently, the addition of angiogenesis stimulating factors to fibrin scaffolds has
been developed to improve the regeneration of ischemic tissue [132]. Interestingly,
higher thrombin concentration in fibrin matrices appears to diminish neovasculariza-
tion and epithelization time [133]. This is potentially due to slow scaffold degradation
as thrombin activates factor XIII which induces the cross-linking of fibrin monomers
and consequently reduces the natural degradation process.
6.3.2.3 Collagen
Collagen is the most abundant protein in the human body and the main component of
the extracellular matrix [134]. It is the main structural protein in the dermal layer of the
skin with an essential role in wound healing. Therefore, many skin scaffolds have been
developed based on collagen as primary component [135]. A total of 29 collagen types
have been described. Collagen type 1 is most frequently used in skin scaffolds, as it is
the abundant protein in native dermal tissue. In the early 80s Burke and Yannas pub-
lished their first clinical study of a permanent artificial dermal template based on
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bovine collagen and shark chondroitin 6-sulfate which led to the development of the
commercialized dermal substitute Integra [136,137]. At the same time, the first burn
patient was treated by grafting of their wounds with cultured autologous keratinocytes
[138] following the method that Rheinwald and Green had developed just a few years
before [139,140]. Based on the developments in that decade Hansbrough and Boyce
were able to develop a collagen-glycosaminoglycan scaffold seeded with viable
cultured autologous keratinocytes and fibroblasts and published successful engraft-
ment into burns patient [141].
Ever since, collagen-based materials in different forms have been developed for
wound healing and translated to clinical practice, such as hydrogels for hydration of
dry wounds (Woun’Dres Collagen Hydrogel), as injectable scaffold [142], collagen
sponges [143] (SkinTemp II dressings for superficial wound and blisters), powder
[144], and an extensive list of collagen films/dressings [145]. The natural mechanical
strength of collagen is weakened by its extraction process. To reinforce the collagen
and control its in vivo degradation, new bonds can be formed by in vitro cross-
linking. Collagen hydrogels are typically formed by chemical, physical, or enzymatic
cross-linking [135], such as in Pelnac, a lyophilized porcine atelocollagen porous
sponge that is cross-linked by 0.05 M acetic acid containing 0.2 wt% glutaraldehyde
[146]. For biomaterials, chemical cross-linking is usually less suitable as cytotoxicity
can occur upon degradation in vivo [147].
Other forms include composite acellular skin substitutes such as Biobrane, Integra
[148], and Matriderm [149]. In Matriderm collagen types III and V are incorporated in
combination with type 1 collagen and coated with elastin hydroxylate [150].
The majority of cellular skin scaffolds available on the market are based on animal-
derived collagen. Collagen-based cellular skin substitutes include Orcel, StrataGraft,
Apligraft [151,152], DenovoSkin, Transcyte [153], and Engineered Skin Substitute
(ESS) [154]. These substitutes are incorporated with autologous cells from a healthy
part of the patient’s skin or allogenic cells. More recently, the incorporation of
adipose-derived stem cells in a collagen hydrogel was investigated and seem to
improve wound healing in a rodent burn model [155].
Collagen gels as bio-ink [156] and in cell-laden bioprinted scaffolds have also been
studied. For example, in an attempt to stimulate vascularization in neural tissue, Lee
et al. conducted an experimental study where cells, collagen, and VEGF-releasing
fibrin gel were bioprinted to form a scaffold [157].
6.4 Applications of natural polymers in skin repair and
regeneration
6.4.1 Wound dressings for partial thickness skin wounds
Awound is a lesion of the skin that can occur following several types of trauma such as
thermal injury, laceration, ulceration, skin de-gloving, and certain skin diseases that
result in severe skin loss (skin blistering diseases: SJS/TEN; epidermal bullosa; and
bacterial, fungal, or viral-related skin diseases).
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The depth of a wound can be described by the layers affected, from superficial
(purely epidermal damage such as a sunburn), to partial thickness (epidermis and
dermis involved), and finally full thickness (epidermis, dermis, and subcutaneous fat
and/or underlying tissues are involved) injuries.
Wounds can also be divided into acute or chronic wounds. Design of effective
polymer-based dressings relies on knowledge of wound etiology, wound healing,
patient condition and the desired effects of the material used on the wound.
Current polymer-based dressings for wounds include:
• Temporary applications with elements that may accelerate healing and reduce complications
such as infection and scarring.
• Temporary or definite (partial) replacement of skin to restore skin function rapidly.
6.4.1.1 Important properties for wound dressings
Polymer-based scaffolds are appealing for biomedical purposes due to their mechan-
ical tunability. However, it is important for researchers to understand which properties
are crucial for their application. Many natural polymerebased materials have been
introduced as wound dressings into clinical practice often as hemostatic and/or absor-
bent wound dressings.
For superficial wounds that lack the epidermis but have a supporting healthy
dermis, a dressing can be designed to act as temporary barrier until the autologous
epidermis has healed, meanwhile supporting the wound by facilitating nutrient supply
and controlling fluid loss. For chronic wounds, more emphasis on debridement of un-
healthy tissue, antimicrobial effects, and attraction of nutrients is desired. Examples
are Intrasite gel and Purilon gel, both based on carboxymethylcellulose, which aim
to debride superficial wounds and provide a moist wound environment.
In acute wounds the emphasis lies on reducing blood loss and supporting the under-
lying healthy tissue to recover and start regenerating. Hemostatic features of chitosan
have been recognized in the treatment of acute wounds that require rapid hemostasis
and resulted in chitosan-based products such as HemCon Bandage and Xstat that are
used for both civilian and combat medicine [55,158]. Also, calcium alginateebased
products such as Kaltostat and Curasorb are widely used in superficial wounds as
they form a hydrophilic gel at application creating a moist environment [159]. The
calcium from these dressings is exchanged for sodium in the wound bed which then
interacts with procoagulant proteins that participate in the clotting cascade. The
main dressing features for the treatment of acute wounds are summarized in Table 6.3
and an overview of acellular applications based on natural polymers for healing of
superficial wounds is shown in Table 6.4.
6.4.2 Scaffolds for repair and regeneration of full thickness
wounds
6.4.2.1 Temporary scaffolds
Deeper wounds usually lack epidermal adnexa (hair follicles, sweat glands, and seba-
ceous glands) that have their roots in the dermis. Without these adnexa, regeneration of
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the skin is unlikely to occur or occurs very slowly resulting in severe contractures. To
avoid these complications, a partial thickness skin graft (epidermal layer with a vari-
able thickness of dermis) is transplanted from either autologous skin from a healthy
part of the patient’s body or a skin substitute. Skin substitutes can be temporary or
permanent. Temporary skin substitutes are used as short-term wound coverage and
aim to boost healing and prepare the wound bed for optimizing engraftment of autol-
ogous skin grafting. It is usually removed after a few weeks before final grafting takes
place. Examples of temporary skin substitutes are cadaver allograft, porcine xenograft,
Apligraf, and Oasis wound matrix.
6.4.2.2 Permanent scaffolds
Traditional tissue engineering with natural polymers for wound healing applications
involves the encapsulation of autologous cells within a polymer scaffold, which
then can be transplanted to the patient’s wound. For wound repair and regeneration,
the matrix should either degrade while releasing bioactive components that stimulate
extracellular matrix (ECM) production or the matrix permanently integrates into the
host tissue supporting the bodies’ tissue architecture and stimulating cells to infiltrate
the matrix such as seen in Matriderm and Integra [168].
Scaffolds containing natural components are typically well tolerated which mini-
mizes the risk of developing undesirable responses such as inflammation or rejection
upon transplantation to the human body. Therefore, components that naturally exist in
extracellular matrix such as collagen and hyaluronic acid seem obvious materials for
scaffold formation and have been widely used. However, other natural polymers have
also been extensively investigated for this purpose due to their unique characteristics
that could provide the structure for a regenerative template to enhance wound healing.
Commonly used natural polymers for tissue engineered cellular scaffolds are alginate
Table 6.3 Desirable wound dressing properties.
Biocompatible
Non-toxic






Mechanical properties (strong, elastic, transparent)
Easy application and removal
Available in a variety of sizes and thicknesses
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Table 6.4 Acellular natural polymerebased dressings for superficial to partial thickness wounds.
Superficial partial thickness wounds
Name (company) Components Action References
Intrasite gel (Smith and Nephew, US) Modified carboxymethylcellulose
(2.3%) and propylene glycol (20%)
Amorphous sterile hydrogel dressing
for use in shallow and deep open
wounds
[160,161]




Necrotic and sloughy wounds þ first
and second degree burns. Secondary
dressing needed
[162,163]
Granugel (ConvaTec) Pectin, carboxymethylcellulose and
propylene glycol
Provide a moist wound environment for
dry partial and full thickness wounds.
(Transparent for wound review)
[164]
HemCon bandage (HemCon medical
technologies inc., portland, OR, US)
Lyophilized chitosan dressing Hemostatic, cross-links RBCs to form a
mucoadhesive barrier
[165]
XStat (RevMedx inc, wilsonville, OR, US) Cellulose sponges coated with chitosan
to assist with a mucoadhesive barrier
Hemostatic, cross-links RBCs to form a
mucoadhesive barrier
[166]
Celox gauze (MedTrade Products ltd,
crew, UK)
Chitosan granules Hemostatic, cross-links RBCs to form a
mucoadhesive barrier
[165]
Calcium alginate dressings: Algosteril
(johnson & johnson), comfeel alginate
dressing (coloplast), CarrasorbH
(Carrington laboratories), kaltostat
(ConvaTec), Nu-Derm (johnson and
johnson, USA), Curasorb (kendall), and
AlgiSite (smith and nephew)
Calcium alginate Hemostatic, calcium alginate dressings
are designed to interact with sodium
in wounds to create an ionic exchange
and help enhance the epithelialization
process
[24]
Woun’Dres Collagen hydrogel (coloplast,
humlebaek, Denmark)












[28], agarose [169], collagen [151], chitosan [56], fibrin [80], gelatin [170], hyaluronic
acid [97], or blends of the above mentioned polymers. Besides the collagen and
hyaluronic-based cellular scaffolds, no other natural polymerebased cellular scaffold
has been translated to a commercial product available for skin regeneration.
Some can be derived from abundant marine sources (alginate) or from material
that otherwise would have been discarded such as silk sericin, usually a waste prod-
uct during the production of silk fibroin for textile manufacture [109]. Others are
derived from animal or human tissue and blood (collagen, fibrin, hyaluronic acid).
Importantly, most of these materials have mild preparation conditions well-suited
for cell encapsulation.
Important properties for polymer scaffolds as regenerative templates
Many researchers have summarized currently available skin substitutes, their sources,
and (dis)advantages [154,171,172]. Some have suggested that the ideal skin substitute
or replacement should be durable, autologous, vascularized, and consist of all skin
adnexa and stem cells. Such a skin substitute does not yet exist [173], but recent
advances in regulation and genetically modification of skin (stem) cells could bring
us a step closer to developing fully functional skin regeneration templates [174].
As described by Nicholas et al. five major criteria are thought to be important for a






Barrier function Following skin injury the barrier function of epidermal layer is
destroyed allowing pathogens to freely enter the body. A well-designed scaffold
should block or decrease the influx of pathogens. This can be achieved by creating
a favorable bed for early application of an autologous epidermal layer (skin graft)
onto the substitute. Success depends on early vascularization of the scaffold which
in turn depends on, among other things, a pore size suitable for fibroblast and endothe-
lial cell infiltration.
Another approach includes a synthetic layer on top of the scaffold that mimics the
properties of the epidermis as seen in commercially available substitutes (Integra
[176], Renoskin, Hyalomatrix and Pelnac [146,177e179]).
Meanwhile, hydrogel scaffolds should maintain a moist wound environment to
encourage healing [180,181] while preventing extensive fluid loss as seen in burn pa-
tients. However, very wet wounds can stimulate bacterial growth which can reduce
healing as well.
Cell compatibility The currently available noncellular polymer scaffolds do not aim
to fully replace the host tissue but have a more supporting function. These scaffolds
can stimulate cell influx by their material design; important features are thickness,
pore size, and (surface) morphology.
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Fibroblasts and keratinocytes are the most common cell types to be incorporated in
polymer-based scaffolds designed to replace or regenerate skin [154]. However, in or-
der to fully restore all skin structures also other cell types have been under the attention
of researchers. For example, melanocytes [182], adipose cells[183], amniotic fluide
derived cells (AFS) [156], and mesenchymal stem cells [184] have been incorporated
in polymer scaffolds [185]. Preliminary in vitro and animal studies [156,183] are
promising, but still far from translation to human.
Epidermal cells are anchor-dependent cells that will need to attach and spread out
over a substrate in order to proliferate and differentiate. Material pretreated with- or
consistent of extracellular matrix constituents like collagen and fibronectin are more
likely to bind cells as cell adhesion is mediated by specific cell surface receptors for
molecules in the extracellular matrix. Epithelial cells, like keratinocytes, also require
cell to cell adhesion in order to proliferate [186]. Proliferation and/or differentiation
prior to transplantation are not always desired. When designing a scaffold, this
should be taken into account so that cells are entrapped within an optimal environ-
ment before transplantation to the skin. Cells should remain viable in the scaffold
prior to transplantation, integrate homogenously, and their proliferation and/or
differentiation capacity after transplantation to the wound bed should not be compro-
mised [173].
Biocompatibility (non-toxic, non-immunogenic, and non-inflammatory)
Failure of a scaffold to integrate into the body is often caused by rejection due to
a foreign body response. This basically means that the body recognizes the new
tissue as foreign and initiates the immune reaction, resulting in excess inflammation
and rapid degradation of the scaffold structure together with the transplanted
cells. Besides losing the cellular matrix, this intense inflammatory response triggers
the release of more proinflammatory cytokines that increase fibrosis and ultimately
scarring. In wound care treatment of burns the traditional autologous skin grafts
have a very high take rate without rejection, but they can fail due to infection or
an unfavorable wound bed preparation. When allogenic or xenogenic skin grafts
are used, rejection is a common result. Therefore, when designing scaffolds, the
focus must lie on modifying the scaffold so that the host tissue recognizes it as
its own.
Natural polymers are known for their low toxicity [14]. They usually undergo
degradation by cleavage of enzymes present in the human body or through hydrolytic
degradation resulting in body friendly degradation products. Biodegradable materials
are attractive for implantation in the body, but rapid degradation can also be undesir-
able. Polymers can be modified to reduce this degradation process, but care must be
taken to avoid production of toxic byproducts or induce toxic effects of the modified
material. An example is chitosan, a polymer with overall low toxicity, but when the
charge density is modified into a higher charge molecule, this is related to increased
toxicity [45].
Blending of polymers can optimize scaffold biocompatibility as seen in blends of
fibrin and hyaluronic acid [124]. Another example is the use of fibrin to coat a
collagen-chitosan scaffold to improve cell adherence [125].
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Several approaches to optimize biocompatibility can be considered:
• To include natural components that can easily be recognized by the body
• Use natural polymers that are known for their low toxicity
• Use mild processing conditions to minimize toxic byproducts
Biodegradable, long-lasting, flexible Polymer scaffolds functioning as regenera-
tive templates should be firm enough to resist tear during surgical application and
have some resistance against shearing of applied dressings and movement of patient.
However, the ability to stretch over joint regions is desired.
Early vascularization is key to ensure successful engraftment. Some scaffolds are
expected to initially support the transplantation of cells and promote healing but even-
tually degrade and are replaced by autologous tissue. Duration of degradation time
should be adapted by speed of vascularization, as the supporting skeleton should
last until the graft is sufficiently integrated. Up to 3 weeks is usually described for scaf-
fold vascularization in vivo but this duration has been shortened to about 1 week in a
noncross-linked bovine collagen scaffold coated with elastin hydrolysate (Matriderm)
[187]. The collagen scaffold with skin graft on top was compared to conventional skin
graft in a full thickness pig wound model. More endothelial cells were detected with a
positive Von Willebrand factor stain in the scaffold group after 1 week of treatment
indicating neovascularization compared to less positively stained cells in the control
arm. Lamme et al. postulate that the collagen matrix acts as an ECM facilitating cell
attachment and deposition of fibronectin along the collagen fibers, which might attract
endothelial cells resulting in faster vascularization [187]. Also, the presence of elastin
hydroxylate might speed up vascularization as elastin-derived peptides are known to
promote endothelial cell migration and angiogenesis [188]. Interestingly, when the
skin substitute with elastin hydrolysate incorporated was compared to Integra in a
rat study, both substitutes performed well in terms of take rate, vascularization, and
inflammatory response. As shown in Fig. 6.4 the key differences were that the
collagen-elastin skin substitute, Matriderm, formed a thinner neodermis, but had
been populated with more cells compared to single-layer Integra [190]. Matriderm
is a noncross-linked collagen-based matrix, which might have encouraged faster
degradation in comparison to Integra single-layer, which is a cross-linked bovine
tendon collagen matrix. This reflects the importance of critical scaffold design to
meet clinical needs.
Cost-effective In order to translate promising scaffolds to clinical practice and be
adopted for widespread use, low-cost designs are preferred. When designing a scaf-
fold, attempts to reduce final costs can be sought in reducing labor intensity, use of
low-cost materials, short manufacture time with minimal use of specialized equipment,
and an efficient sterilization process.
In 1998 the FDA approved the first bioengineered skin scaffold for use in clinical
practice, Apligraf (Organogenesis), which is a collagen-based bilayered product incor-
porated with human fibroblasts in the lower layer and human keratinocytes in the upper
layer. The development of many other cellularized scaffolds followed, but only a few
have been commercialized and fully approved by the FDA [191]. A commonly
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(a)
(d) (e) (f)
(b) (c) (g) (h)
(j)(i)
(k) (l)
Figure 6.4 Comparison of Matriderm and Integra acellular scaffolds. HE stain 14 days after single stage application of Matriderm (1 mm thickness)
(a), Integra single-layer (1.3 mm) (b) and control (c) to full thickness skin defects in rats. Successful formation of epidermis (between markers) and
populated neodermis (arrows) in all transplants, with highest cell density seen in Matriderm neodermis. Both substitutes formed a thicker neodermis
than the control; however, Integra formed a thicker neodermis than Matriderm. Scale bars 100 mm. CD31 stain (red) to visualize endothelial cells and
Hoechst (blue) for cell nuclei and autofluorescent collagen (green) in Integra 14 days after single stage application of Matriderm (1 mm thickness) (d),
Integra single-layer (1.3 mm) (e) and control (f) to full thickness skin defects in rats. All transplants show comparable development of a capillary
network in the superficial neodermis. Scale bars 50 mm. HE stain of Matriderm (g) and Integra (h) shows a more dense network of collagen fibers
formed in Matriderm compared to Integra. Clinical application of Matriderm (i) and Integra at day 7 after injury (j) with results of treatment after 11
and 55 days of application for Matridem (k) and Integra (l), respectively.
Permission to publish adapted figures obtained from©Springer-Verlag 2011 (aef), Elsevier (g,h) V.C. van der Veen, M.B.A. van der Wal, M.C.E. van
Leeuwen, M.M.W. Ulrich, E. Middelkoop, Biological background of dermal substitutes, Burns. 36 (2010) 305e321. doi:10.1016/j.burns.2009.07.012,
(i,k) M. Madaghiele, C. Demitri, A. Sannino, L. Ambrosio, Polymeric hydrogels for burn wound care: advanced skin wound dressings and regenerative
templates, Burn Trauma 2 (2015) 153e161. doi:10.4103/2321-3868.143616 and (j,l) A. Danin, G. Georgesco, A. Le Touze, A. Penaud, R. Quignon,













mentioned limitation is the high costs of these scaffolds, which can vary widely per
product [192]. The cost-effectiveness of advanced cellular and acellular scaffolds in
venous ulcers [193] was not proven, but lack of comparable studies makes it difficult
to draw valid conclusions. However, Bradfords et al. suggest that in diabetic foot ul-
cers the use of cellular scaffold may lower overall costs by reducing clinic visits burden
on healthcare systems [194].
It is important to realize that most regenerative templates available in clinical
care have not been investigated thoroughly in randomized controlled trials. Snyder
et al. noted that in only 7 out of 57 skin substitutes, investigated for the use in
chronic wounds, this was the case [145]. Furthermore, most studies selected pa-
tients that are more likely to heal and exclude those with poor healing conditions.
Care must be taken when interpreting outcomes of these studies and extrapolating
findings as the effect in a general population in a representable setting is yet to be
examined [195].
Permanent acellular scaffolds
Permanent engraftment of scaffolds for wound regeneration requires more complicated
material features. Currently available acellular scaffolds aim to create a stable dermal
layer by stimulating neovascularization and reformation of the basement membrane to
secure the transplanted material to underlying tissue. The formation of an adequate
basement membrane is a challenge in acellular scaffolds [150]. Boyce et al. addressed
the issue by surfacing their porous collagen-GAG dermal substitute with a flat layer of
nonporous collagen-GAG to facilitate keratinocyte adherence and spreading [196].
Also, Lamme et al. [187] have shown that their collagen-elastin scaffold had positive
chondroitin sulfate and laminin labeling 6 weeks after application in a pig model, indi-
cating formation of the basement membrane. Some substitutes provide a (temporary)
epidermal layer as well, but once the dermal templates are engrafted they usually
require autologous epidermal (split-skin) grafts for definite coverage [174]. Further-
more, these materials can promote cellular ingrowth and may model scar development
[73,74]. Commonly used permanent scaffolds are Integra, Matriderm, Pelnac, and
Alloderm.
An overview of acellular applications based on natural polymers for healing of su-
perficial to partial thickness wounds is shown in Table 6.5 and full thickness wounds in
Table 6.6.
Permanent cellular scaffolds
Although the ingrowth of fibrovascular tissue might be promoted by acellular
scaffolds, cellular scaffolds aim to provide a more rapid and complete regenera-
tion of the skin by incorporating skin cells such as fibroblasts and keratinocytes to
the matrix. However, regeneration of many other skin components that contribute
to the full function of the skin is still lacking. Deficiencies such as hypopigmen-
tation, absence of adnexa, and nerve innervation reduce the quality of the recon-
structed skin. An overview of available cellular scaffolds to date is given in
Table 6.6.
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Table 6.5 Acellular natural polymerebased scaffolds for regeneration of deep dermal to full thickness wounds.
Deep dermal to full thickness wounds - dermal substitutes





















30e120 mm Yes [176,197,198]






















3 mm 70e110 mm Yes [146]
Hyalomatrix (anika
Therapeutics, bedford, MA,
US former fidia Advanced
Biopolymers, padua, Italy)
Derivative of hyaluronic






































































0.4 or 1.5 mm n.a. Yes [206]






0.2e0.6 mm n.a. No [207]
Renoskin (groupe perouse,
bornel, France)


















1, 1.4, or 2 mm n.a. No [208e210]









Table 6.6 Cellular natural polymerebased scaffolds for wound healing and regeneration of deep dermal to full thickness wounds.
Deep dermal to full thickness woundsdcellular scaffolds
Name

























































































































































n.a., not applicable; n.k. ¼ not known.










Natural polymers have been exploited widely for repair and reconstruction of the skin
and have transitioned to a number of successful commercial products. Despite this suc-
cess, there still remain some very significant challenges to overcome. None of the
existing materials allow for full regeneration of the skin adnexa, meaning that func-
tional and esthetic outcome is often poor. Furthermore, although materials exist that
integrate well into the host tissue without causing rejection, none of the skin scaffolds
to date fully support or degrade following the natural regeneration process. Future
challenges exist to redesign natural polymeric materials so that they facilitate the
bodies’ own regenerative processes and degrade at a consistent and appropriate rate.
Ultimately, such scaffolds should support regeneration of all functions of the skin
while allowing a scarfree wound closure.
List of abbreviations
ECM extracellular matrix
CD44 cluster of differentiation 44
IPN interpenetrating polymeric network
Semi-IPN semi-interpenetrating polymeric network
TGF-b1 transforming growth factor beta one
SJS StevenseJohnson syndrome
TEN toxic epidermal necrolysis
FDA food and drug administration
RGD arginyl-glycyl-aspartic acid
HA hyaluronic acid
LMW low molecular weight
HMW high molecular weight
kDa kilodaltons
RHAMM receptor for hyaluronic acid mediated motility
VEGF vascular endothelial growth factor.
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